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Abstract.
Transdermal drug delivery is the delivery of drugs across the skin without using needles. Since most
drugs diffuse slowly across unperturbed skin, many techniques have been investigated to increase
molecular transport. One technique is skin electroporation, where short (-1 ms), high-voltage pulses
(~100 Vskin) are applied to the skin. Previous studies have shown dramatic increases in transport.
However, an understanding of how transport occurs was needed, which was the goal of this thesis.
Human cadaver skin and snake skin were used to determine transport pathways across the skin.
Snake skin was used as a model of human skin that lacked hair follicles or sweat ducts. By applying
high-voltage pulsing to human and snake skin, it was shown that transport occurs through "localized
transport regions" (LTRs), which were small, randomly distributed regions forming away from hair
follicles and sweat glands. The LTRs appeared in both human and snake skin, along with comparable
molecular transport, indicating the importance of these regions during transport.
Molecular transport during skin electroporation occurs very rapidly, usually within the first few pulses
(s to min). The voltage that forms across the skin cannot be predicted from the applied voltage alone,
and changes with repeated pulsing. A flow-through system was constructed that allowed the simul-
taneous real-time measurement of the transdermal voltage, the molecular flux, and the inter-pulse
impedance.
The transdermal voltage was found to initially decrease rapidly during pulsing, then continue
decreasing more slowly with additional pulsing. The impedance at 100 Hz decreased with repeated
pulsing, but increased somewhat between pulses, indicating recovery of the skin. The molecular fluxes
of four charged fluorescent molecules (sulforhodamine, lucifer yellow, cascade blue, and calcein) were
also studied. These molecules were chosen since they had similar molecular weights, hydrophilicities,
and electronic charges. However, with repeated pulsing, the flux of sulforhodamine increased steadily,
lucifer yellow and cascade blue achieved steady state, and calcein initially increased rapidly, then later
decreased.
Skin electroporation is a dynamic process, where the transdermal voltage and molecular flux vary
rapidly with repeated pulsing. To achieve control of skin electroporation, these parameters should be
carefully monitored in real time.
Thesis Supervisor: Robert Langer
Title: Germeshausen Professor of Chemical and Biomedical Engineering
Thesis Supervisor: James C. Weaver
Title: Senior Research Scientist, Harvard-MIT Division of Health Sciences and Technology
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Mom and Dad
- and -
To
Hongming
-3-
The investigator should have a robust faith - and
yet not believe.
- Claude Bernard
French Physiologist
(1813-1878)
When we try to pick out anything by itself, we find
it hitched to everything else in the universe.
- John Muir
American Naturalist
(1838-1914)
If we knew what it was we were doing, it would not
be called research, would it?
- Albert Einstein
Swiss-American Physicist
(1879-1955)
Sometimes a scream is better than a thesis.
- Ralph Waldo Emerson
American Essayist
(1803-1882)
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1. Introduction to Skin Electroporation.
Transdermal drug delivery offers many advantages compared to other methods of drug delivery.
Transdermal drug delivery can be defined as the transport of drugs across the skin without the use of
needles (direct injection). One obvious advantage is that needles and the associated pain are avoided.
This is especially important for drugs that have to be repeatedly administered. Avoiding the
unpleasantness of needles would lead to improved patient compliance of drug regiments.
Another advantage of transdermal drug delivery is its ability to offer prolonged or sustained
delivery, potentially over several days to weeks. Some methods, such as oral or pulmonary delivery
techniques, require that the drug be given repeatedly (maintenance dosing) to sustain the proper
concentration of drug within the body. With sustained delivery, maintenance dosing could be
performed automatically, over a long period of time. Drugs with short half-lives in the body, such as
peptides or proteins, could also be delivered over long times.
A final advantage is that molecules only have to cross the skin to reach the bloodstream for
systemic circulation. Many molecules taken orally are quickly degraded by the low pH's and enzymes
found in the gastrointestinal tract. Especially vulnerable are protein or peptide drugs. Molecules
transported across the skin would experience much less harsh conditions than those delivered orally.
The most common form of transdermal drug delivery is the drug "patch," where the drug is
contained within a reservoir placed next to the skin (typically resembling a "sticker") (Schaefer and
Redelmeier, 1996). The drug molecules cross the skin by simple diffusion ("passive delivery").
Generally speaking, passive transdermal drug delivery is limited to small, lipophilic molecules such as
scopolamine, nitroglycerine, and nicotine, which readily permeate the skin. The delivery kinetics are
slow, typically taking hours to cross the skin.
Since passive delivery can be slow, many techniques have been developed to enhance molecular
transport rates. These techniques include chemical enhancers to enhance transport kinetics; ultra-
sound, which induces cavitation within the skin to decrease its barrier properties; and iontophoresis,
which is the application of a small, constant current that causes molecular transport through the hair
follicles and sweat ducts.
One other technique that has recently shown promise is the application of a series of very short
(typically -1 ms, although longer pulses have also been tried), high-voltage pulses (~100 Vskinf) to the
skin, which causes the lipids within the stratum corneum to rearrange, in a phenomenon related to
electroporation; hence the term, "skin electroporation." Rearrangement of these lipids allows molecular
transport across the skin to take place. Strictly speaking, the high-voltage pulses are applied to the
skin, which then causes the phenomenon called "skin electroporation" to occur within the lipids of the
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stratum corneum. However, in common speech, many people refer to the entire process more simply as
"skin electroporation."
In the 1970's, it was found that the application of a series of short, high-voltage electrical pulses to
cells or lipid membranes caused "pores" to form within the lipid membranes, through which ions and
molecules could be transported through (Chang, et at, 1992; Weaver and Chizmadzhev, 1996 [a]).
After pulsing, these pores would spontaneously reseal; thus, the cells or lipid membranes were not
permanently damaged. This process was called "electroporation." Many drugs and even DNA were
efficiently delivered into cells by this technique.
By the 1980's, workers had begun applying high-voltage pulsing to sheets of tissues, such as frog
skin (Powell, et at, 1989). This led to the idea of applying high-voltage pulsing directly to human
skin, to enhance transdermal drug delivery. Early experiments in the lab were highly successful,
showing significant enhancements in the transport of several model compounds (Prausnitz, et at., 1993
[a]).
Since then, many compounds have been successfully transported across the skin by skin electro-
poration techniques. However, the mechanism behind this transport was not well understood. To
optimize the applied electrical conditions in skin electroporation to maximize drug transport, a better
understanding of how and where molecules cross the skin was needed. This was the goal of this
research.
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2. Background of the Research.*
The goal of transdermal drug delivery is to find a safe, controllable way to deliver large amounts of
drug from the outside of the body, to the blood vessels within the skin, without the use of needles or
direct mechanical penetration of the skin. Drug reaching the blood vessels can then be delivered
systematically. Important issues in transdermal drug delivery research include increasing delivery
rates, controlling drug delivery (the ability to start and stop transport), and ensuring patient safety.
2.1. Structure of the Skin.
The skin is the largest organ of the body. It is highly impermeable to prevent loss of water and
electrolytes, dry to prevent microorganism growth, and physically tough to protect the underlying
tissues (Ackerman, 1978). The skin is negatively charged (Kasting and Bowman, 1990), and has an
electrical resistivity of -100 kQ cm (Bose, 1994). The skin is subdivided into two main layers: the
outer epidermis and the inner dermis (Figure 2.1).
Stratum corneum (~15 p)
Epidermis (~100 m)
Dermis (~2 mm)
Sweat gland Blood vessels
Nerve ending Hair follicle
FIgure 2.1. Diagram of human skin. The skin is divided into three layers: the stratum corneum, the epidermis, and
the dermis. The stratum corneum is the outermost layer of the skin, and the rate-limiting barrier to the entry of
molecules into the body. In the dermis are located sweat ducts and hair follicles which extend outward to the surface
of the skin, nerve endings, and blood vessels. The drug has to reach the blood vessels in the dermis for systemic circu-
lation of the drug to occur. Figure from Montagna, et al. (1992).
*Some of the introductory material in this chapter has also been published in Chen (1998 [a]) and Chen, et al.
(submitted) [b].
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2.1.1. The Epidermis.
The epidermis is the outer layer of the skin, 50 to cornified cell
100 g thick (Monteiro-Riviere, 1991; Champion, et al.,
1992). The epidermis does not contain nerve endings or granular cell
blood vessels. The main purpose of the epidermis is to
generate a tough layer of dead cells on the surface of the - u cell
skin, to separate the body from the environment. This top
layer is called the stratum corneum, and the dead cells
that comprise it are called corneocytes or keratinocytes.
The rest of the epidermis is divided into three additional
layers: the stratum granulosum, the stratum spinosum,
and the stratum basale (at the bottom). These three layers
are collectively called the viable epidermis, since the cells basal cell
in these layers are still alive (Ackerman, 1978).
As the cells of the stratum basale mature into dead
corneocytes, they are continuously pushed outward
towards the surface of the skin (Figure 2.2), a process
Figure 2.2. Differentiation of epidermal cells to
that takes -28 d. Each stage of differentiation is charac- form the stratum corneum. This figure shows
representative epidermal cells in the process of
terized by a layer of the epidermis. forming stratum corneum (cornified cell or corneo-
cyte), the uppermost layer of the skin. The
The stratum basale consists of stacked columns of remaining cells are found in various layers of the
epidermis: the stratum granulosum (granular
cell), the stratum spinosum (spinuous cells), and
corneocytes. As these cells divide, they are pushed the stratum basale (basal cell). Figure taken from
Ackerman (1978).
upward towards the stratum spinosum, where the cells
form interconnecting desmosome junctions and flatten out. At this level, the cells also produce keratin
and keratohyalin proteins, giving the cells increased mechanical strength. The cells are then further
pushed outwards to the stratum granulosum, where they form course lamellar granules, which are
secreted extracellularly to produce intercellular lipids. Most of the organelles, including the nucleus,
disappear here (Ackerman, 1978).
Once the corneocytes are fully matured, they die to form the stratum corneum. At this point, the
corneocytes are almost completely full of keratin, surrounded by sheets of lipid bilayer membranes.
The corneocytes in the stratum corneum are continually sloughed off into the environment and are
replaced by the underlying cells (Ackerman, 1978; Wertz and Downing, 1989).
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2.1.2. The Stratum Corneum.
The stratum corneum remains fairly
constant in thickness around the body,
around 10 to 20 p thick, with the ex-
ception of the hands and feet, where it
is much thicker. It is commonly model-
ed as a brick wall (Figure 2.3) (Elias,
1983; Elias, 1988). The "bricks" are
the flattened, dead corneocytes. The
corneocytes are shaped as flattened
hexagons, roughly 30 p in diameter by
0.5 to 0.8 s thick, and are composed Figure 2.3. Photomicrograph of the stratum corneum. The bricks-
and-mortar structure (corneocytes and intercellular lipids, respectively)
primarily of keratin and keratohyalin can clearly be seen here in the uppermost layer of the skin. Photo-
micrograph from Wertz and Downing (1989).
proteins (Wertz and Downing, 1989).
Typically, there are about 10 to 15 corneocytes stacked vertically across the stratum corneum
(Monteiro-Riviere, 1991; Champion, et al., 1992).
The corneocytes are encased in sheets of lipid bilayers (the "mortar"). The lipid bilayer sheets are
separated by -50 nm. Typically, there are about 4 to 8 lipid bilayers between each pair of corneocytes.
The lipid matrix is primarily composed of ceramides, sphingolipids, cholesterol, fatty acids, and
sterols, with very little water present (Lampe, et al., 1983 [a]; Lampe, et al., 1983 [b]; Elias, 1988).
Although it is the thinnest layer of the skin, the stratum corneum is the primary barrier to the entry
of molecules or microorganisms across the skin, due to its construction and composition. Most
molecules pass through the stratum corneum only with great difficulty, which is why the transdermal
drug delivery route has not been more widely used traditionally. Once the molecules have crossed the
stratum corneum, diffusion across the epidermis and dermis to the blood vessels occurs rapidly. Thus,
most of the attention in transdermal drug delivery research has been focused on transporting molecules
and drugs across the stratum corneum.
2.1.3. The Dermis.
The dermis is the inner layer of the skin and varies from 1 to 3 mm in thickness. The dermis forms
a tough, flexible, elastic covering of the body (Gray and Clemente, 1985), and supplies the epidermis
with nutrients, which are transported throughout the epidermis by diffusion. The dermis is composed
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-~, .mainly of connective tissues and is about 60
e to 70% water (Monteiro-Riviere, 1991;
Stratt Champion, et al., 1992).
Cornu -- --
- piderm The dermis can be subdivided into the
External roo'. 7 Oe J, papillary dermis and the reticular dermis.
sheath Sebaceous
... .- gland The papillary dermis is the outer layer of the
Heir cutic eha r
dermis and contains an extensive network of
Medul WMed . capillaries for heat regulation and nourish-
Connective ment of the epidermis, which lacks capil-
tinuo V1 .,, " r muscle
sheat - laries (Ackerman, 1978). The reticular der-
mis is the innermost layer and is composed
mainly of connective collagen fibers. The
nternal root sheath goal of transdermal drug delivery is to get
the drug to this layer of the skin, where the
Soft blood capillaries are located, to allow the
Hard drug to be systematically delivered.
keratin Nerve endings are located in the dermis,
Keratogenous f including thermoreceptors (for detecting
zone
heat and cold), mechanoreceptors (touch
it ~and pressure), and noiceptors (itch and
Connective tissue
-papila pain). They are usually found near the
Figure 2.4. Schematic diagram a hair follicle. Note that the hair junction between the dermis and the epi-
follicle starts in the dermis and penetrates the epidermis and the
stratum corneum to reach the surface of the skin. Based on a dermis (Champion, et al, 1992),
figure from Leblond (1951).
Hair follicles start from the dermis and
extend outwards to the surface of the skin. Besides the hair bulb, hair shaft, inner root sheath, and
outer root sheath, other major components within the dermis are the apocrine sweat gland and the
arrector pili muscle (Figure 2.4) (Ackerman, 1978; Champion, et al., 1992).
Sweat glands are located in the dermis and extend outwards to the surface of the skin, completely
penetrating the epidermis (Figure 2.5). There are two types of sweat glands: apocrine and eccrine
sweat glands. Apocrine sweat glands empty into hair follicles and produce sebaceous fluids continu-
ously at slow rates. Eccrine sweat glands produce sweat to control body temperature. Humans have a
much higher density of eccrine sweat ducts than other animals; thus, choosing an animal model can be
difficult (see Section 7.1) (Ackerman, 1978; Champion, et al, 1992).
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2.2. Transdermal Drug Delivery.
The delivery of drugs or other molecules across the skin offers
many advantages over other drug delivery techniques, including the
following: (1) no degradation of the drug (especially peptide and
protein drugs) by the gastrointestinal tract, especially in the liver;
(2) no variation in drug absorption rates due to daily variations in
the state of the gastrointestinal system; (3) increased control in the
administered dosage, reducing the chances for overdoses, under-
doses, or missed doses, and allowing for rapid termination of drug
delivery; (4) steady, periodic, long-term, or rate-controlled drug
delivery; and (5) increased patient compliance (Bronaugh and
Maibach, 1989; Chien, et al., 1989; Hadgraft and Guy, 1989;
Champion, et al., 1992; Cullander, 1992; Schaefer and Redel-
meler, 1996). Rate-controlled drug delivery is especially important
for drugs that are most effective when delivered monthly (estradiol)
or daily (insulin) instead of continuously (Hrushesky, 1991).
The most common method of drug delivery is passive diffusion,
where the drug is placed next to the skin in a "patch," and allowed
to diffuse across. However, this is a very slow technique. The drug
can often take hours to cross the skin, and so other techniques
have been developed to enhance drug delivery rates. Besides skin
electroporation, there include chemical enhancers, ultrasound, or
iontophoresis.
Chemical enhancers enhance the diffusion characteristics of
the drug across the skin, although the main driving force is still
passive diffusion. Ultrasound induces cavitation within the lipids
of the stratum comeum, also enhancing diffusion kinetics. Ionto-
phoresis is the application of a small, DC electrical current to the
skin, providing an additional driving force for transport.
Sweat gland
E.. "pidermis
Epithelium
Sudoriferous
subcutanea
Secreting tubule of
sudoriferous gland
Figure 2.5. Structure of a sweat
gland. The sweat gland starts from
the dermis and extends to the surface
of the skin. From Gray and Clemente
(1985).
2.2.1. Passive Delivery.
The most commonly used devices for transdermal drug delivery are passive delivery patches (Guy
and Hadgraft, 1989; Hadgraft and Guy, 1989; Langer, 1990; Santus and Baker, 1993). Transport is
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governed by the rate of molecular diffusion into and out of the skin, and partitioning of the drug into the
skin. Very hydrophilic drugs partition poorly into the skin, due to the lipid bilayers of the stratum
corneum; yet very lipophilic drugs which partition easily into the stratum corneum will not partition out
again into the bloodstream. The delivery kinetics for passive delivery are usually very slow, typically
requiring hours to days for molecular transport across the skin.
Only small, uncharged drugs (typically <400 Da) can be delivered passively, and treatment is only
effective when a very small amount of drug is required to have a biological effect (Guy and Hadgraft,
1989). Commercially available drugs delivered passively include clonidine, estradiol, isosorbide
dinitrate, nicotine, nitroglycerin, norethisterone, salicylate, scopolamine, and testosterone (Santus and
Baker, 1993).
2.2.2. Penetration Enhancers.
Chemical enhancers (or penetration enhancers) are used to decrease the barrier properties of the
stratum corneum. Many different classes of enhancers have been identified, including cationic,
anionic, and nonionic surfactants (sodium dodecyl sulfate, polyoxamers); fatty acids and alcohols
(ethanol, oleic acid, lauric acid, liposomes); anticholinergic agents (benzilonium bromide, oxy-
phenonium bromide); alkanones (n-heptane); amides (urea, N,N-diethyl-m-toluamide); fatty acid
esters (n-butyrate); organic acids (citric acid); polyols (ethylene glycol, glycerol); sulfoxides (dimethyl-
sulfoxide); and terpenes (cyclohexene) (Hadgraft and Guy, 1989; Walters, 1989; Williams and Barry,
1992; Chattaraj and Walker, 1995).
Most of these enhancers interact either with the skin, or with the drug. Interactions with the skin
include enhancer partitioning into the stratum corneum, causing disruption of the lipid bilayers (azone,
ethanol, lauric acid), binding and disruption of the proteins within the stratum corneum (sodium
dodecyl sulfate, dimethyl sulfoxide), or hydration of the lipid bilayers (urea, benzilonium bromide).
Drug interactions include modifying the drug into a more permeable state (a prodrug), which would
then be metabolized inside the body back to its original form (6-fluorouracil, hydrocortisone) (Hadgraft,
1985); or increasing drug solubilities (ethanol, propylene glycol). In addition, many enhancers may
include several mechanisms in their effects. For example, ethanol can simultaneously increase the
drug solubility within the donor solution, as well as increasing drug partitioning into the stratum
corneum. Thus, it has the paradoxical effect of decreasing the diffusion of certain compounds, such as
steroids, across the skin (Johnson, 1996).
Despite a great deal of research (well over 200 compounds have been studied) (Chattaraj and
Walker, 1995), there are still no universally applicable mechanistic theories for the chemical enhance-
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ment of molecular transport. Most of the work in chemical enhancers has been done largely on a trial-
and-error basis (Johnson, 1996).
2.2.3. Sonophoresis (Ultrasound, Phonophoresis).
Sonophoresis (also called ultrasound or phonophoresis) is the application of high-frequency
(>20 kHz), low intensity (<1 W / cm 2 ) sound waves to the skin. Most commonly used are "therapeutic"
ultrasound ranges (1 to 3 MHz), which have already been established to be safe when applied to
humans (Williams, 1983). Enhanced transport occurs primarily due to heating of the skin (Kost, et al.,
1989).
However, at "low frequency ultrasound" ranges (20 kHz to 1 MHz), ultrasound is believed to induce
cavitation (the formation of gas bubbles) within the lipid bilayers of the stratum corneum. Both stable
cavitation (gas bubbles that oscillate at the applied sound frequency) and transient cavitation (bubbles
that form and spontaneously implode) occur within the lipid bilayers, causing disruption of the bilayers
and allowing molecular transport to take place (Bommannan, et al., 1992 [a]; Bommannan, et al., 1992
[b]; Hsieh, 1994; Mitragotri, et al., 1995 [b]). Several large compounds (insulin, erythropoeitin) have
been transported by sonophoresis across the skin at therapeutically useful levels (Mitragotri, et al.,
1995 [a]).
2.2.4. Iontophoresis.
Iontophoresis can be used to transport drugs or other molecules across the skin. This low-voltage
method involves the application of a small, usually constant current to the skin (typically <0.1 to
0.5 mA / cm2) (Tyle, 1986; Banga and Chien, 1988; Bumette, 1989; Chien and Banga, 1989; Singh
and Roberts, 1989; Cullander and Guy, 1992; Amsden and Goosen, 1995; Guy, 1996) to cause
molecular transport to occur. lontophoretic transport occurs primarily through the hair follicles and
sweat ducts in the skin (Abramson and Gorin, 1940; Abramson and Engel, 1942; Grimnes, 1984;
Bumette and Marrero, 1986; Burnette and Ongpipattanakul, 1988; Cullander and Guy, 1991; Scott,
et al., 1993; Chen, et al., 1998 [b]; Chen, et al., in press [b]), although some transport may also be
occurring through the corneocytes as well (Potts, et al., 1992; Monteiro-Riviere, et al., 1994).
Iontophoresis has been used successfully in many clinical settings (Abramson, 1941; Schwarz, et
al., 1968; Arvidsson, et al., 1984; Sloan and Soltani, 1986; Banga and Chien, 1988; Duvanel, et al.,
1988; Chien, et al., 1989; Singh and Roberts, 1989; Meyer, et al., 1990; Ledger, 1992); however,
electrical currents greater than 0.5 mA / cm2 can stimulate nerves within the skin, causing pain or
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irritation, and generally limiting its use (Zlotgorski, 1987; Banga and Chien, 1988; Burnette and Ong-
pipattanakul, 1988; Ledger, 1992). Molecular transport occurs on a scale of a few minutes. Transport
occurs primarily by electrical drift, although some transport also occurs by electroosmosis. This
phenomenon has been used advantageously in the extraction of glucose (Burnette, 1989).
2.3. High-Voltage Pulsing Causes Electroporation.
Electroporation is believed to be the creation of transient, nanometer-sized pores in lipid bilayer
membranes by the application of short, high-voltage pulsing (Neumann, et at., 1989; Chang, et al.,
1992). During electroporation, large increases in molecular flux and ion transport occur across the
membrane, and changes in membrane structure are thus inferred. Electroporation is a phenomenon
found in all lipid bilayer membrane systems (planar lipid bilayer membranes, plasma membranes in
cells, and the skin), and is reversible under certain conditions (Weaver, 1993 [b]).
The mechanism for electroporation is not fully understood. The "pore" in electroporation is defined
to be some type of aqueous pathway created during the high-voltage pulse. Inferential evidence sup-
ports an opening appearing in the lipid membrane during the pulse (Neumann, et al., 1989; Chang
and Reese, 1990; Chang, et al., 1992; Orlowski and Mir, 1993; Weaver, 1993 [a]).
2.3.1. Electroporation of Cells and Planar Membranes.
Although electroporation has commonly been used to introduce DNA, RNA, or proteins into cells
(Neumann, et al., 1982; Potter, 1988), the mechanism is not fully understood. Typical electroporation
waveforms for cells or lipid bilayer membranes may be square or exponentially-decaying, with a trans-
membrane voltage of ~1 V and a pulse duration of 10 ps to 10 ms (Neumann, et at., 1989; Chang and
Reese, 1990; Chang, et al., 1992; Orlowski and Mir, 1993; Weaver, 1993 [b]). During short pulses
(0.1 to 10 gs) of less than I V, medium pulses (10 to 100 gs) of 0.5 to 1 V, and long pulses ( 1 ms) of
0.2 to 0.5 V, electroporation of cells and membranes is generally reversible (Benz and Zimmermann,
1980; Neumann, et al., 1989).
The mechanism for pore formation in cells or lipid membranes is believed to be as follows. During
the high-voltage pulse, hydrophobic or "primary" pores are created in the lipid membrane (Figure 2.6a)
and can increase in size up to -10 nm in diameter (Barnett and Weaver, 1991; Freeman, et al., 1994).
After the pulse, the lipid molecules composing the pore rearrange to form hydrophilic or "secondary"
pores in -10 ms, that are ~1 nm in diameter (see Figure 2.6b) (Abidor, et al., 1979; Glaser, et al.,
1988). These secondary pores later disappear in >10 s (Glaser, et al., 1988).
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2.3.2. Electroporation of Human Skin.
Recently, high-voltage pulsing has been applied
to biological tissues (Grasso, et al., 1989; Powell, et
al., 1989; Okino, et al., 1992; Salford, et al.,
1993; Sukharev, et al., 1994), including human
skin (Prausnitz, et al., 1993 [a]), to increase the rate
of molecular transport for drug delivery applications.
Molecules that have been successfully
transported across the skin include charged,
fluorescent molecules such as calcein (Prausnitz, et
al., 1993 [a]; Prausnitz, et al., 1993 [c]; Prausnitz,
et al., 1994; Pliquett, et al., 1995 [b]; Kost, et at.,
1996; Pliquett and Weaver, 1996 [a]; Pliquett and
Weaver, 1996 [b]; Pliquett, et al., 1996 [b];
Prausnitz, et al., 1996 [b]; Chen, et al., 1998 [b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted),
sulforhodamine (Kost, et al., 1996; Pliquett and Weaver, 1996 [a]; Pliquett, et al., 1996 [b]; Chen, et
al., 1998 [b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted), lucifer yellow (Prausnitz, et al.,
1993 [a]; Chen, et al., 1998 [c]), and cascade blue (Chen, et al., 1998 [c]). Several drugs have also
been transported across the skin during high-voltage pulsing, including luteinizing hormone releasing
hormone (LHRH) (Bommannan, et al., 1994; Riviere, et al., 1995), metoprolol (Vanbever, et al., 1994;
Vanbever and Priat, 1995), fentanyl (Vanbever, et al., 1996 [a]; Vanbever, et al., 1996 [b); Vanbever,
et al., 1998 [a]; Vanbever, et al., 1998 [b]), domperidone (Jadoul and Prnat, 1997 [a]), alnitidan
(Jadoul, et al., 1998), and cyclosporin A (Wang, et al., 1998). Larger molecules have also been
successfully transported across the skin, including heparin (Prausnitz, et al., 1995 [b]; Vanbever, et
al., 1997; Weaver, et al., 1997), and several oligonucleotides (Zewert, et al., 1995).
High-voltage pulsing has been directly applied clinically to humans for the treatment of head and
neck tumors. Bleomycin, a drug used to treat the tumors, was not delivered across the skin by high-
voltage pulsing, but rather was directly injected into the body. High-voltage pulsing was then applied
to the head and neck tumors, causing the bleomycin dissolved in the bloodstream to become incor-
porated into the tumor cells, which in turn caused the tumor cells to die. Significant reductions in
tumor size were noted after both high-voltage pulsing and bleomycin were applied to the tumor, com-
pared to controls of high-voltage pulsing only or bleomycin only. Side effects noted during treatment
were some muscle twitches during pulsing and slight edema after pulsing (Mir, et al., 1991; Bele-
hradek, et al., 1993).
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b
Figure 2.6. Hydrophobic (a) and hydrophilic (b) pores.
The hydrophobic pores form during the high-voltage
pulse. The lipid molecules then spontaneously rearrange
after the pulse to form hydrophilic pores. Based on a
drawing from Glaser, et aL. (1988).
In skin electroporation, new aqueous pathways are created across the stratum corneum, through
which molecular transport takes place. The aqueous pathways that form during high-voltage pulsing
across the stratum corneum are hypothesized to be the result of rearrangements of lipids within the
lipid bilayers surrounding the corneocytes (Prausnitz, et at., 1993 [a]; Chizmadzhev, et at., 1995;
Pliquett and Weaver, 1996 [a]; Chizmadzhev, et at., 1998 [a]).
Typically, the high-voltage pulses applied to the skin are exponentially decaying pulses, -1 ms
long (Prausnitz, et at., 1993 [a]), although longer pulses have been tried (Vanbever, et at., 1998 [b];
Vanbever, et at., submitted). The voltage drop that forms across the stratum corneum is typically
~100 V skin The voltages across the dermis and epidermis are usually much smaller and negligible,
due to the much lower electrical resistivities of the dermis and epidermis, compared to the stratum
corneum. Stratum corneum voltages less than ~50 Vski appear to be insufficient to cause significant
molecular transport during pulsing (Chen, et al, 1998 [c]; Chizmadzhev, et at., 1998 [a]).
The high-voltage pulses are usually applied at the rate of one pulse every 5 s for 1 h (-720 pulses
totally), although this frequency and duration were chosen somewhat arbitrarily (Prausnitz, et at., 1993
[al); quicker and slower rates of pulsing have also been applied. Molecular transport usually occurs
almost immediately, with detectable levels of transport after only about a minute of pulsing (Chen, et
at., 1998 [c]). This is significantly much faster than the drug transport rates observed during passive
delivery, where drug transport is usually measured in hours, or in iontophoresis, where transport
occurs on a time scale of several minutes.
During a high-voltage pulse, aqueous pathways are created in the stratum corneum and the elec-
trical resistivity of the skin drops dramatically, by up to 4 orders of magnitude (Prausnitz, et at., 1993
[a]). Molecular transport takes place across the new pathways created during the pulse (Pliquett, et at.,
1996 [b]). After the pulse, the pathways begin to close, and the skin begins to recover its barrier
properties.
2.3.3. Combination of Skin Electroporation with Other Methods.
Further enhancements in transdermal drug delivery have also been achieved by combing high-
voltage pulsing with other transdermal enhancement techniques. Studies combining high-voltage
pulsing with ultrasound (Kost, et at., 1996), iontophoresis (Bommannan, et at., 1994), or novel chemi-
cal enhancers (Vanbever, et at., 1997; Weaver, et at., 1997) have all shown synergistic increases in
molecular transport. An interesting chemical enhancer for skin electroporation was demonstrated by
using long macromolecules, such as dextrans or polylysines, as the chemical enhancer (Weaver, et at.,
1997; Vanbever, et al, 1997; Prausnitz, et al, in press). This enhancement was believed to work
essentially by a "foot-in-the-door" approach (Weaver, et at., 1997), where the long, thin
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macromolecules appear to keep the aqueous pathways in the skin open longer, allowing more molecular
transport to take place.
2.3.4. New Aqueous Pathways through the Stratum Comeum.
The stratum corneum b
is typically modeled as d Sweat dua Comeocyte Hair follide
-100 lipid bilayers in _ _
series, with the inter-
cellular lipids and the
corneocytes arranged in a
bricks-and-mortar pattern
(Figure 2.3) (Elias, 1983;
Elias, 1988; Wertz and
Downing, 1989). Sweat Figure 2.7. Pathways for transport across the stratum corneum. The "tortuous"
pathway (a) stays only within the lipids in the stratum corneum. The "straight-ducts and hair follicles through" pathway (b) crosses both lipid bilayers and corneocytes. The "shunt" path-
ways go through either hair follicles (c) or sweat ducts (d).
penetrate the stratum cor-
neum from the dermis. There are three potential routes across the skin for molecular transport:
through only the lipid bilayers (called the "intracellular" or "tortuous" pathway), through the lipids and
keratinocytes (called the "intercellular" or "straight-through" pathway), or through sweat ducts and hair
follicles (the "shunt" pathways) (Figure 2.7). Electroporation may involve the creation of new aqueous
pathways to increase molecular transport through some or all of these routes.
One pathway for molecular transport remains in the lipid bilayers and goes around the corneocytes.
This pathway is termed the intracellular pathway or the tortuous pathway. Since the lipid bilayers are
continuous throughout the stratum corneum, only a few (<10) bilayers have to be penetrated to form a
continuous route through the stratum corneum for molecular transport. This is believed to be the main
pathway during passive diffusion (Figure 2.7a) (Bodde, et al., 1989; Bodde, et al., 1991; Cullander,
1992; Potts and Guy, 1992).
A transport pathway that crosses both the lipid bilayers and the corneocytes is called the inter-
cellular pathway or the straight-through pathway (Figure 2.7b). This pathway crosses more lipid
bilayers, including the corneocyte lipid envelopes (Swartzendruber, et al., 1987), than does the intra-
cellular pathway. This pathway could be part of the skin "reservoir" effect, or the continued high rate
of molecular flux out of the skin after high-voltage pulsing (Prausnitz, et al., 1993 [a]) or iontophoresis
(Wearley, et al., 1989), as molecules can get trapped within the corneocytes during transport.
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A third transport pathway goes through hair follicles (Figure 2.7c), or sweat ducts (Figure 2.7d),
called the shunt pathway. The hair follicles and sweat ducts are collectively called the "appendages" of
the skin. Only a few lipid bilayers separate the appendages from the dermis. Sweat ducts and hair
follicles cover -0.1% of the skin surface area (Abramson and Gorin, 1940); however, this pathway may
still be important for molecular transport (Abramson and Gorin 1940; Grimnes, 1984; Burnette and
Marrero, 1986; Burnette and Ongpipattanakul, 1988; Cullander, 1992; Potts and Guy, 1992; Scott,
et al., 1992; Scott, et al., 1993).
2.3.5. Formation of Localized Transport Regions (LTRs).
On a larger scale, the aqueous
pathways formed during high-voltage
pulsing are concentrated in small
regions which are distributed ran-
domly throughout the stratum cor-
neum. These regions have been
named "LTRs," for "localized transport
regions" (Figure 2.8) (Pliquett, et al.,
1996 [b]).
The LTRs are typically ~100 g in
diameter. Microscopic analyses of the
LTRs have not shown any intrinsic Figure 2.8. LTRs on the surface of the skin. The localized transport
regions (LTRs) form randomly on human skin duing high-voltage pulsing,
skin structures in these regions, such seen in this photomicrograph of the surface of the skin as red circles
surrounded by green rings. The LTRs are typically -100 g in diameter.
as sweat ducts or hair follicles. The
LTRs form spontaneously and randomly during high-voltage pulsing, but have not been observed
during iontophoresis (Chen, et al., 1998 [b]). Experiments have shown that both molecular transport
and electrical currents occur primarily through these regions during pulsing (Pliquett, et al., 1996 [b]).
Molecular transport through the LTRs is believed to occur by a combination of electrical drift (ion
movement in the electric field during the pulse) and electroosmosis (solvent movement in response to
the electric field). Since the LTRs are created spontaneously during pulsing, the number of LTRs does
not appear to be limited to pre-existing structures within the skin, a limitation of iontophoretic trans-
dermal methods.
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2.3.6. In Vivo Experiments.
There have been fewer in vivo studies of skin electroporation, and none in humans. In an early
study, calcein was successfully transported into the circulating blood of anesthetized hairless rats
during high-voltage pulsing, although these studies did not include optimized electrodes or pulsing
conditions. Under some pulsing conditions, however, no visible damage to the skin was observed
(Prausnitz, et at, 1993 [a]; Prausnitz, et al., 1993 [b]).
In later studies, fentanyl, a potent painkiller, was delivered into hairless rats by high-voltage
pulsing. The analgesia caused by fentanyl was measured by the tail-withdraw reaction method in
response to a 55 'C water bath, and by head twitching in response to stimulation of the eyes and ears
with a small metal rod. Analgesia due to fentanyl transport across the skin occurred very quickly
(~5 min) after high-voltage pulsing, but no significant analgesia was observed during transport by
iontophoresis or passive diffusion, thus demonstrating both molecular transport and retention of
activity during high-voltage pulsing (Vanbever, et at., 1998 [b]).
After high-voltage pulsing had been applied to the hairless rats, the condition of the skin was not
significantly different from control specimens, where acceptable iontophoretic currents had been
applied instead of pulsing. The condition of the skin was determined by transepidermal water loss
measurements (how fast water was lost through the skin), skin coloration techniques (especially
redness), and laser Doppler flowmetry (to measure blood flowrates). All of the skin measurements
showed comparable skin irritation for both high-voltage pulsing and iontophoresis (Vanbever, et al.,
1998 [a]).
In a different set of experiments, LHRH was delivered across an isolated perfused porcine skin flap
by either iontophoresis, or iontophoresis plus several high-voltage pulses. After the experiment, the
skin was assessed using histological evaluation, and various tests for erythema (redness) and edema
(swelling). The addition of several high-voltage pulses to iontophoresis did not result in any more irri-
tation than iontophoresis alone (Riviere, et at., 1995). Thus, as shown in both systems, the application
of high-voltage pulsing to the skin does not irritate the skin any more than does iontophoresis, an
already accepted technique.
-31-
3. Electrical Properties of Phosphate-Buffered Saline (PBS).
In skin electroporation research, many authors have reported the average molecular flux through
the skin as a function of the voltage applied to the permeation chamber (Prausnitz, et at, 1993 [a];
Vanbever, et at., 1994; Prausnitz, et at., 1995 [b]; Vanbever and Preat, 1995; Vanbever, et at, 1996
[a]; Vanbever, et at, 1996 [b]; Vanbever, et at., submitted). However, it has been shown that the peak
transdermal voltage governs molecular transport, not the applied voltage (Pliquett and Weaver, 1996
[a]). Thus, an accurate measurement of the transdermal voltage is vital in understanding the
phenomenon of skin electroporation. Typically, the transdermal voltage is measured by placing two
additional "measurement" or "sensing" electrodes on either side of the skin, between the two pulsing
electrodes. Directly using the pulsing electrodes for voltage measurements could introduce problems
with electrochemistry or electrode polarization.
However, the transdermal voltage cannot be measured simply by placing the two measurement
electrodes directly onto the skin itself. If the electrodes were placed flush against the skin, there could
be pinching or shearing of the skin, as well as electrochemical reactions with the skin. Thus, there
always should be a slight gap between the measurement electrodes and the skin, filled with an
electrolytic solution. Typically the electrolytic solution is phosphate-buffered saline (PBS) (Prausnitz,
et al, 1993 [a]).
In many experiments, such as the ones described in this thesis, there may be other components
between the two measurement electrodes besides PBS and the skin, such as polyacrylamide gel
(Appendices IV and V) or polycarbonate membranes (Section 5.3.4). Typically, however, the resis-
tivities of these things are comparable to the resistivity of PBS.
Thus, for accurate measurements of the transdermal voltage during high-voltage pulsing, it is first
necessary to get an accurate measurement of the resistance of only PBS within the chamber. Once this
is known, the voltage drop across the skin during pulsing can be calculated, using Ohm's Law and
subtracting the contribution due to PBS.
3.1. Method of Determining the Resistance of PBS.
Applying Ohm's Law to find the transdermal voltage, U,,,, gives the following equation:
Uskn ="' Uir - I R Donor - I RReceptor (3.1)s Uinniier PBS PBS '
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where Uinner is the voltage drop across the inner measurement electrodes during the pulse, I is the
current through the skin during the pulse, and R Door and RRceptor are the resistances of the PBS
solutions in the donor and receptor compartments, respectively. The two PBS resistances can be
lumped together into one overall resistance, RPBS, giving the following equation:
U~ski = Uinner - I RPBS. (3.2)
R PBS is a constant that depends on the actual geometry of the apparatus. It can be estimated from the
resistivity of saline, PPBS, an intrinsic property, by this equation:
R = - PPBS L (3.3)
A
where L is the distance between the measurement electrodes and A is the cross-sectional area between
them. This equation is exact only for an electric field between two infinite parallel plates (a perfectly
homogeneous field) (Sears, et al., 1987); however, it can be used as a reasonable approximation of the
resistances in this system. The resistivity of saline is typically given as 0.67 Q m (from Lide, 1991).
Practically speaking, it is better to directly measure the resistance of PBS in the system rather than
estimating it from the resistivity and the geometry of the system. Directly measuring the resistance of
PBS accounts for any non-idealities in the system. Setting Usin to 0 in Equation 3.2 and solving for
RPBS yields the following:
RPBS -Uinner (3.4)
By separately measuring Uinner and I during pulsing, without any skin present (Uskif = 0), the constant
RPBS can thus be directly obtained.
Since RPBS was an extrinsic property that depended on the actual geometry of the system, each
time a new experimental apparatus was constructed, the experiments had to be repeated to obtain a
new value for RPBS. A check on each value of RPBS was also obtained by solving Equation 3.3 for each
new geometry.
3.2. Preparation of PBS.
Phosphate-buffered saline (PBS) was prepared by combining 138 mM NaCl (or 16 g NaCl per 2 1
water) (Sigma, St. Louis, MO), 8.1 mM Na 2HPO 4 (2.30 g) (Mallinckrodt, Paris, KY), 2.7 mM KCl
(0.40 g) (Mallinckrodt), and 1.1 mM KH 2 PO 4 (0.40 g) (Mallinckrodt) in de-ionized water (for a total of
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150 mM_). The solution was adjusted to pH 7.4 by adding HCl (Mallinckrodt) and NaOH (Mallinckrodt)
as necessary (Prausnitz, et al., 1993 [a]). The solution was then stirred under vacuum for >30 min to
de-gas the solution (see Section 4.1.3).
3.3. PBS Resistance in the Original System (Prausnitz, et al. 1993 [a]).
The first experimental system used to study skin electroporation in vitro simply consisted of two
pulsing electrodes and the skin in a glass permeation chamber, surrounded by PBS solution
(Prausnitz, et al., 1993 [a]; also see Appendix II). Since there were no inner measurement electrodes
present, the resistance of PBS was determined by using the voltage settings on the high-voltage pulser
itself (Uapplied ) and measuring the current during the pulse. Thus, Uapplied was used in place of Uinner
in Equation 3.4 (Prausnitz, et al., 1993 [a]):
R - Uapplied (3.5)PBS ~ :
By applying pulses to the chamber without any skin present, and measuring the resulting current,
Prausnitz, et al. (1993 [a]) determined RPBs to be 480 Q.
Based on the original system described in Prausnitz, et al., (1993 [a]), the author of this thesis,
using the same equipment, independently measured A to be 0.63 cm2 and L to be 6.1 cm. With these
geometrical values, Equation 3.3 estimated RPBS to be 649 Q. The large discrepancy between the
measured (480 Q) and calculated (649 Q) values for RPBS shows the importance of independently
determining the transdermal voltage with measurement electrodes during pulsing.
3.4. PBS Resistance in the Original System, using a High-Voltage Probe.
Because of the discrepancy between the measured and the calculated values for RPBS, new
measurements of RPBS were taken with a grounded, 1000 x high-voltage probe (Tektronix, Wilsonville,
OR), connected to an inner pair of measurement electrodes. The voltage drop across the inner elec-
trodes was determined by measuring the voltage at each electrode separately on subsequent pulses,
* Uapplied is used in this thesis to represent the voltage produced by the high-voltage pulser. Although the notation
Uelectrode or Ue is more commonly used in the literature, this notation could become confused with the voltage drop
appearing across the inner electrodes (called Ul in this thesis). Thus, U applied is used instead.
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and subtracting the two measurements.
These measurements of RPBS are shown 2.0 -I = 0.080423 + 0.0037393 V
in Figure 3.1, after a series of pulses were
applied to the permeation chamber with- 1.5-
The peak current during each pulse a 1.0
is plotted against the peak voltage drop -
across the inner electrodes. For an ideal .PBS #1acros0a.5_ PBS #21
o N A PBS #3
Ohmic resistance, this plot should yield a PBS #4
----Line Fit
straight line through the origin (Sears, et 0. 1
al., 1987). As can be seen in Figure 3.1, 00 100 200 300 400 500 600Voltage (V)
these experiments were repeated four
Figure 3.1. Current versus voltage relationship for PBS. Fourtimes, using new PBS solutions and new different PBS solutions in the original permeation chamber are
plotted here. Measurements of the voltage-current relationship for
electrodes each time. The four PBS solu- each of the four solutions all fall on the same line. Thus, PBS
behaves as an ideal Ohmic resistance of 271 Q .
tions fall on the same line, and are in-
distinguishable. The reciprocal of the slope, or R PBS, is 271 Q. Thus, not only did PBS behave like
an ideal Ohmic resistance, it could be consistently prepared every time.
The distance between the inner measurement electrodes, L, was 3.1 cm and A, the cross-sectional
2
area of the chamber, was found to be 0.64 cm . Equation 3.3 would thus estimate RPBS to be 330 0,
reasonably close to the measured value of 1000
RPBS of 271 Q. -
B. Actual
In a different set of experiments, 800_ Idea
shown in Figure 3.2, the voltage actually
produced by one of the high-voltage ",600
pulsers (Electroporation System 600, 0
BTX, San Diego CA) was plotted against 40-
the voltage the pulser was set to produce. <
200--
Note that especially at high-voltages, the
voltage the pulser shows that it is pro-
ducing and the voltage actually being 200 400 600 800 1000
Displayed Voltage (V)
produced can be off by more than 20%.
Figure 3.2. Deviation of the actual voltage versus the displayed
Thus, the display on the pulser itself voltage on a high-voltage pulser. The displayed voltage on the pulser
(Electroporation System 600, BTX), and the actual voltage produced
should not be used for the transdermal by the pulser can be off by as much as 20%. The transdermal
voltage should thus be measured independently, and the display on
voltage measurements (see Section 3.3). the high-voltage pulser should not be used.
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PBS Resistance in the Flow-Protection System (Appendix III).
The flow-protection system de-
scribed in Appendix III consisted of 1 .6 ' ' '.1 ' 0.0057674 V1' ' 1-1.6 1-I -0.0033413 +0.0057674 V7
the two outer pulsing electrodes
1.4 --
surrounded by polyacrylamide gel 1.2
and bathed in a stream of PBS.
1.0--Between the two inner measurement - .
electrodes were the skin and PBS 0.8 -
solution. During experimentation 0.6 -
with this equipment, the voltage 4 PBS#20.4 . PBS #1SPBS #2-
measurements were switched from PBS #3
0.2 -Line Fit
the grounded voltage probe to an
0.0-
active differential high-voltage probe 0 50 100 150 200 250 300
Voltage (V)
(Active Differential Probe B9017RT,
Figure 3.3. Current versus voltage relationship for the flow-protected
Yokogawa, Newman, GA), allowing electrodes, grounded probe. Voltage measurements were taken separately
on inner electrodes on either side of the skin during subsequent pulses.
the voltage drop to be directly mea- The line fit gave a resistance of 173 Q. Note the overlap of the three PBS
solutions, indicating that PBS was made consistently each time.
sured, instead of determining the --
difference between two subsequent voltage measurements. Also, a newly redesigned permeation cham-
ber was used, featuring a smaller inner volume. This caused the measurement electrodes to be
positioned closer together.
I ' I I ' Figure 3.3 shows the RPBS
2.0 I = -0.031793 + 0.0043048 V
. - - measurements using the original
grounded high-voltage probe, and
1.5 
- Figure 3.4 shows the RPBs measure-
ments using the new differential
2 1.0 - high-voltage probe, in the new per-
o- meation chamber. Each plot shows
0.5 * PBS #1 the results from three different
h PBS #2
A PBS #3 experiments. Each set of experi-
------ - Line Fit
ments used fresh PBS solution and
0 100 200 300 400 500 polyacrylamide gel.
Voltage (V)
The resistance of the PBS solu-
Figure 3.4. Current versus voltage relationship for the flow-protected
electrodes, differential probe. The voltage drop across the inner electrodes tion, as determined by the grounded
was measured using a differential high-voltage probe during pulsing.
Measurements of the three solutions overlap, indicating that the PBS solu- high-voltage probe, was 173 Q;
tions were made consistently each time. The resistance of PBS was found
to be 232 Q. Compare with Figure 3.3. however, for the same system, the
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3.5.
differential high-voltage probe found the resistance of PBS to be 232 Q. The differential high-voltage
probe was more accurate, since it directly made single measurements, unlike the grounded high-
voltage probe, which used the difference between subsequent measurements in the calculation of RPBS'
The inner volumes of the new permeation chambers were slightly smaller than the original cham-
2
bers. The cross-sectional area (A) of the inner compartment remained 0.64 cm2; however, the volume
of this compartment was decreased from 3.1 ml to 2.6 ml. The distance between the inner electrodes
(L) was shortened from 3.1 cm to 2.4 cm. Equation 3.3 thus estimated RPBS to be 255 Q.
The estimated value of RPBS (255 Q) was closer to the measurements made by the differential high-
voltage probe (232 Q), than the grounded probe (173 0). Thus, in the remaining skin electroporation
experiments, the differential high-voltage probe was used to measure the transdermal voltage.
3.6. PBS Resistance in the Flow-Through System (Appendix IV).
In the flow-through system de- 3.5 , I , I I I I I I I a I I I I I I 1 1 , 1 1 1 . .1 .1 .1 .1 1 .
scribed in Appendix IV (also see Chen, I =0.043736 + 0.0041212 V
3.0 --
et al., in press [a]), polyacrylamide gel
was used to decrease the volume of the 2.5
receptor compartment to -200 p1. The
2.0 --
same permeation chambers from the *
previous section were used here; the 1.5-
decrease in volume was due to addi-
1.0-
tional polyacrylamide gel in the re- PBS #1
-I. PBS#2-
ceptor compartment. Tygon and teflon 0.5 - - - eFi
tubing were used to allow PBS solution
to flow in and out of the receptor 100 200 300 400 500 600 700 800
compartment during the experiment.
Figure 3.5. Current versus voltage relationship in the flow-through
Thus, between the two inner measure- system. Between the inner measurement electrodes were the skin,
PBS, polyacrylamide gel, and two plastic tubes. The resistivity of this
ment electrodes were the PBS solution, system was 243 Q, similar to the value of 232 Q when no poly-
acrylamide gel was present.
the polyacrylamide gel in the receptor
compartment, and two plastic tubes used to allow for PBS flow.
Despite these modifications, the electrical properties of the system did not change significantly.
The resistance of the PBS and the polyacrylamide gel in this new system, after two independent
experiments (shown in Figure 3.5), was found to be 243 12, similar to the old value of 232 Q.
The structure of polyacrylamide gel consists of networks of polymer filaments, surrounded by the
bathing solution, which in this case was PBS. Thus, the electrical resistivity of polyacrylamide gel
-37-
should have been very close to the resistivity of PBS. Experimentally, similar resistivities were found
(243 Q with the gel, versus 232 Q for only PBS). Assuming that the resistivity of polyacrylamide gel is
equal to the resistivity of PBS, then from Equation 3.3, RPBS for this system would be estimated to be
255 Q. This estimate was very close to what was observed experimentally. Thus, polyacrylamide gel
does not contribute to the resistances within the system any more than PBS does.
3.7. PBS Resistance in the Double Flow-Through System (Appendix V).
In the last set of experiments, 1.4
the donor compartment was fitted I=-0.027137+0.0038432V
1.2-
with a flow-through system, sim- -
ilar to the one in the receptor 1.0
compartment. Thus, between the -
two measurement electrodes were 08
the skin, PBS solution, poly- 0.6-
acrylamide gel, and four plastic 0
tubes, to allow the flow of liquid in 0.4 --
and out of both the donor and
0.2 .
receptor compartments.
As previously described, the 0.01.''' . I'' ''' ' ' ' '''' '
0 50 100 150 200 250 300 350
resistivity of the polyacrylamide Voltage (V)
gel was found to be comparable to
Figure 3.6. Current versus voltage relationship in the double flow-through
the resistivity of PBS. Thus, since system. Despite differences in the amount of polyacrylamide gel present, the
measured resistance, 260 Q, was comparable to previous measurements
the same glass chamber was used using the same chamber (232 Q and 243 Q, from Figures 3.4 and 3.5,
respectively).
in these experiments, with the
same geometry, Equation 3.3 would still estimate 255 Q for RPBS
Experimentally, a value of 260 Q was measured for R PBS, as shown in Figure 3.6. Although only
one set of measurements was performed, the value of RPBS that was found was very close to the
previously measured values (232 Q and 243 Q), as well as the estimated value (255 Q). Thus, even
though nearly all of the chamber was filled with polyacrylamide gel, the resistance of the system was
still comparable to only PBS.
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The System is Non-Ohmic at Very High Voltages.
In some experiments, the pulser 4.0 -
was set to produce very high voltages 3.5-
(Uapplied > 1000 V)). This is higher
than the highest voltage actually used 3.0
during any of the skin electroporation -2.5
experiments described in this thesis E(D 2.0
(Uapplied 1000 V).
o1.5
In this regime, some unpredictable
deviations in the current versus voltage 1.0
relationship (Ohm's Law) were ob- 0.5 PBS #1
served, as shown in Figure 3.7. Since F Voltage (V)
the transdermal voltages in this regime 0 200 400 600 800 1000
could not be accurately determined, the
Figure 3.7. Current versus voltage relationship at very high voltages.
higher applied voltages were not used. At large applied voltages (Uappied > 1000 V, which corresponds to
Uinner - 1000 V), PBS no longer behaves as an ideal Ohmic resistance.
3.9. RBS is Constant in the Skin Electroporation Experiments.
In conclusion, PBS was found to behave as an ideal Ohmic resistance at low to moderate applied
voltages (Uapplied < 1000 V). PBS could be made consistently every time. The measured values of PBS
resistance agreed with resistance values estimated from the known resistivity of saline (0.67 Q m)
(from Lide, 1991), and the geometry of the system (Equation 3.3).
The polyacrylamide gel used in these experiments, which was composed of polymer filaments
surrounded by PBS solution, also had similar resistivities as PBS. Thus, the resistivity of the poly-
acrylamide gel was assumed to be that of PBS in subsequent calculations.
At very high voltages (Uapplied > 1000 V), significant deviations from linearity were seen in the
current versus voltage relationship. Fortunately, these voltages were much higher than the voltages
used in the skin electroporation experiments described in this thesis, and thus the resistance of PBS
between the two measurement electrodes was assumed to be constant during the skin electroporation
experiments.
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3.8.
4. Physical Properties of the Fluorescent Tracers.
Although many biologically relevant substances have been successfully transported across the skin
by skin electroporation, such as luteinizing hormone releasing hormone (LHRH) (Bommannan, et al.,
1994; Riviere, et al., 1995), heparin (Prausnitz, et al., 1995 [b]; Vanbever, et al., 1997; Weaver, et
al., 1997), oligonucleotides (Zewert, et al., 1995; Regnier, et al., in press [a]), cyclosporin A (Wang, et
al., 1998), and several small molecular weight drugs (Vanbever, et al., 1994; Vanbever and Preat,
1995; Vanbever, et al., 1996 [a]; Vanbever, et al., 1996 [b]; Jadoul and Preat, 1997 [a]; Jadoul, et
al., 1998; Vanbever, et al., 1998 [b]), surrogate fluorescent tracers are often used instead of biological
compounds in molecular transport studies, since the tracers can be selected to have certain desired
physical properties.
In particular, the tracers should have small to medium molecular weights, to mimic the sizes of typi-
cally important biological compounds. Also, the tracers should be hydrophilic, so that they remain in
solution (and within the aqueous pathways created during pulsing), and the tracers should not partition
passively through the skin. The tracers should be charged, to facilitate transport during pulsing.
Finally, the tracers should give a very strong signal and be quantifiably detectable at concentrations as
low as 10 8 M, as well as being easy to use and prepare.
During the course of this thesis, four fluorescent compounds were identified that had most or all of
these physical properties: calcein, sulforhodamine, lucifer yellow, and cascade blue (Table 4.1).
Calcein (Prausnitz, et al., 1993 [a]; Prausnitz, et al., 1993 [c]; Prausnitz, et al., 1994; Pliquett, et al.,
1995 [b]; Kost, et al., 1996; Pliquett and Weaver, 1996 [a]; Pliquett, et al., 1996 [b]; Pliquett and
Weaver, 1996 [b]; Prausnitz, et al., 1996 [b]; Chen, et al., 1998 [b]; Chen, et al., 1998 [c];
Vanbever, et al., submitted), sulforhodamine (Kost, et al., 1996; Pliquett and Weaver, 1996 [a];
Pliquett, et al., 1996 [b]; Chen, et al., 1998 [b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted),
and lucifer yellow (Prausnitz, et al., 1993 [a]; Chen, et al., 1998 [c]) have been used in previous skin
electroporation studies. All four compounds have similar molecular weights (ranging from 457 Da for
lucifer yellow to 623 Da for calcein), and were all negatively charged, varying from -1 for sulfo-
rhodamine to -4 for calcein. All four molecules were considered to be very hydrophilic and brightly
fluorescent.
However, since molecular transport during skin electroporation depends not only on the applied
Table 4.1. Physical Properties of the Four Fluorescent Tracers.
Nominal Charge Excitation Emission
Name MW (Da) at pH 7.4 K Wavelength (nm) Wavelength (nm) Source (Catalog Number)
Sulforhodamine 607 -1 -0.057 586 607 Molecular Probes (S-359)
Lucifer Yellow 457 -2 <<1 428 535 Molecular Probes (L-453)
Cascade Blue 596 -3 <<1 399 421 Molecular Probes (C-687)
Calcein 623 -4 <<1 496 517 Molecular Probes (C-481)
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electrical conditions, but also on the physical properties of the molecules (Prausnitz, et at., 1993 [a];
Pliquett and Weaver, 1996 [a]; Vanbever, et al., 1997; Chen, et al., 1998 [c]; Vanbever, et at., 1998
[c]), a study of the physical properties of these molecules was also needed. This chapter looks at some
of the physical properties of these fluorescent tracers. Calcein was studied the most intensely, due to
its extensive use as a tracer, and its unusual transport behavior (Pliquett and Weaver, 1996 [b]; Chen,
et al., 1998 [c]; Vanbever, et al., submitted).
4.1 Calcein.
In skin electroporation research, one of the most widely used fluorescent tracers is calcein
(Prausnitz, et al., 1993 [a]; Prausnitz, et al., 1993 [c]; Prausnitz, et al., 1994; Pliquett, et al., 1995
[b]; Kost, et al., 1996; Pliquett and Weaver, 1996 [a]; Pliquett and Weaver, 1996 [b; Pliquett, et al.,
1996 [b]; Prausnitz, et al., 1996 [b]; Chen, et al., 1998 [b]; Chen, et al., 1998 [c]; Vanbever, et al.,
submitted), a low molecular weight (623 Da), highly charged, green fluorescent molecule (496 nm exci-
tation, 517 nm emission) (Haugland, 1992; Prausnitz, et al., 1993 [a]; Pliquett and Weaver, 1996 [a]).
Calcein was originally picked as a tracer because of its small molecular weight, high electronic charge
(nominally -4 at pH 7.4), high hydrophilicity, and intense fluorescence.
Calcein (or 2', 7'-bis[[bis(carboxymethyl)amino]methyl fluorescein; N,N'-1(3',6'-dihydroxy-3-
oxospiro-[isobenzofuran- 1(3H),9'-[9H]xanthene]-2',7'-diyl)bis(methylene)]bis[N-(carboxymethyl)glycine;
CAS #1461-15-0) (Figure 4.1) is a derivative of fluorescein, and it has traditionally been used to detect
trace amounts of calcium ions in solution, hence its name. When calcein chelates a calcium ion, it
results in a slight shift in its fluorescence spectra. Concentrations as low as 0.08 ppm (or 4.4 [tM) of
Ca can be detected with calcein solutions (Cheng, et al., 1982).
Commercial sources of calcein typically include up to five different isomers besides the 2,7 form
(Figure 4.2), which are very difficult to separate (Cheng, et al., A
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Figure 4.1. The molecular structure of calcein. Calcein is a brightly
fluorescent, hydrophilic molecule (C3 0H 2 60 13 N 2, 622.54 Da), that is
often used in skin electroporation experiments.
OH 0 OH
2 7
> rO =
Figure 4.2. The two [bis(carboxymethyl)-
aminolmethyl groups isomerize to the 2, 4,
5, and 7 positions. Each numbered posi-
tion is identified in the above figure. There
are six different possible isomers of calcein.
Only the 2,7 isomer is considered to be the
correct form of calcein.
1982; Haugland, 1992). The two [bis(carboxymethyl)aminolmethyl groups can isomerize to any two of
the 2, 4, 5, and 7 positions on fluorescein, such that only about 50% of the calcein is in the correct 2,7
form. The isomeric mixtures are usually sufficient for Ca 2+ detection purposes, although high purity
calcein (up to 95% pure) can be obtained which has been chromatographically purified (Haugland,
1992; Molecular Probes, personal communication).
When investigators researching skin electroporation began studying the transdermal flux of calcein
in real time, they found a puzzling drop in the observed efflux of calcein after repeated pulsing (Pliquett
and Weaver, 1996 [a]; Pliquett and Weaver, 1996 [b]; Chen, et at., 1998 [c]; Vanbever, et al., sub-
mitted; see also Section 8.2.2). This drop had been seen by different investigators, using different
equipment, different pulsing protocols, and even different suppliers of calcein.
The drop in calcein intensity had typically been attributed to the degradation of calcein by either
electrochemical by-products, or pH changes due to the pulsing electrodes, instead of a drop in the
transdermal flux of calcein across the skin (Pliquett and Gusbeth, in preparation). Another possibility
that was proposed was that calcein was chelating calcium ions in the skin as it was transported across,
causing its fluorescence to decrease. Further possibilities include quenching of calcein by either light
or oxygen, enzymatic degradation by the skin, and the nonspecific binding of calcein to the equipment.
However, despite many control experiments, no single cause had been identified. The purpose of the
following series of experiments was to determine what the drop in the intensity of calcein was due to.
4.1.1. Calcein Drop Observed in Different Systems.
The drop in calcein efflux with repeated 0.25
pulsing has been seen in at least three inde- .... .. 230V
0.2 --.- 
- - -- .-..
pendent systems. The drop was first observed -
in Pliquett and Weaver (1996 [b]), where E
0.15
pulses were applied from U = 65 to 230 V, L
with a time constant (,t) of 1.1 ms, 1 pulse per 0.1 160V
minute for 1 h (Figure 4.3). Different electrical -
conditions were used in Vanbever, et al. (sub- ............ 120VE 0.05 .
mitted), and a much faster drop in calcein 9ov
--. -------. ... ...--... 65Vfluorescence was observed (in Figure 4.4, ;. . . ..'-.1
00 20 40 60 80 100 120
20 pulses were applied, Uappied = 300 V, with time (minI
' = 100 ms, 1 pulse every 6 min; in Figure Figure 4.3. The flux of calcein drops with repeated pulsing.The flux at 230 V shows the greatest decrease with repeated
4.5, 20 pulses were applied, Uapplide = 400 V, pulsing. Pulsing conditions used were U = 65 to 230 V,
pe = 1.1 ms, 1 pulse every min for 1 h. From Pliquett and
, = 300 ms, 1 pulse every 6 min). In both Weaver (1996 [b]).
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cases, the fluorescence of calcein began to drop after the first 5 or 6 pulses. Finally, in Chen, et al.
(1998 [c]) and Section 8.2.2, the drop in calcein fluorescence was observed in both human skin and
shed black rat snake skin (Figures 8.4d and 8.8d). The same protocol was used in both cases:
Uapplied = 1000 V, t = 1 ms, 1 pulse every 5.6 s for 1 h).
These results imply that the drop in calcein fluorescence is real and not simply an artifact of the
experimental apparatuses used. At least two different sources of calcein were used (Sigma and Mole-
cular Probes, Eugene, OR), as well as two types of skin (human and snake). The preparation pro-
cedures were different for human skin and snake skin (see Section 7.3.1). Despite these variations in
electrical protocols, equipment, calcein sources, and types of skin, drops in the fluorescence of calcein
were observed in all of these cases.
4.1.2. Calcein has 6 pKa's. Table 4.2. Calcein pKa's (Cheng, et al., 1982).
Calcein has 6 pKa values, which indicates that H6 L H 5 L + H pK. = 2.1
the calcein molecules can be present in solution with H L H4L + H pK a= 2.9
charges anywhere from 0 to -6. However, at pH 7.4, H4L H3L3- + H pK a= 4.2
most of the calcein is present at charge -4. The pKa's HL3 3 H2L
4  
+ H pK a= 5.5
of calcein are shown in Table 4.2 (L represents the H2L4  HL5  + H + pK = 10.8
calcein molecule). The distribution of calcein at a pH HL L~ + H+ pK = 11.7
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Calcein flux / gg/h.cm 2
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Time / h
Figure 4.4. The flux of calcein drops with
repeated pulsing. Pulsing conditions used were
U applied = 300 V, t = 100 ms, 1 pulse every
6 min for 20 pulses. From R. Vanbever (per-
sonal communication).
Calcein flux / pg/h.cm 2
40-
30-
20-
10-
0 1 2 3 4
Time / h
Figure 4.5. Calcein fluxes drop faster with
longer pulses. Pulsing conditions were Uapplied =
400 V, T = 300 ms, 1 pulse every 6 min for 20
pulses. Compare with Figure 4.4. From R.
Vanbever (personal communication).
of 7.4, relative to the nominal form ( H2 L-), is Table 4.3. Calcein Distribution at pH 7.4, Relative to H2L4-
shown in Table 4.3.
Thus, 72.9% of the calcein molecules in H6L 5.01x10-
PBS solution at pH 7.4 are in the -4 state. H5L 3.16 x 10 5
The remaining 27.1% of the calcein molecules H4 6.31 x 10
can be in configurations that vary in charge H3L2 1.26 x 10
2
from 0 to -6. However, calcein retains a nega- H2 L4  1
tive charge in nearly all of these states. Only HL? 3.98 x 10 -
L 5.01x 10 5
5.01 x 10 4% of the calcein molecules in solu-
tion are not negatively charged (in the H6 L state).
4.1.3. Calcein Not Quenched by Light or Oxygen.
From a stock solution of 10-3 M calcein 108
(Molecular Probes) in 150 mM degassed PBS
(Section 3.2), a standard curve for calcein in 7107
C 1 -
solution was prepared, decreasing by an order of
magnitude stepwise, down to a final concentration -
310 6
of 10 M. Fluorescence measurements were
taken immediately after the standard curve was
(105
prepared (0 h). This is the solid curve shown in 1
Figure 4.6. Further measurements were taken W
4 -O h
again after 1, 2, and 3 h. Between measurements, 0 104  -1 h
the calcein calibration solutions were allowed to - - 3 h
sit on an undisturbed bench in the lab. The 103 " '
solutions were not covered, thus permitting ex- Ca-4 C cti (7)Calcein Concentration (M)
posure to both light and oxygen in the air. Figure 4.6. Calcein intensities after 3 h of exposure to
However, after degassing, there was no oxygen in light and 02. The fluorescence intensity of calcein in
solution. solution 
drops only slightly after 3 h.
As shown in Figure 4.6, even after 3 h of exposure, there was only a small drop in the fluorescence
intensity of calcein. This was most pronounced in the first hour of the 10-8 M sample, where the
fluorescence decreased from 1.1 x 05 (in arbitrary fluorescence units) to 5.9 x 10-4 in the first hour.
However, this drop may not be important, since during a typical skin electroporation experiment,
the calcein donor solution is prepared 2 to 3 h before the start of an experiment. The solution is not
used immediately, since calcein takes about 30 min to fully dissolve, and a 1 h passive control period
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is also needed at the start of the experiment to
allow the skin to fully hydrate. After 2 to 3 h of
exposure to light and oxygen, the calcein
calibration solutions do not continue to decrease
as quickly in intensity.
4.1.4. Calcein not Quenched by Exposure to
the Skin or the Pulsing Electrodes.
Besides the standard calibration curve de-
scribed in the previous section, three other stand-
ard curves were prepared, using PBS that had
either been exposed to human skin (passively) for
1 h, unprotected electrodes used to apply high-
voltage pulsing for 1 h to PBS, or to both the skin
and the high-voltage pulsing electrodes (as would
be experienced in a typical skin electroporation
experiment). The high-voltage pulsing conditions
used were Uapplied = 1000 V, r = 1 ms, one pulse
every 5 s. For all three calibration curves, fluore-
scence measurements were taken immediately
after preparation (0 h, shown as the solid curves
in Figures 4.7, 4.8, and 4.9), and 1, 2, and 3 h
afterwards. All of the solutions were left on an
undisturbed bench in the lab between measure-
ments. The solutions were not covered, thus
permitting exposure to both light and oxygen in
the air.
Figure 4.7 shows the calcein calibration curve
using PBS exposed to human skin, Figure 4.8
shows the standard curve using PBS exposed to
108
110
Co 10
- 104
1031
10-4 10~5 10~6 10-7 10-8 10~9
Calcein Concentration (M)
10-10
Figure 4.7. Calcein intensities after 3 h of exposure to
light, 02, and human skin. Only a slight drop is seen in
the fluorescence, even after 3 h.
108
'1071
.) 5
6
C1
a) 510
C1
610
IZ1O
1111111
10-4 10-5 10-6 1 0 -7 10-8 10- 10-10
Calcein Concentration (M)
Figure 4.8. Calcein intensities after 3 h of exposure to
light, 02, and the pulsing electrodes. There is a slight drop
in the fluorescence of calcein after 3 h.
only the pulsing electrodes, and Figure 4.9 shows the standard curve after exposure to both human
skin and the pulsing electrodes. In all three cases, the standard curves after 1 h decreased slightly
(especially at the 10-9 M concentration), but did not decrease further afterwards.
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As in the previous section, this drop is prob-
ably unimportant, since the calcein donor solution
is typically prepared 2 to 3 h before an experi-
ment. In addition, all three calibration curves are
not significantly different from calibration curves
prepared with unexposed PBS (Figure 4.6), which
would not be the case if the skin or the pulsing
electrodes released substances that degrade cal-
cein. Thus, these results indicate that exposure
to either human skin, or to electrochemical by-
products generated by the pulsing electrodes (or
both, as in a typical experiment) do not signifi-
cantly affect the fluorescence intensity of calcein.
4.1.5. Calcein Intensity Constant at Moderate
pH's (5 to 9).
10l
107
C 106
0
) 510
U)
10- 0- 07 0110~ 1o5  10-6 107  108 10:-10
Calcein Concentration (M)
Figure 4.9. Calcein intensities after 3 h of exposure to
light, 02, skin, and the pulsing electrodes. Despite these
influences, there is only a slight drop in the fluorescence of
calcein, even after 3 h.
Eleven different standard curves for calcein (Molecular Probes) in degassed PBS were prepared, in
which the pH of the PBS solution was systematically altered from 3 through 13, through addition of
0- 1 M '10-8 L
106M -0--10-9
-o1 -7 M - 1010 M
4 5 6 7 8 9 10 11 12 13
pH
Figure 4.10. The intensity of calcein as a function of the
solution pH. At moderate pH's (between 5 and 9), the fluor-
escence of calcein is essentially constant.
appropriate amounts of either HCl (Mallinckrodt)
or NaOH (Mallinckrodt). In some cases this re-
quired fairly large amounts of HCl or NaOH, which
significantly changed the molarity of the final
solution, especially for the strongly acidic or
strongly basic solutions. Each PBS solution was
prepared at the appropriate pH before the addi-
tion of calcein. The concentration of calcein at
each pH was varied stepwise by an order of
magnitude from 10 3 M to 1010 M. Each stand-
ard curve was measured for calcein fluorescence
immediately after preparation.
As can be seen in Figure 4.10, the standard
curve for calcein did not significantly change for
pH's between 5 and 9. However, if the solution
was too acidic (pH < 5) or too basic (pH > 9), a
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decrease in calcein fluorescence
was observed. 100- .---
These results are in agreement
80-
with the literature. In Cheng, et al.
(1982), the fluorescence intensity 60C O
of calcein was shown to vary
C
slightly with the pH at moderate pH 40-
ranges (from 6 through 9) (see Fig-
20-
ure 4.11). And in Pliquett and
Gusbeth (in preparation), calcein
was shown to be degraded at low 3 5 6 7 8 9 10 11 12pH
pH's (Figure 4.12). The pH that
Figure 4.11. The intensity of calcein as a function of the solution pH. At
caused calcein degradation in moderate pH's, the fluorescence of calcein stays fairly constant. From
those experiments was not speci- Cheng, et al. 
(1982).
fled; however, further calculations* indicate that a pH of around 4 was reached during the experiment.
Thus, small changes in pH during an experiment (±2 pH units) should not have a significant effect on
the fluorescence intensity of calcein, but larger changes in pH would. With flow-protected electrodes
(see Appendix III), the pH's of the donor and receptor solution should not change significantly during a
typical skin electroporation experiment; thus, the effect of pH on calcein fluorescence should not pre-
sent a problem.
4.1.6. Calcein Intensity Unaffected by Ca 2  in Solution.
Five standard curves of calcein (Molecular Probes) in degassed PBS were prepared, ranging in
concentrations from 10-3 M to 10-10 M in order-of-magnitude steps. To test the effect of Ca 2+ concen-
trations on the fluorescence of calcein, varying concentrations of CaCl 2 were added to each standard
curve. The concentration of CaCl 2 in PBS was systematically changed from 10-4 M to 1 M. The 1 M
concentration was near the saturation point of CaCl 2, so higher concentrations were not possible. In
each case, the appropriate amount of CaCl2 was first added to PBS and allowed to fully dissolve, before
adding calcein and preparing the standard curves. Each standard curve was measured for calcein
fluorescence immediately after preparation.
* In the experiments of Pliquett and Gusbeth (in preparation), 500 pA of iontophoretic current was applied to a flow-
through chamber for 10 min, with fresh PBS being supplied at the rate of -1 ml/min. Dividing the current by the
flowrate and a Faraday (96 484 C/mol) gives the final concentration of ions produced, 3.11 x 10-4 M. If these ions are
assumed to be all hydrogen ions, then the pH of the solution would be 3.51 (ignoring the effects ofthe PBS buffering).
Thus, with PBS buffering, the pH of the solution after 500 iA of iontophoresis can be estimated to be -4.
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The calcein standard curves
can be seen in Figure 4.13. At low 1
concentrations of CaCl 2 , the fluor-
escence of calcein stayed constant. a 0,8
High concentrations (1 M) of CaCl 2  -
W
in PBS turned the solution a milky 0 0,6
white color, affecting the measure-
ment of the calcein fluorescence 0,4
0
intensities. A concentration of 1 M
CaCl 2 in PBS is probably above the 0,2
saturation point, and thus a milky
white suspension was formed. 0
0
The intensity of calcein was not
expected to change much with the
2+ Figure 4.12.
addition of Ca ions in solution. dation of calcei
The primary effect of the binding of applied to a so
2+ causing the pH
Ca to calcein is a small shift in 40 min, the adc
izes the acidic]
the fluorescence emission of cal- control curve,
10%) in the flu
cein, rather than a decrease in trol. From Plig
fluorescence (Cheng, et at., 1982;
Haugland, 1992).
4.1.7. Calcein Not Affected by Chemical By-
Products.
In a different set of experiments, using a per-
meation chamber containing cadaver skin, as well
as pulsing electrodes protected by polyacrylamide
gel and a steady PBS stream (Chen, et at., 1998
[a]; Appendix IV), the polyacrylamide gel sur-
rounding the donor side pulsing electrode was
intentionally broken, to allow any chemical by-
products produced by the pulsing electrode to
contaminate the calcein donor solution. The in-
tensity and shape of the calcein efflux curve
20 40 60
time / min
80 100 120
Degradation of calcein. The dotted curve shows the degra-
in (in arbitrary fluorescence units) as 500 pA of current is
lution of 10 M calcein in PBS in a flow-through system,
to drop to roughly 4 (see footnote on previous page). After
dition of sodium thiosulfate (Na 2 S 2 0 3 [sic in figure]) neutral-
pH, and calcein recovers its fluorescence. The solid line is a
where no current was applied. A slight decrease (roughly
orescence of calcein over time was observed during the con-
uett and Gusbeth (in preparation).
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Figure 4.13. Calcein intensities as a function of Ca2
concentration. Except for the saturated CaCl 2 solutions
which appeared cloudy (1 M CaCl 2 ), the intensity of calcein
was not significantly affected by the presence of Ca ions.
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Figure 4.14. Calcein drops with and without the flow-
protection system. Error bars removed for clarity. The
efflux profile of calcein as it is transported across the skin
during electroporation is not affected by the condition of the
polyacrylamide gel surrounding the pulsing electrodes.
Chemical by-products from the pulsing electrodes do not
significantly affect molecular transport. Although the two
experiments were performed under the same nominal con-
ditions with the same applied voltages, the differences in
flux are due to differences in the transdermal voltage.
polyacrylamide gel surrounding the flow-protection electrode, without affecting the receptor flow-
through system. However, the receptor side electrode is not only protected by the flow-protection sys-
tem, but the receptor flow-through system as well. Fresh PBS is continuously pumped through the
receptor compartment in both systems, so that any pH changes or chemical by-products would be
immediately washed out of the system.
4.1.8. Integrity of the Flow-Protection System.
In another set of experiments, using skin in an in vitro system with flow-protected electrodes
(Chen, et at, in press [a]; see also Appendix IV), a solution of calcein in PBS (at approximately 1 mM
concentration) was intentionally pumped through the electrode flow-protection system, while only fresh,
uncontaminated PBS was used in the donor solution and the receptor flow-through system. High-
voltage pulsing (Uapplied = 1000 V, T = 1 ms) was applied to the skin, one pulse every 5.6 s for 1 h.
As the data in Figure 4.15 indicate, the flow-protection system was able to maintain separation of
the PBS in the receptor compartment, and the PBS flowing around the electrodes throughout the entire
experiment. Even after 1 h of pulsing, there was no significant transport of calcein into the flow-
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through the skin, as measured by the flow-
through system, was compared to the usual ex-
periments in which the polyacrylamide gel did not
break. High-voltage pulsing (Uapplied = 1000 V,
' = 1 ms) was applied to the skin, one pulse
every 5.6 s for 1 h.
Even at large voltages (Uapplied = 1000 V),
there were no appreciable differences in the efflux
profiles of calcein through the skin, between
experiments involving flow-protected electrodes,
and the experiments without flow-protected elec-
trodes (Figure 4.14). Both sets of experiments
had similar efflux profiles and similar drops in
calcein fluorescence during the experiment.
Thus, it appears that the chemical by-products
produced by the donor side pulsing electrode do
not significantly affect the fluorescence of calcein.
The receptor side pulsing electrode was not
tested, due to the difficulty in breaking only the
I I I I I I I I I '-
through sampling system from the flow-protection
system. Thus, the polyacrylamide gel can main-
tain separation of the two compartments during a
typical flow-through experiment.
It was noted that after the end of the first
hour, calcein had diffused from the electrode
flow-protection system into the polyacrylamide
gel. Calcein had penetrated approximately 1.0 cm
into the polyacrylamide gel, as determined by
visual inspection. Given this rate, it would take
several hours (at least 10 to 15 h before calcein
could diffuse entirely across the polyacrylamide
gel. Since the time for diffusion (-10 h) is much
greater than a typical experiment (-2 h), the
diffusion of calcein through the polyacrylamide
gel could safely be ignored.
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Figure 4.15. Calcein in the flow-protection system does not
reach the receptor compartment. Error bars removed for
clarity. The flow-through sampling stream does not record
any calcein fluorescence during a typical 1 h skin electro-
poration experiment. The typical fluorescence of only PBS
Ino calcein) in the flow-through system is -800 (in arbitrary
fluorescence units).
4.1.9. Skin Does Not Release Calcein-Degrading Products.
A piece of human epidermis was grounded in
a solution of PBS to produce a thick "slurry,"
which was then used instead of PBS to produce a
standard curve for calcein (stepwise from 103 M
to 1010 M). This standard curve was compared
against a normal calcein standard curve prepared
using only PBS.
Figure 4.16 indicates that there was no signi-
ficant degradation of calcein by the PBS mixed
with ground skin. Since the "slurry" was a sus-
pension of organic particles, it appeared some-
what cloudy, which caused a slight increase in
the fluorescence of the skin-exposed calcein
solution at the 10~9 M concentration, compared to
the PBS control. At higher concentrations of cal-
cein, however, the two curves were indistinguish-
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Figure 4.16. Calcein exposed to ground human skin does
not decrease in intensity. The fluorescence of calcein was
not significantly different from the control solution.
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able. Thus, the skin does not appear to be releasing any substances that cause the degradation of
calcein.
4.1.10. Iontophoresis of Calcein.
Instead of applying high-voltage pulsing, constant current iontophoresis at 1 mA / cm2 was applied
to human skin for 1 h. As before, the molecular transport across the skin was measured in vitro in real
time, using a flow-through apparatus (Chen, et al., in press [al; Appendix IV).
The flux of calcein across the skin during this experiment is shown in Figure 10.2d. The flux of
calcein slowly increased until it reached a steady-state plateau, at approximately 45 min (-2700 s).
Steady-state transport was maintained until the end of the experiment (-3600 s). While iontophoresis
was being applied, no decrease in the fluorescence of calcein was observed.
Although molecular transport during iontophoresis probably uses a different pathway through the
skin than does electroporation (Pliquett, et al., 1996 [b]; Chen, et al., 1998 [b]), the skin does not
appear to directly cause the degradation of calcein during molecular transport.
4.1.11. Water/Octanol Partition Coefficient of Calcein.
A calcein standard curve was prepared in a mixture of 50 vol% 1-octanol (Sigma) and 50 vol% de-
ionized water. Calcein concentrations were varied stepwise from 10-3 M to 1010 M. In each case, after
vigorous shaking of the mixture for -1 min, the solution was allowed to separate into a hydrophobic
(1-octanol) and a hydrophilic (water) phase. The ratio of the amount of material in the 1-octanol phase
to the amount in the water phase is defined as the octanol-water partition coefficient, K,,, a commonly
accepted measure of the hydrophilicity or hydrophobicity of a substance.
The fluorescence from each phase was measured separately and compared to the corresponding
standard curve of calcein prepared in either water or 1-octanol. However, calcein appears to be too
hydrophilic to be measured by this technique. Calcein does not dissolve in 1-octanol to any measur-
able extent; thus, a calibration curve could not be constructed. The Kow for calcein was thus found to
be <<1 (Table 4.1), but a numerical value could not be determined.
Calcein appears to stay within the aqueous pathways that form across the skin during skin electro-
poration. It does not dissolve well in lipophilic environments, and it is probably not getting bound to
the lipid regions of the skin. However, nonspecific binding of calcein to the skin might account for the
increase in the fluorescence of calcein on the surface of the skin after pulsing.
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4.1.12. Drop in Calcein Flux is Not an Artifact.
As can be seen in this extensive series of experiments, calcein does not appear to be degraded by
light, oxygen, moderate pH's, or changes in the concentration of Ca 2+. The drop in calcein flux during
skin electroporation has also not been satisfactorily explained by electrochemical by-products or
degradation by the skin. One final explanation may simply be that the drop in flux is real, not an
artifact. Drops in molecular transport have also been observed during pulsing in other, unrelated
fluorescent molecules (lucifer yellow and cascade blue) during skin electroporation experiments using
snake skin instead of human skin (see Section 8.3.1, Figures 8.8b and 8.8c). Thus, the drop in
calcein flux during pulsing may be a property of skin electroporation, not a property of the calcein
molecule.
4.2. Sulforhodamine.
Sulforhodamine (or sulforhodamine 101; 9-(2,4-disulfophenyl)-2,3,6,7,12,13,16,17-octahydro-
LH,5H,11H,15H-xantheno[2,3,4-i,j:5,6,7,i',j'diquinolizin-18-ium; CAS #60311-02-6) (Figure 4.17)
has not been used as extensively as calcein in the research of skin electroporation (Kost, et al., 1996;
Pliquett and Weaver, 1996 [a]; Pliquett, et at, 1996 [b]; Chen, et al., 1998 [b]; Chen, et at., 1998 [c];
Vanbever, et al., submitted). It is commonly used alongside calcein (Kost, et al., 1996; Pliquett and
Weaver, 1996 [a]; Pliquett, et al., 1996 [b]; Chen, et al., 1998 [b]; Vanbever, et al., submitted), since
the fluorescence spectra of the two compounds do not
significantly interfere with each other (Pliquett and Weaver,
1996 [a]; also see Section 4.2.2). Sulforhodamine fluore- N 0 N
sces in the red region (excitation at 586 nm, emission at
607 nm) (Haugland, 1992; Pliquett and Weaver, 1996 [al).
The molecular weight of sulforhodamine is similar to that of S03-
calcein (607 Da, compared to 623 Da), and although it is
zwitterionic, its total electronic charge is -1 at pH 7.4
(Molecular Probes, personal communication; M. R. Praus-
nitz, personal communication). Sulforhodamine was origi- S03H
nally selected since it was thought to be very hydrophilic; Figure 4.17. The molecular structure of
sulforhodamine (C3 H30 0.7 N2 S2, 606.72 Da).
however, later experiments (described in Section 4.2.1) Sulforhodamine is often used simultaneously
with calcein in skin electroporation experiments.
have shown that it is not. However, it is only weakly hydrophilic.
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4.2.1. Sulforhodamine is Only Weakly Hydrophilic.
To measure the partition coefficient for sulforhodamine, a standard curve was prepared using a
mixture of 50 vol% 1-octanol (Sigma) and 50 vol% de-ionized water. Sulforhodamine concentrations
were varied stepwise from 10- M to 10'1 M. In each case, after -1 min of vigorous shaking, the solu-
tion was allowed to separate into a hydrophobic (1-octanol) and a hydrophilic (water) phase. The
fluorescence of each phase was measured separately and compared to the corresponding standard
curve of sulforhodamine in either water or 1 -octanol.
It was found that sulforhodamine dissolved quite readily in 1-octanol and still maintained its
intense fluorescence. Its K0 w was found to be 0.057 ± 0.28 (in other words, 1 part in 1-octanol to 16
parts in water) (Table 4.1), indicating that sulforhodamine is only weakly hydrophilic.
Thus, sulforhodamine should not have been used as a tracer of the aqueous pathways formed
during skin electroporation (Pliquett, et al., 1996 [b]; Kost, et al., 1996; Chen, et al., 1998 [b]; Van-
bever, et al., submitted). Sulforhodamine is only weakly hydrophilic, and it can also enter hydrophobic
regions of the skin. Since calcein and sulforhodamine have much different Ko, s, this may explain
why calcein and sulforhodamine are
not observed in the same regions
within the LTRs of the skin (see Fig-
ure 7.13a). The centers of the LTR's
are probably very hydrophobic, ex-
plaining the separation of calcein and
sulforhodamine within the LTRs.
4.2.2. Independence of the Fluore-
scence of Calcein and
Sulforhodamine.
Since calcein and sulforhodamine
have often been used simultaneously
in skin electroporation research (Kost,
et al., 1996; Pliquett and Weaver,
1996 [a]; Chen, et al., 1998 [b];
Vanbever, et al., submitted), it was
important to first establish that the
fluorescence spectra of both com-
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Figure 4.18. Calcein fluorescence intensity is not affected by sulfo-
rhodamine ("Sr"). The heavy line indicates the standard curve that would
be observed if no sulforhodamine were present. The other curves indi-
cate the calcein standard curve in the presence of varying amounts of
sulforhodamine. These curves are not significantly different than the
heavy line with sulforhodamine concentrations from 10 M to 10 M,
indicating the range where calcein and sulforhodamine can be used and
quantified simultaneously. Also see Figure 4.19.
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4.19). Beyond 10~- M, however, there is some interference of fluorescence intensities between the two
species, seen as a slightly higher background. Thus, calcein and sulforhodamine can be detected and
quantified independently of each other, allowing their simultaneous use in skin electroporation experi-
ments.
0
NH2
NH NH
4.3. Lucifer Yellow. 0
2Li
Comparatively less has been done with lucifer yellow as a tracer
in skin electroporation. Prausnitz, et al. (1993) examined the aver-
age flux of lucifer yellow through the skin, and found it to be similar S03- 07
SO3- S03
to calcein. Real-time measurements of the lucifer yellow flux can be
seen in Chen, et al., (1998 [c]) and in Figure 8.4b. In addition, a NH 2
passive permeation study of lucifer yellow through the stratum Figure 4.20. The molecular structure
of lucifer yellow (L12 (C 1 3 H9 09 N5 S2 )'
corneum was conducted by Mansbridge and Knapp (1993), who 457.25 Da.
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pounds do not significantly interfere
with each other, thus allowing quanti-
tative measurements of both species
to be taken simultaneously.
A calibration matrix was prepared
with both calcein and sulforhodamine.
The concentrations of calcein and
sulforhodamine in PBS were each
independently varied stepwise from
10- M to 1010 M, and compared
with calibration curves containing
only calcein or sulforhodamine.
As Figures 4.18 and 4.19 show,
calcein and sulforhodamine do not
significantly affect each other's fluore-
scence. Working ranges from 10-5 M
to 10-8 M were established for both
species, where the standard curve is
essentially linear. This is the same
working range for each molecule by
itself (heavy lines in Figures 4.18 and
04
10
4
found that lucifer yellow did not diffuse significantly through the stratum corneum, although it diffused
quite readily through the epidermis and dermis, where it stayed in the intercellular regions.
Lucifer yellow (also known as 6-amino-2-[(hydrazinocarbonyl)amino-2,3-dihydro- 1,3-dioxo- 1H-
benz[delisoquinoline-5,8-disulfonic acid, dilithium salt; CAS #67769-47-5) has a nominal charge of -2
and a molecular weight of 457 Da, somewhat smaller than the other three molecular tracers discussed
in this chapter. Its molecular structure can be seen in Figure 4.20. It is excited by ultraviolet light
(428 nm) and emits yellow light (555 nm) (Haugland, 1992).
Lucifer yellow was found to be very hydrophilic (K, << 1), using a procedure similar to the one
described in Section 4.1. 11, using lucifer yellow instead of calcein. Like calcein, lucifer yellow proved
unable to dissolve in 1 -octanol; thus, a lucifer yellow calibration curve could not be constructed.
4.4. Cascade Blue.
Cascade blue (or 8-hydroxypyrene- 1,3,6-trisulfonic acid, o
trisodium salt; acetic acid, [(3,6,8-trisulfo-1-pyrenly)oxyl-1- SC 3 , 0 NH 2
hydrazide, trisodium salt; CAS #137182-38-8) has been NH
studied much less than the other fluorescent tracers. Cas-
cade blue has not been previously used in skin electro-
poration or transdermal drug delivery research. 3Na'
Using the procedure of Section 4.1.11, cascade blue was
found to be very hydrophilic (Kow << 1). Cascade blue was So SO3
also unable to dissolve significantly in 1-octanol; thus, a
Figure 4.21. The structure of cascade blue.
calibration curve for cascade blue could not be constructed. It is a fluorescent molecule that is excited by
ultraviolet light and emits blue light. It has a
Cascade blue is excited by 399 nm light (ultraviolet light) molecular formula of Na 3 ( 18 H1101 N2S 3 )
and fluoresces at 421 nm (blue light) (Haugland, 1992). It and a molecular weight 
of 596.45 Da.
has a molecular weight of 596 Da and a nominal electric charge of -3. The structure of cascade blue
can be seen in Figure 4.21. It is highly water-soluble (Haugland, 1992) and has previously been used
in the staining of yeast cells (Whitaker, et at., 1991). It is one of the few molecules which fluoresces
brightly at wavelengths less than 500 nm (Whitaker, et at., 1991). It can be used in conjunction with
lucifer yellow, since the absorption spectra for lucifer yellow and cascade blue do not overlap signi-
ficantly (Haugland, 1992).
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5. Particles are Not Transported across the Skin.*
Numerous studies have shown that applying a series of high-voltage electrical pulses to human
skin causes the enhanced transport of various molecules across the skin, which may be useful in
transdermal drug delivery. Molecules that have been successfully transported across human skin
include fluorescent, low molecular weight tracers such as lucifer yellow (457 Da) (Prausnitz, et at.,
1993 [a]; Chen, et at., 1998 [c), cascade blue (596 Da) (Chen, et al., 1998 [c]), sulforhodamine (607
Da) (Kost, et al., 1996; Pliquett and Weaver, 1996 [a]; Pliquett, et al., 1996 [b]; Chen, et al., 1998
[b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted), and calcein (623 Da) (Prausnitz, et al., 1993
[a]; Prausnitz, et al., 1993 [c]; Prausnitz, et al., 1994; Pliquett, et al., 1995 [b]; Kost, et al., 1996;
Pliquett and Weaver, 1996 [a]; Pliquett and Weaver, 1996 [b]; Pliquett, et al., 1996 [b]; Prausnitz, et
al., 1996 [b]; Chen, et al., 1998 [b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted). Biologically
relevant compounds have also been successfully transported across human skin in vitro, including
luteinizing hormone releasing hormone (LHRH, 1182 Da) (Bommannan, et al., 1994; Riviere, et al.,
1995), several oligonucleotides (4.8 to 7.0 kDa) (Zewert, et al., 1995; Regnier, et al., in press [al) and
heparin (5 to 30 kDa) (Prausnitz, et al., 1995 [b]; Vanbever, et al., 1997; Weaver, et al., 1997).
Recently, there have been several reports of the transport of particles (10 nm to 45 p. in diameter)
(Hofmann, et al., 1995; Prausnitz, et al., 1996 [a]) into (Prausnitz, et al., 1996 [a]) or across human
skin (Hofmann, et al., 1995; Zhang, et al., 1997).
It has been hypothesized that the application of high-voltage pulsing to human skin causes mole-
cular transport by electroporation (Prausnitz, et al., 1993 [a]; Chizmadzhev, et al., 1995;
Chizmadzhev, et al., 1998 [a]). Moreover, high-voltage pulses have been shown to cause the formation
of small, localized transport regions ("LTRs") within the stratum corneum (Zewert, et al., 1995; Pliquett,
et al., 1996 [b]; Prausnitz, et al., 1996 [a]; Chen, et al., 1998 [b]; Vanbever, et al., submitted). For
short pulses (1 to 10 ms), the LTRs are approximately 100 p in diameter, and are randomly distributed
on the stratum corneum, not associated with the sweat ducts or hair follicles (Pliquett, et al., 1996 [b]).
LTRs have also been shown to be sites of charged particle entry into the stratum corneum (Prausnitz, et
al., 1996 [a]).
However, only one study (Zhang, et al., 1997) reports the number of particles actually delivered
across the skin after high-voltage pulsing. Using microspheres 20 p in diameter, it was reported that
the transport of 1.62 x 105 particles / cm2 through human skin xenograft on nude mice was achieved
after the application of three 120 Vapplied, 10 ms pulses. However, for a better understanding of how
*These results have also been reported in Chen, et aL (submitted, [al).
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different size particles might be transported across human skin during various high-voltage pulsing
protocols, more accurate, quantitative measurements of the amount of particle transport were needed,
which motivated the current investigation.
5.1. Overview.
The detection and quantification of particle transport through the skin during high-voltage pulsing
was found to be a surprisingly difficult process. During this investigation, several different detection
techniques, particle suppliers, and skin preparations were tested, in an attempt to come up with a
viable and reproducible protocol for particle detection. A summary of the protocols tried in this investi-
gation is shown in Table 5.1. The rest of this chapter describes the successes and results of each of
these protocols.
Table 5.1. Summary of Particle Experiments.
Detection TechniQue Particles Skin Section Results
Confocal Microscopy 2.16 g Sigma Epidermis Ambiguous detection
Light Microscopy All Sigma Epidermis LTRs on surface (does
not determine transport)
Gel Trapping 2.16 g Sigma, Epidermis <5 particles / mm 2
2.000 g Bangs
Membrane Trapping 2.16 g Sigma Epidermis No detectable transport
Fluorescence Spectrometry All Molecular Probes Epidermis, No detectable transport
Stratum Corneum
5.2. Particle Characteristics.
In these experiments, green fluorescent, carboxylate-modified polystyrene latex particles ("beads")
were supplied in the donor compartment. The green fluorescence allowed ready detection of the parti-
cles, the carboxylated surface groups gave a large net negative charge to each particle, and polystyrene
was not reactive with the skin. Three suppliers of the latex particles were used: Sigma, Bangs Labora-
tories (Carmel, IN), and Molecular Probes.
Table 5.2. Particles from Sigma (Sigma, personal communication).
Diameter ([) Concentration (particles / ml) Charge (e)
5.2.1. Particles from Sigma.
2.16 4.7 x 10 8  -2.77 x 10
7
1.01 4.6 x 10 9  -4.58 x 10
7
The green fluorescent (470 nm exci- 0.431 6.0 x 10 0  -2.33 x 10 6
tation, 505 nm emission), carboxylate- 0.105 4.1 x 1012 -1.39 x 10 5
modified polystyrene latex particles 0.035 1.1x O4 -4.05x10 3
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(Sigma) were shipped as a suspension of 2.5 vol% particles in water. No surfactants were used to
prevent possible bead aggregation (Sigma, personal communication). The particles were diluted 9:1 by
volume in PBS, to a final suspension concentration of 0.25 vol% particles. Particle diameters, surface
charges, and final concentrations are provided in Table 5.2. The 2.16 pi diameter particles were used
in the particle trapping experiments; the other sizes were used only for fluorescence microscopy
5.2.2. Microspheres from Bangs Laboratories.
Yellow fluorescent (460 nm excitation, 540 nm emission), 2.000 i diameter, carboxylated dyed
microspheres were obtained from Bangs Laboratories. The particle suspension had 10% solids and
contained an anionic surfactant to prevent aggregation. To remove the surfactant, 1 ml of microspheres
was centrifuged (Eppendorf Centrifuge 5415C, Brinkman Instruments, Westbury, NY) for 2 min, then
sonicated (Branson Ultrasonic Cleaner, Shelton, CT) for 2 min. After sonication, the supernatant was
decanted off and the microspheres resuspended in 1 ml of PBS. This process was repeated 5 times.
In the fifth cycle, the microspheres were sonicated for 10 min instead of 2 min. The final concentration
of microspheres was ~10% solids (~2.4 x101 beads/ml, -3.0 x 107 charge) (Bangs Laboratories, per-
sonal communication).
5.2.3. Particles from Molecular Probes.
The green fluor- Table 5.3. Particles from Molecular Probes (Molecular Probes, personal communication).
escent (490 n m Diameter ([) Fluorescence Color Concentration (particles / ml) Charge (e )
excitation, 515 nm 2.10 Green (490/515) 3.9 x 109  -5.75 x 10
emission) carboxylate- 1.03 Green (490/515) 3.3 x 1010 -4.68 x 10
modified polystyrene 0.557 Green (490/515) 2.1 x 10'" -1.13 x 10
latex particles prod- 0.216 Green (490/515) 3.6 x 10 -1. 29 x 10
0.093 Green (490/515) 4.5 x 1013  -1.73x 105
0.014 Green (490/515) 1. 3 x 1016  -2.65 x 102
Probes were slightly 1.03 Red (580/605) 3.3 x 1010 -4.68 x 107
brighter and more 0.557 Red (580/605) 2.1 x 10" -1.13x 107
highly charged than 0.216 Red (580/605) 3.6 x 10 2  -1. 29 x 10
6
the particles from 0.093 Red (580/605) 4.5 x 1013 -1.73 x 105
0.020 Red (580/605) 4.5 x 1015  -1. 26 x 103
Sigma (physical prop-
erties shown in Table 5.3), but sometimes aggregated when left undisturbed for several days. The red
fluorescent, carboxylate-modified polystyrene latex particles were similar to the green latex particles.
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The most important difference between the two types of particles was their fluorescence wavelengths
(580 nm excitation, 605 nm emission for the red fluorescent particles).
The particles were shipped as a suspension of 2 vol% beads in water, without any surfactant
(Haugland, 1992; Molecular Probes, personal communication). The diameters of the particles ranged
from 14 nm to 2.10 g. Before use, each particle suspension was diluted 9:1 by volume in PBS to a
final suspension concentration of 0.2 vol% solids, then sonicated for 15 to 30 min to prevent aggre-
gation (Branson Ultrasonic Cleaner). These particles were used for the fluorescence spectrometry
experiments.
5.3. Detection Procedures.
Many detection schemes were tried in this investigation, with varying degrees of success in the
unambiguous detection and quantification of particle transport. Either high-voltage pulsing, ionto-
phoresis, or no electrical treatment (passive control) was applied for I h (see Section 5.4). Afterwards,
one of the following detection methods was then used to assess particle transport through the skin.
5.3.1. Confocal Microscopy.
Initially, confocal microscopy was used as the particle detection technique. Since confocal micro-
scopy can focus on "optical planes" throughout a given specimen, without interference from underlying
or overlying planes, the goal was to unambiguously detect fluorescent particles completely contained
within the epidermis, indicating that transport of the particle through the entire stratum comeum had
occurred. Others (Hofmann, et at., 1995; Zhang, et at., 1997) had reported particle transport through
the stratum corneum; however, in those investigations, the skin was cut open using a knife (U. Pli-
quett, personal communication)! Obviously, this technique could distribute particles throughout the
skin simply by the mechanical grinding action of the knife blade, and thus, an unambiguous detection
method was needed.
A Bio-Rad MRC-600 Confocal Axioplan Microscope (Bio-Rad, Hercules, CA) was used to study
mounted skin specimens. After pulsing, the skin was stained with Nile Red (Molecular Probes), chosen
for its ability to stain the lipid regions in the stratum corneum (Prausnitz, et at., 1996 [a]). When ex-
cited, Nile Red emits red light; the latex particles used here were fluorescent green (Section 5.2.1).
Thus, the stratum corneum and the particles could be differentiated from each other under confocal
microscopy (Prausnitz, et al., 1996 [al).
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Immediately after each experiment, both the donor and receptor compartments were emptied, then
the skin was carefully removed and gently placed on a microscope slide (Gold Seal Rite-On, No. 3050,
Clay Adams, Becton Dickinson, Franklin Lakes, NJ). Excess liquid was blotted off with a paper towel.
Next, a drop of mounting solution was added (see Appendix 11.3). A 22 x22 No. 1 cover slip (Clay
Adams) was placed on top and sealed in place with nail polish (Hard as Nails, Sally Hensen, Del
Laboratories, Framingdale, NY) (Prausnitz, et at., 1996 [a]).
5.3.2. Fluorescence Microscopy.
In both fluorescence and light microscopy, light is passed through the entire specimen to the
observer. Thus, it is not possible to differentiate between the different layers of the skin with this
technique, unlike in confocal microscopy.
The goal of this section was not to determine if particle transport through the skin had occurred,
but to determine under what conditions LTRs formed on the surface of the skin after pulsing with a
particle suspension as the donor. LTRs had previously been observed after pulsing (Zewert, et at.,
1995; Pliquett, et at., 1996 [b]; Prausnitz, et at., 1996 [a]; Vanbever, et at., submitted), including
with a particle suspension (Prausnitz, et at., 1996 [a]).
A biocular fluorescence microscope (Olympus BH-2, Olympus, Woodbury, NY) allowed simul-
taneous fluorescence and light illumination of slides, gels, or membranes at 4x and lOx magnifi-
cations. The excitation source was a mercury arc lamp (Mercury-100, Chiu, Glen Cove, NY), using a
488 nm wavelength filter. Emitted light was viewed using a 515 nm wavelength filter (0515 filter,
Olympus). Pictures were taken using a camera (Olympus OM2, Olympus) mounted on the microscope
(Pliquett, et at., 1996 [b]).
After each experiment, the donor and receptor compartments were emptied. The skin was carefully
removed and gently placed on a microscope slide (Gold Seal Rite-On, No. 3050, Clay Adams, Becton
Dickinson). Excess liquid was blotted off with a paper towel. A drop of mounting solution was added
(see Section 11.3), and a 22x22 No. 1 cover slip (Clay Adams) was placed on top and sealed in place
with nail polish (Hard as Nails, Sally Hensen, Del) (Prausnitz, et at., 1996 [a]).
5.3.3. Particle Trapping with Gels.
Due to the difficulties in interpreting the confocal microscopy results (see Section 5.6, below), a
new approach was needed to detect and quantify particle transport. The goal of this section was to use
a gel to trap particles that have crossed the stratum corneum and the epidermis during pulsing. The
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gel had to allow ions and currents to move freely across, yet trap any Filter Paper Rubber
particles entering into it from the epidermis. with Hole
Two gels were tested in this investigation: an agarose gel and a Skin
polyacrylamide gel. Both had low electrical resistivities (each gel had a
resistivity of -100 Q m, comparable to PBS), were easy to prepare, and
did not allow any particles to diffuse across. The gel was held in place
behind the skin by a rubber hose washer (Price Hose Washers 0
No. 010W, Gilmour, Somerset, PA). The inner diameter of the washer
was smaller than that of the skin sample to ensure an electrically tight
seal (see Figure 5.1).
Agarose solution was first prepared by heating a 2 wt% solution of
agarose powder (Gibco BRL, Life Technologies, Gaithersburg, MD) in Gel Inside Washer
PBS to 100 *C. Upon cooling to room temperature, agarose solution Figure 5.1. Schematic diagram
of the gel trapping equipment. Be-
hardens into a gel. hind the skin was a rubber wash-
er containing either agarose or
Polyacrylamide solution was first prepared mixing together 0.75 g sacr gesk Partces tacrossed the skin would become
of 19:1 acrylamide:bis(N,N'-methylene-bis-acrylamide) powder (Bio- embedded in the gel.
Rad), 43.75 g1 of 440 mM (NH 4 )2 S 2 0 8 solution (Mallinckrodt), and 3 pl of N,N,N',N'-tetramethyl-
ethylenediamine (Bio-Rad) in 5 ml PBS. The polyacrylamide solution needed -10 min to harden into a
gel.
Immediately after preparation, the agarose or polyacrylamide solution was poured into the hose
washer and allowed to cool (for agarose) and harden into a gel (-10 to 15 min). Excess gel was carefully
scraped away with a razor blade.
A 0.5 inch diameter hole was punched out of a piece of 4.25 cm diameter filter paper (S & S Filter
Paper #595, Schleicher and Schuell, Keene, NH). The hole was smaller than the epidermis, so that the
epidermis could completely cover the hole.
Before the epidermis was loaded into the permeation chambers, the epidermis was first placed on
the filter paper. Both the epidermis and filter paper were then carefully laid on top of the gel. The
washer (with the skin, filter paper, and gel) was then loaded into the permeation chambers, with the
stratum corneum facing the donor side.
After each experiment, the donor and receptor chambers were emptied, then the washer containing
the gel was removed. The washer was set on a microscope slide and examined under a fluorescence
microscope (the one described in Section 5.3.2) at lOx magnification. Five locations were chosen at
random and the particles in those sections were visually counted and averaged together. Since the
diameter of the field-of-view under the microscope was known for this magnification (1.60 mm), by
assuming a uniform density of particles on the surface, the number of particles on the surface of the
stratum comeum could be estimated.
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5.3.4. Particle Trapping by Polycarbonate Membranes.
Since there was still some ambiguity in the results Filter Paper Polycarbonate Membranes
with Hole
obtained by the gels (see Section 5.8, below), poly-
carbonate membranes (Poretics, Livermore, CA) were
Skin ..
also used to trap particles for quantitative measure-
ment after they had been transported across the skin.
A filter hole size of 0.1 p was chosen since it would
not hinder ionic transport or offer any significant
electrical resistance, yet it would still be sufficient to
trap the 2.16 g diameter particles.
The epidermis (including the overlying stratum
corneum) was placed on a piece of filter paper with a
Figure 5.2. Schematic diagram of the membrane
hole in the middle. This was then placed on five trapping equipment. Particles are trapped in a series
of polycarbonate membranes. Particles crossing the
sheets of polycarbonate membrane filters, each with a skin become embedded in the first membrane. Theother membranes protect the first one from possible
mesh size of 0.1 p (see Figure 5.2). The entire ontamination.
assembly (skin, filter paper, and membranes) was loaded into the permetion chambers, with the
stratum corneum facing the donor side.
Fluorescent latex particles, with a diameter of 2.16 p (Sigma), were supplied in the donor com-
partment (0.25 vol% in PBS). During an experiment, particles transported across the epidermis and
the stratum corneum should become lodged in the first membrane. As a conservative precaution, the
other four membranes were used to protect the first membrane from contamination.
After each experiment, the donor and receptor compartments were emptied. The first polycarbonate
membrane was removed from the chamber, placed on a microscope slide, covered with a cover slip, and
sealed in place with nail polish. The other four membranes were discarded.
A biocular fluorescence microscope (described in Section 5.3.2), set at a magnification of 10 x, was
used to examine the first membrane and count the particles on it. Since the 2.16 la particles were large
enough to be individually seen at a magnification of 10 x, they could be individually identified and
counted. All of the particles on the polycarbonate membrane were counted several times to ensure an
accurate measurement. Typically, however, the total number of brightly fluorescent particles observed
on the polycarbonate membrane was <25.
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5.3.5. Detection by Fluorescence Spectroscopy.
In some experiments, particle transport was measured by spectrofluorimetry, which responds to the
total fluorescence within a sample volume and is not an actual particle count. In some of these experi-
ments, only the stratum corneum (no epidermis) was used to ensure that any particles transported
across the stratum corneum would not become trapped in the epidermis, allowing the detection of the
particles. Any particles transported across the skin should accumulate in the receptor compartment
during the experiment. Fluorescent latex particles from Molecular Probes were used in the donor com-
partment at a concentration of 0.20 vol% in PBS. The diameters of the fluorescent particles ranged
from 14 nm to 2.10 g.
After each experiment, the particle suspension in the receptor compartment was pipetted into a
1.5 ml disposable polystyrene microcuvette (Elkay, Shrewsbury, MA) and vigorously stirred to prevent
settling of particles. The microcuvette was then analyzed for fluorescence with a spectrofluorimeter
(Fluorolog II F1 12, Spex, Metuchen, NY). Excitation and emission wavelengths used were 490 nm and
515 nm, respectively.
5.4. Experimental Protocols.
Procedures used to prepare the skin (epidermis or stratum corneum only preparations) are
described in Appendix I; the experimental apparatus and detailed techniques used to prepare it are
described in Appendix III. Briefly, custom-designed, six port side-by-side permeation chambers, with
2
a skin exposure area of 0.64 cm (circular opening, 0.9 cm in diameter) (Crown Bio Scientific,
Somerville, NJ) (Friend, 1992), were fitted with silver wire electrodes in the donor and receptor com-
partments (Figure 111.2), surrounded by a PBS flow-protection system encased in polyacrylamide gel.
During an experiment, PBS was pumped around each electrode at a flowrate of -6 ml/min. This pre-
caution prevented contamination of the donor and receptor compartments by chemical by-products from
the electrodes, such as H+ and OH ions.
Applied electrical conditions included passive conditions (no pulsing) for 1 h, and constant current
iontophoresis at 1.0 and 10 mA / cm2 for 1 h, using a custom-built iontophoresis device (U. Pliquett,
personal communication). In the high-voltage pulsing experiments, high-voltage, exponentially-
decaying pulses were delivered to the permeation chamber by an exponential pulser (Electroporation
System 600, BTX), modified to deliver 1 pulse every ~5 s for 1 h (U. Pliquett, personal communication).
The time constant (r) for each pulse was set to -5 ms, but in some experiments it was systematically
changed from 1 to 15 ms. The applied voltage (Uapplied) was set to 1000 V, corresponding to a trans-
dermal voltage (U ski) of -150 V. However, in other experiments, Uapplied was also systematically
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changed, from 0 to 1500 V, corresponding to a Uski of 0 to -200 V (Chen, et at., 1998 [c]). Pulses
were applied to the skin for 1 h (approximately 720 pulses total). The negative pulsing electrode was
placed on the donor side of the chamber, and the positive electrode placed on the receptor side, to
provide a favorable driving force for the negatively charged particles.
The current delivered across the skin was determined by measuring the voltage drop across a
noninductive 1.2 Q, 50 W resistor in series with the chamber (Figure 111.6), and voltage drops across
the skin were measured using grounded high-voltage probes (Tektronics). The electrical resistance
between the two measuring electrodes due to the intervening PBS was previously determined by
pulsing the chamber without any skin present, as discussed in Section 3.5. Both the current and the
voltage drop were recorded every 15 min during pulsing and averaged together to approximately char-
acterize the transdermal voltage.
Initially, prepared cadaver skin (epidermis or stratum corneum) was floated in PBS to remove the
wax paper backing.
In the particle trapping experiments, five polycarbonate membranes with a mesh size of 0.1
(Poretics), were then placed on the epidermal side of the skin.
In the gel trapping experiments, the epidermis was first placed on the filter paper. Both the
epidermis and filter paper were then carefully laid on top of the washer containing the gel. The washer
(with the skin, filter paper, and gel) was then loaded into the permeation chamber.
In all cases, the skin was loaded into the permeation chamber with the stratum corneum side facing
the donor compartment. The temperature of the chamber was kept constant at 37 'C using a thermo-
stated water bath to continuously flush 37 'C water through the outer jackets of the chamber (see
Appendix III).
The condition of each piece of skin was checked by measuring its electrical impedance using a
custom-built device that applied a -1 kHz, -50 mV bipolar square wave across the skin, and measuring
the resulting voltage (U. Pliquett, personal communication). Skin with impedances <50 kQ cm 2 were
immediately discarded (Prausnitz, et al., 1993 [a]; Chen, et al., 1998 [b]; M. R. Prausnitz, personal
communication).
The donor compartment was filled with a donor particle suspension consisting of a single size of
particle in PBS, and the receptor compartment was filled with only PBS. Both compartments were
continuously stirred by magnetic stir bars. Prior to the experiment, a 1 h passive control period was
used to hydrate the skin (Prausnitz, et al., 1993 [a]) and check for leaks (holes or tears) in the skin.
Leaky skin (passive flux above the detection limit) was immediately discarded. After hydrating the
skin, either high-voltage pulsing, iontophoresis, or no pulsing (passive control) was applied for 1 h.
Each pulsing condition was repeated on 3 to 6 different pieces of skin to ensure reproducibility.
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5.5. Cleaning the Equipment.
Although the latex particles were highly charged, due to the large number of carboxylated surface
groups (-COO-), they were also found to be very hydrophobic as well, due to their composition
(polystyrene). Because of the strong hydrophobicity of the particles, extra care had to be taken to en-
sure adequate cleaning from the equipment.
A remarkably extensive amount of cleaning and washing was found to be required, to ensure that
the permeation chambers were adequately decontaminated of all fluorescent particles between experi-
ments. Between each experiment, the permeation chambers had to be soaked in a >10% bleach solu-
tion for >30 min, rinsed in de-ionized water three times, soaked in de-ionized water for >30 min,
soaked in chloroform (J. T. Baker, Phillipsburg, NJ) for >30 min, rinsed in de-ionized water' three
times, washed with detergent (Alconox, Fischer Scientific, Pittsburgh, PA) overnight (~12 h), rinsed in
de-ionized water three times, sonicated (Branson Ultrasonic Cleaner) for >30 min, then rinsed again in
de-ionized water three more times. The chambers were then carefully checked for contamination by
wiping all of the exposed surfaces with tissue paper and carefully examining the tissue paper under a
fluorescence microscope; any chamber still found contaminated with fluorescent particles was then
subjected to the entire washing protocol again. Other pieces of equipment, such as the pipettes, mem-
branes, and electrodes, were immediately discarded after each experiment to prevent contamination.
Without these extremely thorough precautions, it was found that contamination of the equipment by the
fluorescent particles between experiments could give completely erroneous results in the amount of
particle "transport" observed.
5.6. Confocal Microscopy Results.
It was found that under confocal microscopy, it was nearly impossible to determine the location of a
given particle, whether within the stratum corneum, epidermis, or on the surface. There was enough
ambiguity in the data that any results and interpretations from these experiments could be open for
debate. Reasons for the ambiguity came from the thickness of the optical section (comparable to the
thickness of the stratum corneum), the inability of the skin to lay perfectly flat on the microscope slide,
and the difficulty in distinguishing the stratum corneum and the epidermis. Given these difficulties,
confocal microscopy could not be satisfactorily used to determine whether particles were actually
transported through the stratum comeum or not.
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5.6.1. Optical Section Thickness Comparable to Stratum Corneum Thickness.
The confocal microscope allowed individual planes (optical sections) within the sample to be
studied, without interference from underlying or overlying planes. Although ideally these sections are
two-dimensional planes, in reality, there is some thickness to these optical sections. The optical sec-
tion thickness for the confocal microscope used in these experiments was found to be ~10 p. Thus,
objects separated by <10 pt would all appear to be within the same plane.
The stratum corneum itself is about 10 to 20 p thick (Elias, 1983). Thus with a 10 t thick optical
section, it would be nearly impossible to accurately determine if a given particle located by confocal
microscopy was actually in the epidermis, stratum corneum, or simply on the surface.
5.6.2. Skin Not Flat.
One problem with mounting the skin on a microscope slide is that the skin itself does not lie
perfectly flat on the slide. Skin is not a flat tissue, and on a microscopic scale, the skin appears some-
what warped. Thus, in optically sectioning the skin, the same optical plane may image the stratum
corneum in one section, but the epidermis in another section. This effect made it very difficult to
determine if a particle in a given location was actually in the epidermis or stratum corneum.
5.6.3. Cannot Distinguish the Stratum Corneum from the Epidermis.
Nile Red is a lipid staining compound; however, the intercellular regions of both the stratum
corneum and epidermis are rich in lipids. Thus, the cell outlines of both regions will be stained by
Nile Red. Usually the stratum corneum and epidermis are differentiated by cell morphologies; how-
ever, under confocal microscopy, since the skin does not lie flat on the microscope slide, it is im-
possible to accurately distinguish between the two regions. Thus, it was not possible to accurately
determine if a particle in a given location was within the epidermis or stratum corneum.
5.7. Light Microscopy Results.
In light or fluorescence microscopy, light is passed through the specimen to the observer. Thus,
molecular transport through the skin cannot be determined; light or fluorescence microscopy only
allows the direct observation of the skin after an experiment.
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Others have previously established a connection
between fluorescent regions within the skin after
pulsing and sites where molecular transport occurs
during pulsing with fluorescent molecules (Pliquett, et
al., 1996 [b]). Thus, experiments using fluorescence
microscopy can still give useful information.
5.7.1. No Bead Clustering during Passive Controls.
Figure 5.3. Particles on the skin after passive con-
trols. Scale bar = 200 g. Fluorescent latex particles
4rnteract vepr wePaklh ith the sulrfacep nf the skin No
After passive treatment of the skin (no high-voltage significant clustering of particles on the surface of the
skin were observed.
pulsing or iontophoresis) with the 2.16 p diameter
Sigma particles in the donor compartment for 2 h, a sparse, mostly homogenous dispersion of particles
was seen on the top surface of the skin under light microscopy (see Figure 5.3). Similar results were
obtained with 1.01, 0.431, and 0.035 p diameter particles. Without an external driving force, the
particles interacted only weakly with the stratum corneum and did not cluster together on the surface.
5.7.2. Iontophoresis Causes Clustering of Particles at Hair Follicles.
Application of constant current, 1 mA / cm2 lonto-
phoresis with the 2.16 p diameter Sigma particles in
the donor compartment for 1 h gave a sparse, mostly
homogenous dispersion of particles on the surface of
the skin. Moderate clustering of the particles was
found at the tips of the hair follicles. Similar results
were found with the 1.01 and 0.105 g diameter
particles.
Under 10 mA / cm2 lontophoresis, with 2.16 g Figure 5.4. Particles on the skin after iontophoresis.
diameter particles in the donor compartment for 1 h, lontophoresis caused the transport of latex particlesprimarily into the hair follicles (bright spots near
center of photomicrograph). Particles were also trans-
very large concentrations of fluorescent particles were ported to the skin in areas away from the hair folli-
cles. Compare with Figure 5.3. Scale bar = 200 t.
found at the tips of the hair follicles. The rest of the
surface of the skin showed very dense, homogenous dispersions of particles (Figure 5.4).
Ion transport across the skin during iontophoresis is believed to occur primarily across sweat ducts
and hair follicles (Grimnes, 1984; Burnette and Ongpipattanakul, 1988; Cullander and Guy, 1991;
Scott, et al., 1993); however, some current may also cross the stratum corneum itself (Potts, et al.,
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1992; Monteiro-Riviere, et al., 1994). In the current set of experiments, most of the charged particles
appeared to follow the electric field lines and cluster near the hair follicles; however, away from the
hair follicles, particles could also be found on the surface of the stratum corneum. This effect seemed
more pronounced at higher applied currents. Thus, during iontophoresis, the transport of particles
into the skin appears consistent with previous observations of molecular transport through the skin.
5.7.3. Particle Clusters on the Skin after Pulsing were Similar to LTRs.
With the 2.16 g diameter Sigma particles, fluorescence microscopy after pulsing (Uapplied = 1000 V,
corresponding to Uskin - 150 V, t = 5 ms, 1 pulse every 5 s for 1 h) revealed the presence of small,
fluorescent clusters of particles on the surface of the stratum corneum (Figure 5.5), ~200 g in dia-
meter. These clusters were not observed in the passive controls. These clusters were randomly
distributed on the surface of the skin, and were not associated with sweat ducts or hair follicles.
The clusters of particles observed on the surface of the skin after pulsing were reminiscent of the
"localized transport regions" (LTRs) that were seen on the surface of the skin after applying high-voltage
pulsing to the skin (Zewert, et at., 1995; Pliquett, et al., 1996 [b]; Prausnitz, et al., 1996 [a]; Chen, et
al., 1998 [b]; Vanbever, et al., submitted). The clustering of particles after high-voltage pulsing has
previously been reported by Prausnitz, et al. (1996 [a]), who demonstrated the transport of fluorescent
latex particles to the surface of the skin by confocal microscopy; however, there was no attempt to
measure particle fluxes through the skin.
The clusters of particles present on the surface of the skin are not actually LTRs, since there was
no significant transport of any particles through these regions or even through the skin itself (see Sec-
tions 5.8 through 5.10, below). However, the appearance of the particle clusters on the surface of the
skin was found to be similar to the LTRs. The clusters of particles were randomly distributed, and not
associated with sweat ducts or hair follicles (Zewert, et al., 1995; Pliquett, et al., 1996 [b]; Prausnitz,
et al., 1996 [a]; Chen, et al., 1998 [b]; Vanbever, et al., submitted).
Given that the particles were highly negatively charged, the same mechanism could be transporting
both molecules and particles to the surface of the skin. During high-voltage pulsing, localized ion
currents are believed to cross the skin and may be responsible for creating the LTRs for calcein and
sulforhodamine (Pliquett, et al., 1996 [b]). Thus, localized ion currents across the surface of the skin,
created during high-voltage pulsing, could also be responsible for transporting particles to the surface
of the skin and depositing them in clusters. Although there is no significant transport of particles
through the stratum corneum during high-voltage pulsing, the appearance and behavior of particle
clusters on the surface of the skin is very similar to the appearance and behavior of LTRs.
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Figure 5.5. Particles on the skin after pulsing as a function of particle size. These photomicrographs of the stratum
corneum of human skin were taken under fluorescence microscopy after pulsing. Scale bar = 200 pg. The diameters
of the particles present in the donor compartment were as follows: (a) 2.16 g, (b) 1.01 g, (c) 431 nm, (d) 105 nm,
and (e) 35 nm. For all of the particles except the 35 nm diameter particles (e), prominent clusters of particles were
observed on the surface of the skin (some indicated by arrows), randomly distributed, and not associated with sweat
ducts or hair follicles. The circular regions in (b) are trapped air bubbles.
5.7.4. Similar Clusters Observed for Different Particle Sizes.
Under the same pulsing conditions (Uapplied = 1000 V, corresponding to U -~ 150 V, t = 5 ms,
1 pulse every 5 s for 1 h), using fluorescent particles in the donor compartment with diameters ranging
from 35 nm to 2.16 g (particle diameters shown in Table 5.2), resulted in the appearance of small,
fluorescent particle clusters on the surface of the stratum corneum (Figures 5.5a through 5.5e). The
number of clusters appearing on the skin in each case was approximately the same, -3 clusters / mm2
-69-
I
(Figure 5.6a). The diameter of the clusters for each case was also similar, -200 t (Figure 5.6b), except
with the smallest (35 nm diameter) particles, where no particle clusters were observed.
The size or charge of the particles did not appear to have a major effect on the formation of clusters
on the surface of the skin during high-voltage pulsing. The formation of particle clusters appears to
depend more on the applied pulsing conditions, rather than the physical properties of the particles.
5.7.5. Clusters of Particles Found Above ~70 Vskin .
With 2.16 g diameter particles in the donor compartment, using the same protocol (t = 5 ms,
1 pulse every 5 s for 1 h), Uapplied was systematically changed from -1000 V (which corresponds to
U~ski - -100 V) through 0 V (passive control), up to 1500 V (corresponding to Ukin ~ 200 V).
Fluorescence microscopy of the skin revealed an increase in the surface density of particle clusters
observed on the surface of the skin with increasing voltage (see Figures 5.7a through 5.7e, data shown
in Figure 5.8a), up to ~8 clusters / mm2 at Uapplied = 1500 V; however, after Uapplied = 500 V
(corresponding to U - 100 V), the diameter of the particle clusters appearing on the surface of the
skin stayed fairly constant at ~200 p (Figure 5.8b).
Very few particle clusters were observed on the skin after pulsing at Uapplied = 500 V, which corre-
sponds to Usin -70 V. No particle clusters were observed at voltages less than U,,ki - 70 V,
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Figure 5.6. Effect of particle size on number density (a) and diameter (b) of particle clusters. (See Figures 5.5a
through 5.5e). The diameter of the particles used in the donor compartment varied from 35 nm to 2.16 g. Except
for the smallest (35 nm) particles, both the density and the size of the clusters observed on the stratum corneum after
high-voltage pulsing were almost the same, regardless of the size of the particles.
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Figure 5.7. Particles on the skin after pulsing as a function of the applied voltage. These photomicrographs of the
stratum corneum were taken under fluorescence microscopy, with varying applied voltages (2.16 p diameter particles,
Uapplied from 0 V to 1500 V, c = 5 ms, 1 pulse every 5 s for 1 h). Scale bar = 200 g. Clusters of particles were
observed on the surface of the skin at U appl > 250 V, randomly distributed on the surface, and not associated with
sweat ducts or hair follicles (some particle clusters indicated by arrows). (a) Uapplied = 0 V (passive control, no applied
pulses. Us = 0 V). (b) Uapplied = 250 V (U l - 50 V). (c) Uapplied = 500 V (U - 100 V). (d) UappIed = 1000 V
(Ua - 150 V). (e) Uapplied = 1500 V ( U8 - 200 V).
including reverse pulsing at Usk ~ - 100 V (pulsing with the positive electrode in the donor compart-
ment and the negative electrode in the receptor compartment). This is similar in behavior to the LTRs,
which also increase in number density with increasing Uapplied (and hence U sin), while remaining
constant in size (Vanbever, et al., submitted).
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Figure 5.8. Effect of applied voltage on number density (a) and diameter (b) of particle clusters. These data corre-
spond to Figures 5.7a through 5.7e. For Uapplied > 250 V, the sizes of the clusters of particles remained fairly
constant, but the number of clusters observed increased with the voltage.
These results were consistent with the idea that high-voltage pulsing of the skin below Us, - 75 V
does not cause electroporation of the stratum corneum (Chizmadzhev, et al., 1998 [a]), or increased
molecular or ionic transport (see also Section 8.2.4). Since the creation of both particle clusters and
LTRs appears similar under various conditions, similar mechanisms are probably responsible for their
creation.
5.7.6. Cluster Sizes Increase with Time Constant.
Using the same pulsing protocol (U applied = 1000 V, corresponding to Usi 150 V, with 1 pulse
every 5 s for 1 h) with the 2.16 pt diameter particles, systematically altering x from 1 ms to 15 ms,
resulted in changes in both the number and size of the particle clusters observed after 1 h of pulsing
(Figures 5.9a through 5.9f). The diameters of the clusters of particles increased from almost un-
detectable clusters at r = 1 to 3 ms, up to -700 pt at t = 15 ms (Figure 5. 10a). Conversely, the
number of clusters observed on the surface of the skin decreased, from ~2 clusters / mm2 at t = 5 ms,
down to -0.2 clusters / mm 2 at x = 15 ms (Figure 5. 1Ob).
With the application of high-voltage pulsing with T = 15 ms, red regions were found in the skin in
the centers of the particle cluster areas. These regions appeared red due to the presence of the Nile
Red stain, indicating that these areas were filled with lipophilic material.
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With increasing c, there was an increase in the size of the particle clusters (Figure 5. 1Ob), and a
decrease in the number density (Figure 5. 10a). Similarly, for LTRs, with increasing t, there was an
increase in the size of the LTRs and a decrease in the number density (Vanbever, et al., submitted).
The similarity in results between particle transport and molecular transport could indicate that similar
mechanisms are involved.
Figure 5.9. Particles on the skin after pulsing as a function of the time constant. These photomicrographs of the
stratum corneum were taken under fluorescence microscopy, with r varying from 1 ms up to 15 ms (2.16 g diameter
particles, U = 1000 V, corresponding to U 150 V, 1 pulse every 5 s for 1 h). Scale bar = 200 .
Increasing T resulted in smaller numbers and larger clusters of particles, randomly distributed on the surface of the
skin, not associated with sweat ducts or hair follicles (some clusters indicated by arrows). (a) r = 1 ms. (b) T = 2 ms.(c) T = 3 ms. (d) r = 5 ms. (e) r = 10 ms. () r = 15 ms. The circular rings in (d) are trapped air bubbles.
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Figure 5.10. Effect of time constant on number density (a) and diameter (b) of particle clusters. These data corre-
spond to the experiments described in Figures 5.9a through 5.9e. The clusters of particles observed on the surface of
the skin appeared to increase in size and decrease in number, for increasing 'r.
5.8. Particle Counting by Gel Trapping.
During the gel trapping experiments, it was eventually found that the amount of particle transport
appeared to be a function of the date of the experiment. In general, more particle transport was ob-
served on later dates rather than on earlier dates. In fact, the date appeared to have a much stronger
effect than the actual electrical conditions applied to the skin.
Further investigation into this phenomenon yielded the cause of this relationship: the fluorescent
polystyrene particles were very hydrophobic and adhered so strongly to the glass chambers that after
several months' worth of experimentation, all of the glass chambers had been severely contaminated by
polystyrene particles. Given this contamination, a very stringent washing program was established
(previously described in Section 5.5), but even with these precautions, some contamination of particles
still remained. Despite the lower level of contamination, it was still impossible to conduct any more gel
trapping experiments due to the remaining contamination problems, so only an upper limit of particle
transport could be established.
5.8.1. Particles Adhere to Equipment.
Despite much careful washing of equipment as previously described (Section 5.5), it was found that
the polystyrene particles adhere to the equipment very strongly and come off only slowly. Some
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be adhering to the equipment even after
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Due to the particle contamination
problems, only an upper limit could be
established for particle transport. This Figure
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previously described in Section 5.5. The was nea
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same upper limit was found in the
passive controls (no pulsing for 2 h), ionto-
phoresis (1 mA / cm2 for 1 h), and high-voltage
pulsing (U 8 f -100 V, 1 pulse every 5 s for 1 h,
T = 5 ms) (Figure 5.11).
5.9. Particle Counting by Membrane
Trapping.
The total number of 2.16 p diameter particles
found in the polycarbonate membranes after 1 h
of pulsing was comparable to the passive controls
(Figure 5.12). Smaller particle sizes were more
difficult to trap with the polycarbonate membranes
and hence were not counted.
Examination of blank slides exposed to just
human skin for 1 h (no fluorescent particles)
under fluorescence microscopy showed that ran-
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r the detection limit, -5 particles / mm2, corresponding to
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FIgure 5.12. Counts of particles trapped by polycarbonate
membranes. These counts are only for the 2.16 ~±dia-
meter particles, which were easily trapped by the 0.1 p
mesh po ycarbonate membrane filters. There was no sig-
nificant difference between the passive controls and high-
voltage pulsing. Measurement values were near the detec-
tion limit of the system. Hence, there does not appear to
be any transport of particles across the stratum corneum
due to high-voltage pulsing
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dom bits of dust were sometimes fluorescent, and these bits of dust could sometimes be confused with
the particles. Thus, an error of ±1 particle per field-of-view was used (one field-of-view under the
microscope was a circle 1.60 mm in diameter). This is the detection limit drawn in Figure 5.12. An
error rate of 1 particle per field-of-view corresponds to a total error rate of ±60 particles transported
across the skin, much less than the 1.4 x 10 particles provided in the donor compartment.
2
Thus, with this detection system, <1 particle / mm of transport was observed in both the high-
voltage pulsing experiments (Uapplied = 1000 V, which corresponds to Uskin - 150 V, T = 5 ms, 1 pulse
every 5 s for 1 h) and in the passive controls (no pulsing), where the lower limit of particle detection,
1 particle / mm 2, was governed by the amount of fluorescent debris present on the surface of the skin.
5.10. Particle Detection by Fluorescence Spectrometry.
Unlike the particle counting experiments, fluorescence spectroscopy techniques were not limited by
particles >1 p in diameter. Thus, in this set of experiments, particles ranging in diameter from 14 nm
to 2.10 g were used, all from Molecular Probes (Table 5.3). In addition, some of the experiments used
stratum corneum only preparations instead of epidermis, eliminating the epidermis as a possible
barrier to particle transport.
5.10.1. No Increase in Fluorescence After High- 4.0
Voltage Pulsing or Iontophoresis.
II-
. 3.0
The fluorescence detected in the receptor 0. 2.5
compartments after passive controls (no pulsing for C 2.0
2 h), iontophoresis (1 mA / cm 2 for 1 h), and high-
1.5
voltage pulsing (Uapplied = 1000 V, corresponding to IL
1.0 -
Un - 150 V, r = 5 ms, 1 pulse every 5 s for 1 h) .9
did not differ significantly from each other, for E 0.5d
experiments involving either the epidermis (with 0
> O ) c > O > O C
the stratum corneum) or only stratum cormeum. a.
See Figures 5.13 (epidermis) and 5.14 (stratum 0 0 [ LO LO)6 i 60 0 60 C
corneum only). In addition, increasing x from 5 ms Figure 5.13. Particle detection after transport through
the epidermis. The particles were detected in the receptor
to 300 ms did not increase the fluorescence compartment using fluorescence spectroscopy. The re-
sults of high-voltage pulsing conditions ("Pls") are normal-
detected in the receptor compartment (data not ized to passive controls ("Psv"). Points represent individual
experiments; columns represent averages. No significant
shown). enhancement to particle transport was observed.
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In Figure 5.14, the striped bars show the 8
receptor compartment fluorescence after 1 h of Passive ControlII g Pulsing for 1 hS7passive control (no pulsing), and the solid bars C
0
show the receptor compartment fluorescence after 6
1 h of pulsing. For each of the particle sizes
%C15
used, the calibration curves showed a linear (D0
relationship between the concentration of the 4
particles and the observed fluorescence; how- 0
ever, there was a lower limit of fluorescence that I
o 2
could be detected by the spectrofluorimeter. This N
Detection
level has been normalized to 1 in Figure 5.14. In 1 Limit
0Table 5.4, the minimal number of particles that Z
c0 (no beads) 0.014 0.216 0.557 1.03 2.10
could be detected with this technique are given. Diameter of Particles in the Donor Compartment (p)
In Figure 5.14, each of the passive controls
Figure 5.14. Particle detection after transport through the
did not show significantly more fluorescence than stratum corneum. All of the fluorescence data have been
normalized to the detection limit. With both the zero parti-
the detection limit of the spectrofluorimeter. cle control and all of the particle sizes used, applyingIusing caused a roughly 3- to 5-fold enhancement in the
Nuorescence. This increase is probably not due to particleThus, under passive controls, no significant Part- transport, but instead may be due to the release of fluore-
scent materials from the skin.
icle transport through the skin was detected.
At first glance, it may appear that high-voltage pulsing causes some particle transport across the
stratum corneum. However, even if there are no particles in the donor compartment, there is still a
roughly 5-fold increase in the fluorescence of the receptor compartment (pair of bars on the far left).
This "enhancement" of fluorescence is probably not due to particle transport across the stratum
corneum, but instead it could possibly be the release of autofluorescent materials from the stratum
corneum.
5.10.2. Upper Limit of 14 nm Established for Pathway Size.
Previous studies have shown that the LTRs on the surface of the skin represent areas of increased
ionic and molecular transport during pulsing (Pli- Table 5.4. Particle Detection Limits.
quett, et al., 1996 [b]). With the current set of experi-
Diameter (ji) Detection Limit (particles / mm2I
ments, it was shown that the particles collect on the
2.10 3.0 x 103
surface of the skin during pulsing (Figures 5.5a 1.03 8.7 x 103
through 5.5e, 5.7a through 5.7e, and 5.9a through 0.557 1.8 x 10 5
5.9f), yet there is no significant transport of any of the 0.216 2.6 x 106
particles across the stratum corneum (Figures 5.11 0.014 8.5 x 109
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I
through 5.14). Hence, the transient aqueous pathways that are believed to be forming during high-
voltage pulsing (Prausnitz, et al., 1993 [al; Chizmadzhev, et al., 1995; Chizmadzhev, et al., 1998 [a])
appear to be too small to allow the transport of particles. The smallest particles used here had a
diameter of 14 nm; thus, if aqueous pathways are forming through the stratum corneum during
pulsing, the average diameter of the pathways must be less than 14 nm. This is in agreement with
theoretical calculations that have predicted a pathway diameter of -0.4 nm (Chizmadzhev, et al., 1995),
which would allow the passage of ions and molecules across the skin, but not microparticles.
5.11. Conclusions.
Applying a series of short (,t - 5 ms), high-voltage pulses to human skin (Uapplied - 1000 V,
corresponding to U ski - 150 V, 1 pulse every 5 s for 1 h) caused fluorescent, latex particles (14 nm to
2.10 i in diameter) to form clusters on the surface of the stratum comeum, where the clusters were
randomly distributed and not associated with sweat ducts or hair follicles. This was similar in appear-
ance to "localized transport regions" observed with the molecular transport of fluorescent tracers.
These clusters of particles were roughly 100 p in diameter, regardless of the size of the particles used.
The clusters increased in number density with the transdermal voltage, and increased in size with the
time constant. They appeared to form at transdermal voltages >70 V. Under passive controls (no
pulsing), no clusters of particles appeared. Under 1 mA / cm2 iontophoresis, particles appeared near
the hair follicles. Overall, the behavior of the particles on the surface of the skin was very similar to the
LTRs observed after molecular transport.
However, no particle transport was ever observed through the stratum comeum, under any of the
electrical pulsing protocols, or with any of the detection techniques. Since the smallest particles used
were 14 nm in diameter, the size of the aqueous pathways that form across the skin during high-voltage
pulsing ("electroporation") must be <14 nm.
Extremely careful analysis, preparation, and cleaning techniques are essential to ensure that false
positive results do not occur during experimentation. Based on these results, it was felt that particles
could not be transported through the human stratum corneum simply by means of high-voltage pulsing.
Additional effects, such as mechanical or pressure forces, may be required to transport particles
through the skin, but were not studied here.
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6. On the Use and Detection of Peptides to Study Molecular Transport.
In the study of skin electroporation, factors important for molecular transport include both the
properties of the applied electrical pulse (transdermal voltage, shape, time constant, pulsing frequency,
and the number of pulses) (Prausnitz, et al., 1993 [a]; Vanbever, et al., 1994; Pliquett, et al., 1995
[a]; Vanbever and Pr6at, 1995; Pliquett and Weaver, 1996 [a]; Prausnitz, et al., 1996 [b]; Vanbever,
et al., 1996 [b]), and the physical properties of the molecules being transported (size, charge, and
hydrophilicity) (Prausnitz, et al., 1993 [a]; Pliquett and Weaver, 1996 [al). The original purpose of this
study was to determine how the size and charge of a molecule can affect transport across the skin
during high-voltage pulsing.
HPLC, or high performance liquid chromatography, is a technique that has been developed to detect
and separate molecules at low concentrations. Molecules that have been analyzed using HPLC include
biological entities such as peptides, proteins, sugars, and hormones. Molecules are put into solution
(the "mobile phase"), which is run through a silica column under high pressures. The molecules are
separated by their differences in their interactions with the column packing (the "stationary phase"),
which affects how long the molecules will remain in the column (the "retention time"). Interactions with
the column packing can be through hydrophilic interactions ("normal phase"), hydrophobic interactions
("reverse phase"), size exclusion, antibody binding, as well as many other types. The most common
type of molecular detection is with UV absorbence (190 nm to 400 nm). It has been known to detect
proteins at concentrations down to 1 nM (Hancock and Sparrow, 1984; Henschen, et al., 1985).
6.1. Peptides.
A set of molecules with similar properties, varying only one property at a time, was to be studied.
Peptides were chosen for this study, since any sequence could be easily synthesized (MIT Biopolymers
Laboratory, Cambridge, MA, personal communication), and the size and charge of the peptide could be
independently specified, based on the chosen amino acid sequence. However, due to the lack of a de-
fined protocol, this section will briefly describe some of the techniques tried in this project, and their
limitations.
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Table 6.1.
Formula
Glu
Glu 
- Leu 2
Glu - Leu 4
Sources and Molecular Weights of Glu - Leu..
MW (DaL Source
147 Sigma
373 MIT Biopolymers Laboratory
600 MIT Biopolymers Laboratory
6.1.1. Glu - Leun Series.
Glutamate, Glu Leucine, Leu
Figure 6.1. Molecular structures of glutamate
The first series of peptides examined was Glu - Leun , and leucine. Glutamine is negatively charged, but
leucine is neutral at pH - 7.
where Glu is the abbreviation for glutamate and Leu is the
abbreviation for leucine. The number of leucine residues varied from 0 to 4, as shown in Table 6.1.
Figure 6.1 shows that glutamate had a net charge of -1 at a pH of -7.4, while leucine was uncharged.
Amino acids link together to become peptides via an amide bond, where the -COOH group reacts with
the -NH 2 group to form a -CO - NH - bond, linking the two amino acids, with H 2 0 as the by-product.
Thus, each of these molecules had a charge of -1, while the molecular weights varied from 147 Da to
600 Da.
These peptides were found to be unsatisfactory, due to their very low solubilities in PBS. Although
Glu and Glu - Leu 2 were able to dissolve at concentrations of 1 mM, the solubility of Glu - Leu 4 in PBS
was found to be about 0.3 mM. Since the leucine residues were very hydrophobic, further additions of
leucine onto the peptide chain would decrease the solubility of the peptide chain even further, making
this series of peptides unsuitable for study.
6.1.2. Glu - G1nn Series.
The second series of peptides examined was Glu - Gln,, where glutamine, or
Gln, was chosen to replace leucine. See Table 6.2. Glutamine was an amine
and was therefore less hydrophobic than leucine. As shown in Figure 6.2,
glutamine had no net charge. Thus, these peptides should have been more
hydrophilic than the Glu - Leun series.
The Glu - Glnn peptides, all with -1 net charge, were indeed found to be
very hydrophilic and dissolved easily in PBS. The MIT Biopolymers Laboratory
reported that these peptides were, in fact, too hydrophilic to adhere well to their
HPLC C18 column (MIT Biopolymers Laboratory, personal communication).
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NH 2 - CH -COOH NH 2 -CH -COOH
CH2 CH2
CH 2CH 
-CH32 2
C00~ CH
NH2 -- CH-COOH
CH
2
OH
2
CO
NH 2
Glutamine, Gin
Figure 6.2. Molecular
structure of glutamine.
Glutamine is a hydro-
philic amino acid.
6.2. HPLC Machines.
There were two HPLC machines that were Table 6.2. Sources and Molecular Weights of Glu - Gin .
examined in this study. The first machine Formula MW IDa) Source
was a Millennium/Waters 510 system (Mil- Glu 147 Sigma
ford, MA). The columns tried on this system Glu - Gin 2  402 MIT Biopolymers Laboratory
were the polyaspartic acid column (see Glu - Gln4 659 MIT Biopolymers 
Laboratory
Section 6.3.1), and the C18 column (Section 6.3.2). The second HPLC machine was a Hewlett-Packard
HP 1090 system (Palo Alto, CA). The columns tried on this system were the C1 8 small bore column
(Section 6.3.3), and the polyhydroxyethyl aspartamide hydrophilic interaction column (Section 6.3.4).
For both machines, the mobile phase consisted of two parts: an aqueous phase (PBS) and an organic
phase (HPLC-grade acetonitrile, J. T. Baker), mixed in different ratios.
6.3. HPLC Columns.
Four different HPLC columns were tested to see if they could adequately separate and resolve the
peptide sequences. Many operating conditions were also tried for each column to determine if separa-
tion of the peptides could be readily achieved.
6.3.1. Polyaspartic Acid Column.
The first column was a polyaspartic acid weak cation exchange column (4.6 mm inner diameter x
200 mm length, 5 p silica packing, 300 A pores) (Nest Group, Southborough, MA). The aqueous phase
was varied from 0 to 100% of the mobile phase. Despite the claims of the supplier, this column was not
suitable for separating negatively charged peptides, and could only be used to separate positively
charged peptides. It was unable to resolve small peptides which differed only on the basis of their size.
6.3.2. C 18 Column.
The second column was a C18 reverse phase column (4.6 mm inner diameter x 200 mm length,
5 g silica packing, 300 A pores) (Nest Group). The aqueous phase was varied from 0 to 100% of the
mobile phase. This column was borrowed from a co-worker and was about a year old when used.
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Although early experiments had shown promise, after several months, it was found that this column was
losing its performance characteristics and was no longer able to adequately separate peptides.
6.3.3. C1 8 Small Bore Column.
The third column was a C,8 reverse phase small bore column (4.6 mm inner diameter x 200 mm
length, 5 g silica packing, 90 A pores) (Vydac, Hesperia, CA). The smaller pores (90 A pores instead of
300 A) allowed the column to separate smaller and more hydrophilic peptides. The aqueous phase was
varied from 0 to 100% of the mobile phase. Unfortunately, the Glu - Glnn peptides were still too
hydrophilic to be adequately separated by this column.
6.3.4. Polyhydroxyethyl Aspartamide Column.
The final column used was a polyhydroxyethyl aspartamide hydrophilic interaction chromatography
column (4.6 mm inner diameter x 200 mm length, 5 silica packing, 200 A pores) (PolyLC, Columbia,
MD). The aqueous phase was 80% of the mobile phase. Both phases were also spiked with 5 mM
triethylamine phosphate (made from triethylamine (Aldrich, Milwaukee, WI) in phosphoric acid (Aldrich)
and water, then pH adjusted). Due to the hydrophilic stationary phase, this column was able to ad-
equately resolve the Glu - Gln. peptides into distinct peaks.
6.4. Conclusions.
The Glu - Gln, peptides developed in this study were found to be separable by HPLC techniques
under suitable conditions (polyhydroxyethyl aspartamide column, 215 nm wavelength detection). The
peptides could be detected down to a concentration of -0. 1 mM. Unfortunately, with a starting donor
concentration of 1 mM, this technique would give a working detection range of only 1 order of mag-
nitude. This would not be suitable for detecting peptide transport through the skin after high-voltage
pulsing, which would require a detection range of at least 4 orders of magnitude, down to ~100 nM.
Using a higher starting concentration of peptides would not be reasonable, due to both the change
in donor osmolarity and the cost. Both the donor and receptor compartments need to have the same
osmolarity, to prevent passive transport due to osmolarity gradients. Also, the receptor compartment is
usually filled with 150 mM PBS, mimicking physiological conditions. Thus, the donor concentration of
peptide could not be increased above 150 mM. In addition, the cost of the peptide was about
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$300/100 mg, or about $3 per experiment. Increasing the donor concentration of peptide to 100 mM
would thus cost $300 per experiment, which would not be a reasonable cost for the -100 experiments
that would have eventually been required.
During this study, it was found that the reason peptides cannot be detected at lower concentrations
was due to the number of double bonds within the peptide. UV detection measures, in essence, the
number of double bonds present within a sample. A typical protein has a molecular weight of
~100 kDa and has many double bonds, even at low concentrations. The small molecular weight
peptides used here, on the other hand, were -100 Da and had only a few double bonds. A greater
concentration of the peptide would therefore be necessary for adequate detection. Thus, to measure a
peptide at a concentration of -100 nM, HPLC techniques are not adequate, and a fluorescent or
radioactive tag on the peptide would be necessary.
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7. Localized Transport Regions are Created during Skin Electroporation.*
Applying a series of high-voltage pulses to human skin has been shown to cause the transport of
many types of molecules through the skin in significant amounts. Molecules that have been trans-
ported across the skin include charged, fluorescent molecules such as calcein (Prausnitz, et at, 1993
[a]; Prausnitz, et al., 1993 [c]; Prausnitz, et al., 1994; Pliquett, et al., 1995 [b]; Kost, et al., 1996;
Pliquett and Weaver, 1996 [a]; Pliquett and Weaver, 1996 [b]; Pliquett, et al., 1996 [b]; Prausnitz, et
al., 1996 [b]; Chen, et al., 1998 [b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted), sulfo-
rhodamine (Kost, et al., 1996; Pliquett and Weaver, 1996 [a]; Pliquett, et al., 1996 [b]; Chen, et al.,
1998 [b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted), and lucifer yellow (Prausnitz, et al.,
1993 [a]; Chen, et al., 1998 [c]), and drugs such as luteinizing hormone releasing hormone (LHRH)
(Bommannan, et at, 1994; Riviere, et al., 1995), metoprolol (Vanbever, et al., 1994; Vanbever and
Pr6at, 1995), fentanyl (Vanbever, et at., 1996 [al; Vanbever, et at., 1996 [b]; Vanbever, et al., 1998
[a]; Vanbever, et at., 1998 [b]), domperidone (Jadoul and Preat, 1997), alnitidan (Jadoul, et at., 1998),
and cyclosporin A (Wang, et at., 1998). Larger molecules have also been successfully transported
across the skin, including heparin (Prausnitz, et at., 1995 [b]; Vanbever, et at, 1997; Weaver, et at,
1997) and several oligonucleotides (Zewert, et al, 1995; Regnier, et at, in press [a]).
It has been hypothesized that the mechanism for molecular transport during high-voltage pulsing
involves electroporation (Prausnitz, et al., 1993 [a]; Chizmadzhev, et at., 1995; Pliquett and Weaver,
1996 [a]; Chizmadzhev, et at., 1998 [a]). Applying a series of high-voltage pulses to the skin causes
small, localized transport regions, or "LTRs," to appear in the stratum comeum (the uppermost layer of
the skin), through which molecular transport is concentrated (Zewert, et al, 1995; Pliquett, et at., 1996
[b]; Prausnitz, et at., 1996 [a]; Chen, et al., 1998 [b]; Vanbever, et at., submitted). The LTRs are
typically -100 i in diameter and can be found randomly distributed in the stratum corneum after
pulsing. The LTRs are not associated with the sweat ducts or hair follicles (Pliquett, et at., 1996 [b]).
lontophoresis can also be used to transport drugs or other molecules through the skin. This low-
voltage method involves application of a small, often constant current (typically <0.5 mA / cm2) to the
skin (Tyle, 1986; Banga and Chien, 1988; Burnette, 1989; Chien and Banga, 1989; Singh and
Roberts, 1989; Cullander and Guy, 1992; Amsden and Goosen, 1995; Guy, 1996). lontophoretic
transport occurs primarily through hair follicles and sweat ducts in the skin (collectively called the
"appendages") (Abramson and Gorin, 1940; Abramson and Engel, 1942; Grimnes, 1984; Burnette
and Marrero, 1986; Burnette and Ongpipattanakul, 1988; Cullander and Guy, 1991; Scott, et at,
1993; Chen, et at., 1998 [b]; Chen, et at, in press [b]), although some molecular transport may also
*The fluorescence microscopy work has also been reported in Chen, et al (1998 [b]).
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be occurring through the stratum corneum itself (Potts, et al., 1992; Monteiro-Riviere, et al., 1994).
However, electrical currents greater than 0.5 mA / cm2 can stimulate nerves within the skin, causing
irritation or pain (Banga and Chien, 1988; Burnette and Ongpipattanakul, 1988; Ledger, 1992).
The purpose of this investigation was to determine whether electroporation and iontophoresis are
fundamentally different phenomena, a distinction that has previously been raised (Inada, et al., 1994).
In these experiments, both phenomena were studied using different animal skins as models for human
skin, which have different densities of hair follicles, but were otherwise similar to human skin. Hair
follicles are believed to be important for molecular transport during iontophoresis (Abramson and
Gorin, 1940; Abramson and Engel, 1942; Grimnes, 1984; Burnette and Marrero, 1986; Burnette and
Ongpipattanakul, 1988; Cullander and Guy, 1991; Scott, et al., 1993; Chen, et al., 1998 [b]; Chen,
et al., in press [b]), but not during high-voltage pulsing (Pliquett, et al., 1996 [b]; Prausnitz, et al.,
1996 [a]). By selecting skin models with different surface densities of hair follicles, the effect of the
hair follicles on molecular transport during electroporation and iontophoresis could be studied.
7.1. Animal Models.
Besides human cadaver skin, the model skins chosen for this study were hairless rat skin and
shed black rat snake skin (Elaphe obsoleta). The hairless rat, despite its name, is covered with very
short, fine hair, giving it the appearance of being hairless (Figure 7.1). In fact, it has more hair follicles
(typically 75 follicles / cm2) (Bronaugh, et al., 1982) than human skin (typically 11 follicles / cm2
(Bronaugh, et al., 1982), and it is somewhat thinner, with a stratum corneum thickness of 10 to 15 g
instead of 15 to 20 p thick for human stratum corneum (Blair, 1968; Bronaugh, et al., 1982).
Hairless rat stratum corneum also has fewer corneocyte layers, 7 to 8 cell layers thick instead of the 15
to 20 cell layers in human skin. Nevertheless, hairless rat skin has often been used as a model for
human skin in transdermal drug delivery research (Rougier, et al., 1983; Wester and Maibach, 1985;
Bouclier, et al., 1990; Morimoto, et al., 1992; Wester and Maibach, 1993).
In contrast to the hair-
less rat, the black rat snake
(Figure 7.2) is hairless, and
its shed skin has been pre-
viously used as a model of
human skin in passive per-
meation studies (Itoh, et al.,
Figure 7.1. A hairless rat. The hairless rat is not really hairless, but is covered
1990 [a]; Itoh, et al., 1990 with very short, fine hair, giving it only the appearance of being hairless. In fact,
the hairless rat has more hair follicles per area than does human skin (Bronaugh,
[b]; Rigg and Barry, 1990; et a, 1982).
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Takahashi, et al., 1993). The rate-
limiting barrier to the entry of water and
other molecules into snake skin is the
mesos layer, which is a layer of the skin
that is analogous to human stratum
corneum (Banerjee and Mittal, 1978;
Maderson, et al., 1978; Landmann,
1979; Roberts and Lillywhite, 1980;
Landmann, et al., 1981; Lillywhite and
Maderson, 1982; Roberts and Lillywhite,
1983; Itoh, et al., 1990 [a]). The mesos
layer is ~8 p thick, with 3 to 5 layers of
cornified cells (Banerjee and Mittal,
1978; Landmann, 1979), and it covers Figure 7.2. A black rat snake. Shed skin from the black rat snake
(Elaphe obsoleta) can be used as a model of human skin that lacksthe entire snake, including underneath hair follicles or sweat ducts. Since snake skin that has already been
shed off the snake is used, the snake is not harmed in any way.
the scales. The scales are only used for
mechanical protection, and do not affect molecular transport or water evaporation (Roberts and Lilly-
white, 1980; Itoh, et al., 1990 [a]).
7.2. Overview.
Either no electrical stimulus (passive control), iontophoresis (1.0 mA / cm2), or a series of high-
voltage pulses (exponential pulses, applied electrode voltage of 1000 V, time constant of 1 ms, corre-
sponding to -100 V across the skin) was applied to human epidermis, hairless rat epidermis, or shed
black rat snake skin for 1 h. The 1.0 mA / cm2 iontophoresis current value was selected since it
represents the maximum limit of what could potentially be applied to humans (weaker currents would
not cause as much transport or staining of the stratum corneum). The high-voltage pulsing conditions
were similar to other, previous in vitro experiments using human skin, and corresponded to approxi-
mately 100 V across the skin (Prausnitz, et al., 1993 [a]; Pliquett, et al., 1995 [a]; Pliquett and
Weaver, 1996 [a]; Chen, et al., 1998 [c]).
Two fluorescent polar tracer molecules, calcein and sulforhodamine, were used in the donor solu-
tion (see Section 4.2.2). Molecular fluxes were measured by spectrofluorimetry, and transport regions
were determined by fluorescence microscopy. No measurable transport of calcein or sulforhodamine
occurred in the passive controls. During iontophoresis, molecular transport occurred near hair follicles
in human and hairless rat epidermis, but no transport was observed in snake skin, which lacked hair
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follicles or sweat ducts. During high-voltage pulsing, molecular transport occurred in small, localized
transport regions ("LTRs"), distributed randomly around the surface of the skin, in all three types of
skin. Another important conclusion that came from this work is that 1 h sampling methods are not
suitable for studying electroporation of human skin, which led to the development of the real-time
measurement techniques described in Chapter 8 and Appendix IV.
7.3. Materials and Methods.
Either high-voltage pulsing, iontophoresis, or no electrical stimulus (passive control) was applied in
vitro to human cadaver skin, hairless rat skin, or shed skin from the black rat snake. Custom-
designed, six port, side-by-side permeation chambers were used to hold the skin. The donor solution
consisted of calcein and sulforhodamine in PBS (see Section 4.2.2). The application electrodes were
surrounded by a PBS flow-protection system encased in polyacrylamide gel, to prevent contamination of
the donor and receptor compartments by chemical by-products from the electrodes (Appendix III).
Furthermore, a different set of electrodes was used to take measurements of the transdermal voltage
(see Section 3.5). After the experiment, the molecular flux was determined by spectrofluorimetry, and
the regions for molecular transport through the skin were determined by fluorescence microscopy.
7.3.1. Skin Preparation.
Human skin and hairless rat skin were prepared by the heat-stripping method, more fully de-
scribed in Appendix I. Snake skin did not need to be heat-stripped, since snake skin is somewhat
thinner and stronger than human or hairless rat skin.
Briefly, human cadaver skin was stored at -80 'C for up to 6 months (Gummer, 1989). Before use,
the epidermis was removed from the dermis and subcutaneous fat. The skin was thawed to room
temperature, then submerged for 2 min in de-ionized water at 60 'C. The epidermis (with the overlying
stratum corneum) was gently scraped off the dermis, cut into 3/4 inch diameter circles, and stored on
wax paper at 4 'C and 95% humidity for up to 10 d (Gummer, 1989).
The preparation techniques for hairless rat skin were similar to those for human skin. Hairless rats
(CD strain, Charles River Breeding Laboratories, Cambridge, MA) (Prausnitz, et al., 1993 [al) were
sacrificed by CO2 asphyxiation. The skin of the rat was removed and submerged in de-ionized water at
60 *C for 2 min. The epidermis (with the stratum corneum) was gently scraped off the dermis, cut into
3/4 inch diameter circles, and stored on wax paper at 4 'C and 95% humidity for up to 10 d.
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Shed snake skin from the black rat snake (gift from J. H. Rytting) was collected immediately after
shedding and stored at -20 'C. Before use, the snake skin was warmed to room temperature (25 C).
The skin was then placed in de-ionized water for 15 min, cut into 3/4 inch diameter circles, and stored
on wax paper at 4 'C and 95% humidity for up to 10 d. Immediately before the experiment, the skin
was placed in de-ionized water at 40 'C for 30 min to fully hydrate the skin, before loading into the
permeation chamber (Itoh, et at., 1990 [b]; J. H. Rytting, personal communication).
7.3.2. Equipment Preparation.
Phosphate-buffered saline (PBS) was prepared using the methods described in Section 3.2. PBS
was used as the receptor solution in the permeation chamber.
The donor solution was composed of high purity calcein (623 Da, -4 charge) (Molecular Probes) and
sulforhodamine (607 Da, -1 charge) (Sigma), dissolved in PBS at a concentration of 1 mM each (Pliquett
and Weaver, 1996 [al). The solution was gently stirred for >30 min, (Nutator, Clay Adams, Becton
Dickinson) until the calcein and sulforhodamine dissolved.
The permeation chambers are more fully described in Appendix III. Briefly, custom-designed, six
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port, side-by-side permeation chambers, with a total area of 0.64 cm (circular opening, 0.9 cm in
diameter) (Crown Bio Scientific) (Friend, 1992), were fitted with silver wire electrodes in the donor and
receptor compartments. Since the application of either high-voltage pulses or constant DC currents
caused the electrodes to release chemical by-products (including AgCI, H+ and OH~ ions), the elec-
trodes were surrounded by a PBS flow-protection system encased in polyacrylamide gel. This pre-
caution prevented electrochemical contamination of the donor and receptor compartments. The flow-
protected electrodes were used in all of the experiments (pulsing, iontophoresis, and passive control).
The flow-protected electrodes were constructed by soldering a piece of 0.040 inch diameter
silver wire, -0.5 cm long, to bell wire. The solder and exposed wire were covered by non-conducting
silicone rubber (General Electric, Waterford, NY), so that only the silver wire was exposed. A piece of
Tygon tubing, 1/32 inch ID, and the electrode were inserted through a truncated 100 gl pipette tip.
The top of the pipette was sealed off with epoxy (Devcon, Wood Dale, IL).
Before each experiment, the polyacrylamide gel in the permeation chamber was prepared as
follows. A plastic tube was inserted through each half of the permeation chamber and sealed in place
with Parafilm (American National Can, Greenwich, CT). Each compartment was turned sideways, and
polyacrylamide solution was poured in, completely immersing the plastic tube, leaving empty a
compartment volume of 2.1 ml. The polyacrylamide solution was composed of 0.75 g of 19:1 acryl-
amide:bis(N,N'-methylene-bis-acrylamide) powder (Bio-Rad), 43.75 p1 of 440 mM (NH 4 )2S20 8
solution, and 3 pl of N,N,N',N'-tetramethylethylenediamine (Bio-Rad) in 5 ml of PBS. The poly-
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acrylamide solution was allowed to harden (- 10 min). After the polyacrylamide gel solidified, the
plastic tube and Parafilm were removed from the side, leaving behind an empty channel through the
gel. The electrode was then inserted into this channel. During the experiments, PBS was pumped
through each channel at a flowrate of -6 ml/min, using a peristaltic pump (Polystaltic Pump, Buchler
Instruments, Kansas City, MO).
7.3.3. Electrical Conditions.
The electrical circuit is more fully described in Section 111.4. For both iontophoresis and high-
voltage pulsing, the negative electrode was placed on the donor side, and the positive electrode on the
receptor side, to provide a favorable driving force for calcein and sulforhodamine, both negatively
charged.
Constant current iontophoresis at 1.0 mA / cm2 (0.64 mA total) was applied for 1 h, using a
custom-built, constant current device (Prausnitz, et al., 1993 [a]; U. Pliquett, personal communication).
High-voltage, exponentially decaying pulses were delivered by an exponential pulser (Electro-
poration System 600, BTX), custom-modified to deliver 1 pulse every 5 s (U. Pliquett, personal commu-
nication). The time constant for each pulse was -1 ms, and the applied voltage was 1000 V, corre-
sponding to a transdermal voltage of approximately 100 V (Pliquett, et al., 1995 [a]; Chen, et al., 1998
[b]; Chen, et al., 1998 [c]). Pulses were applied for 1 h (-720 pulses total).
The current delivered across the skin during high-voltage pulsing was determined by measuring
the voltage drop across a noninductive 1.2 Q, 50 W resistor in series with the permeation chamber.
The voltage drop across the resistor was measured by a 10 x voltage probe (HP 10071A, Hewlett
Packard) connected to a digital oscilloscope (Hewlett Packard 54601, Hewlett Packard), allowing the
current to be calculated by Ohm's Law (Prausnitz, et al., 1993 [a]; also see Section 3.5). The voltage
drop across the chamber was measured with a grounded, 1000 x high-voltage probe (Tektronix),
connected to immobilized 0.040 inch diameter, -0.5 cm long silver wire measuring electrodes placed in
each compartment.
The resistance between the two measuring electrodes due to the intervening PBS was previously
determined by pulsing the chamber without any skin present to be 171 Q (Section 3.5). Since the
current was measured and recorded during the experiment, Ohm's Law would give the voltage drop
between the two measuring electrodes due solely to PBS. The difference between that value, and the
value actually measured between the receptor and donor compartments, was the voltage drop across the
skin itself. Voltages were recorded every 15 min during pulsing and averaged together to characterize
the transdermal voltage.
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7.3.4. Experimental Protocol.
The skin (human epidermis, hairless rat epidermis, or shed black rat snake skin) was first floated
in PBS to remove the wax paper backing, then loaded into the permeation chamber, with the stratum
corneum side (human or hairless rat) or the outer surface (black rat snake) facing the donor compart-
ment. Both outer water jackets (donor and receptor compartments) were kept at 37 0C using a thermo-
stated water bath (Neslab, Newington, NH).
The condition of each piece of skin was checked by measuring its electrical resistance with a
custom-built device that applied a -1 kHz, -50 mV bipolar square wave across the skin, and measured
the resulting voltage (U. Pliquett personal communication; Gowrishankar, personal communication).
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Skin with resistivities <50 kQ cm were not used (Prausnitz, et al., 1993 [a]; Chen, et al., 1998 [b];
M. R. Prausnitz, personal communication).
The donor compartment was filled with the donor solution (calcein and sulforhodamine in PBS),
and the receptor compartment filled with only PBS. Both compartments were continuously stirred by
magnetic stir bars (Thermix Stirring Hot Plate Model 2 1OT, Fischer Scientific; Spinbar, VWR, West
Chester, PA). A 1 h period prior to the experiment was used to fully hydrate the skin (Prausnitz, et al.,
1993 [a]) and check for leaks (holes or tears) in the skin. Leaky skin (passive flux above the detection
limit, ~10- M / m2 s, or ~10 mol / m2 s for this particular experimental apparatus) was not used.
After hydration, either no electrical stimulus (the control, to measure passive molecular fluxes),
constant current iontophoresis, or high-voltage pulsing was applied for 1 h. In the iontophoresis ex-
periments, a current of 1.0 mA / cm2 was applied. In the high-voltage pulsing experiments, expo-
nentially-decaying pulses, with a time constant of 1 ms and an applied voltage of 1000 V, were applied
at the rate of one pulse every 5.6 s.
7.3.5. Fluorescence Measurements.
After electrical exposure (high-voltage pulsing, iontophoresis, or the passive control), the solution
in the receptor compartment was removed and analyzed for fluorescence, to determine if molecular
transport through the skin had taken place. The fluorescence was measured with a spectrofluorimeter
(Fluorolog II F1 12, Spex). Excitation and emission wavelengths used were 496 nm and 517 nm, res-
pectively, for calcein, and 586 nm and 607 nm, respectively, for sulforhodamine (Pliquett and Weaver,
1996 [al). Aliquots were taken after 1 h of passive control, and after 1 h of pulsing. After each aliquot,
the receptor compartment was flushed 3 x and refilled with fresh PBS. Controls used were PBS only,
and a 1:10 dilution calibration series starting from the donor solution. The controls were also
measured every hour.
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Using the calibration curve, the concentration of tracers within the cuvette could be determined. To
convert the concentration to average molecular flux, the concentration was multiplied by the volume of
the chamber (measured by completely emptying out the receptor compartment into a graduated
2
cylinder), and divided by the exposed area of the skin (0.64 cm ) and the time of pulsing (1 h).
7.3.6. Light Microscopy.
The skin was also removed and examined using fluorescence microscopy immediately after experi-
mentation, to determine where the fluorescent molecules were located in the skin. The location of these
molecules was interpreted as indicating the regions where molecular transport through the skin had
occurred. It has been previously shown that a correlation exists between skin staining and molecular
transport (Pliquett and Weaver, 1996 [a]).
The skin was carefully removed and gently placed onto a microscope slide. Excess liquid was
gently blotted off with a paper towel. A cover slip was carefully placed on top and sealed in place with
clear nail polish (Prausnitz, et aL., 1993 [a]; also see Appendix II). This procedure would typically take
-10 min.
A biocular fluorescence microscope (Olympus BH-2, Olympus) was used to study the skin, set at a
magnification of 10 x. The excitation source was a mercury arc lamp (Mercury-100, Chiu), passing
through a 488 nm wavelength filter. Emitted light 10-7
was then viewed using a 515 nm wavelength filter
(0515 filter, Olympus). All of the photomicrographs o
were taken using a camera (Olympus OM2, Olym- 108 -EI
pus) loaded with 1600 speed Fuji Film (Fuji Photo - -
E
Film, Tokyo, Japan), mounted on top of the micro-
109
scope (Pliquett and Weaver, 1996 [a]). The camera
was set on automatic exposure (typically, 0.5 to
3.0 s). Microscope fields selected for photography -10 -
were randomly chosen.
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7.4. Problems with 1 h Aliquots. Transdermal Voltage (V)
Figure 7.3. Average molecular flux versus the average
A plot of the molecular flux versus the trans- transdermal voltage. Calcein fluxes are indicated byA squares: sulforhodamine fluxes are indicated by circles.
Transdermal voltage error bars are not plotted here; see
dermal voltage is shown in Figure 7.3. No apparent the discussion in Section 7.4. There do not appear to be
any identifiable relationships between the molecular fluxes
trends were observed for either calcein or sulfo- and the transdermal voltage.
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rhodamine. Figure 7.4 shows a plot of the LTR
number density versus the transdermal voltage. No
identifiable trends were observed for the LTR den-
sity.
These results came as a surprise, since many
authors have described a clear relationship be-
tween the molecular flux and the voltage (for ex-
ample, see Figure 7.7) (Prausnitz, et al., 1993 [a];
Zewert, et al, 1995; Vanbever, et al., 1996 [b]).
The molecular flux was expected to increase with
the transdermal voltage, yet the results presented
in Figures 7.3 and 7.4 do not show an obvious
relationship.
However, if the same data were plotted with
respect to applied voltage, not the transdermal vol-
tage, then increasing trends could easily be seen,
as shown in Figure 7.5 for the molecular flux and
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Figure 7.5. Molecular flux versus the applied voltage.
There appears to be a relationship between the molecular
flux, and the applied (not transdermal) voltage. Both cal-
cein (squares) and sulforhodamine (circles) appear to
follow the same trend. Passive fluxes are not shown, but
were measured to be below the detection limit of the
equipment, - 10 mol / m 2 s.
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Figure 7.4. Number density of LTRs versus the trans-
dermal voltage. Each individual photomicrograph is
shown by an open square: since many photomicrographs
were taken during each experiment, the average number
density for each experiment is shown as a filled square.
Transdermal voltage error bars are not plotted here; see
the discussion in Section 7.4. There was no identifiable
relationship between the LTR number density and the
average transdermal voltage.
16
14
E 12
E
C 10
H
z
2
01
0
* LTR Density
7 Mean LTR Density
' i 'o' I' I 
200 400 600 800 1000
Applied Voltage (V)
Figure 7.6. Number density of LTRs versus the applied
voltage. There appears to be a relationship between the
LTR number density after pulsing, and the applied (not
transdermal) voltage. Individual photomicrographs are
shown as open squares; the average of each set of photo-
micrographs is shown as a filled square.
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Figure 7.6 for the LTR density. This
is obviously an incorrect procedure,
since it completely ignores the voltage
drop contribution due to the PBS
solution, yet it produced data that
show significant relationships for both
the molecular flux and LTR density.
In addition, the trends for the mole-
cular flux were similar to the calcein
flux results from Prausnitz, et al.,
(1993 [a]), shown here in Figure 7.7
(100 pg / cm 2 s ~ 10-9 mol / m2 s, for
comparison purposes). The investiga-
tion into this surprising and some-
what counterintuitive result is dis-
cussed in this section.
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Figure 7.7. Calcein flux appears proportional to
Figure from Prausnitz, et aL., (1993 [a]).
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7.4.1. Transdermal Voltages Change during the Experiment.
After acquiring the voltage and flux data shown
in Figure 7.3, the transdermal voltage measure-
ments were then examined more closely to deter-
mine whether there were any systematic measure-
ment errors. The measured transdermal voltages,
instead of being averaged together, are plotted with
respect to time in Figure 7.8. The measured trans-
dermal voltages exhibited several different be-
haviors. Some experiments showed approximately
constant transdermal voltages (within ±10 V), but
most experiments showed a decrease in the trans-
dermal voltage (up to -60 V), and a few experiments
showed an increase in the transdermal voltage (up
to -30 V). Figure 7.9 shows a few representative
experiments of these data. Later experiments,
using more sensitive equipment, have shown that
100
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Figure 7.8. Transdermal voltages vary during high-
voltage pulsing. Error bars removed for clarity. Despite
the large scatter in the data, many of the transdermal
voltage measurements are decreasing, indicating a drop
in the transdermal voltage over time. This trend was
verified in later experiments (see Figures 8.5 and 8.9).
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the applied voltage.
I I I I I
I
I
the transdermal voltage consistently decreases with
repeated pulsing (see Figures 8.5 and 8.9; a hint
of this decrease may be seen in the predominantly
downward slanting lines in Figure 7.8); thus, the
scatter in the measurements in Figure 7.8 was due
to the equipment, not the skin itself.
Simply reporting the average peak transdermal
voltage does not adequately describe the experi-
mental conditions. The voltage for each pulse
should be reported, especially when it is believed
that molecular flux is a strong function of trans-
dermal voltage rather than just the applied voltage.
Using averaged values for the transdermal flux
could result in systematic measurement errors of
up to ±30 V, which could help explain the scatter in
the data shown in Figure 7.3.
E)
E)
W)
Vz
80
60
40
20
15 30
Time (min)
Figure 7.9. Representative transdermal
ments. Error bars removed for clarity.
ments are taken from Figure 7.8.
45 60
voltage measure-
These measure-
7.4.2. Voltage Drops Should be Measured from Donor to Receptor Compartments.
A grounded high-voltage probe was used in the current set of experiments, which measures the
voltage drop from the probe to ground. However, others have indicated (Pliquett, et al., 1995 [a]), that
there is a significant, variable contribution due to the electrode-electrolyte (PBS) interface. The resis-
tance of the interface can vary, even from pulse to pulse, by up to 30 Q (U. Pliquett, personal commu-
nication). Reasons for these resistance changes include side chemical reactions and gas formation and
evolution. Although the flow-protected electrodes prevent chemical contamination from these effects
into the donor and receptor solutions, it does not prevent these effects from occurring.
Given a peak current of -1 A during each pulse, by Ohm's law, a 30 Q change in resistance would
be equivalent to a change of 30 V. Since the transdermal voltage is actually the difference between two
sequential measurements, using error propagation, the error in the transdermal voltage could be esti-
mated to be roughly ±40 V (-'Ii 30 V).
Errors of ±40 V could account for the scatter in the data shown in Figure 7.3. Later experiments,
using a differential high-voltage probe instead of a grounded probe, have shown very small fluctuations
in the voltage measurements, typically ±5 V (see Section 8.1.4). Thus, the use of a grounded high-
voltage probe should be avoided.
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7.4.3. No Experimental or Procedural Errors.
It might be argued that the scatter in Figure 7.3 is due to experimental or procedural errors. This
does not seem likely, however. Many controls were performed, including passive controls (skin, but no
pulsing), as well as instrument tests (pulsing without any skin, as shown in Figure 3.3). These con-
trols were all highly consistent, with small errors in the voltage measurements. Passive controls did not
show significant molecular fluxes (the passive fluxes that were measured were all below the detection
limit of the spectrofluorimeter) or LTR formation (as observed from fluorescence microscopy).
Further evidence that the experiments were correctly performed is shown in Figures 7.5 and 7.6.
These figures show clear trends between transdermal fluxes and applied voltages; thus, both the
fluxes and the voltages were measured correctly during the experiments. In addition, the trends quani-
tatively match the results of Prausnitz, et al. (1993 [a]), shown in Figure 7.7. Errors in the transdermal
voltage measurements could be estimated to be ±40 V per measurement, enough to account for the
scatter in the data shown in Figure 7.3.
7.4.4. Comparisons with the Literature.
The results of this study did not agree with the skin electroporation literature (Prausnitz, et al.,
1993 [a]; Prausnitz, et al., 1994; Vanbever, et al., 1994; Pliquett, et al., 1995 [b]; Prausnitz, et al.,
1995 [b]; Vanbever and Preat, 1995; Zewert, et al, 1995; Pliquett and Weaver, 1996 [a]; Pliquett and
Weaver, 1996 [b]; Prausnitz, et al., 1996 [b]; Prnat and Vanbever, 1996; Vanbever, et al., 1996 [a];
Vanbever, et al., 1996 [b]; Vanbever, et al., 1996 [c]). The literature has shown clear trends between
molecular fluxes and transdermal voltages, even though less accurate equipment and techniques were
used in most cases than those used here. This set of experiments seems to be unable to duplicate the
trends in the literature. Although a trend between the applied voltage and the resultant molecular flux
could be seen (Figures 7.5 and 7.6), this trend does not appear between the transdermal voltage and
the molecular flux. The lack of any clear trend for the transdermal voltage is presumably due to the
limits and sensitivity of the experimental equipment used, rather than any fundamental problems with
what is known about skin electroporation theory.
In the experiments of Prausnitz, et al., (1993 [a]), no measurement electrodes were used, so that the
transdermal voltage measurements were based on the applied voltage and were not directly measured.
Transdermal voltages were calculated by subtracting the voltage drop due to PBS from the applied
voltage. The PBS voltages were calculated from Ohm's Law (I RPBs), where RPBs was reported to be
480 Q (see Section 3.3). Also, the values given in the paper are for average molecular fluxes and
transdermal voltages over 1 h. However, a clear relationship can still be seen between molecular flux
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and transdermal voltage (Figure 7.7).
180.
It is not known how such accurate
measurements of the transdermal 160-
voltage were taken with the equipment 140
described in the paper, since the use 120 00000
of similar techniques in the current
study led to wide scatter in 
the data,
as shown in Figure 7.3.
Many reports have simply given 60 o
applied pulsing voltages (Vanbever, et
al., 1994; Vanbever and Pr6at, 1995; 0
20r
Preat and Vanbever, 1996; Vanbever,
et al., 1996 [a]; Vanbever, et al., O500 16 0 1500 2000
1996 [b]; Vanbever, et al., 1996 [c])
or estimated the transdermal voltage Figure 7.10. The transdermal voltage is not proportional to the applied
33% voltage. The trend shown here from Pliquett, et at, (1995 [al) indicates
as being of the applied voltage that the relationship between the peak applied voltage (U applied) and the
(Prausnitz, et al., 1995 [b]; Zewert, et peak transdermal voltage (U si, 0) is not a linear function. Assuming
that the transdermal voltage is -33% of the applied voltage could result
al, 1995; Prausnitz, et al., 1996 [bi). in significant errors. Instead, the transdermal voltage during high-
However, it has been shown (Pliquett, voltage pulsing should be measured for each pulse.
et al., 1995 [a]) that this is not a reasonable approach, since the transdermal voltage is not linearly
proportional to the applied voltage (Figure 7.10).
There are only a few reports in the literature (Pliquett, et at, 1995 [a]; Pliquett, et at, 1995 [b];
Pliquett and Weaver, 1996 [b]) that have directly measured the transdermal voltage, using methods
similar to the ones described in the current study. One report has shown that the maximum trans-
dermal voltage obtainable is -120 V (see Figure 7.10) (Pliquett, et al., 1995 [a]). However, other
studies have measured transdermal voltages of over 200 V (Pliquett, et al., 1995 [b]; Pliquett and
Weaver, 1996 [b]). This study found maximum transdermal voltages of -70 V (Figure 7.3), although
these numbers are not conclusive, owing to the problems previously discussed. Thus, more work will
still be required in this area.
7.4.5. Transdermal Voltages Should be Measured for Each Pulse.
The original purpose of this study was to determine the relationship between the molecular flux and
the transdermal voltage, essentially repeating the work of Prausnitz, et al., (1993 [a]) (Figure 7.7). The
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purpose of repeating this work was to serve as a control for the experiments described later in this
chapter, in the study of the skin electroporation mechanism.
However, the failure to reliably reproduce those earlier results (Figure 7.3), even with the proper
controls and measurements (Figures 3.3, 7.5, and 7.6) led to further investigation of the use of the
aliquot system for studying the skin electroporation phenomenon. It was discovered that the trans-
dermal voltage can change significantly during a 1 h experiment (Figures 7.8 and 7.9); thus, reporting
time-averaged transdermal voltages could introduce measurement errors of up to ±40 V. Instead, the
transdermal voltage for each pulse needs to be individually measured and reported. While this
approach would require more sophisticated equipment, the results shown in this study indicate that
these measurements are necessary.
7.5. Results and Discussion.
For all three types of skin (human epidermis, hairless rat epidermis, and shed black rat snake
skin), the passive controls showed insignificant molecular transport, as measured by the fluorescence
of the receptor compartment solution (Table 7.1). The fluorescence in all three passive controls was
below the detection limit of the spectrofluorimeter, ~10- M / m2 s, or -10 mol / m2 s for this appa-
ratus. Under fluorescence microscopy, no significant staining of the surface of the skin was observed
(Figure 7.11 a for human epidermis, Figure 7.11 b for hairless rat epidermis, and Figure 7.11 c for black
rat snake skin).
Examination of both the human (Figure 7.12a) and the hairless rat epidermis (Figure 7.12b) pre-
parations after 1 h of 1.0 mA / cm2 iontophoresis showed brightly stained hair follicles (arrows in both
figures). Fluorescence measurements of the receptor compartment solution indicated that significant
molecular transport had occurred for both types of skin (Table 7.1).
Table 7.1. Molecular Fluxes of Calcein and Sulforhodamine.
2 2
Protocol Skin Calcein Flux (mol / m s) Sulforhodamine Flux (mol / m s)
Passive Control Human <1010 <10
Hairless Rat <10 0 <1010
Snake <1010 < 1010
Iontophoresis Human (1.7 i 0.7) x 108 (3.5 1.2) x 10
1.0 mA / cm2 Hairless Rat (8.7 0.8) x 108 (1.5 0.5) x 10
for 1 h Snake <1010 <1010
High-Voltage Pulsing Human (57 ±16 V ski) (1.1 t 0.8) x 10 (2.7 ± 1.3) x 10
1000 Vapplied Hairless Rat (72 ± 20 V ski) (1.9 0.1) x 108 (1. 4 ±0.8) x 10'
' = 1 ms Snake (115 ±38 V (1.4 0.8) x 10- (3.6 ±1.6) x 10
1 pulse/5 s for 1 h
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However, examination of the black
rat snake skin preparation after the
application of iontophoresis (1 h of
1.0 mA / cm2 current) did not show
any significant staining of the skin
(Figure 7.12c). Visually, the shed
snake skins that had been subjected
to iontophoresis treatments were in-
distinguishable from the passive con-
trols where there was no electrical ex-
posure (compare Figure 7.12c with
Figure 7.11c). In addition, no signif-
icant fluorescence was detected in the
receptor compartment (see Table 7.1),
indicating that there was no signif-
icant molecular transport across
snake skin.
After 1 h of high-voltage pulsing,
microscopic examination of the human
skin (Figure 7.13a), hairless rat skin
(Figures 7.13b and 7.14), and shed
black rat snake skin (Figure 7.13c)
preparations revealed the presence of
LTRs, randomly distributed on the
surface (some identified by arrows in
the photomicrographs). The LTRs
were not correlated with any visible
physical structures of the skin, such
as sweat ducts or hair follicles, which
were also brightly stained in the
human and hairless rat skins. Signif-
icant molecular fluxes were recorded
for all three types of skin, as deter-
mined by the fluorescence of the
receptor compartment solution after
pulsing (Table 7.1). The LTRs were
Figure 7.11. No significant staining of the skin during passive controls.
With all three skins, no preferential staining was seen. (a) Background
absorption into the stratum corneum of human skin. (b) With hairless
rat skin, the hair was stained, but the stratum corneum itself cannot be
seen. Small circular rings are trapped air bubbles. (c) Background ab-
sorption into the mesos layer of snake skin. The red regions are scales.
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Figure 7.12. lontophoresis causes molecular transport across the hair
follicles. (a) Human skin showed prominent staining near the hair follicles
(arrow). Away from the hair follicle, there is only passive background
staining. (b) Staining of hair follicles (arrows) was also observed in hair-
less rat skin. (C) Snake skin after iontophoresis did not show any promi-
nent staining of the mesos layer Compare with Figure 7.1 1c.
observed after high-voltage pulsing,
but were not seen after iontophoresis.
It was also noted that the background
staining of the skin, not near any of
the hair follicles, appeared visually
brighter than in the passive controls
(however, this cannot be seen in these
photomicrographs, due to the auto-
matic exposure of the film).
7.5.1. Poor Quantitative
Measurements.
Due to the problems discussed in
Section 7.4, the quantitative measure-
ments in Table 7.1 include some
rather large errors. It was nearly
impossible to report the transdermal
voltages and molecular fluxes with a
reasonable degree of confidence.
Essentially, the table only indicates
whether or not molecular transport
occurred across the skin, and not a
quantitative measurement of the mole-
cular flux.
7.5.2. No Passive Transport.
Since calcein and sulforhodamine
do not significantly affect each other's
fluorescence (Pliquett and Weaver,
1996 [a]; Pliquett, et al., 1996 [b];
see Section 4.2.2), both tracers were
used simultaneously in the donor
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compartment. Neither tracer diffused
passively across any of the skins,
studied, even after 2 h of exposure, as
measured by the fluorescence of the
receptor compartment solutions (Ta-
ble 7.1). The fluorescence of the
receptor solution was comparable to
the fluorescence of PBS only. Under
fluorescence microscopy, no signif-
icant staining of the surface was ob-
served (Figures 7.11a, 7.11b, and
7.11c).
Thus, calcein and sulforhodamine
are useful tracer molecules to employ,
since any fluorescence observed
during microscopy would be due to
molecular transport caused by either
constant current iontophoresis or
high-voltage pulsing, and not due to
background staining or passive diffu-
sion.
7.5.3. Iontophoresis Causes
Transport through
Hair Follicles.
Examination of both the human
(Figure 7.12a) and the hairless rat
skin (Figure 7.12b) preparations after
1 h of mA / cm2 iontophoresis re-
vealed brightly stained hair follicles.
This was due to the high concen-
trations of both calcein and sulfo-
rhodamine in the hair follicles, indi-
cating that most of the molecular
Figure 7.13. Skin electroporation causes molecular transport through
LTRs. The LTRs were observed on the surface of each type of skin, ran-
domly distributed; some are identified in the photomicrographs with
arrows. The LTRs were not correlated with hair follicles or sweat ducts.
Photomicrographs of (a) human skin, (b) hairless rat skin (one hair follicle
is identified with a "*"), and (c) shed black rat snake skin.
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transport during iontophoresis occurs
through the hair follicles. Fluor-
escence measurements of the receptor
solution indicated that significant
molecular transport through the skin
had occurred (Table 7.1). Also, it was
noted that the background staining of
the skin, not near any of the hair
follicles, was significantly brighter
than the passive controls.
In contrast, examination of the
shed black rat snake skin preparation Figur 7.14. Hairless rat skin after hgh-voltage pulsing, showing an
array of LTRs. The LTRs where molecular transport occurs appear toafter iontophoresis (same conditions be arranged in lines. This photomicrograph is at a lower magnification
than Figure 7.13b, to better illustrate the linear arrangement of LTRs.
as before) did not show any staining, 
_
as observed by fluorescence microscopy (Figure 7.12c). Visually, shed snake skins that had been
subjected to 1 h of mA / cm2 iontophoresis were indistinguishable from control experiments where no
electrical conditions were applied (compare Figure 7.12c with Figure 7.11 c). In addition, no fluore-
scence was detected in the receptor compartment solution (Table 7.1), indicating that there was no
significant molecular transport across the skin.
This is direct evidence that molecular transport across the skin during iontophoresis occurs
through hair follicles. This was observed as brightly stained hair follicles in both human skin and
hairless rat skin, as well as significant amounts of fluorescence in the receptor compartment after the
experiment. The black rat snake skin experiments did not show significant molecular transport or any
staining of the skin. This is presumably because there are no hair follicles in snake skin to participate
in iontophoresis, so no molecular transport could occur.
These observations are in agreement with the literature, where molecular transport during ionto-
phoresis has been shown to occur through hair follicles (Abramson and Gorin, 1940; Abramson and
Engel, 1942; Grimnes, 1984; Burnette and Marrero, 1986; Burnette and Ongpipattanakul, 1988;
Cullander and Guy, 1991; Scott, et al., 1993; Chen, et al., 1998 [b]; Chen, et al., in press [b]),
although some molecular transport may also occur through the corneocytes in the stratum corneum as
well (Potts, et al., 1992; Monteiro-Riviere, et al., 1994).
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7.5.4. High-Voltage Pulsing (Electroporation) Causes Transport through LTRs.
Microscopic examination of the human skin (Figure 7.13a) and black rat snake skin (Figure 7.13c)
preparations after 1 h of high-voltage pulsing revealed the presence of LTRs on the skin. The LTRs
appeared to be randomly distributed, not correlated with any physical structures of the skin, such as
sweat ducts or hair follicles (which were also brightly stained), in agreement with previous findings
(Zewert, et al, 1995; Pliquett, et al., 1996 [b]). The LTRs in human skin (Figure 7.13a) appeared to be
somewhat larger than in shed snake skin (Figure 7.13c); this may be due to species-to-species diff-
erences.
The background fluorescence intensity (not near the LTRs or appendages) was also much brighter
than in the passive controls. Significant molecular fluxes were also recorded after pulsing, as deter-
mined by the fluorescence of the receptor compartment solution (Table 7.1). LTRs were not seen after
constant current iontophoresis or in the passive controls.
LTRs and significant molecular transport were both observed in black rat snake skin (Table 7.1
and Figure 7.13c), which lacked hair follicles and sweat ducts. This is in direct contrast to ionto-
phoresis, where no significant molecular transport was observed in snake skin and no LTRs formed
(Table 7.1 and Figure 7.12c). Thus, the LTRs form in the corneocytes of the stratum corneum, and are
not associated with the appendages in the skin. LTRs have been previously reported in human skin
(Zewert, et al, 1995; Pliquett, et at., 1996 [b]; Prausnitz, et al., 1996 [a]; Vanbever, et al., submitted),
but this is the first time that LTRs were seen in other animal skins as well (Chen, et al., 1998 [b]).
Molecular transport during high-voltage pulsing is believed to occur through the LTRs, which have
previously been reported to be the dominant transport pathway through the skin during electroporation
(Pliquett, et al., 1996 [b]). However, based on the increase in fluorescence intensities in the back-
ground of the skin, observed in the current set of experiments, there may also be a sizable amount of
molecular transport through the background regions as well.
7.5.5. Hairless Rat Skin is a Poor Model of Human Skin for Skin Electroporation.
Microscopic examination of the hairless rat skin preparation after 1 h of high-voltage pulsing
(Figures 7.13b and 7.14) revealed the presence of small, brightly stained regions on the surface of the
skin. These regions were reminiscent of LTRs, but were much smaller, being -25 in diameter and
comparable to the size of a hairless rat corneocyte, whereas a typical LTR in human skin under these
conditions would be -100 t in diameter and encompass several corneocytes (Pliquett, et al., 1996 [b];
Vanbever, et al., submitted). These fluorescent regions in hairless rat skin were not correlated with
sweat ducts or hair follicles, which were also brightly stained.
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However, instead of being distributed randomly on the surface of the skin like the LTRs in human
and snake skin, they were observed to be lined up in rows (Figure 7.14). No known physical struc-
tures in the surface of rat skin corresponded to this phenomenon. These rows were also observed in
experiments using full-thickness (non-heat stripped) hairless rat skin (data and photomicrographs not
shown). However, significant amounts of molecular transport were detected across the skin, as deter-
mined by measurements of the fluorescence of the receptor compartment solution after pulsing.
Thus, hairless rat skin is not a good model for studying the electroporation of human skin. Besides
being significantly more hairy, hairless rat skin does not model LTR formation well. Although hairless
rat skin has similar molecular fluxes as human skin during pulsing, it should not be used to model
human skin.
7.5.6. Shed Black Rat Snake Skin LTRs Similar to Human Skin.
Shed black rat snake skin seems to be a good model of human skin. The molecular fluxes through
both shed black rat snake skin and human skin during electroporation were similar, and LTRs could
be found on the surfaces of both types of skin after high-voltage pulsing. Although shed snake skin
lacks appendages, this may not be important, since a significant amount of molecular flux is occurring
through the LTRs (see Table 7.1). The molecular fluxes through snake skin were comparable to the
fluxes through human skin. In addition, shed black rat snake skin is easy to prepare and use, and has
previously been used as a model of human skin (Itoh, et al., 1990 [a]; Itoh, et al., 1990 [b]; Rigg and
Barry, 1990; Takahashi, et al., 1993).
Snake skin does not have any hair follicles or sweat ducts, and the relatively thick scales do not
affect molecular transport, as they provide only mechanical protection (Roberts and Lillywhite, 1980;
Itoh, et al., 1990 [a]). Thus, the LTRs that form in snake skin during high-voltage pulsing are inter-
preted as forming in the corneocytes in the mesos layer, which covers the entire surface, including
under the scales (Banerjee and Mittal, 1978; Landmann, 1979). Molecular transport was observed only
for high-voltage pulsing, and not during iontophoresis, indicating that the LTRs are involved in mole-
cular transport during pulsing, in agreement with previous studies (Pliquett, et al., 1996 [b]).
Since all three types of skin (human, hairless rat, and shed black rat snake skin)) showed similar
results after high-voltage pulsing, LTR formation and molecular transport appear to not be affected by
the presence of hair follicles. Thus, the LTRs must be forming in the corneocytes of the stratum
corneum (or in the mesos layer, the analog to stratum corneum in snake skin). During high-voltage
pulsing, most of the molecular transport across the skin takes place through LTRs that form in the
corneocytes, and not through hair follicles or sweat ducts.
-103-
7.6. Conclusions.
High-voltage pulsing or constant current iontophoresis was applied to human, hairless rat, and
shed black rat snake skin. The three models were chosen since they have differing densities of hair
follicles. The goal was to determine where molecular transport across the skin occurs under these
conditions, using calcein and sulforhodamine, two fluorescent compounds, to trace the molecular
transport pathways.
No molecular transport was seen during the passive controls. Constant current iontophoresis
caused molecular transport to occur through the hair follicles in both human and hairless rat skin.
Shed black rat snake skin, which does not have any hair follicles, did not show any molecular trans-
port.
Electroporation (high-voltage pulsing) caused molecular transport to occur through localized trans-
port regions (LTRs) that form spontaneously during pulsing, in all three types of skin. The LTRs formed
in the corneocytes of the stratum corneum, were randomly distributed, and were not correlated with the
appendages. Evidence of this comes from the pulsing of shed black rat snake skin, which showed
molecular transport and LTR formation, but lacked appendages. Thus, electroporation and ionto-
phoresis are fundamentally different phenomena.
There are some large uncertainties in the measurements of the molecular flux and transdermal
voltage during these experiments, which accounts for the large scatter in the data shown in Figure 7.3.
Measurements need to be taken much more frequently than simply once an hour, since skin electro-
poration is a rapidly changing phenomenon.
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8. Molecular Fluxes through Human and Snake Skin in Real Time.*
Many studies have shown that applying a series of short (~ I ms), high-voltage (-100 V si) elec-
trical pulses to human skin can dramatically increase the rate of transdermal molecular transport,
hypothesized to involve electroporation (Prausnitz, et at., 1993 [a]; Chizmadzhev, et at., 1995; Pliquett
and Weaver, 1996 [a]; Chizmadzhev, et at., 1998 [a]). This method may provide a useful technique for
the transdermal delivery of drugs. Although many experiments have been conducted, using a wide
range of molecules (Prausnitz, et at., 1993 [a]; Bommannan, et at., 1994; Vanbever, et at., 1994;
Prausnitz, et at., 1995 [b]; Riviere, et at., 1995; Zewert, et at., 1995; Pliquett and Weaver, 1996 [a];
Prausnitz, et at., 1996 [a]; Vanbever, et at., 1996 [b]; Jadoul and Priat, 1997 [a]; Vanbever, et at.,
1997; Weaver, et at., 1997; Jadoul, et at., 1998; Wang, et at., 1998; Regnier, et at., in press [a]),
electrical conditions (Prausnitz, et at., 1993 [a]; Vanbever, et at., 1994; Pliquett, et at., 1995 [a]; Van-
bever and Priat, 1995; Pliquett and Weaver, 1996 [a]; Prausnitz, et at., 1996 [b]; Vanbever, et at.,
1996 [a]; Vanbever, et at., 1996 [b]; Gallo, et at., 1997; Vanbever, et at., 1997; Vanbever, et at.,
submitted), and types of skin (Prausnitz, et at., 1993 [a]; Prausnitz, et at., 1993 [c]; Vanbever, et at.,
1994; Riviere, et at., 1995; Gallo, et at., 1997; Chen, et at., 1998 [b]), few studies have been con-
ducted to determine the quantitative relationship between the electrical conditions and molecular
transport.
While many authors have described the average transdermal flux across the skin in terms of the
peak applied voltage (Prausnitz, et at., 1993 [a]; Vanbever, et at., 1994; Prausnitz, et at., 1995 [b];
Vanbever and Preat, 1995; Vanbever, et at., 1996 [a]; Vanbever, et at., 1996 [b]; Vanbever, et at.,
submitted), others have shown that it is actually the peak transdermal voltage (Ui 0) that governs
molecular transport (Pliquett and Weaver, 1996 [a]). For a given experimental system, the applied
voltage may be correlated with the transdermal voltage, but with widely varying experimental appa-
ratuses in use (Prausnitz, et at., 1993 [a]; Vanbever, et at., 1994; Pliquett, et at., 1995 [b]; Pliquett,
et at., 1996 [b]; Gallo, et at., 1997; Chen, et at., 1998 [b]; Chen, et at., 1998 [c]), comparison of the
applied voltages is nearly impossible. Hence, it would be more useful to report the average molecular
flux versus the average transdermal voltage (Zewert, et at., 1995; Pliquett and Weaver, 1996 [a]; Pli-
quett and Weaver, 1996 [b]). Theoretical calculations have also predicted a relationship between the
molecular flux and the transdermal voltage (Chizmadzhev, et at., 1995; Chizmadzhev, et at., 1998 [a]).
In addition, a recent theory has predicted a transition from electroporation of the skin's appendages
(the sweat ducts and hair follicles) at 5 V < U s < 30 V, to electroporation of the bilayer membranes
within the stratum corneum at U skin 0 > 30 V (Chizmadzhev, et at., 1998 [al).
*The results with human skin have also been reported in Chen, et at. (in press, [c]).
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Many studies have used 1 h aliquot measurements of the receptor compartment to study the
molecular flux across the skin during pulsing (Prausnitz, et at., 1993 [a]; Bommannan, et at., 1994;
Vanbever, et al., 1994; Prausnitz, et al., 1995 [b]; Riviere, et al., 1995; Vanbever and Pr6at, 1995;
Zewert, et al., 1995; Prausnitz, et al., 1996 [b]; Vanbever, et al., 1996 [a]; Vanbever, et al., 1996 [b];
Jadoul and Pr6at, 1997 [a]; Vanbever, et al., 1997; Weaver, et al., 1997; Vanbever, et al., submitted).
However, other studies have used a "flow-through" system, where the contents of the receptor compart-
ment are continuously pumped to a spectrofluorimeter for detection (Friend, 1992; Pliquett, et al.,
1995 [b]; Pliquett and Weaver, 1996 [a]; Chen, et al., 1998 [c]; Chen, et al., in press [a]; see also
Appendices IV and V). The first use of this method improved the time resolution for molecular transport
detection to approximately 1 min (Prausnitz, et al., 1994), and showed that the molecular flux of various
fluorescent tracers through the skin can vary considerably with repeated pulsing (Prausnitz, et al.,
1994; Pliquett and Weaver, 1996 [al). These changes in molecular flux were undetectable with 1 h
aliquot measurement techniques. Since then, the use of various flow-through systems has been carried
out in conjunction with high-voltage pulsing of human skin in several studies (Prausnitz, et al., 1994;
Pliquett, et al., 1995 [b]; Kost, et al., 1996; Pliquett and Weaver, 1996 [a]; Pliquett and Weaver, 1996
[b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted).
Shed skin from the black rat snake (Elaphe obsoleta) (Figure 7.2) has previously been used as a
model of human skin in passive diffusion experiments (Itoh, et al., 1990 [a]; Itoh, et al., 1990 [b];
Rigg and Barry, 1990; Takahashi, et al., 1993). Snake skin models human skin well, due to a layer of
the skin called the mesos layer. This layer is analogous to human stratum corneum (Banerjee and
Mittal, 1978; Maderson, et al., 1978; Landmann, 1979; Roberts and Lillywhite, 1980; Landmann, et
al., 1981; Lillywhite and Maderson, 1982; Roberts and Lillywhite, 1983; Itoh, et al., 1990 [a]),
composed of cornified cells and sheets of lipid bilayer membranes. It is ~8 i thick, with 3 to 5 layers
of cornified cells (Banerjee and Mittal, 1978; Landmann, 1979). Snake skin lacks sweat ducts and
hair follicles; thus, it is a model of only the stratum corneum of human skin.
To obtain quantitative information during skin electroporation, the simultaneous measurement of
the peak transdermal voltages, on a per-pulse basis, and the molecular transport across the skin in
real time were sought. The goal of this study was to determine the relationship between the peak
transdermal voltage and the resulting molecular flux. In addition to human cadaver skin, shed skin
from the black rat snake was used as a control, to determine how the presence of hair follicles and
sweat ducts affects molecular transport, on a quantitative basis.
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8.1. Materials and Methods.
The flow-through system for measuring the contents of the receptor compartment is more fully dis-
cussed in Appendix IV. In these experiments, 1 mM of a fluorescent tracer (either sulforhodamine,
lucifer yellow, cascade blue, or calcein; see Chapter 4) was used in the donor compartment. Both
human cadaver skin and shed snake skin were used, to determine the importance of hair follicles and
sweat ducts in the formation of transport pathways through the skin during high-voltage pulsing.
During pulsing, PBS flow-protection was used to protect the donor and receptor compartments from
chemical by-products produced by the pulsing electrodes. After the experiment, the skin was removed
and examined under fluorescence microscopy. The data stored in real time from the spectrofluorimeter
(flux measurements) and the oscilloscope (voltage measurements) were calibrated and processed to give
information about the conditions of the experiment.
8.1.1. Skin Preparation.
Human cadaver skin was prepared by the "heat-stripping" method described in Appendix I. Snake
skin did not need to be heat-stripped, since it was thinner and stronger than human skin.
Briefly, stored cadaver skin at -80 *C (Gummer, 1989) was thawed to room temperature, then sub-
merged for 2 min in de-ionized water at 60 *C. The epidermis (including the stratum corneum) was
gently scraped off of the dermis, cut into 3/4 inch diameter circles, and stored at 4 'C, 95% humidity
for up to 10 days (Gummer, 1989). The epidermis was used in all of the experiments described here.
Shed snake skin from the black rat snake was collected immediately after shedding and stored at
-20 *C. Before use, the snake skin was allowed to warm to room temperature (25 'C). The skin was
then submerged in de-ionized water for 15 min, cut into 3/4 inch diameter circles, and stored on wax
paper at 4 'C, 95% humidity for up to 10 days. On the day of the experiment, the skin was placed in
de-ionized water at 40 'C for 30 min to rehydrate the skin, before loading into the permeation chambers
(Itoh, et at., 1990 [b]; J. H. Rytting, personal communication).
8.1.2. Permeation Chamber with Four-Electrode System.
Phosphate-buffered saline (PBS) was prepared using the methods described in Section 3.2. PBS
was used as the receptor solution in the permeation chamber. The donor solution consisted of a fluore-
scent tracer (one of either sulforhodamine, lucifer yellow, cascade blue, or calcein; see Chapter 4),
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dissolved in PBS to a concentration of 1 mM. The solution was gently stirred for >30 min (Nutator, Clay
Adams, Becton Dickinson), to allow the tracer time to dissolve.
The flow-through system is more fully described in Appendix IV. Briefly, the permeation chambers
2
were custom-designed, side-by-side permeation chambers, with a skin exposure area of 0.64 cm
(circular opening, 0.9 cm in diameter) (Crown Bio Scientific) (Friend, 1992). Each chamber half con-
sisted of an outer water jacket and an inner compartment. Ports extending from the inner compartment
allowed direct access to the inner compartment. Each chamber half had one large port near the skin
(for the measuring electrodes and the flow-through system) and two small ports away from the skin (for
the pulsing electrodes and the electrode flow-protection system). To keep the skin and the donor and
receptor solutions constant at 37 0C, water heated by a thermostated water bath (Neslab) was pumped
through both outer jackets.
The flow-protected electrodes were constructed by soldering a piece of 0.040 inch diameter silver
wire, -0.5 cm long, to copper bell wire. The solder and exposed wire were covered by nonconducting
silicone rubber (General Electric), so that only the silver wire was exposed. A piece of Tygon tubing,
1/32 inch ID, and the electrode were inserted through a truncated 200 gl pipette tip. The top of the
pipette was then sealed off with epoxy (Devcon).
The donor compartment measuring electrode was constructed by soldering a piece of 0.040 inch
diameter silver wire, -0.5 cm long, to copper bell wire. The solder and exposed wire were covered by
nonconducting silicone rubber, exposing only the silver wire. The wire was inserted through a trun-
cated 1 ml pipette tip and sealed in place with epoxy.
The receptor compartment electrode was constructed by soldering a piece of 0.040 inch diameter
silver wire, ~0.5 cm long, to copper bell wire. The solder and exposed wire were covered by
nonconducting silicone rubber, so that only the silver wire was exposed. A piece of Teflon tubing,
1/16 inch ID, was used for outflow and a longer piece of Tygon tubing, 1/32 inch ID, was used for
inflow. The wire and the two tubes were inserted through a truncated 1 ml pipette tip. A hole was
drilled into the side of the 1 ml pipette tip and the Teflon tube was extended through the hole. All of
the tubes and wires were sealed in place with epoxy.
The top of a 2 ml centrifuge tube was removed and two holes were drilled the tube: one in the
bottom and one in the side. Tygon tubing, 1/32 inch ID, was epoxied to the bottom hole. The Teflon
tube from the pipette was extended through the side hole. The centrifuge tube was held in place to the
side of the pipette with Parafilm (American National Can).
Before each experiment, plastic tubes were inserted through both compartments and sealed in
place with Parafilm. In the receptor compartment, the measuring/flow-through electrode was inserted
into the compartment and sealed in place with Parafilm. The tubing within the receptor chamber was
wired in place for the gel with stainless steel wire. Both compartments was turned sideways, and poly-
acrylamide solution was poured in, completely immersing everything, leaving empty a volume of ~2.1 ml
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in the donor compartment and -450 gl in the receptor compartment. The polyacrylamide solution was
composed of 0.75 g of 19:1 acrylamide:bis(N,N'-methylene-bis-acrylamide) powder (Bio-Rad), 43.75 pl
of 440 mM (NH 4 )2S20 8 solution, and 3 g1 of N,N,N',N'-tetramethylethylenediamine (Bio-Rad) in 5 ml of
PBS.
The polyacrylamide solution was allowed to harden (~10 min). After the solution solidified into a
gel, the outer plastic tubing and the Parafilm were removed from both compartments, leaving behind an
empty channel through the gel. The flow-protected electrodes were then inserted into these channels.
During an experiment, PBS was pumped through each outer channel at a flowrate of -6 ml/min, using
two peristaltic pumps (VWR). The stainless steel wire was removed from the receptor compartment,
since the tubing in the receptor compartment was immobilized in place by the solidified gel.
8.1.3. Fluorescence Measurements.
Fluorescence measurements were taken with a spectrofluorimeter (Fluorescence Master Series
Spectrometer, Photon Technology, Brunswick, NJ). Excitation and emission wavelengths for each
fluorescent compound are given in Table 4.1.
The cuvette in the spectrofluorimeter was constructed by drilling two holes into a disposable poly-
styrene microcuvette (VWR), to allow for inflow and outflow from the cuvette. One hole was drilled
approximately 1/4 inch from the bottom of the cuvette for outflow, and the other hole drilled higher in
the cuvette (approximately 1/2 inch from the bottom) for inflow. Both holes were connected with Tygon
tubing to a peristaltic pump ("Sarah" Cassette Peristaltic Pump, Barnant, Barrington, IL).
The final volume of the cuvette was -200 pl, and was the minimum amount needed by the spectro-
fluorimeter for accurate detection and quantification of fluorescent molecules within the cuvette, as
determined empirically. Mixing was accomplished by dripping fluid down into the cuvette (the drops
entering the cuvette were a sizable fraction of the total volume of the cuvette). The performance of this
system was very close to an idealized continuous-stirred tank reactor (Fogler, 1992), and the residence
time for the combined chamber-tubing-pump-cuvette system (volume of ~400 pl) was measured to be
-14 s. This was taken to be the time resolution for the flux measurements.
It was found that liquid within the cuvette could not be sucked out by the pump until the level of
liquid within the cuvette had completely covered the outlet (which was Tygon tubing, 1/32 inch ID). If
the liquid did not completely cover the opening, then air would get sucked into the tubing instead of
liquid. This could result in variations in the volume of the liquid within the cuvette. To minimize this
problem, a 200 pl pipette tip was affixed to the outlet opening of the cuvette, greatly reducing the dia-
meter of the outlet and minimizing this problem.
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A calibration curve was constructed by pumping known concentrations of the donor solution
through the flow-through system, starting from the lowest concentrations and going to the highest. The
concentrations used were a 1:10 dilution series starting from the donor solution concentration (1 mM).
8.1.4. Electrical Equipment.
High-voltage, exponentially decaying pulses were delivered by a high-voltage pulser (Electro-
poration System 600, BTX), custom-modified to deliver 1 pulse every -5 s (U. Pliquett, personal com-
munication). Since the fluorescent tracers were all negatively charged, the negative terminal of the
pulser was connected to the pulsing electrode in the donor compartment, and the positive terminal to
the receptor compartment, to provide a favorable driving force for the fluorescent tracers.
The time constant on the high-voltage pulser was set at 1 ms. Pulses with peak transdermal
voltages between 0 V and ~ 150 V across the skin were applied for 1 h at the rate of one pulse every
5.56 ± 0.01 s (640 pulses total). This rate was used to facilitate comparison with other experiments in
the literature where pulses were given every -5 s (Prausnitz, et al., 1993 [a]; Prausnitz, et al., 1994;
Prausnitz, et al., 1995 [b]; Zewert, et al., 1995; Pliquett and Weaver, 1996 [a]; Pliquett and Weaver,
1996 [b]; Prausnitz, et al., 1996 [b]; Weaver, et al., 1997; Chen, et al., 1998 [b]; Chen, et al., sub-
mitted [b]).
Current delivered across the skin during the pulse was determined by measuring the voltage drop
across a 1.2 Q noninductive resistor, connected in series with the permeation chamber. The voltage
drop across the resistor was measured by a lOx voltage probe (HP 10071A, Hewlett Packard) con-
nected to a digital oscilloscope (Hewlett Packard 54601, Hewlett Packard). The oscilloscope was con-
nected through an RS-232 interface card (54641A RS-232 Interface Module, Hewlett Packard), attached
to the back of the oscilloscope, to a serial port on a 486DX computer (Power Spec 1, manufacturer
unknown).
The voltage drop from the receptor to the donor compartment was measured by connecting a
differential high-voltage probe (Active Differential Probe B9017RT, Yokogawa) to the immobilized silver
wire measuring electrodes in each compartment. This probe was also connected to the same
oscilloscope.
The computer was programmed using Turbo C++ (Borland, Scotts Valley, CA), running a program
that would count and record both voltage waveforms recorded by the oscilloscope for every pulse. The
program is given in Section IV.4.3. The program recorded the waveform data as ASCII characters and
did not do any mathematical processing, since between pulses, there was barely sufficient time to
download the waveforms from the oscilloscope (at 1200 baud and 1 is time resolution) and record the
data onto the hard drive.
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8.1.5. Skin Experimental Protocol.
Prepared, stored skin (human or snake) was floated in PBS for ~1 min to remove the wax paper
backing. The skin was loaded into the side-by-side chambers, with the stratum corneum (human) or
outer surface (snake) facing the donor compartment. The donor compartment was filled with a donor
solution and the flow-through pumps were started. The donor compartment was continuously stirred
by a magnetic stir bar (Thermix Stirring Hot Plate Model 2 1OT, Fischer Scientific; Spinbar, VWR).
The condition of the skin was checked by measuring its electrical impedance. A 100 Hz, 0.1 V
(peak-to-peak) bipolar sine wave was applied to the skin and the resulting impedance was measured
using an LCR meter (Model 5R715 LCR Meter, Stanford Research Systems, Sunnyvale, CA).
The skin was considered bad and was immediately discarded if its electrical resistivity was
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<50 kQ cm (or <70 kQ for this particular apparatus) (Prausnitz, et al., 1993 [a]; M. R. Prausnitz, per-
sonal communication). For this apparatus, however, the skin's impedance, not its resistance, was
measured. Less current is needed for an accurate measurement of the skin's impedance, and there is
no overall net current from the applied bipolar sine wave, and hence no potential iontophoresis. Since
the impedance of the skin decreases as the applied frequency increases, a value of <25 kQ cm 2 Of
impedance at a frequency of 100 Hz (or <40 kQ for this apparatus) was used as an indicator of bad
skin. Previous experiments have shown that this value compares favorably with the accepted DC resis-
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tance of <50 kQ cm (Gowrishankar, personal communication).
The resistances and impedances of the PBS solution and the polyacrylamide gel were neglected,
since their combined resistances were previously measured to be 251 Q (see Section 3.6), much less
than the -40 kK resistances of acceptable skin.
After determining if the skin was acceptable or not, the apparatus was allowed to sit for 1 h to fully
hydrate the skin (Prausnitz, et al., 1993 [a]) and check for leaks. Leaky skin (passive flux above the
detection limit, -10-8 M, or -10 mol / m2 s for this particular experimental apparatus), was immedi-
ately discarded.
8.1.6. Pulsing Protocol.
High-voltage exponential pulses, with a time constant of 1 ms and transdermal voltages between 0 V
and -150 V across the skin (applied voltages between 0 V and 1000 V) were applied for 1 h at the rate
of one pulse every 5.56 s. PBS was pumped through the flow-protection system (across the electrodes)
at -6 ml/min using a peristaltic pump (VWR). PBS was also pumped through the flow-through system
(through the receptor compartment and the spectrofluorimeter) at the rate of 0.0322 ml/s (setting "99"
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on the "Sarah" pump). Both the spectrofluorimeter computer and the computer recording voltage
waveforms were set to record ~1 h of data.
After the experiment, the skin was removed from the chamber for fluorescence microscopy. The
data from the two computers (spectrofluorimeter and voltage data) were downloaded to a Sun Sparc 10
(workstation Sun, Palo Alto, CA) for analysis.
8.1.7. Fluorescence Microscopy.
A biocular fluorescence microscope (Olympus BH-2, Olympus) allowed the simultaneous fluore-
scence and light illumination of the specimen at 4 x and 10 x magnifications. Pictures were taken
using a camera (Olympus OM2, Olympus) mounted on the microscope (Pliquett, et al., 1996 [b]).
Immediately after pulsing, the skin was carefully removed and gently placed onto a microscope
slide (Gold Seal Rite-On, No. 3050, Clay Adams, Becton Dickenson). Excess liquid was blotted off with
a paper towel. A drop of staining solution was added and a 22 x22 No. 1 cover slip (Clay Adams,
Becton Dickenson) was placed on top and sealed in place with clear nail polish (Hard as Nails, Sally
Hensen, Del) (Prausnitz, et al., 1996 [a]).
Localized transport region (LTR) densities (Pliquett, et al., 1996 [b]) were determined by taking
photographs of the skin and visually counting the number of LTRs on each photograph. Since the area
2
of the photograph (at 4 x magnification) was known to be 4.91 mm , the number density of LTRs on the
skin could be determined.
8.1.8. Numerical Analysis.
All of the fluorescence, voltage and calibration data were first downloaded onto a Sun Sparc 10
workstation (Sun). A program written in MatLab 5 (Mathworks, Natick, MA) used these data to deter-
mine the molecular flux versus the transdermal voltage for each pulse.
This program can be seen in Section IV. 13.4. The program first loaded the voltage and current
waveforms and fitted these to an exponential. Since the resistance of the chamber without any skin was
251 Q, the voltage across the skin could then be calculated by Ohm's Law (see Equation 3.2). The
program then loaded the calibration and fluorescence data, and, using deconvolution routines (Pliquett,
et al., 1995 [b] see also Section IV. 13.2), calculated the molecular flux across the skin. The two data
files were synchronized together in time, allowing the program to determine the measured flux for each
pulse.
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8.2. Human Skin Results.
Rapid changes in both the transdermal voltage and the molecular flux occurred during the repeated
pulsing of human skin. These changes occurred very rapidly, on time scales of -1 to 10 min. Waiting
1 h between measurements could miss many crucial features.
8.2.1. Measurements Yielding Average Values Can Give Significant Errors.
To simulate the 1 h aliquot measurements commonly used in the literature (Prausnitz, et al., 1993
[a]; Bommannan, et al., 1994; Vanbever, et al., 1994; Prausnitz, et al., 1995 [b]; Riviere, et al.,
1995; Vanbever and Preat, 1995; Zewert, et al., 1995; Prausnitz, et al., 1996 [b]; Vanbever, et al.,
1996 [a]; Vanbever, et al., 1996 [b]; Jadoul and Pr6at, 1997 [a]; Vanbever, et al., 1997; Weaver, et
al., 1997; Vanbever, et al., submitted) with the current data, the transdermal molecular fluxes
measured throughout each experiment were averaged over 1 h. Plotting these data versus either the
applied voltage (Figure 8.1) or the transdermal voltage (Figure 8.2) resulted in a lot of scatter in the
data.
Since it was known that the applied voltage does not correctly predict the transdermal voltage
(Pliquett, et al., 1995 [a]; Pliquett and Weaver,
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Figure 8.1. The average molecular flux plotted versus
the average peak applied voltage. Four different
molecules were used in the donor solution:
sulforhodanine, lucifer yellow, cascade blue, and calcein.
There does not seem to be a clear relationship between
the average peak applied voltage and the average
molecular flux.
1996 [a]) the scatter in Figure 8.1 was to be expected.
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Figure 8.2. The average molecular flux plotted versus
the average peak transdermal voltage. This figures is
based on the same experiments and data shown in
Figure 8.1. Although a generally increasing trend can be
seen for the average molecular flux versus the average
peak transdermal voltage, there still is not a clear
relationship.
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More evidence of this can be seen in Figure 8.3,
where the average transdermal voltages were
plotted versus the applied voltages, showing a poor
relationship between the two voltages. However,
the average fluxes plotted against the average trans-
dermal voltage in Figure 8.2 also show a poor rela-
tionship.
Thus, by using average measurements of either
the molecular flux or the transdermal voltage, sig-
nificant errors can be introduced into the analyses,
which motivates the use of a flow-through system in
the current set of experiments.
Others have reported molecular flux versus
either the average peak applied voltage (Prausnitz,
et at., 1993 [a]; Vanbever, et at., 1994; Prausnitz,
et al., 1995 [b]; Vanbever and Pr6at, 1995; Van-
bever, et al., 1996 [a]; Vanbever, et al., 1996 [b];
Vanbever, et al., submitted) or the average peak
transdermal voltage (Zewert, et al., 1995; Pliquett
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Figure 8.3. The average peak transdermal voltage
versus the peak applied voltage. Although a generally
increasing trend can be seen between the applied voltage
and the resulting transdermal voltage, there is still a lot
of scatter. For example, 18 experiments were conducted
at an applied voltage of 1000 V, and the resulting peak
transdermal voltages ranged from 102 V to 213 V.
and Weaver, 1996 [a]; Pliquett and Weaver, 1996
[b]). Many authors have reported only the average molecular flux after 1 h of pulsing (Prausnitz, et al.,
1993 [a]; Bommannan, et al., 1994; Vanbever, et al., 1994; Prausnitz, et al., 1995 [b]; Riviere, et
al., 1995; Vanbever and Preat, 1995; Zewert, et al., 1995; Prausnitz, et al., 1996 [b]; Vanbever, et
al., 1996 [a]; Vanbever, et al., 1996 [b]; Jadoul and Preat, 1997 [a]; Vanbever, et al., 1997; Weaver,
et al., 1997; Vanbever, et al., submitted). Those methods, while easier to apply, do not properly
account for the time-varying nature of both the molecular flux and the transdermal voltage, and can be
misleading, as was demonstrated here.
8.2.2. Molecular Flux and Transdermal Voltage Vary with Repeated Pulsing.
Time resolutions for the data recorded in these experiments were -14 s for the molecular flux and
-1 ps for the transdermal voltage. This time resolution allowed the direct measurement of the instan-
taneous molecular flux versus the applied voltage for each pulse. With a time resolution of ~14 s, the
molecular flux was actually averaged over -3 pulses (one pulse is applied every 5.56 s). However, this
is very close to a flux-per-pulse basis and a vast improvement over the traditional 1 h measurements.
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Figure 8.4. The molecular flux as a function of pulse number for four fluorescent compounds. Representative experi-
ments shown; error bars removed for clarity. In all cases, 640 pulses were applied to the skin for 1 h, one pulse
every 5.56 s. A flow-through system was used to measure the molecular flux through the skin in real time, with a time
resolution of -14 s. Even though the four donor molecules had similar properties, very different behaviors were ob-
served. (a) The flux of sulforhodamine increased throughout the course of the experiment. (b) The flux of lucifer yellow
increased to steady state. (c) The flux of cascade blue also went to steady state. (d) The flux of calcein quickly reached
a maximum, then began decreasing with repeated pulsing.
Figure 8.4 shows the molecular flux through human skin, plotted for each pulse during a typical
experiment (1000 Vapplied, corresponding to 150 V skin, = 1 ms, one pulse every 5.56 s for 1 h), for
each of the four fluorescent donor molecules (8.4a, sulforhodamine; 8.4b, lucifer yellow; 8.4c, cascade
blue; and 8.4d, calcein). The molecular flux the deconvoluted flux through the skin during pulsing.
Even though the four donor molecules had roughly similar molecular weights (457 Da to 623 Da)
and were all hydrophilic and negatively charged, several different profiles of molecular flux versus
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Figure 8.5. The transdermal voltage for each pulse in a
typical experiment. Error bars have been removed for
clarity. The peak transdermal voltage quickly drops
(from -180 V to -140 V) with repeated pulsing, then
continues decreasing at a slower rate afterwards (from
-140 V to ~130 V). Note that the peak transdermal
voltage does not reach steady state, even after 1 h.
(including iontophoresis and passive exposure to
does not react with the skin. This decrease
(Prausnitz, et at., 1994; Pliquett, et al., 1995 [b];
1996 [b]; Chen, et al., 1998 [c]; Vanbever, et al.,
pulse number were observed. The flux of
sulforhodamine (Figure 8.4a) increased steadily,
without reaching a steady-state plateau. Longer
experiments indicated that the molecular flux does
not reaches a steady-state plateau, even after 7 h of
pulsing (see Section 11.3). However, the fluxes of
lucifer yellow (Figure 8.4b) and cascade blue
(Figure 8.4c) did reach steady state within an hour
(verified in later experiments involving pulsing over
several hours; see Figures 11.3 and 11.4, for
lucifer yellow and cascade blue, respectively). The
flux of calcein (Figure 8.4d) first increased quickly
during pulsing, then decreased with additional
pulsing. This decrease is not an artifact, since PBS
flow-protection of the pulsing electrodes was used
to prevent contamination of the donor and receptor
compartments by electrochemical by-products or
pH changes from the electrodes. Other controls
calcein, see Section 4.1) have confirmed that calcein
in calcein flux has also previously been reported
Pliquett and Weaver, 1996 [a]; Pliquett and Weaver,
submitted).
Figure 8.5 shows that U s e for each pulse drops quickly with the first few pulses, decreases
more slowly with repeated pulsing, and does not reach steady state. This behavior was observed
regardless of the tracer used. This is in agreement with earlier measurements of the transdermal
voltage, made at 15 min intervals, that showed a generally decreasing trend in the transdermal voltage
with repeated pulsing (see Section 7.4.1).
Thus, both the molecular flux and the transdermal voltage vary considerably with repeated pulsing.
More experiments will be needed to better understand why different behaviors in the transdermal
fluxes of similar molecular compounds was observed.
8.2.3. Formation of Localized Transport Regions.
Previously, many authors have reported the formation of "localized transport regions" (LTRs) after
high-voltage pulsing (Zewert, et al., 1995; Pliquett, et al., 1996 [b]; Prausnitz, et al., 1996 [a]; Chen,
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Figure 8.6. Photomicrographs of human skin after pulsing for four fluorescent compounds. Representative fields
shown. Scale bar = 50 g. Each fluorescent tracer shows a different pattern of staining, possibly indicating that
different transport pathways are involved. (a) Sulforhodamine appears only in the interiors of the LTRs. (b) Lucifer
yellow uniformly stains the entire surface of the skin, with the exception of the interiors of the LTRs, which appear
darker. (c) Cascade blue uniformly stains the entire surface of the skin. No LTRs were identified. (d) Calcein forms
"rings" around each LTR. The edges of the LTRs are brightly stained, but the interiors do not stain with calcein.
et al., 1998 [b]; Vanbever, et al., submitted). However, in nearly all of these cases, either calcein or
sulforhodamine (but usually both, simultaneously) was used in the donor solution.
In the current set of experiments, each of the four fluorescent tracers (sulforhodamine, lucifer
yellow, cascade blue, and calcein) was used independently in the donor solution. The fluorescent
regions observed in human stratum corneum after pulsing indicates those regions where molecular
transport took place through the skin (Pliquett, et al., 1996 [b]). Since molecular transport and ionic
transport (electrical current) occur in the same regions in the skin (Pliquett, et al., 1996 [b]), the same
pattern of fluorescent staining of the skin would be expected for all four tracers.
In this study, however, each fluorescent tracer produced a different pattern of staining of the skin
after 1 h of high-voltage pulsing. Calcein (Figure 8.6d) produced the LTR "ring" patterns previously
observed in human skin (Pliquett, et al., 1996 [b]). Sulforhodamine (Figure 8.6a) stained the interiors
of the LTRs. The LTRs with lucifer yellow (Figure 8.6b) appeared as dark spots, although the back-
ground of the skin, not near the LTRs, appeared somewhat brighter. Cascade blue (Figure 8.6c) did not
show any LTR formation.
Thus, the pathways for molecular transport may not necessarily be the same ones used for ionic
transport (electrical current). Each molecule may have a different set of transport pathways available to
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it, that are not necessarily available to other molecules. Partitioning of each compound into the skin,
facilitated by electroporation, may be as important as the electrical driving forces (electrical drift,
electroosmosis). Other unidentified molecular properties may also be important.
8.2.4. Onset of Molecular Transport at -50 Vskin.
Combining Figures 8.4 and 8.5 for each experiment yields a plot of the molecular flux versus the
peak transdermal voltage, as can be seen in Figure 8.7 (8.7a, sulforhodamine; 8.7b, lucifer yellow;
8.7c, cascade blue: and 8.7d, calcein). These data were plotted as the molecular flux versus U 5kn 0
for each pulse, irrespective of pulse number, for every experiment. These data are from the same
experiments shown in Figures 8.1, 8.2 and 8.3.
For each molecule, a nearly linear relationship was observed between the molecular flux and
U~s, 0 for voltages > ~50 V (indicated by dotted lines in Figures 8.7a through 8.7d). However, in each
case, the molecular flux tapered off for transdermal voltages < -50 V. Although the molecular flux
varied both in time, and from molecule to molecule, a transdermal voltage of at least ~50 V was neces-
sary to cause significant molecular transport across the skin, regardless of the fluorescent tracer used.
Theoretical calculations and supporting experimental evidence in the literature have predicted
electroporation predominantly at the appendages at Us5 , 0 < 30 V, and electroporation of the lipid-
corneocyte matrix at Us 0 > 30 V (Chizmadzhev, et al., 1998 [a]). Although those calculations were
based on a different system than the one used in the current study (for example, full-thickness instead
of heat-stripped skin, 25 'C instead of 37 'C, rectangular pulses instead of exponential pulses), the
value of 30 V for a transition to lipid-corneocyte electroporation (based primarily on electrical mea-
surements) is reasonably close to the value determined in this study of ~50 V for the onset of significant
molecular transport (based primarily on fluorescence measurements). Based on those calculations, the
transcellular pathway through the skin, accessible primarily at higher transdermal voltages, allows
significantly more molecular transport than the appendageal pathways that predominate at lower trans-
dermal voltages. Most of the molecular transport takes place through the stratum comeum, not through
the appendages.
8.3. Snake Skin Results.
In similar experiments involving shed snake skin instead of human skin, somewhat different
results were obtained for the molecular flux on a per-pulse basis and the formation of LTRs. However,
the drop in the transdermal voltage with repeated pulsing was very similar to human skin.
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Figure 8.7. The instantaneous molecular flux versus the peak transdermal voltage. The instantaneous molecular flux
for each of the four donor molecules (sulforhodamine, lucifer yellow, cascade blue, and calcein) is plotted for each ex-
periment for every single pulse. Error bars have been removed for clarity. In all four cases an almost linear relation-
ship can be seen between the flux and the peak transdermal voltage, with an intercept at -50 V. This is indicated by
the dotted line (this is not a quantitative determination; it is simply for illustrative purposes only). (a) Sulforhodamine
flux. Data from 7 experiments shown. Since the flux of sulforho amine continually rises throughout the experiment
(see Figure 8.4a), the flux on a per-pulse basis starts towards the bottom of the graph and continuous to rise through-
out the course of the experiment. The peak transdermal voltage slowly decreases with repeated pulsing, causing the
"track" of data points to lean slightly to the left. (b) Lucifer yellow flux. Data from 13 experiments shown. The flux of
lucifer yellow reaches a steady-state profile (Figure 8.4b), resulting in a "cloud" of points at the top of each track. Each
track leans slightly to the left, due to the decrease in peak transdermal voltage with continued pulsing. (c) Cascade
blue flux. Data from 13 experiments shown. The flux of cascade blue reaches steady state with repeated pulsing
(Figure 8.4c), causing a "cloud" of points at the top of each track. Each track leans slightly to the left, since the peak
transdermal voltage decreases with repeated pulsing. (d) Calcein flux. Data from 14 experiments shown. The flux of
calcein quickly increases during pulsing initially, then begins to slowly decline with repeated pulsing (see Figure 8.4d).
Hence, the tracks of calcein fluxes on this figure actually start towards the top of the figure, then head downwards with
repeated pulsing. Since the peak transdermal voltage also decreases with repeated pulsing, each track leans towards
the right.
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8.3.1. Molecular Flux Changes with Repeated Pulsing.
Figure 8.8 shows the instantaneous molecular flux through shed snake skin in a typical experi-
ment, plotted versus the pulse number for the same four fluorescent compounds (8.8a, sulforhodamine;
8.8b, lucifer yellow; 8.8c, cascade blue; and 8.8d, calcein). The molecular flux reported here is the
deconvoluted average flux through the skin.
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Figure 8.8. The molecular flux through snake skin as a function of pulse number. Representative experiments
shown. Error bars have been removed for clarity. In all cases, 640 pulses were applied, 1 pulse every 5.56 s. A flow-
through system was used to measure the flux in real time, with a time resolution of ~14 s. (a) The flux of
sulforhodamine increased throughout the experiment, similar to in human skin (Figure 8.4a). (b) The flux of lucifer
yellow quickly increased then decreased with additional pulsing. (c) The flux of cascade blue also increased quickly,
then decreased with repeated pulsing. (d) The flux of calcein quickly reached a maximum, then began decreasing with
repeated pulsing. This behavior was similar to human skin (see Figure 8.4d).
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The behaviors of the sulforhodamine flux (gradual increase in the flux with repeated pulsing) and
the calcein flux (quick rise, followed by a slow decrease in the flux) through snake skin were similar to
human skin (compare Figure 8.8a versus 8.4a and Figure 8.8d versus 8.4d). However, very different
behaviors were observed for the lucifer yellow and cascade blue fluxes (compare Figure 8.8b versus
8.4b and Figure 8.8c versus 8.4c). In human skin, both lucifer yellow and cascade blue rose to a
steady-state plateau with repeated pulsing. However, the molecular flux of both lucifer yellow and cas-
cade blue in snake skin quickly increased, then decreased with continued pulsing, similar to the be-
havior of calcein.
Decreases in the molecular flux with repeated pulsing have previously been observed for calcein
(Prausnitz, et al., 1994; Pliquett, et al., 1995 [b]; Pliquett and Weaver, 1996 [a]; Pliquett and Weaver,
1996 [b]; Chen, et al., 1998 [c]; Vanbever, et al., submitted), but this is the first time that this drop
has been observed with other fluorescent tracers. The pulsing electrodes were well-protected by poly-
acrylamide gels and streams of PBS (see discussion in Section 4.1), so it seems more likely that the
drop in molecular flux, measured for three different fluorescent molecules in snake skin, is a real effect
and not an artifact of the experimental system.
8.3.2. Transdermal Voltages Drop with Repeated Pulsing.
Figure 8.9 shows the voltage drop across shed
snake skin during each pulse in a typical experi-
ment. The transdermal voltage dropped quickly
with the first few pulses, then decreased more
slowly with additional pulsing. In particular, it did
not go to steady state. This behavior was observed
regardless of the fluorescent tracer used in the
donor compartment.
The rate at which the transdermal voltage
dropped in snake skin was similar to that of human
skin (compare Figure 8.9 to Figure 8.5). The
magnitude of the transdermal voltage created across
snake skin during pulsing was also similar to
human skin. Thus, in skin electroporation, shed
black rat snake skin is a good model of the elec-
trical properties of human skin.
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Figure 8.9. The transdermal voltage across snake skin
versus pulse number. Error bars have been removed for
clarity. Like human skin, in snake skin, the transdermal
voltage initially drops rapidly, then continues decreasing
at a slower rate afterwards.
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8.3.3. Localized Transport Regions in Snake Skin.
Although LTR formation was also observed in snake skin, both the formation of LTRs and the
molecular fluxes in time with repeated pulsing were quite different in snake skin than in human skin.
Representative LTRs that formed on snake skin are shown in Figure 8.10. Unlike with human skin, the
pattern of LTR staining was very similar for all four molecules (8. 1Oa, sulforhodamine; 8. 1Ob, lucifer
yellow; 8. 1Oc, cascade blue; and 8. 1Od, calcein). In all four cases, the LTRs appeared as rings with
slightly darker interiors, similar to calcein in human skin (Figure 8.6d). The rest of the skin, away
from the LTRs, showed very poor staining. Thus, in the electroporation of snake skin, molecular trans-
port occurs through the LTRs, with the same transport pathways being used in all four cases. There
does not appear to be any significant transport through the skin away from the LTRs.
8.3.4. Transport Pathways are through Corneocytes.
As there are no sweat ducts or hair follicles in snake skin, and since the mesos layer covers the
entire snake, including underneath the scales (Roberts and Lillywhite, 1980; Itoh, et al., 1990 [a]),
Figure 8.10. Photomicrographs of snake skin after pulsing for four fluorescent compounds. Scale bar = 50 g .
Representative fields shown. After 1 h of high-voltage pulsing, the appearance of the LTRs was very similar with all
four tracers: (a) sulforhodamine, (b) lucifer yellow, (c) cascade blue, and (d) calcein.
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then molecular transport through snake skin during high-voltage pulsing must be occurring through
either the corneocytes, or the intercellular spaces.
However, the LTRs in both human (Figures 8.6a through 8.6d) and snake skin (Figures 8.lOa
through 8.lOd) appear to be much bigger than the corneocytes (typically, an LTR is -100 g in diameter,
versus -30 g in diameter for a corneocyte [Elias, 1983]). The LTRs only form during high-voltage
pulsing, along with significant molecular transport (Pliquett, et al., 1996 [b]; see also Sections 8.2.3
and 8.3.3). Thus, molecular transport during high-voltage pulsing occurs through the corneocytes of
snake skin. With the large similarity in the results of human and snake skin, the corneocytes in
human stratum corneum are probably also involved in molecular transport.
8.3.5. Transport Profiles.
In snake skin, the transport pathways across the skin used by lucifer yellow and cascade blue are
probably the same pathways as for calcein, given the similarity of the molecular fluxes (compare Fig-
ures 8.9b, 8.9c, and 8.9d), and the similarity of the LTRs (compare Figures 8.10b, 8.10c, and 8.1Od).
This is in contrast to the human skin results, which showed very different behaviors for the fluxes of
calcein, lucifer yellow, and cascade blue. Additional transport pathways, away from the LTRs and the
appendages, may be used during molecular transport through human skin, causing different patterns
of staining and different molecular flux profiles.
For sulforhodamine, a different mechanism may be involved in molecular transport than for the
other three molecules, as sulforhodamine is significantly less hydrophilic than the others (Table 4.1).
In both human and snake skin. the molecular flux of sulforhodamine increased slowly with repeated
pulsing and did not reach steady state. Staining of the LTRs after pulsing in human skin was unlike
the other molecules. Sulforhodamine appears to stain the centers of the LTRs, possibly indicating
hydrophobic regions within the LTRs. This would account for the lack of fluorescence in the centers of
the LTRs observed with calcein and lucifer yellow.
8.4. Conclusions.
This study showed that during high-voltage pulsing of the skin, both the molecular flux and the
peak transdermal voltage need to be measured with high time resolutions, on the order of seconds, not
hours, due to the changing nature of both the transdermal voltage and the resultant molecular flux.
Molecules which are very similar (similar molecular weights, similar charges, etc.) can pass through the
skin at significantly different rates, and cause quite different patterns of staining in the skin. Careful
-123-
measurements during repeated pulsing (exponential pulses, 1 ms time constant, 1 pulse every 5.56 s)
have shown that the transdermal molecular flux increases markedly at transdermal voltages >50 V,
possibly indicating the onset of electroporative molecular transport through the skin.
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9. Time Course of Skin Electroporation.*
In skin electroporation, a series of short (~1 ms), high-voltage (V100 V~ski) pulses are typically
applied to the skin, causing dramatic increases in molecular transport, potentially useful for drug de-
livery (Prausnitz, et al., 1993 [a]). Many molecules have been successfully transported across the skin
in vitro, including low molecular weight compounds such as sulforhodamine (Pliquett and Weaver,
1996 [al; Pliquett, et al., 1996 [b]; Chen, et al., 1998 [b]; Chen, et at., 1998 [c]; Vanbever, et al.,
submitted) and calcein (Prausnitz, et al., 1993 [a]; Prausnitz, et al., 1993 [c]; Prausnitz, et al., 1994;
Pliquett, et al., 1995 [b]; Pliquett and Weaver, 1996 [a]; Pliquett and Weaver, 1996 [b]; Pliquett, et
al., 1996 [b]; Prausnitz, et al., 1996 [b]; Chen, et al., 1998 [b]; Chen, et al., 1998 [c]; Vanbever, et
al., submitted). Larger compounds have also been successfully transported across human skin as well,
including luteinizing hormone releasing hormone (LHRH) (Bommannan, et al., 1994; Riviere, et al.,
1995), oligonucleotides (Zewert, et al., 1995; Regnier, et al., in press [a]), and heparin (Prausnitz, et
al., 1995 [b]; Vanbever, et al., 1997; Weaver, et al., 1997).
Molecular transport across the skin is believed to take place across spontaneously forming
"localized transport regions" (LTRs), distributed randomly on the surface of the skin, and are specifi-
cally not hair follicles or sweat ducts (Zewert, et al., 1995; Pliquett, et al., 1996 [b]; Prausnitz, et al.,
1996 [a]; Chen, et al., 1998 [b]; Vanbever, et al., submitted).
Pulses are typically applied to the skin at the rate of one pulse every 5 s (Prausnitz, et al., 1993 [a];
Prausnitz, et al., 1994; Prausnitz, et al., 1995 [b]; Zewert, et al., 1995; Pliquett and Weaver, 1996
[a]; Pliquett and Weaver, 1996 [b]; Prausnitz, et al., 1996 [b]; Weaver, et al., 1997; Chen, et al.,
1998 [b]; Chen, et al., submitted [b]) or one pulse every minute (Kost, et al., 1989; Vanbever, et al.,
1994; Pliquett, et al., 1995 [b]; Vanbever and Priat, 1995; Pliquett and Weaver, 1996 [a]; Pliquett
and Weaver, 1996 [b]; Prausnitz, et al., 1996 [b]; Vanbever, et al., 1996 [a]; Vanbever, et al., 1996
[b]; Vanbever, et al., 1997; Vanbever, et al., 1998 [al). However, in most of these experiments,
measurements of the condition of the skin, or the amount of transport across the skin, are typically
made once an hour. In essence, each measurement is the average of 60 to 720 pulses.
Recent experiments have shown that many dramatic changes occur in the skin on the time scale of
a few pulses. For instance, the transdermal voltage can drop rapidly during the first few pulses (Chen,
et al., 1998 [c]). Also, the impedance of the skin can vary with repeated pulsing (Pliquett, et al., 1995
[a]; Pliquett and Weaver, 1996 [a]). The molecular flux across the skin in time can also vary
dramatically (Pliquett, et al., 1995 [b]; Pliquett and Weaver, 1996 [a]; Chen, et al., 1998 [c]; Chen, et
al., in press [a]), even for similar compounds (Chen, et al., 1998 [c]).
*Some of the material in this chapter has also been published in Chen, et at., (submitted) [b].
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Much work has been done on individually measuring some of these properties of the skin during
high-voltage pulsing. However, the combination of all these measurements would be useful in gaining a
better understanding of the mechanism behind molecular transport during skin electroporation, as
many of these factors undoubtedly could affect each other. The investigation of this subject is the topic
for this chapter.
9.1. Real-Time Measurements and Time Resolutions.
In the skin electroporation experiments in this chapter, high-voltage, exponentially-decaying pulses
with a time constant of -1 ms were applied to the skin once every -5 s, to facilitate comparison with
previous experiments from the literature (Prausnitz, et al., 1993 [a]; Prausnitz, et al., 1994; Prausnitz,
et at., 1995 [b]; Zewert, et at., 1995; Pliquett and Weaver, 1996 [a]: Pliquett and Weaver, 1996 [b]:
Prausnitz, et at., 1996 [b]; Weaver, et at., 1997; Chen, et at., 1998 [b]; Chen, et at., in submitted
[b]). While high-voltage pulses were being applied to the skin, several measurements were taken as
rapidly as possible: the molecular flux, the transdermal voltage, the impedance of the skin between
pulses, the amount of material loaded into the skin (the so-called "reservoir" effect) (Prausnitz, et at.,
1993 [a]), and the formation of LTRs (Table 9.1).
The molecular flux was measured with a time resolution of -14 s (Chen, et at., 1998 [c]; Chen, et
al, in press [a]), using a flow-through system in the receptor compartment, connected to a spectro-
fluorimeter. In this system, the contents of the receptor compartment were continuously pumped to a
spectrofluorimeter and replaced with fresh PBS. The residence or "mixing" time of the receptor com-
partment (Fogler, 1992) was taken to be the time resolution for this system. Key factors governing this
time are the volume of the receptor compartment, and the flowrate of PBS.
The transdermal voltage for every single pulse was recorded on a per-pulse basis while the pulses
were applied once every -5 s. Besides just the peak transdermal voltage, the entire waveform during
the pulse was also measured and recorded, with a time resolution of 10 Is. As this was mostly an
electrical measurement, the time resolution was limited only by the time needed to download and store
the data, which had to be kept under 5 s.
Inter-skin impedance measurements gave a useful indication of the condition of the skin between
pulses. Like the transdermal voltage measurements, the time resolution was limited only by the time
Table 9.1. Available Time Resolutions.
Measurement Technique Time Resolution
Molecular flux Flow-through system. -400 pl 14 s
Transdermal voltage Differential high-voltage probe/computer 10 ps
Inter-pulse impedance Impedance meter/computer 200 ms
Material transported into skin Removal of donor followed by additional pulsing 1 pulse
LTR formation Fluorescence microscopy 1 pulse (4 ms)
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needed to download and save the impedance data, and this could be as little as 200 ms between
measurements. The impedance measurements were a surrogate for the DC resistance of the skin, since
directly measuring the DC resistance could potentially cause iontophoresis of the skin to occur. Thus,
measuring the impedance of the skin at a low frequency, rather than the DC resistance, ensures that
the net current is zero.
The amount of material (the fluorescent tracer) loaded into the skin during pulsing could not be
determined in real time. To determine the amount of material present within the skin, after applying a
series of high-voltage pulses, the donor and receptor compartments were then emptied, and additional
pulses applied to remove the remaining material within the skin ("extraction"). Thus, to determine the
amount of material in the skin with respect to the pulse number, a new experiment had to be conducted
for each pulse number. The time resolution for this technique is therefore theoretically one pulse,
although to conduct enough experiments for that great of a time resolution would be impractical.
Like the extraction experiments, to monitor the formation of LTRs in the stratum corneum during
pulsing, the experiment needed to be stopped, and the skin removed from the chamber, prepared on a
microscope slide, and studied under fluorescence microscopy. After mounting the skin on the micro-
scope slide, the skin could not be reused, due to potential mechanical sheering; thus, a new experi-
ment had to be conducted for each pulse number. This limited the time resolution to one pulse.
Others have successfully built chambers that could be examined under fluorescence microscopy
during pulsing (Pliquett, et at., 1996 [b]). By connecting a VCR to the microscope, the formation of
LTRs could be monitored in real time during the experiment, giving an effective time resolution of 4 ms
(VCRs typically record images at 24 frames per second). However, this technique was not used for the
experiments described in this paper.
9.2. Materials and Methods.
The experimental apparatus used in these experiments has been modified from the ones previously
described in the literature (Chen, et at., 1998 [c]; Chen, et at., in press [a]). The major additions in-
clude the skin impedance measurement system and the donor extraction system.
This system is described in greater detail in Appendix V. Human skin was placed in a diffusion
chamber, equipped with independent flow-through systems in both the donor and the receptor com-
partments. A PBS solution containing 1 mM of a fluorescent tracer (sulforhodamine, lucifer yellow,
cascade blue, or calcein; see discussion in Chapter 4) was used as the donor solution. The pulsing
electrodes were surrounded by polyacrylamide gel and washed in a steady stream of PBS, to protect the
donor and receptor compartments from chemical by-products produced by the electrodes during
pulsing. The transdermal voltage during each pulse was measured separately using a different set of
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inner "measuring" electrodes. The inter-pulse impedance of the skin was measured using an
impedance meter that was disconnected from the chamber whenever a high-voltage pulse was applied.
Data stored in real time from the spectrofluorimeter (flux measurements), the oscilloscope (voltage
measurements), and the impedance meter were calibrated and processed to give information about the
conditions of the experiment. After pulsing, the skin was removed, mounted on a microscope slide, and
examined by fluorescence microscopy. Alternatively, the donor solution was flushed out and replaced
with fresh PBS. Additional pulses were then applied to extract the material still within the skin.
9.2.1. Skin Preparation.
Human cadaver skin was prepared by the heat-stripping method, described in Appendix I. Briefly,
stored cadaver skin at -80 0C (Gummer, 1989) was thawed to room temperature, then submerged in
de-ionized water for 2 min at 60 'C. The epidermis (including the stratum corneum) was gently
scraped off of the dermis, cut into 3/4 inch diameter circles, and stored at 4 'C, 95% humidity for up to
10 d (Gummer, 1989).
9.2.2. Permeation Chamber and Electrodes.
Phosphate-buffered saline (PBS) was prepared as described in Section 3.2. The donor solution
consisted of a fluorescent tracer (either sulforhodamine, lucifer yellow, cascade blue, or calcein),
dissolved in PBS at a concentration of 1 mM. The solution was gently stirred for >30 min (Nutator, Clay
Adams, Becton Dickinson).
The flow-through system is described more fully in Appendix V (see Figure V.2). The permeation
2
chambers were specially designed, side-by-side chambers, with a skin exposure area of 0.64 cm
(circular opening, 0.9 cm in diameter) (Crown Bio Scientific) (Friend, 1992). The chamber consisted of
an outer water jacket and an inner compartment. Ports from the inner compartment allowed direct
access to the inner compartment. Each chamber half had one large port near the skin (for the mea-
suring electrodes and the flow-through system) and two small ports away from the skin (for the pulsing
electrode and the electrode flow-protection system). To keep the skin and the donor and receptor solu-
tions at 37 *C, water heated by a thermostated water bath (Neslab) was continually pumped through
both outer jackets.
The flow-protected electrodes were constructed by soldering a piece of 0.040 inch diameter silver
wire, -0.5 cm long, to copper bell wire. The solder and exposed wire were covered by nonconducting
silicone rubber (General Electric), so that only the silver wire was exposed. A piece of Tygon tubing,
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1/32 inch ID, and the electrode were inserted through a truncated 200 tl pipette tip. The top of the
pipette was sealed with epoxy (Devcon).
The two measurement/flow-through electrodes were constructed as follows. A piece of 0.040 inch
diameter silver wire, -0.5 cm long, was soldered to copper bell wire. The solder and exposed wire were
covered by nonconducting silicone rubber, so that only the silver wire was exposed. Teflon tubing,
1/16 inch ID, was used for the outflow and Tygon tubing, 1/32 inch ID, was used for the inflow. The
wire and the two tubes were inserted through a truncated 1 ml pipette tip. A hole was drilled into the
side of the pipette tip and the Teflon tube was extended out through the hole. All of the tubes and
wires were sealed in place with epoxy.
Next, the top of a 2 ml centrifuge tube was removed and two holes were drilled the tube: one in the
bottom and one in the side. Tygon tubing, 1/32 inch ID, was epoxied to the bottom hole. The Teflon
tube from the pipette was extended through the side hole in the centrifuge tube. The centrifuge tube
was held in place to the side of the pipette with Parafilm (American National Can).
Before each experiment, plastic tubes were inserted through both compartments and sealed in
place with Parafilm. The measuring/flow-through electrodes were also inserted into both compartments
and sealed in place with Parafilm. The tubing within both compartments was wired in place with
stainless steel wire. Both compartments was turned sideways, and polyacrylamide solution was poured
in, completely immersing everything, leaving empty a volume of -450 p1 in each compartment. The
polyacrylamide solution was composed of 0.75 g of 19:1 acrylamide:bis(N,N'-methylene-bis-acrylamide)
powder (Bio-Rad), 43.75 g1 of 440 mM (NH 4 )2 S 2 0 8 solution, and 3 d of N,N,N',N'-tetramethyl-
ethylenediamine (Bio-Rad) in 5 ml of PBS.
The polyacrylamide solution was allowed to harden (-10 min). After the solution solidified, the
outer plastic tubing and the Parafilm were removed from the outer ports, leaving behind an empty
channel through the gel. The flow-protected electrodes were inserted into this channel. During an
experiment, PBS was pumped through each outer channel at a flowrate of ~6 ml/min, using two peri-
staltic pumps (VWR). The stainless steel wire was removed from each compartment, since the tubing
was now immobilized in place by the gel.
9.2.3. Fluorescence Measurements.
Fluorescence measurements were taken with a spectrofluorimeter (Fluorescence Master Series
Spectrometer, Photon Technology, Brunswick, NJ). Excitation and emission wavelengths for each
fluorescent compound are given in Table 4.1.
The cuvette in the spectrofluorimeter was constructed by drilling two holes into a polystyrene
microcuvette (VWR), to allow for inflow and outflow. One hole was drilled approximately 1/4 inch from
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the bottom of the cuvette to allow liquid outflow, and the other hole was drilled higher in the cuvette to
allow liquid inflow. Both holes were connected by Tygon tubing to a peristaltic pump ("Sarah" Cassette
Peristaltic Pump, Barnant).
The final volume of the cuvette was ~200 pl, and was the minimum amount needed by the spectro-
fluorimeter for accurate detection and quantification of the receptor solution. Mixing within the cuvette
was accomplished by the dripping of liquid into the cuvette. The performance of this system was close
to an idealized continuous-stirred tank reactor (Fogler, 1992), and the residence time for the combined
chamber-tubing-pump-cuvette system (volume of ~400 pl) was measured to be -14 s. This was taken
to be the time resolution for the flux measurements.
9.2.4. Electrical Equipment.
High-voltage exponential pulses were delivered by a high-voltage pulser (Electroporation System
600, BTX), specially modified to deliver 1 pulse every -5 s (U. Pliquett, personal communication).
Since the fluorescent tracers were all negatively charged, the negative terminal of the pulser was
connected to the pulsing electrode in the donor compartment, and the positive terminal to the receptor
compartment, to provide a favorable driving force.
The time constant on the high-voltage pulser was set to 1 ms. Pulses with peak transdermal
voltages between 0 V and ~150 V across the skin were applied for 1 h, one pulse every 5.56 ± 0.01 s
(640 pulses total).
Current delivered across the skin during each pulse was measured by measuring the voltage drop
across a 1.2 Q noninductive resistor placed in series with the permeation chamber. The voltage drop
across the resistor was measured by a 10 x voltage probe (HP 1007 1A, Hewlett Packard) connected to
an oscilloscope (Hewlett Packard 54601, Hewlett Packard). The oscilloscope was connected through an
RS-232 interface card (54641A RS-232 Interface Module, Hewlett Packard) to the serial port on a per-
sonal computer.
The voltage drop from the receptor to the donor compartment was measured by connecting a differ-
ential high-voltage probe (Active Differential Probe B9017RT, Yokogawa) to the immobilized silver wire
measuring electrodes in each compartment. This probe was also connected to the same oscilloscope.
The computer was programmed using Turbo C++ (Borland), running a program that would count
and record both voltage waveforms recorded by the oscilloscope for every pulse. The program is given
in Section V.4.5. The program recorded the waveform data as ASCII characters and did not do any
mathematical processing.
Between pulses, the impedance of the skin was measured using an impedance meter (Model 5R715
LCR Meter, Stanford Research Systems), connected to a personal computer via a RS-232 cable (not the
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same one as before). The impedance meter was connected to the permeation chamber, via an electro-
mechanical relay switch, connected to the timing circuit of the pulser (E. Gift, personal communication).
Whenever a pulse was applied to the skin, the impedance meter would be physically disconnected from
the pulser as a safety precaution.
This computer was also programmed in Turbo C++. It ran a program to continuously download and
save the data from the impedance meter. This program is listed in Section V.4.2. Impedance mea-
surements were taken once every ~200 ms.
9.2.5. Skin Experimental Protocol.
Prepared, stored skin was floated in PBS for ~1 min to remove the wax paper backing. The skin
was loaded into the permeation chambers, with the stratum corneum facing the donor compartment.
PBS was then pumped into each compartment.
The condition of the skin was checked by measuring its electrical impedance. A 100 Hz, 0.1 V
bipolar sine wave (peak-to-peak) was applied across the skin and the resulting impedance measured
using the LCR meter. The skin was considered bad and was discarded if its electrical impedance was
2
<25 k cm at a frequency of 100 Hz (or <40 kK2 for this apparatus). Previous experiments have
2
shown that this impedance value compares favorably with the accepted DC resistance of <50 kQ cm
(Gowrishankar, personal communication). The resistances and impedances of the PBS and the
polyacrylamide gel were neglected, since their combined resistances were previously measured to be
260 Q (see Section 3.7), compared to -30 kQ for the skin.
After determining if the skin was acceptable or not, the apparatus was allowed to sit for 1 h to fully
hydrate the skin (Prausnitz, et al., 1993 [a]) and check for leaks. Leaky skin (passive flux above the
detection limit, -10-8 M, or -101 mol / m2 s for this experimental apparatus), was discarded.
9.2.6. High-Voltage Pulsing Protocol.
High-voltage exponential pulses, with a time constant of 1 ms and transdermal voltages between 0 V
and -150 V across the skin (applied voltages between 0 V and 1000 V) were applied for 1 h at the rate
of one pulse every 5.56 s. PBS was pumped through the flow-protection system (across the electrodes)
at -6 ml/min using a peristaltic pump (VWR). PBS was also pumped through the receptor flow-through
system at the rate of 0.0322 ml/s. The donor compartment flow-through system was initially set to
recycle the donor solution in the donor compartment. The three computers (spectrofluorimeter, voltage
waveforms, and impedance meter) were set to begin recording data.
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In the extraction experiments, after pulsing was stopped, the flow-through system in the donor
compartment was changed from the recycling mode to a flow-through mode (see Figure V.3), where
fresh PBS was continuously pumped through the donor to a waste beaker (the other measuring sys-
tems, such as for the impedance of the skin or the fluorescence, were not shut down). After waiting for
30 min to allow the donor and receptor compartments to be fully flushed out with fresh PBS, >1 h of
high-voltage pulsing was then applied to the skin.
After the experiment, the skin was removed from the chamber for fluorescence microscopy analysis.
All of the data from the three computers (spectrofluorimeter data, impedance data, and voltage data)
were downloaded onto a Sun Sparc 10 (Sun, Palo Alto, CA) workstation for analysis.
9.2.7. Fluorescence Microscopy.
A biocular fluorescence microscope (Olympus BH-2, Olympus) allowed simultaneous fluorescence
and light illumination of the specimen at 4 x and lOx magnifications. Pictures were taken using a
camera (Olympus OM2, Olympus) mounted on the microscope (Pliquett, et al, 1996 [b]).
Immediately after pulsing, the skin was carefully removed and gently placed onto a microscope
a b
Figure 9.1. Time sequence of photomicrographs after pulsing with sulforhodamine. Scale bar = 50 g. The number
of applied pulses were: (a) 3 pulses, (b) 10 pulses, (c) 100 pulses, and (d) 680 pulses. The LTRs for sulforhodamine
were well-defined regions that formed early during high-voltage pulsing, then grew in size with additional pulsing.
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Figure 9.2. TIme sequence of photomicrographs after pulsing with lucifer yellow. Scale bar = 50 g. The number of
high-voltage pulses were: (a) 3 pulses, (b) 10 pulses, (c) 100 pulses, and (d) 680 pulses. The LTRs for lucifer yellow
appeared as dark regions on the surface of the skin. No fluorescence was seen in the interiors of the LTRs. However,
the regions of the skin away from the LTRs were brightly fluorescent, and that fluorescence appeared to increase with
pulse number.
slide (Gold Seal Rite-On, No. 3050, Clay Adams, Becton Dickenson). Excess liquid was gently blotted
off with a paper towel. A drop of staining solution was added and a 22 x22 No. 1 cover slip (Clay
Adams, Becton Dickenson) was placed on top and sealed in place with clear nail polish (Hard as Nails,
Sally Hensen, Del) (Prausnitz, et al., 1996 [al).
9.2.8. Numerical Analysis.
All of the fluorescence, voltage, impedance, and calibration data were first downloaded onto a Sun
Sparc 10 workstation (Sun). A program written in MatLab 5 (Mathworks), running on a Sun Sparc 10,
used these data to determine the flux, voltage, and impedance for each pulse during the experiment.
This program can be seen in Section V.11.2. The program first loaded the voltage and current wave-
forms and fitted each curve to an exponential to determine voltages. Since the resistance of the cham-
ber without any skin was 260 kL2, the voltage across the skin could then be calculated by Ohm's Law.
Next, the program loaded in the impedance data and calculated the impedance with respect to time for
each pulse. The program then loaded the calibration and fluorescence data, and, using deconvolution
-133-
Figure 9.3. Time sequence of photomicrographs after pulsing with cascade blue. Scale bar = 50 g. The number of
applied pulses were: (a) 3 pulses, (b) 10 pulses, (c) 100 pulses, and (d) 680 pulses. No LTRs were observed for
cascade blue during the entire pulsing protocol.
routines (Pliquett, et al., 1995 [b]), calculated the molecular flux across the skin for each pulse. The
three sets of data (flux, impedance, and voltage) were then synchronized together in time. In the
extraction experiments, the flux measurements made during the extraction phase (with only PBS in the
donor compartment) were integrated to determine the amount of material released from the skin.
9.3. Molecular Fluxes and Peak Transdermal Voltages.
The molecular fluxes for all four compounds (sulforhodamine, lucifer yellow, cascade blue, and cal-
cein) were similar to those discussed in Section 8.2.2 (see Figures 8.4a through 8.4d). The flux of
sulforhodamine increased throughout the entire experiment; lucifer yellow and cascade blue both
achieved steady state; and the flux of calcein increased rapidly at the start of pulsing, then began de-
creasing afterwards.
The peak transdermal voltages were also similar to the previous experiments, also discussed in
Section 8.2.2 (Figure 8.5). The transdermal voltages initially dropped quickly with the first few pulses,
then leveled out with additional pulsing.
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9.4 Localized Transport Region Formation.
After applying 3, 10, 100, and 680 pulses, the skin was removed and examined under fluore-
scence microscopy. Four donor solutions were used: sulforhodamine (Figures 9.la through 9.1d),
lucifer yellow (Figures 9.2a through 9.2d), cascade blue (Figures 9.3a through 9.3d), and calcein
(Figures 9.4a through 9.4d). The pattern of staining observed on the surface of the skin was different
for each donor solution used.
9.4.1. Observations of the Skin.
Sulforhodamine showed the formation of bright red fluorescent spots, randomly distributed on the
surface of the skin, which were the LTRs (Figures 9. la through 9. 1d). These areas appeared within the
first 1 to 10 pulses (Figures 9. la and 9.2b), then grew larger with additional pulsing, although the
Figure 9.4. Time sequence of photomicrographs after pulsing with calcein. Scale bar = 50 g. The number of pulses
were: (a) 3 pulses, (b) 10 pulses, (c) 100 pulses, and (d) 680 pulses. Like the photomicrographs taken with lucifer
yellow (see Figure 9.2), the LTRs after 1 h of pulsing appeared as dark centers surrounded by brightly fluorescent
background staining of the skin. However, the LTR staining process appeared to be somewhat different than with
lucifer yellow. With calcein, the centers of the LTRs initially appeared very bright (a and b), then darkened with addi-
tional pulsing, so that the LTRs appeared as "rings" (c). With additional pulsing, the "rings" enlarged and the fluor-
escence of the skin away from the LTRs increased, resulting in a more uniform staining pattern of the skin. However,
the LTRs still remained dark.
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number of spots on the surface of the skin did not appear to change significantly (Figures 9. 1c and
9. 1d). The behavior of these LTRs was consistent with the LTRs previously observed during pulsing
with sulforhodamine (Pliquett, et at., 1996 [b]).
In contrast, no readily identifiable brightly fluorescent regions were observed for lucifer yellow
(Figures 9.2a through 9.2d). Instead, the entire skin appeared to be uniformly stained, with the excep-
tion of small, dark spots, randomly distributed on the surface of the skin, in the manner of the LTRs.
Like the LTRs, these dark spots appeared to be randomly distributed, and not associated with the sweat
ducts or hair follicles, which themselves were more brightly stained. The dark spots first become
noticeable at around pulse 10, as the fluorescence intensity of the background increased (Figure 9.2b).
The dark spots did not appear to grow in size or number with additional pulsing (Figures 9.2c and
9.2d). However, the dark spots themselves appeared to become more well-defined with additional
pulsing. The background fluorescence of the skin also appeared to steadily brighten during the first
half hour of pulsing (roughly 300 pulses), then leveled off with additional pulsing.
The staining of the skin with cascade blue was similar to that of lucifer yellow, except that no dark
spots were observed (Figures 9.3a through 9.3d). The skin appeared to be uniformly stained. The
background staining of cascade blue increased steadily with pulsing for the first half hour of pulsing
(~300 pulses), then leveled off with additional pulsing (Figures 9.3c and 9.3d)
During pulsing with calcein, small, brightly green fluorescent spots formed on the surface of the
skin, randomly distributed (Figure 9.4a). These spots appeared to enlarge with additional pulsing, in
the manner of LTRs (Pliquett, et at., 1996 [b]). However, the centers of the LTRs began to darken with
additional pulsing, and by pulse 10, the centers of the LTRs appeared noticeably darker (Figure 9.4b).
Meanwhile, the fluorescence of the skin, away from the LTRs, appeared to increase in intensity. By
pulse 300, the skin appears to be covered by "rings" of fluorescence (Figure 9.4c). By pulse 680 (1 h
of pulsing), the rings had spread out and the intensity of the skin away from the LTRs had increase
enough so that the staining of the skin away from the LTRs appeared uniform, while the LTRs them-
selves appeared dark, similar to the results with lucifer yellow (Figure 9.4d).
9.4.2. Molecular Transport away from the LTRs.
These observations are in general agreement with other observations of LTRs (Zewert, et at., 1995;
Pliquett, et al., 1996 [b]; Prausnitz, et at., 1996 [al; Chen, et al., 1998 [b]; Vanbever, et at., sub-
mitted). However, the staining of the skin observed with lucifer yellow and cascade blue appeared
quite different than the staining of the skin previously observed with sulforhodamine and calcein
(compare Figures 9.2 and 9.3 with Figures 9.1 and 9.4).
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Lucifer yellow, cascade blue, and calcein all had shown significant staining of the skin, away from
the LTRs. This observation has not been previously recorded in the literature. Measurements of the
current through the skin during pulsing, however, have indicated that most of the ionic transport
(electric current) appears to cross the skin through the LTRs (Pliquett, et al., 1996 [b]). Thus, the
driving force for the transport of fluorescent tracers into the skin, away from the LTRs, does not appear
to be either electroosmosis (convection) or electrical drift, as these driving forces would follow the elec-
tric field lines through the skin at the LTRs. The driving force could be facilitated diffusion, if electro-
poration of the skin away from the LTRs is occurring, which would allow easier passage of these
molecules into the skin away from the LTRs.
9.4.3. Centers of LTRs are Hydrophobic.
The centers of the LTRs appear to brightly stain with sulforhodamine, although with calcein and
lucifer yellow, the centers of the LTRs stain poorly or not at all. Sulforhodamine can partition signifi-
cantly into a lipophilic environment, unlike the other fluorescent tracers (see Section 4.2.1). Assuming
that the LTRs form regardless of the fluorescent tracer present, then cascade blue appears to be able to
stain both the LTRs and the non-LTR regions equally well, since no LTRs were ever directly observed
with cascade blue.
In addition, Nile red, a lipophilic stainer, also brightly stains the LTR centers (Prausnitz, et al.,
1996 [a]; also see Section 11.3), as do the polystyrene particles used in Chapter 5. The polystyrene
particles, despite their high negative charge, in fact prefer hydrophobic environments over hydrophilic
ones. Thus, the difficulty in cleaning them off of the glassware with only water; chloroform, an organic
solvent, was necessary for cleaning (Section 5.5).
In conclusion, despite the molecular transport that occurs through the LTRs, the centers of the LTRs
are probably very hydrophobic in nature.
9.5 Extraction of Compounds from the Skin after Pulsing.
The goal of these experiments was to determine how much material was transported into (not
through) the stratum comeum during high-voltage pulsing. After applying a certain number of pulses
to the skin with a fluorescent tracer as the donor, pulsing was stopped and the donor solution was
replaced by fresh PBS (no fluorescent tracer). Pulsing was then started to extract the tracers still pre-
sent within the skin.
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There are two important confounding factors in these experiments. First, not all of the material can
be extracted out of the skin simply by applying additional pulsing. Photomicrographs of the skin taken
after lengthy extraction experiments (>2 h of additional pulsing) were identical to those where no ex-
traction pulsing had been applied. The skin in both cases remained brightly fluorescent compared to
the passive controls. Thus, a large amount of material still remained bound to the skin (either specifi-
cally or non-specifically), even after much additional extraction pulsing.
The second confounding factor is the epidermis. These experiments were conducted with the epi-
dermis present, even though the epidermis is roughly 5 x thicker than the stratum corneum and can
also bind fluorescent compounds. Thus, even if the extraction of compounds from the stratum corneum
took place, the compounds might become remain trapped within the epidermis instead. Alternatively,
some extraction of materials from the epidermis instead of the stratum corneum may be occurring in
these experiments.
9.5.1. Extraction Results.
The amount of material extracted versus the number of pulses applied to initially "load" the skin
with fluorescent tracer is shown in Figure 9.5 (9.5a, sulforhodamine; 9.5b, lucifer yellow; 9.5c, cas-
cade blue; and 9.5d, calcein). Most of these experiments were conducted with lucifer yellow, although
a few experiments were conducted with the other fluorescent molecules for comparison purposes.
In general, the amount of material extracted from the skin was proportional to the number of pulses
required to load the skin. There was a significant amount of sulforhodamine extracted from the skin.
There was some loading of lucifer yellow and calcein, although not nearly as much as sulforhodamine.
There was no measurable extraction of the skin with cascade blue.
9.5.2. Loading of the Epidermis, not only of the Stratum Corneum.
Assuming that the entire stratum corneum was completely filled with only donor solution (with an
area of 0.64 cm 2 , thickness of 10 pt, donor solution concentration of 1 mM), the maximum amount that
could be extracted from the stratum corneum would be 0.64 nmol. The amount of material actually
extracted from the skin was much larger, 1 to 50 nmol, indicating that loading within the epidermis may
be playing an important role in these experiments.
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Figure 9.5. Extraction of fluorescent compounds from the skin after high-voltage pulsing. A given number of pulses
were applied to the skin, with a fluorescent tracer as the donor. Afterwards, the donor compartment was flushed out
with fresh PBS, and additional pulsing was applied to extract the materials trapped in the skin (the "reservoir" effect).
In general, more pulses caused higher loadings. (a) Sulforhodamine showed the most loading. (b) Lucifer yellow showed
some loading, although not as much as sulforhodamine. (c) Cascade showed no significant loading. (d) Calcein showed
some loading for the conditions used.
Including the epidermis in this calculation (with a thickness of 100 vt), and assuming that the
entire epidermis is filled with only donor solution (with a concentration of 1 mM), the maximum amount
that could be extracted from the epidermis would be 6.4 nmol. This is consistent with the observed
extractions for lucifer yellow and calcein, indicating that the epidermis has also been loaded with donor
solution to some extent.
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However, the amount of sulforhodamine extracted from the skin was nearly an order of magnitude
larger (up to 50 nmol) than the maximum amount of sulforhodamine which could be loaded into the
skin, based on this calculation. It is unclear why this much sulforhodamine was extracted from the
skin; one possible explanation is that sulforhodamine somehow is concentrated into the lipid regions
of the skin during pulsing, or strongly binds to the skin during transport.
9.5.3. Need for Further Experiments.
Given the limited number of experiments shown in Figures 9.5a through 9.5d, and the incon-
sistency between the amount of material actually extracted from the skin and the maximum amount that
was estimated to be present, more experiments will undoubtedly be needed to understand these
results. However, it appears that both the hydrophobicity of the molecule being transported, and the
number of pulses applied are important factors in the loading of the skin. Other factors, such as the
time constant or the inter-pulse spacing, should also be examined.
9.6. Electrical Impedances.
Rapid measurements of the impedance of the sk
the entire course of the experiment, including the 1
h passive control/skin hydration period. The im-
pedance measurements were taken at a frequency
of 100 Hz, using a bipolar sine wave with a peak-
to-peak voltage of 0.1 V. Other experiments have
shown a good correlation between the DC resis-
tance of the skin, and the 100 Hz impedance
(Gowrishankar, personal communication).
9.6.1. Passive Impedances.
The 100 Hz impedance measurements of the
skin during the initial 1 h hydration period typi-
cally show a rise in the impedance. A representa-
tive experiment is shown in Figure 9.6, where the
in (time resolution of -200 ms) were taken during
251
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Figure 9.6. Passive 100 Hz impedance measurements of
the skin during the 1 h passive control. The impedance
of the skin in this particular case rose from -21 kQ to
-24 kQ in 1 h.
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impedance of the skin was initially measured to be
-20 ki . After 1 h, the impedance of the skin had
risen to -24 ki.
This experiment was performed many times
(-70 total), and rises in the impedance of the skin
during the 1 h passive control period were ob-
served in nearly all of these experiments, usually
with increases of ~5 to -20 kL2.
It is unclear why the impedance (or the
resistance) of the skin should increase as the skin
becomes hydrated with PBS in that first hour. The
addition of PBS (a highly conductive substance) to
the skin should cause the impedance to drop, not
increase. One possible explanation for the con-
sistent increase in the impedance of the skin may,
be that the skin is already filled with water and
ions, at a much higher concentration than in PBS
(150 mM). Thus, hydration and equalization of the
skin with the outside PBS solution would cause a
net flux of ions out of the skin, with correspond-
ingly higher impedance measurements.
9.6.2. Impedances during Pulsing.
The impedance of the skin quickly drops after
the first few pulses, then continues to drop more
slowly with additional pulsing (Figure 9.7). This is
consistent with the skin electroporation hypothesis,
where most of the aqueous pathways across the
skin are initially formed in the first few pulses
(Prausnitz, et al., 1993 [a]; Chizmadzhev, et al.,
1995; Chizmadzhev, et al., 1998 [a]). Additional
pulses serve to keep these pathways open, and
occasionally add new pathways as well, but at a
much slower rate, thus the continuing drop in the
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Figure 9.7. Impedance measurements at 100 Hz of the
skin during pulsing. The impedance initially drops very
quickly, then continues to decrease more slowly with
additional pulsing. Pulses in the above experiment were
given once every 5 s. The first 10 pulses from the above
experiment can be seen in Figure 9.8.
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Figure 9.8. Impedance measurements at 100 Hz of the
first 10 pulses. Impedance measurements were taken
every -200 ms, and pulses were applied to the skin every
-5 s. During high-voltage pulsing, the impedance meter
was disconnected from the circuit, causing the gaps in the
impedance measurements. After each pulse, the impe-
dance of the skin started to rise, indicating that some re-
covery was taking place. However, the impedance of the
skin after the pulse was lower than before. This trend
continued throughout the entire experiment, as can be
seen in Figure 9.7.
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impedance of the skin with repeated pulsing.
An enlargement of the impedance measure-
ments of the skin between the first several pulses
can be seen in Figure 9.8. The gaps in the data
were those regions where the impedance meter was
disconnected from the chamber by the electro-
mechanical relay, while the high-voltage pulse was
being applied to the skin.
Between each of the pulses, the impedance of
the skin begins to rise, indicating that some re-
covery (i. e., closing of the aqueous pathways) is
occurring. However, the impedance of the skin
after each pulse was lower than the pulse before it.
This trend continued throughout the entire experi-
ment.
The rise in the impedance of the skin continues
after pulsing has stopped. Figure 9.9 shows the
impedance of the skin after pulsing was stopped for
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Figure 9.9. Normalized recovery of the impedance of the
skin after pulsing. The impedance measurements have
been normalized to pre-pulse values. The applied voltage
was 1000 V, corresponding to a transdermal voltage of
-100 V (see Section 8.2.1). After one pulse, there was
some recovery, to -77%. However, after just 10 pulses,
there was only poor recovery of the impedance of the
skin.
1, 10, 25, 100, and 640 pulses (normalized to the impedance of the skin before pulsing was started).
In every case, the impedance of the skin increased after pulsing had been stopped, indicating that
some recovery of the skin was taking place. However, the impedance did not rise to pre-pulsing levels.
The recovery of impedance of the skin appears to become increasingly difficult with additional
pulsing. The impedance after 1 pulse recovers to -77% of its pre-pulsing value, yet after 10 pulses,
the impedance only recovers to -5% of its pre-pulsing value. Thus, high-voltage pulsing appears to
cause some irreversible changes in the structure of the skin, which accumulate with additional pulsing.
9.7. Course of a Typical Skin Electroporation Experiment.
The summation of all of the available data (transdermal voltage from Figure 8.5, molecular flux from
Figure 8.4b, inter-pulse skin impedance from Figure 9.8, loading within the skin from Figure 9.5a, and
LTR formation from Figure 9.2) for a typical experiment involving lucifer yellow as the donor is shown in
Figure 9.10. The data are presented in this way to allow a side-by-side summary of the typical events
that occur during skin electroporation.
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Figure 9. 10. Skin electroporation parameters, measured in real time, during a typical experiment with lucifer yellow.
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Many changes occur within the first few pulses. Significant transdermal fluxes can be measured
after roughly 5 to 10 pulses. Loading of the donor within the skin is also significant during the first few
pulses, which is consistent with the amount of molecular flux observed through the skin in the first few
pulses; loading into the skin and transport through the skin should both be occurring simultaneously
during high-voltage pulsing. The formation of LTRs on the surface of the skin can also be seen.
The peak transdermal voltage during pulsing drops significantly. The impedance of the skin
during the first few pulses also drops quickly, going from a reversible regime to a less reversible one.
Even with many pulses, the system does not quite reach quasi-steady state. The peak transdermal
voltages and the impedance of the skin continue to drop with continued pulsing, although much more
slowly than in the first few pulses. In some cases the molecular flux reaches steady state (lucifer
yellow, cascade blue), although in other cases it does not (sulforhodamine, calcein). Very few LTRs
continue to form on the surface of the skin, although molecular transport through the skin away from
the LTRs may also be significant.
Thus, to control transdermal transport for drug delivery purposes, the events that occur during
skin electroporation must first be understood. Many things can happen within the first few pulses, and
measurement of these parameters is necessary before control can be achieved.
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10. Real-Time Iontophoresis of the Skin.
Although most of this thesis has dealt with the topic of skin electroporation, enough experiments
have been conducted using iontophoresis (primarily as positive controls during the skin electroporation
experiments) to warrant a separate discussion of skin iontophoresis.
Iontophoresis is the application of a small, usually constant DC current to the skin, which is
commonly used to transport drugs and other molecules across the skin (Tyle, 1986; Banga and Chien,
1988; Burnette, 1989; Chien and Banga, 1989; Singh and Roberts, 1989; Cullander and Guy,
1992; Amsden and Goosen, 1995; Guy, 1996). Typically, currents are kept <0.5 mA / cm2 , as higher
currents stimulate nerves within the skin, causing irritation or pain (Banga and Chien, 1988; Burnette
and Ongpipattanakul, 1988; Ledger, 1992). During iontophoresis, the resistance of the skin drops by
2
an order of magnitude, to -10 kQ cm . This corresponds to a voltage drop across the skin of <5 V,
which is not enough for electroporation to occur (Chizmadzhev, et at., 1998 [a]).
Without a means to produce new transport pathways, molecular transport during iontophoresis
occurs primarily through the pre-existing pathways across the skin, which are the sweat ducts and hair
follicles (collectively called the "appendages" of the skin) (Abramson and Gorin, 1940; Abramson and
Engel, 1942; Grimnes, 1984; Burnette and Marrero, 1986; Burnette and Ongpipattanakul, 1988;
Cullander and Guy, 1991; Scott, et at., 1993; Chen, et at, 1998 [b]; Chen, et at, in press [b]; also
see Chapter 7, which discusses experiments involving the iontophoresis of human skin and shed black
rat snake skin, a model of human skin which lacks hair follicles and sweat ducts).
10.1. Theory.
The driving force for molecular transport during iontophoresis is believed to be primarily through
electrophoresis (sometimes called electrical drift), as governed by the Nernst-Planck equation:
JC. z1!TC1 DEJ, = -Dt DC + -- , (10.1)
Dx RT ax
where F is the Faraday (96 484 C/mol), R is the molar gas constant (8.3144 J/mol K), T is the
absolute temperature, E is the electric field, and x is the distance across the skin. For a species i, J
is the molecular flux through the skin, Di is the diffusion coefficient, C is the concentration, and z is
the charge. The first term in the equation represents passive diffusion, and the second term represents
electrophoresis.
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However, the skin is a charged membrane, and some molecular transport may also be occurring via
electroosmosis (Burnette, 1989; Singh and Maibach, 1996). Thus, a convective term can be added to
the Nernst-Plank equation to account for electroosmosis:
J, = -Di i + - ubC, (10.2)
Dx 'T ax
where ub represents the bulk velocity (in units of [length/time]) or solvent flow across the skin.
During iontophoresis, bulk fluid flow will occur from the negative electrode to the positive electrode,
since the skin is negatively charged (Singh and Maibach, 1996). An important application of this
phenomenon is the transport of glucose out of the skin by iontophoresis, sometimes called "reverse
iontophoresis."
With the development of an in vitro flow-through system that was able to measure molecular fluxes
across the skin with a time resolution of -14 s (Chen, et at., in press [a]; see Section 8.1.3 and
Appendix IV), and the availability of four hydrophilic, similarly charged fluorescent molecules, differing
primarily in charge (calcein, cascade blue, lucifer yellow, and sulforhodamine) (see Chapter 4), a con-
trolled study of the molecular transport during iontophoresis as a function of the molecular charge
could be performed. The applied current was the same in each case, 1.0 mA / cm 2 , chosen since it
represented the maximum limit of what could be applied to human skin. The electrodes were encased
in polyacrylamide gel and protected by a stream of PBS, so that any chemical by-products or pH
changes produced by the electrodes would not react with the skin, or the donor and receptor compart-
ments.
10.2. Materials and Methods.
The flow-through experimental apparatus used for iontophoresis was generally the same as the one
that was used for the skin electroporation flow-through studies (see Appendix IV), with a few minor
changes. Instead of a high-voltage pulser, a custom-built, constant current device was used that pro-
duced a steady current of 1.0 mA / cm2 (0.64 mA total) (Prausnitz, et at., 1993 [a]; U. Pliquett, per-
sonal communication). Transdermal voltages were not recorded during the experiments.
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10.2.1. Skin Preparation.
Human cadaver skin was prepared by the heat-stripping method, described in Appendix I. Briefly,
stored cadaver skin at -80 0C (Gummer, 1989) was thawed to room temperature and submerged in de-
ionized water for 2 min at 60 'C. The epidermis (with the stratum comeum) was gently scraped off the
dermis, cut into 3/4 inch diameter circles, and stored at 4 'C, 95% humidity for up to 10 d (Gummer,
1989).
10.2.2. Permeation Chamber with Four-Electrode System.
Phosphate-buffered saline (PBS) was prepared as described in Section 3.2. The donor solution
consisted of a fluorescent tracer (one of either sulforhodamine, lucifer yellow, cascade blue, or calcein),
dissolved in PBS to a concentration of 1 mM. The solution was gently stirred for >30 min (Nutator, Clay
Adams, Becton Dickinson), to allow the tracer time to dissolve.
The flow-through system with the four-electrode design is described in more detail in Appendix IV.
Briefly, the permeation chambers were specially designed, side-by-side chambers, with a skin expo-
2
sure area of 0.64 cm (circular opening, 0.9 cm in diameter) (Crown Bio Scientific) (Friend, 1992).
The chamber consisted of an outer water jacket and an inner compartment. To keep the skin and the
donor and receptor solutions constant at 37 'C, water heated by a thermostated water bath (Neslab) was
continually pumped through both outer jackets.
The flow-protected electrodes were constructed by soldering a piece of 0.040 inch diameter silver
wire, -0.5 cm long, to copper bell wire. The solder and exposed wire were covered by nonconducting
silicone rubber (General Electric), so that only the silver wire was exposed. A piece of Tygon tubing,
1/32 inch ID, and the electrode were inserted through a truncated 200 pl pipette tip. The top of the
pipette was sealed off with epoxy (Devcon).
A -2 inch long piece of Teflon tubing, 1/16 inch ID, was used for outflow and a longer piece of
Tygon tubing, 1/32 inch ID, was used for inflow in the receptor compartment flow-through assembly.
The two tubes were inserted through a truncated 1 ml pipette tip. A hole was drilled into the side of the
pipette tip and the Teflon tube was extended out through the hole. All of the tubes and wires were
sealed in place with epoxy.
The top of a 2 ml centrifuge tube was removed and two holes were drilled into the tube: one in the
bottom and one in the side. Tygon tubing, 1/32 inch ID, was epoxied to the bottom hole. The Teflon
tube from the pipette was extended through the side hole. The centrifuge tube was held in place to the
side of the pipette with Parafilm (American National Can).
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Before each experiment, plastic tubes were inserted through both compartments and sealed in
place with Parafilm. In the receptor compartment, the flow-through assembly was inserted and sealed
in place with Parafilm. The tubing within the receptor chamber was wired in place for the gel with
stainless steel wire. Both compartments was turned sideways, and polyacrylamide solution was poured
in, completely immersing everything, leaving empty a volume of -2.1 ml for the donor compartment and
-450 gl for the receptor compartment. The polyacrylamide solution was composed of 0.75 g of 19:1
acrylamide:bis(N,N'-methylene-bis-acrylamide) powder (Bio-Rad), 43.75 d of 440 mM (NH 4 )2S208
solution, and 3 pl of N,N,N',N'-tetramethylethylenediamine (Bio-Rad) in 5 ml of PBS.
The polyacrylamide solution was allowed to harden (-10 min). After the solution solidified, the
outer plastic tubing and the Parafilm were removed from the outer ports, leaving behind an empty
channel through the gel. The flow-protected electrodes were inserted into this channel. During an ex-
periment, PBS was pumped through each outer channel at a flowrate of -6 ml/min, using two peristaltic
pumps (VWR). The stainless steel wire was removed from the receptor compartment, since the tubing
in the receptor compartment was now immobilized in place by the gel.
10.2.3. Fluorescence Measurements.
Fluorescence measurements were taken with a spectrofluorimeter (Fluorescence Master Series
Spectrometer, Photon Technology). Excitation and emission wavelengths for each compound are given
in Table 4.1.
The cuvette in the spectrofluorimeter was constructed by drilling two holes into a polystyrene
microcuvette (VWR), to allow for inflow and outflow. One hole was drilled approximately 1/4 inch from
the bottom of the cuvette for the outflow, and the other hole drilled higher in the cuvette (approximately
1/2 inch from the bottom) for the inflow. Both holes were connected with Tygon tubing to a peristaltic
pump ("Sarah" Cassette Peristaltic Pump, Barnant).
The final volume of the cuvette was -200 pl, which was the minimum amount needed by the
spectrofluorimeter for accurate detection and quantification of tracer concentration within the cuvette.
Mixing within the cuvette was accomplished by dripping fluid into the cuvette. The performance of this
system was modeled as an idealized continuous-stirred tank reactor (Fogler, 1992), and the residence
time for the combined chamber-tubing-pump-cuvette system (volume of -400 pl) was -14 s.
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10.2.4. Electrical Equipment.
A custom-built, constant current Polyacrylamide Gel
device was used that produced a
steady current of 1.0 mA / cm2 (0.64
mA total) (Prausnitz, et al., 1993 [a]; D
U. Pliquett, personal communica-
tion). Since the fluorescent tracers Current Source > PBS PBS PBS
were negatively charged, the negative -T Skin
terminal of the pulser was connected 1.2 Q
to the pulsing electrode in the donor
compartment, and the positive ter- -
minal to the receptor compartment, to
Figure 10.1. Iontophoresis circuit. Before the current source is acti-
provide a favorable driving force vated, the switch next to the Zener diode initially is closed. After activating
the current source, the switch is opened. This arrangement prevents any
(Figure 10.1). The current was mon- electrical transients caused by the activation of the current source from
reaching the skin. Measuring the voltage drop across a 1.2 Q resistor
itored during the experiment by placed in series with the skin gives the current across the skin during the
experiment.
measuring the voltage drop across a
1.2 0 resistor, placed in series with the chamber.
The 5.1 V Zener diode, placed in parallel with the chamber, was used to prevent electrical tran-
sients from occurring across the skin (which could inadvertently cause electroporation to occur) when
the constant current source was first activated. The switch was closed before turning on the constant
current source, then opened afterwards.
10.2.5. Skin Protocol.
Prepared, stored skin was first floated in PBS for -1 min to remove the wax paper backing. The
skin was then loaded into the permeation chamber, with the stratum corneum facing the donor
compartment. The donor compartment was filled with donor solution and the flow-through pumps
started. The donor compartment was constantly stirred with a magnetic stir bar (Thermix Stirring Hot
Plate Model 210T, Fischer Scientific; Spinbar, VWR).
The condition of the skin was checked by measuring its electrical impedance. A 100 Hz, 0.1 V
bipolar sine wave (peak-to-peak) was applied across the skin and the resulting impedance measured
using an LCR meter (Model 5R715 LCR Meter, Stanford Research Systems). Skin was considered bad
2
and immediately discarded if its electrical resistance was <50 kQ cm (or <70 kQ for this particular
apparatus) (Prausnitz, et at, 1993 [a]; M. R. Prausnitz, personal communication). For this apparatus,
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Figure 10.2. Real-time molecular fluxes of four fluorescent compounds during iontophoresis. A current of
1.0 mA / cm2 was applied to the skin for 1 h. Typical experiments are shown. Error bars have been removed for
clarity. Donor molecules used were (a) sulforhodamine, (b) lucifer yellow, (c) cascade, and (d) calcein. For all four
fluorescent molecules, a rapid rise to near-steady state was observed in under 1 h. This behavior was different than
skin electroporation, where the molecular flux often did not reach steady states (compare with Figure 8.8, where the
same four fluorescent molecules were used under skin electroporation).
however, the impedance of the skin, not its resistance, was measured. Since the impedance of the skin
2decreases as the applied frequency increases, a value of <25 kK2 cm of impedance at a frequency of
100 Hz (or <40 kQ for this apparatus) was used as an indicator of bad skin. Previous experiments
2have shown that this value compares favorably with the accepted DC resistance of <50 kQ cm
(Gowrishankar, personal communication).
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The resistances and impedances of the PBS and the polyacrylamide gel were neglected, since their
combined resistances were previously measured to be 251 2 (see Section 3.6), compared to ~40 kQ
for the skin.
Next, the apparatus was allowed to sit for 1 h to fully hydrate the skin (Prausnitz, et al., 1993 [a])
and check for leaks. Leaky skin (passive flux above the detection limit, -10-8 M, or -10 mol / m2 s
for this particular experimental apparatus), was discarded.
10.2.6. Iontophoresis Protocol.
Iontophoresis at 1.0 mA / cm 2 was applied for 1 h. PBS was pumped through the flow-protection
system at -6 ml/min using a peristaltic pump (VWR). PBS was also pumped through the flow-through
system (through the receptor compartment and the spectrofluorimeter) at 0.0322 ml/s. The spectro-
fluorimeter was set to record ~1 h of data.
10.3. Iontophoresis Reaches Steady State within an Hour.
Unlike similar skin electroporation studies,
with iontophoresis, steady-state molecular fluxes
(or very nearly so) were achieved rapidly for all four
fluorescence tracers, usually <1 h (Figures 10.2a,
sulforhodamine; 10.2b, lucifer yellow, 10.2c, cas-
cade blue; and 10.2d, calcein). Sulforhodamine
(Figure 10.2a) and lucifer yellow (Figure 10.2b) did
not quite reach steady state in 1 h, although they
were more nearly so than comparable results ob-
tained during skin electroporation (compare Fig-
ure 10.2a with Figure 8.4a and Figure 10.2b with
Figure 8.4b). In addition, although neither protocol
had been optimized, the molecular fluxes observed
during iontophoresis compared favorably with the
fluxes observed during skin electroporation.
In Figure 10.3, the steady-state molecular
fluxes are plotted versus the molecular charge,
where the molecular weight was kept approximately
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Figure 10.3. Molecular flux is proportional to change. In
the above figure, sulforhodamine has a charge of -1,
lucifer yellow is -2, cascade blue is -3, and calcein is -4.
Although very few skin iontophoresis experiments were
conducted (totally, only 8 flow-through experiments were
performed), there still appeared to be a strong relation-
ship between the charge of the donor molecule and the
resulting molecular flux across the skin. This suggests
that during iontophoresis, the predominant driving force
is electrical drift, not electroosmosis or diffusion.
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constant (-600 Da). There appears to be a reasonably good relationship between the molecular charge
and the measured transdermal flux, in agreement with the Nemst-Planck equation (Equation 10.1).
Greater molecular fluxes were seen with the more highly charged species, which indicated that
electrical drift appears to be a primary driving force. If electroosmosis (the convective term) was the
primary driving force, then similar molecular fluxes would be observed for all four species, without this
charge dependence. Thus, for the four species studied, it appears that electrical drift is the dominant
transport mechanism.
10.4. Conclusions.
The main drawback in the use of iontophoresis is that larger currents, which would cause greater
molecular transport under the Nernst-Planck equation (Equation 10.1), cannot be used since they could
cause stimulation of the nerves within the skin (Banga and Chien, 1988; Burnette and Ongpipattana-
kul, 1988; Ledger, 1992). The electrical exposure of the skin (the voltage times the duration) during
iontophoresis would typically be ~1.8 x 104 V s (1 mA / cm 2 of current results in a voltage of about
-5 V~ski, applied for 1 h), whereas for electroporation the exposure would typically be -64 V s (100 V
pulse, 1 ms time constant, 640 pulses per h).
More experiments would obviously be needed to better understand the relationship between the
charge of the donor molecule and its resultant molecular flux across the skin. As this was not the pur-
pose of this thesis, only a limited subset of experiments were actually conducted under iontophoretic
conditions. However, from these experiments, it does appear to be much easier to predict the molecular
fluxes and the transport properties (see Section 7.3.3) during iontophoresis of the skin than during
electroporation.
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11. High-Voltage Pulsing Over Many Pulses.
The application of 1 mA / cm2 iontophoresis to human cadaver skin in vitro resulted in steady-
state molecular fluxes of small, hydrophilic fluorescent compounds in <1 h (see Figures 10.2a through
10.2d). Steady-state transdermal fluxes during iontophoresis (steady DC current) would be expected,
given the constant applied driving force (electrical drift), as discussed in Section 10.1.
However, when a series of short (~1 ms), high-voltage pulses (~100 V,,,k) are applied to the skin,
causing electroporation in the skin, molecular fluxes across the skin of the same fluorescent com-
pounds in many cases did not reach steady state within 1 h (see Figures 8.4a through 8.4d). However,
the driving force across the skin should not be changing significantly in time, after the first -20 pulses
(see Figures 8.5 and 11.1). After the initial drop, the transdermal voltage does not change rapidly in
time, presumably because the voltage drop across the skin is insufficient to create new aqueous path-
ways. Thus, the electrical driving forces experienced by the donor molecules should not be varying
widely during these experiments (although there will still continue to be some decreases, as shown in
Figures 8.5 and 11.1).
The purpose of this investigation was to determine when quasi-steady state molecular fluxes were
reached during skin electroporation, using the same four compounds previously found to reach steady
state during iontophoresis (Figures 10.2a through 10.2d). Knowing when steady state was reached and
the molecular flux at steady state would be important observations in constructing a theory of molecular
transport during skin electroporation.
11.1. Materials and Methods.
The flow-through system for measuring the contents of the receptor compartment is more fully
discussed in Appendix IV. In these experiments, 1 mM of a fluorescent tracer (either sulforhodamine,
lucifer yellow, cascade blue, or calcein; see Chapter 4) in PBS was used as the donor solution. During
pulsing, PBS flow-protection was used around the pulsing electrodes. Data stored in real time from the
spectrofluorimeter (flux measurements) and the oscilloscope (voltage measurements) were calibrated
and processed to give information about the conditions of the experiment.
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11.1.1. Skin Preparation.
Human cadaver skin was prepared by the heat-stripping method, described in Appendix I. Briefly,
stored cadaver skin at -80 'C (Gummer, 1989) was thawed to room temperature. It was then sub-
merged for 2 min in de-ionized water at 60 *C. The epidermis (including the stratum corneum) was
gently scraped off of the dermis, cut into 3/4 inch diameter circles, and stored at 4 'C, 95% humidity
for up to 10 d (Gummer, 1989). The epidermis was used in all of the experiments described here.
11.1.2. Permeation Chamber with Four-Electrode System.
Phosphate-buffered saline (PBS) was prepared using the method described in Section 3.2. PBS
was used as the receptor solution in the permeation chamber. The donor solution consisted of a fluore-
scent tracer (either sulforhodamine, lucifer yellow, cascade blue, or calcein), dissolved in PBS to a con-
centration of 1 mM. The flow-through system is described more fully in Appendix IV.
The permeation chambers were custom-designed, side-by-side chambers, with a skin exposure
2
area of 0.64 cm (circular opening, 0.9 cm in diameter) (Crown Bio Scientific) (Friend, 1992). Each
chamber half had one large port near the skin and two small ports away from the skin. The chamber
was heated to 37 'C with a water bath.
The donor compartment measuring electrode was constructed by soldering a piece of silver wire to
bell wire. The solder and wire were covered by nonconducting silicone rubber, so that only the silver
wire was exposed. The wire was inserted through a truncated 1 ml pipette tip and sealed in place with
epoxy.
The receptor compartment electrode was constructed by soldering a piece of silver wire to bell wire.
The solder and wire were covered by nonconducting silicone rubber, so that only the silver wire was
exposed. A piece of Teflon tubing was used for outflow and a longer piece of Tygon tubing was used for
inflow. A hole was drilled into the side of the 1 ml pipette tip and the Teflon tube was extended out
through the hole. All of the tubes and wires were sealed in place with epoxy.
The flow-protected electrodes were constructed by soldering a piece of silver wire to bell wire. The
solder and wire were covered by nonconducting silicone rubber, so that only the silver wire was ex-
posed. A piece of Tygon tubing and the electrode were inserted through a truncated 200 pl pipette tip.
The top of the pipette was sealed off with epoxy.
The top of a 2 ml centrifuge tube was removed and two holes were drilled into the tube: one in the
bottom and one in the side. Tygon tubing was epoxied to the bottom hole. The Teflon tube from the
pipette was extended through the side hole in the centrifuge tube. The centrifuge tube was held in
place to the side of the pipette with Parafilm (American National Can).
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Before each experiment, plastic tubes were inserted through both compartments and sealed in
place with Parafilm. In the receptor compartment, the measuring/flow-through electrode was inserted
and sealed in place with Parafilm. The tubing within the receptor chamber was wired in place for the
gel with stainless steel wire. Both compartments was turned sideways, and polyacrylamide solution
was poured in, completely immersing everything. The polyacrylamide solution was composed of 0.75 g
of 19:1 acrylamide:bis(N,N'-methylene-bis-acrylamide) powder (Bio-Rad), 43.75 pl of 440 mM
(NH 4 )2 S 2 0 8 solution, and 3 ptl of N,N,N',N'-tetramethylethylenediamine (Bio-Rad) in 5 ml of PBS.
The polyacrylamide solution was allowed to harden (~10 min). After the solution solidified, the
outer plastic tubing and the Parafilm were removed from the outer ports, leaving behind an empty
channel through the gel. The stainless steel wire was removed from the receptor compartment. During
an experiment, PBS was pumped through each outer channel at a flowrate of -6 ml/min.
11.1.3. Fluorescence Measurements.
Fluorescence measurements were taken with a spectrofluorimeter (Fluorescence Master Series
Spectrometer, Photon Technology). Excitation and emission wavelengths for each compound are shown
in Table 4.1.
The cuvette in the spectrofluorimeter was constructed by drilling two holes into a polystyrene
microcuvette (VWR), to allow for inflow and outflow from the receptor compartment. One hole was
drilled approximately 1/4 inch from the bottom of the cuvette for the outflow, and the other hole drilled
higher in the cuvette (approximately 1/2 inch from the bottom) for the inflow. Both holes were con-
nected to Tygon tubing to a peristaltic pump ("Sarah" Cassette Peristaltic Pump, Barnant).
The final volume of the cuvette was -200 Ll, and was the minimum amount needed by the spectro-
fluorimeter for accurate detection and quantification of the tracer concentration within the cuvette.
Mixing within the cuvette was accomplished by dripping fluid down into the cuvette. The performance
of this system was very close to an idealized continuous-stirred tank reactor (Fogler, 1992), and the
residence time for the combined chamber-tubing-pump-cuvette system (volume of ~400 ptl) was -14 s.
This was taken to be the time resolution for the flux measurements in these experiments.
11.1.4. Electrical Equipment.
High-voltage exponential pulses were delivered by a pulser (Electroporation System 600, BTX),
custom-modified to deliver 1 pulse every -5 s (U. Pliquett, personal communication). The time constant
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was set to 1 ms. Exponential pulses with peak transdermal voltages between 0 V and -150 V across
the skin were applied for 1 h at the rate of one pulse every -5 s.
Current delivered across the skin during the pulse was measured by measuring the voltage drop
across a 1.2 Q noninductive resistor, placed in series with the permeation chamber. The voltage drop
across the resistor was measured by a voltage probe connected to a digital oscilloscope. The oscillo-
scope was connected to a personal computer.
The voltage drop from the receptor to the donor compartment was measured by connecting a differ-
ential high-voltage probe (Active Differential Probe B9017RT, Yokogawa) to the immobilized silver wire
measuring electrodes in each compartment. This probe was also connected to the same oscilloscope.
The computer counted and recorded both voltage waveforms recorded by the oscilloscope for every
pulse. The computer did not do any mathematical processing, since there was barely sufficient time to
download the waveforms from the oscilloscope and record them onto the hard drive.
11.1.5. Skin Experimental Protocol.
Prepared, stored skin was floated in PBS for -1 min to remove the wax paper backing. The skin
was loaded into the permeation chamber, with the stratum corneum facing the donor compartment. The
donor compartment was then filled with the donor solution and the flow-through pumps started. The
donor compartment was constantly stirred by a magnetic stir bar.
The condition of the skin was checked by measuring its electrical impedance. A 100 Hz, 0.1 V
bipolar sine wave (peak-to-peak) was applied across the skin and the resulting impedance measured
using an LCR meter (Model 5R715 LCR Meter, Stanford Research Systems). Skin was considered bad
and was discarded if its impedance was <25 kK2 cm2 at a frequency of 100 Hz (or <40 kQ for this appa-
ratus). Previous experiments have shown that this value compares favorably with the accepted DC
2
resistance of <50 kQ cm (Gowrishankar, personal communication). The resistances and impedances
of the PBS and the polyacrylamide gel were neglected, since their combined resistances were pre-
viously measured to be 251 92 (see Section 3.6), compared to -40 kQ for the skin.
After determining if the skin was acceptable or not, the apparatus was allowed to sit for 1 h to fully
hydrate the skin (Prausnitz, et al., 1993 [a]) and check for leaks. Leaky skin (passive flux above the
detection limit, -10~8 M, or ~10-10 mol / m2 s for this experimental apparatus), was discarded.
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11.1.6. Pulsing Protocol.
High-voltage exponential pulses, with a time constant of 1 ms and transdermal voltages between 0 V
and -150 V across the skin (applied voltages between 0 V and 1000 V) were applied for 1 h at the rate
of one pulse every -5 s. PBS was pumped through the flow-protection system and the flow-through
system during pulsing. Both the spectrofluorimeter computer and the computer recording voltage
waveforms were set to record ~1 h of data.
After the experiment, the skin was removed from the chamber for microscopy analysis. All of the
data from the two computers (spectrofluorimeter data and voltage data) were downloaded onto a work-
station for analysis.
11.1.7. Numerical Analysis.
All of the fluorescence, voltage and calibration data were first downloaded onto a Sun Sparc 10
workstation (Sun). A program was in MatLab 5 (Mathworks) used these data to determine the flux
versus voltage for each pulse. The program loaded in the voltage and current waveforms for each pulse
and fitted each curve to an exponential to determine voltages. Since the resistance of the chamber
without any skin was 251 Q, the voltage across the skin could be calculated by Ohm's Law. The pro-
gram then loaded the calibration and fluorescence data and used deconvolution routines (Pliquett, et
al., 1995 [b]; also see Section IV. 13.2) to calculate the molecular flux across the skin. The two data
files were then synchronized together in time, allowing the program to determine the measured flux for
each pulse.
11.2. The Peak Transdermal Voltage Continues to Decline.
After pulsing for 1 h (-680 pulses, one pulse every -5 s), the transdermal voltage was noted to
decrease dramatically within the first -20 pulses, then continue to decline more slowly afterwards (see
Figure 8.5). The same trend was observed here, when more pulses were applied to the skin. The peak
transdermal voltage dropped rapidly within the first several pulses, then continue to decline more
slowly afterwards (see Figure 11.1). Experiments performed for up to 7 h (>5 000 pulses) continued to
show this same trend (data not shown).
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Figure 11.1. The transdermal voltage versus pulse number for 2 190 pulses. Although a large drop in the trans-
dermal voltage occurs within the first several pulses, the transdermal voltage still continues to decline slowly
afterwards with additional pulsing. Compare with Figure 8.5.
Thus, a steady-state plateau of the peak transdermal voltage is not reached during skin electro-
poration, but instead the transdermal voltage continuously declines with repeated pulsing. However,
the rate of decrease is very slow, typically -1 to 5 V/h. This continued decline could be due to several
causes, including new pathway formation, enlargement of already existing pathways through the skin,
or irreversible changes in the structure of the skin.
In typical 1 h high-voltage pulsing experiment, once pulsing has been stopped, the molecular flux
0 500 1000 1500 2000
Pulse Number
2500 3000 3500
Figure 11.2. The molecular flux of sulforhodamine through human skin for 2 190 pulses. The flux of sulfo-
rhodamine did not reach steady state, even after pulsing for several hours. High-voltage pulses were applied at the
rate of one pulse every -5 s for over 3.5 h (2 190 pulses total). During that time, the flux of sulforhodamine across
the skin increased monotonically. Dotted line in figure indicates first hour. The X-axis in this figure has been ex-
tended to 3 500 pulses, for easier comparison with Figures 11.3, 11.4, and 11.5. Even longer experiments have
been performed (data not shown), lasting over 7 h (5 000 pulses total), without reaching steady state.
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Figure 11.3. The molecular flux of lucifer yellow through human skin for 3 500 pulses. The flux of lucifer yellow
reached steady state within 1 h (dotted line in figure). The averaged steady-state flux in this experiment was
2
-15 nmol / m s. High-voltage pulses were applied to the skin at the rate of one pulse every -5 s for over 5 h (3 500
pulses total). Compare with Figures 11.2. 11.4, and 11.5.
across the skin typically falls to below background levels in under 15 min (except for sulforhodamine).
However, after several hours of pulsing, it takes much longer for the molecular flux across the skin to
drop to below background levels, sometimes >2 h (data not shown). This could indicate that ir-
reversible or only partially reversible changes are occurring in the structure of the skin during pulsing.
11.3. Some Molecules Reach Steady State; Others Do Not.
Unlike in skin iontophoresis, where steady-state molecular fluxes were reached in <1 h (see Fig-
ures 10.2a through 10.2d), steady-state molecular fluxes during skin electroporation were not always
reached, even after pulsing for 7 h (corresponding to >5 000 pulses).
Figure 11.2 shows that the molecular flux of sulforhodamine across the skin during repeated
pulsing continues to rise, without reaching a steady -state plateau. Longer experiments (up to 7 h) also
showed this continued rise in the molecular flux (data not shown). It thus appears unlikely that the
flux of sulforhodamine across the skin would reach steady state in a reasonable amount of time during
skin electroporation.
Both lucifer yellow (Figure 11.3) and cascade blue (Figure 11.4) reached steady state relatively
quickly, within 1 h of pulsing. Additional pulsing did not appear to significantly alter the molecular
flux across the skin. Earlier experiments (see Figures 8.4b and 8.4c, respectively) have also shown
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Figure 11.4. The molecular flux of cascade blue through human skin for 3 500 pulses. In the experiment shown
here, high-voltage pulses were applied at the rate of one pulse every -5 s to the skin for over 5 h (3 500 pulses total),
reaching an averaged steady-state flux of -20 nmol / m 2 s. Dotted line indicates the first hour (-680 pulses). Com-
pare with Figures 11.2, 11.3, and 11.4.
that these two molecules reach steady state in <1 h, unlike sulforhodamine or calcein (Figures 8.4a and
8.4d, respectively).
The flux of calcein (Figure 11.5) was less predictable. The molecular flux of calcein generally
peaked within the first 10 min of pulsing, then began decreasing afterwards (see Figure 8.4d).
However, in some cases, the flux of calcein varied erratically with additional pulsing, as shown in
Figure 11.5.
11.4. Conclusions.
The application of repeated high-voltage pulsing to the skin for very long periods of time (several
hours), involving many thousands of pulses, had different effects on the molecular transport of different
molecules. With some molecules such as sulforhodamine, the molecular flux continued to increase
with repeated pulsing. Other molecules, such as lucifer yellow and cascade blue, reached a steady-
state plateau within 1 h of pulsing. Some molecules, such as calcein, were unpredictable. These same
four molecules were previously observed to reach steady-state molecular fluxes in <1 h during ionto-
phoresis (see Section 10.2).
With repeated pulsing, the peak transdermal voltage initially dropped very quickly, during the first
-20 pulses, and continued to decrease slowly afterwards. This decrease may indicate that small,
irreversible changes are occurring to the structure of the skin with each pulse. However, the electrical
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Figure 11.5. The molecular flux of calcein through human skin for 2 175 pulses. The flux of calcein did not reach
steady state, and behaved unpredictably. In this experiment, high-voltage pulses were applied to the skin at the rate
of one pulse every -5 s for over 3.5 h (2 175 pulses total). Dotted line indicates first hour. The X-axis has been
extended to 3 500 pulses, for comparison with other experiments (Figures 11.2, 11.3, and 11.4).
driving forces experienced by the donor molecules did not vary widely during these experiments
(Figure 11.1).
Very different molecular flux profiles in time were recorded for each of the four fluorescent tracer
molecules used (sulforhodamine, lucifer yellow, cascade blue, and calcein), although they were origi-
nally chosen due to their similarities (hydrophilicity, size, negative charge, fluorescence). Each
molecule may be using different molecular transport pathways across the skin during skin electro-
poration, as previously discussed (see Section 8.2.3 and Figure 8.6).
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12. Summary.
Applying a series of short (~1 ms), high-voltage (~100 V ) electrical pulses to the skin causes
molecular transport to occur by a mechanism related to electroporation, hence the name of this
phenomenon, "skin electroporation." Transport occurs through aqueous pathways that form as a result
of pulsing. This technique can potentially be used for the delivery of drugs directly through the skin,
without the use of needles.
During high-voltage pulsing, molecular transport occurs through or near "localized transport
regions," or "LTRs." The LTRs form randomly and spontaneously on the surface of the skin, away from
the sweat ducts and hair follicles. The LTRs grow in size, but not in number, with additional pulsing.
Molecular transport during skin electroporation occurs via a different process than iontophoresis,
where a low-voltage, constant electrical current is applied to the skin (typically <0.5 mA / cm 2 ), which
causes transport through the sweat ducts and hair follicles in the skin. No new pathways form during
iontophoresis. Skin that lacks sweat ducts or hair follicles (such as snake skin) does not permit
transport during iontophoresis, as there are no pathways available for transport.
The peak transdermal voltage during skin electroporation, the electrical impedance of the skin (a
surrogate for the electrical resistance of the skin), and the molecular flux, all can change rapidly (of
order seconds) with repeated pulsing. These parameters thus need to be rapidly measured in real
time, since using aliquots or averages can lead to erroneous measurements and conclusions. The
transdermal voltage generally decreases rapidly with the first few pulses, then continues decreasing
more slowly afterwards. The impedance of the skin drops with repeated pulsing, with the amount of
recovery of the impedance after pulsing also declining with additional pulsing. However, between each
pulse, there is some recovery of the impedance, indicating that some recovery of the skin's barrier
properties is taking place.
Molecular transport is thus very sensitive to the electrical conditions that are applied to the skin,
especially the transdermal voltage and the number of pulses already delivered. In general, molecular
transport increases with the voltage, the duration (time constant), and the frequency of the applied
pulses. However, since the transdermal voltage can vary in time, it should be carefully monitored
during delivery, possibly involving regulatory real-time feedback to the high-voltage supply. The
monitoring of the transdermal voltage, as well as the number and type of pulses that can be applied
reliably, in turn will be a function of the actual electrode/delivery reservoir configuration used to apply
pulsing.
The molecular flux across the skin is also a function of the specific molecule being transported.
Some molecules (such as lucifer yellow and cascade blue) will quickly reach steady-state fluxes within
1 h of pulsing; some molecules (such as sulforhodamine) do not reach steady state, but their molecular
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fluxes continue to increase with additional pulsing; and other molecules (such as calcein) initially have
large molecular fluxes, but then the flux begins to decrease with repeated pulsing. Even molecules
with similar physicochemical properties appear to exhibit large differences in molecular flux behaviors
during pulsing.
Given the observed inconsistencies in the molecular fluxes across the skin for similar compounds,
a general theory of molecular transport during skin electroporation was not developed here. In general,
however, the instantaneous molecular flux appears to be proportional to the transdermal voltage,
although both can change with repeated pulsing. In skin electroporation, peak transdermal voltages of
>50 V si are needed for molecular transport to occur.
Molecular transport thus depends on physicochemical parameters of the molecule, which have not
yet been identified. Knowledge of the electronic charge and the molecular weight, by themselves, were
not reliable predictors of molecular transport. Some parameters that may be important in predicting
transport include hydrophobicity, size, 3D conformation, surface changes, pKa's, or ionization energies.
Further work will be needed here to determine the relevant physicochemical parameters.
In conclusion, skin electroporation is a highly dynamic process, where the driving forces involved
with molecular transport can change rapidly and somewhat unpredictably with repeated pulsing.
Measurement, control, and prediction of these rapidly changing forces will be essential before skin
electroporation can move from the lab to the clinic.
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The Appendices.*
In these appendices are detailed, step-by-step instructions on how to perform most of the
experiments described in this thesis. Many technical problems have been addressed since the first
skin electroporation experiments (Prausnitz, et al., 1993 [a]), which have led to more complicated
equipment, more rigorous procedures, and much more data to collect. Although these experiments are
extremely time-consuming (preparing an experiment can take 2 to 3 h, the experiment itself can take
another 2 to 5 h, and calibration and disassembly can take an additional 1 to 2 h; a single experiment
can thus take up to 10 h to complete), it has been shown (see Section 7.2) that these careful techniques
are, in fact, necessary for accurate measurements of the skin electroporation phenomenon.
The raw data has not been presented in this thesis, owing to the sheer volume of the data gathered.
The computer data files take up approximately 425 MB of space; if printed out, even at roughly 5 000
closely spaced numbers per page, to show all of the data would still require over 86 000 pages!
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I. Preparation of Human Skin.
Most of the human skin in vitro experiments are performed with a stratum corneum/epidermis
preparation (no dermis). Since the stratum corneum is the main barrier for transport, the other layers
of the skin are not important for studying transdermal drug delivery. The epidermis can usually be left
on the stratum comeum without affecting either molecular transport or the electrical properties of the
stratum corneum. However, the dermis can affect molecular transport, since it is much thicker (1 to
3 mm) than the stratum corneum (10 to 20 ). Thus, the dermis is usually removed, leaving behind
the epidermis and the stratum corneum.
In some experiments, the epidermis needs to also be removed, leaving behind just the stratum
corneum. This can be done by using a dilute trypsin solution to digest away the epidermis. However,
stratum corneum is very difficult to work with. It can tear very easily. Just picking up the stratum
corneum can sometimes cause it to tear. Thus, it is usually simpler to leave the epidermis on as a
mechanical support for the stratum corneum.
1.1. Preparation of the Epidermis (with the Overlying Stratum Corneum).
The procedure for removing the epidermis (including the overlying stratum corneum) from the
dermis by heating the skin to 60 'C is commonly called "heat-stripping" (Gummer, 1989).
1. Cadaver skin should be stored at -80 'C for up to 6 months before use (Gummer, 1989). Ca-
daver skin should be fresh-frozen within 24 h post-op or post-mortem. It should be as hairless
as possible. Good areas are the abdomen, thighs, or back. The skin should not be dermatomed
or frozen with any preservative media.
2. To thaw the skin to room temperature, take the skin from the freezer and place it on an un-
disturbed counter for approximately 2 to 3 h (longer if the piece is large). Wait until the skin has
been completely thawed.
3. Heat a bath of de-ionized water to 60 0 C. It is very important that the temperature be as close to
60 'C as possible. The water bath should be sufficiently large that the addition of the skin will
not significantly change the temperature of the water bath. Note that the temperature "window" at
which the skin can be heat-stripped is very small. If the temperature is too low (<57 'C), the epi-
dermis will not easily separate from the dermis. If the temperature is too high (>62 'C), the lipids
in the stratum corneum will start to disorder, which permanently reduces the electrical resistance
of the stratum corneum (Craane-Van Hisberg, et at., 1994).
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4. Immediately place the skin (removing any packaging) into the 60 'C water bath for 2 min.
5. Remove the skin and place it on a sheet of wax paper.
6. Using a blunt metal object (such as a rounded spatula), gently scrape away the epidermis from
the stratum corneum. Hold the dermis firmly in place with a pair of tweezers while gently
scraping away the epidermis. The epidermis can be folded up and moved aside during this pro-
cess, but it should not be stretched or touched with anything sharp or metal. Try to keep the hair
follicles with the epidermis.
7. Once the epidermis has been completely removed from the dermis, place the epidermis in a tray
of clean, de-ionized water (do not use the 60 'C water bath).
8. At this point, the epidermis is probably folded up. Gently open the epidermis until it is floating
as a flat sheet on top of the water. Metal objects of any kind should not be used. The stratum
corneum (which is hydrophobic) should now be on top, and the epidermis (which is hydrophilic)
is on the underside. For stratum corneum-only preparations, skip to Section 1.2.
9. Take a sheet of wax paper, place it underwater, under the epidermis, and gently lift up the wax
paper out of the water so the epidermis attaches to it and remains flat. Place the wax paper and
skin on a cutting board. Note that several brands of wax paper will curl when soaked in water,
which makes it very difficult to slide the paper under the floating epidermis. One type of wax
paper that works well and does not curl is the 4 inch x 4 inch weighing paper that can be ob-
tained from VWR.
10. Using a 3/4 inch diameter hole punch (Small Parts, Miami Lakes, FL) and a hammer, cut the skin
and wax paper into 3/4 inch discs. Even with a new, sharp hole punch, it can be very difficult to
cut completely through both the skin and the wax paper. The hole punch should be hit very
hard, several times, to ensure a clean cut through both the skin and the wax paper. Keep the
punches as close together as possible. Avoid any regions that are discolored or torn. Place the
discs into a weigh boat.
11. The skin should be stored in a 4 'C, 95% humidity environment before use. Fill the bottom of a
sealed glass chamber (such as a desiccation chamber) with a saturated solution of K 2 SO 4 in
water, which will maintain the chamber at 95% humidity. There should be a level within this
chamber, away from the water, where the weigh boats will remain dry. Place the weigh boats
containing the skin into this chamber. Under these conditions, the skin can last for 10 to 14 d
before use (Gummer, 1989).
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Preparation of Isolated Sheets of Stratum Corneum.
The stratum corneum can be isolated from the epidermis by soaking them overnight in a 0.25 wt%
trypsin solution. This can be done either after the epidermis has been heat-stripped off of the dermis,
or with the dermis still intact. However, with the dermis still in place, it will take much longer (up to
several days) for the trypsin to soak through the dermis and the epidermis.
1. Prepare a solution of 0.25 wt% trypsin (Gibco BRL) in a sealable glass jar.
2. Place the heat-stripped epidermis (from Section 1.1, Step 8, before punching out the circles) or
the dermis into this solution and seal the jar shut.
3. Leave overnight (>12 h) at 4 'C.
4. Remove the skin from the jar, and rinse the skin gently with de-ionized water.
5. The epidermis should now have a "slime"-like consistency. This can be gently sloughed off
either by hand or under a stream of PBS (Raykar, et at., 1988). Be careful not to tear the stratum
corneum.
6. Place the stratum corneum in a tray of clean, de-ionized water. Take a sheet of wax paper, place
it underwater, under the stratum corneum, and gently lift up the wax paper out of the water so the
stratum corneum attaches to it and remains flat. Place the wax paper and skin on a cutting
board.
7. Using a 3/4 inch diameter hole punch (Small Parts, Miami Lakes, FL) and a hammer, cut the skin
and wax paper into 3/4 inch discs. Keep the punches as close together as possible. Avoid any
regions that are discolored or torn. Place the discs into a weigh boat.
8. The stratum corneum should be stored at 4 'C, 95% humidity before use. Fill the bottom of a
sealed glass chamber (such as a desiccation chamber) with a saturated solution of K 2 SO 4 in
water, which will maintain the chamber at 95% humidity. There should be a level within this
chamber, away from the water, where the weigh boats will remain dry. Place the weigh boats
containing the stratum corneum into this chamber. Under these conditions, the stratum corneum
can last for up to 10 d before use (Gummer, 1989).
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I.2.
H. The Original Skin Electroporation System of Prausnitz, et al. (1993 [a]).
This appendix describes the preparation of the original experimental system for studying skin
electroporation. Although this system (shown in Figure I.1) was not actually used in this thesis, most
of the equipmental designs and techniques used in this thesis were originally based on this system,
which consisted of the following: a high-voltage pulser, a permeation chamber, two Ag/AgCl pulsing
electrodes, and a 37 *C water bath. Many modifications were added later to address some of the in-
adequacies of this original system.
Some problems of this system include: no protection of the skin from the pulsing electrodes (pH
changes and chemical by-products from the pulsing electrodes can contaminate the donor and receptor
compartments), no direct measurement of the transdermal voltage, 1 h aliquot fluorescence measure-
ments, DC skin resistance measurements (which causes iontophoresis of the skin), exponential pulsing
time constants of 1.2 ms (which were reported as -1 ms), uncertainty in the 5 s pulse spacing (the un-
certainty was estimated at 5.0 ± 0.5 s), no degassing of PBS (oxygen dissolved in PBS can quench some
of the fluorescent tracers), and multiple experiments using the same pulser performed simultaneously
(which prevented accurate estimation of the transdermal voltage). Many of these problems were
corrected in later "generations" of the equipment; the original system is described here for comparison
purposes.
..................................
Figure I.1. The original skin electroporation system of Prausnitz, et at (1993 [a]). The skin is
placed within the side-by-side permeation chamber on the left (only one chamber shown here; there
could be up to 10 different chambers in parallel). Ag/AgCi electrodes, connected to the custom-
modified high-voltage pulser on the right, are placed on either side of the skin. The fan on top of the
pulser is used to cool the circuitry within the pulser.
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II.1. Modifying the High-Voltage Pulser.
In a commonly used protocol (Prausnitz, et al., 1993 [a]; Prausnitz, et al., 1995 [b]; Pliquett and
Weaver, 1996 [a]; Prausnitz, et al., 1996 [b]), the high-voltage pulser delivers a high-voltage, expo-
nentially-decaying pulse to the permeation chamber once every -5 s. There are no presumably no
commercially available devices that can produce 1000 V exponentially-decaying voltage pulses into a
load of -500 Q , at the rate of 1 pulse every -5 s. Instead, a commercial pulser has to be internally
modified to be able to deliver pulses at that rate (U. Pliquett, personal communication).
The procedure for modifying the internal workings of a high-voltage pulser will depend mainly on
the pulser being modified. Modifying high-voltage equipment is extremely dangerous. Any modifi-
cations to the pulser should only be undertaken by a qualified electrical engineer, thoroughly familiar
with high-voltage electronics. This work should be done in close consultation with the pulser manufac-
turer.
Briefly, the pulser needs to be modified so that it immediately begins recharging its capacitors after
discharging each pulse (some pulsers require a button to be pressed to reset the pulser between
pulses). A flip-flop timing circuit can be used to cause the pulser to discharge itself at a fixed
frequency (here, 1 pulse every -5 s). This timing circuit should be located near the pulse activation
button, so as to avoid the high-voltage areas of the pulser (E. A. Gift, personal communication).
II.2. Typical Experimental Protocol from Prausnitz, et al. (1993 [a]).
The original permeation chamber design is
shown schematically in Figure 11.2 (Prausnitz, et Compartent
al., 1993 [a]; M. R. Prausnitz, personal communi-
cation). The permeation chambers are modified Pulsing Pulsing
Electrode Electrode
side-by-side glass diffusion chambers (Crown Bio
Scientific), with an outer water jacket, and an
inner compartment (Friend, 1992). Two or three
ports extend from the inner compartment, through
the water jacket, to the outside, allowing direct Stir Bar Skin
access to the inner compartment. The volume of Receptor
the inner compartment is -3.1 ml, and the area of Glass Plug Compartment Water Jacket
the main opening is 0.63 cm 2 (0.9 cm in dia-
Figure 11.2. Schematic diagram of the original permeation
meter). chamber.
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1. Phosphate-buffered saline, PBS: 1.1 mM KH 2 PO4, Skin
2.7 mM KCl, 8.1 mM Na 2 HPO4  138 mM NaCl 10 Q
(total of 150 mM) in 500 ml de-ionized H 2 0. Receptor Donor
Adjust to pH 7.4 with HCl and NaOH as necessary.
2. A typical donor solution consists of 1 mM of a Pulser 40 Q
hydrophilic fluorescent tracer in PBS. Examples of -
hydrophilic fluorescent tracers include lucifer
yellow (457 Da) (Prausnitz, et at., 1993 [a]; Chen,
et at., 1998 [c]), calcein (623 Da) (Prausnitz, et at., ~
1993 [a]; Pliquett and Weaver, 1996 [a]; Van-
dsulforhodamine Figure 1.3. Circuit diagram of the original experi-bever, et at, submitted), and smental apparatus. There is a 40 Q shunt path-
wa around the skin. The 10 Q resistor is a(607 Da) (Pliquett and Weaver, 1996 [a]) (all from salety device to protect the pulser in the event of a
short circuit.
Molecular Probes). Wrap the donor solution im-
mediately in aluminum foil to protect it from light. Gently shake on a Nutator (Clay Adams,
Becton Dickinson) for >30 min to ensure complete dissolution. This solution should be made
immediately before use, right after the PBS solution has been made.
3. Assemble 1 to 10 chambers together. Connect each set to a 37 'C water bath.
4. In each chamber half, insert a Ag/AgC pulsing electrode (In Vivo Metrics, Heraldsburg, CA). The
electrodes may be too large to fit in the sampling port, so they must be inserted "tail-first" from
the large opening where the skin belongs. Once inserted, they should be secured in place with
tape, facing the opening for the skin.
5. The electrical circuit is shown in Figure 11.3. The chamber is connected to the circuit so that the
receptor pulsing electrode is positive and the donor electrode is grounded. This provides a
favorable driving force for a negatively charged molecule. However, for a positively charged mole-
cule, the positive and negative terminals to the chamber should be interchanged. This circuit
will provide exponential pulses with a time constant of -1.2 ms. The 10 Q resistor is a safety
device used to protect the system in the event of a short circuit.
6. Float a piece of skin (see Appendix I) in a dish of PBS for -1 min.
7. Gently remove the wax paper backing. Do not use tweezers. The skin should float on the sur-
face, with the stratum corneum side facing upwards.
8. Position the skin in the chamber so that the stratum corneum faces the donor compartment and
the epidermis faces the receptor compartment. Clamp the chamber shut.
9. Fill the donor and receptor compartments with PBS.
10. Check the condition of the skin with a commercial ohmmeter. The resistance of "good skin"
should be >50 ko cm2 (70 kQ for this chamber) (Prausnitz, et at., 1993 [a]; M. R. Prausnitz,
personal communication). The passive flux of the donor solution across the skin should be
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negligible (below the detection limit of the spectrofluorimeter). Low resistances or large passive
fluxes indicate that the integrity of the skin has been compromised in some way, and thus the
skin should be discarded.
11. Add a 1.5 mm "flea"-type magnetic stir bar (VWR) to each compartment.
12. Connect the chamber to the pulsing circuit as shown in Figure 11.3, verifying that the electrodes
are properly connected.
13. Turn on the stirring plate and the water bath. Set the temperature of the water bath to 4 'C and
leave the system running overnight (-12 h).
14. Flush the donor and receptor compartments 3 x with PBS. Check the resistance of the skin again
to verify that the skin is still good (the resistance of the skin may have drifted some from its
2
previous reading). If the resistance has dropped below 50 kQ cm (70 kQ), the skin should be
discarded.
15. Wait 1 h, then empty the receptor compartment into a disposable polystyrene cuvette (VWR) for
analysis, and flush the receptor compartment 3 xwith PBS.
16. Set the pulser to deliver the appropriate types of pulses, and start the pulser. Record the time.
Verify that the pulses are being applied at the rate of 1 pulse every 5 s with a stopwatch.
17. After 1 h, stop the pulser. Empty the receptor compartment into a cuvette. Flush the receptor
compartment 3 xwith PBS.
18. For the post-pulsing measurements, wait 1 h, then empty the receptor compartment into a
cuvette. Flush the receptor compartment 3 xwith PBS. Repeat this step 3 x (3 h total).
19. After 24 h, take a final measurement of the receptor compartment.
II.3. Mounting the Skin for Microscopy.
This procedure is from Prausnitz, et at., (1996 [a])). The skin is mounted in a solution of
glycerol/water and Nile Red, which prominently stains the lipid regions of the stratum corneum
(Prausnitz, et al., 1996 [a]). The skin can then be examined under fluorescence or confocal
microscopy.
Note that fluorescence microscopy does not directly indicate the regions involved in molecular
transport. The fluorescence observed under the microscope could be coming from either the surface or
inside the skin (Pliquett, et al., 1996 [b]; Chen, et al., submitted [a]; also see Section 5.7). Some
authors have established a correlation between the regions of fluorescence on the surface of the skin
and the regions where molecular transport occurs (Pliquett, et al., 1996 [b]).
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1. To make the stock mounting solution, mix 10 mg Nile Red (Molecular Probes) in 20 ml acetone
(Prausnitz, et al., 1996 [al). Wrap in aluminum foil to protect from light. This solution can be
stored indefinitely if protected from light.
2. To make the final mounting solution, thoroughly mix 7.5 ml glycerol in 2.5 ml de-ionized water.
Add 250 pl of the stock mounting solution (from above). Wrap in aluminum foil to protect from
light. This solution can also be stored indefinitely if protected from light.
3. After the experiment has been finished, empty the donor compartment. Flush it out 3 xwith PBS.
4. Open the permeation chamber and carefully remove the skin. Place it carefully on a microscope
slide. Gently spread the skin out so it lies flat, and lightly blot it dry with a paper towel. Do not
rub the skin.
5. Add a drop of mounting solution (from Step 2).
6. Gently put a cover slip on top. This will cause the mounting solution to spread out and cover the
skin. Seal in place with clear nail polish.
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III. Chamber with Flow-Protected Electrodes.
The electrode flow-protection system, as described in this appendix, is designed to solve the prob-
lem of gas production and pH changes from the pulsing electrodes. Further refinements include the
addition of a system for directly measuring the transdermal voltage, irrespective of any polarization
effects at the pulsing electrodes.
The application of an electrical current to water causes the formation of 02 gas at the positive
electrode and H 2 gas at the negative electrode. Within a metal wire, the current is carried by free elec-
trons, but within a hydrolytic solution such as PBS, the current is carried by free ions (H+, OH-, Na+,
Cl , etc.). The conversion between electrons and ions in solution are chemical reactions that occur at
the electrode-electrolyte interface. At the positive electrode*, the following half-cell reaction occurs:
2H 2 0 -> 4H+ + 02 T + 4e-, (111.1)
leading to the production of oxygen gas and an increase in pH. At the negative electrode, the following
half-cell reaction occurs:
2H 20 + 2e --+ 20H + H2 1, (111.2)
causing the formation of hydrogen gas and a drop in pH. Together, these two half-cell reactions form
the hydrolytic or "water-splitting" electrochemical reaction that can be found in any elementary chem-
istry textbook (Metcalfe, et at., 1986):
2H 20 -- 2H 2 +0 2* (111.3)
Therefore, the design of the permeation chamber should not be to prevent the formation of gas,
which is unavoidable, but to prevent these gases and chemical by-products from reaching the donor
and receptor chambers.
The electrodes are encased in polyacrylamide gel, protected by a stream of fresh PBS continuously
flowing past the electrodes. Polyacrylamide gel was chosen since it was electrically conducting, chemi-
cally inert, and easy to prepare. The electrical resistance of polyacrylamide gel was similar to that of
PBS, since its structure is largely composed of polymer strands, surrounded by bulk solution. It is
frequently used in polyacrylamide gel electrophoresis, where proteins on a polyacrylamide gel are
*The terms "cathode" and "anode" are not always used consistently in the electrochemistry literature, so the
unambiguous terms "positive electrode" and "negative electrode" are used here instead. The positive electrode (usually
colored red) is the high-voltage line: the negative electrode (usually colored black) is grounded. The electrons flow from
the negative electrode to the positive electrode; however, the current nonintuitively flows from the positive electrode to
the negative electrode (by convention).
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placed in a strong electrical
field to separate them on the
basis of their charge (in addi-
tion, sodium dodecyl sulfate
is often added to separate
proteins on the basis of their
size) (Stryer, 1988).
Chemical by-products
that are produced at the
pulsing electrodes cross a
stream of PBS (-6 ml/min, or
-0.6 cm/s), and 2 cm of solid
polyacrylamide gel before
reaching the inner compart-
ments. The transit time for Figure III.1. Permeation chamber with flow-protected electrodes. The small
pump on the left pumps fresh PBS from the PBS reservoir (behind the pump),
this process takes several through the permeation chamber and around the pulsing electrodes, to the wastebeaker (behind the chamber). Pulses are applied with the custom-modified high-
hours (Section 4.1.8), much voltage pulser (top right), connected to silver wire electrodes within the chamber.The high-voltage probe (behind the pump), connected to the oscilloscope on the lower
right, goes to two additional measurement electrodes within the chamber. Alonger than the experiment second voltage probe (not visible behind the stirring plate) is connected to a 1.2 Q
itself. Note that all of these Iresistor in series with the chamber, to measure the current during pulsing.
measurements and tests were conducted with the short pulses (t 1 Ims). Most of the experiments in
this thesis used short pulses. For long pulses (t > 100 ms), the volume of gas production exceeds the
capacities of this system, and can cause the polyacrylamide gel within the chamber to fracture. Thus,
the experimental system, as described in this appendix, cannot be used to protect the pulsing elec-
trodes when long pulses are used.
The pulsing electrodes are silver wire electrodes instead of the Ag/AgCl electrodes. Since a high-
voltage probe is used to directly measure the transdermal voltage, any electrode polarization that may
be occurring at the electrode-electrolyte interface can thus be ignored. In addition, with the Ag/AgCl
electrodes, after only a few pulses, enough of the AgCl plating is removed so that the silver becomes
directly exposed to the solution. Using Ag/AgCl electrodes to avoid polarization effects is not an
effective solution; therefore, a system to directly measure the transdermal voltage was added here.
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111.1. Solutions.
The day before the experiment, prepare Solutions 1 through 5 (Solution 5, PBS, is needed to pre-
pare Solution 1). On the day of the experiment, prepare Solutions 5 (again) and 6, since these solu-
tions can not be stored and have to be used immediately.
1. Acrylamide monomer solution: 7.5 g of 19:1 acrylamide:bis(N,N'-methylene-bis-acrylamide)
powder (Bio-Rad, Hercules, CA) in 50 ml PBS (Solution 5, below). Prepare and mix together in a
fume hood (the monomer is carcinogenic). Let the solution stand for >12 h before using, to allow
the monomer to fully dissolve. This solution can be prepared well in advance of the experiment;
it will not polymerize without addition of the catalyst.
2. Stock mounting solution: 10 mg Nile Red (Molecular Probes) in 20 ml acetone (Prausnitz, et at.,
1996 [a]). Wrap in aluminum foil to protect from light. This solution can be stored indefinitely if
protected from light.
3. Final mounting solution: 7.5 ml glycerol in 2.5 ml de-ionized water and mix thoroughly. Add
250 ji of the stock mounting solution (Solution 2). Wrap in aluminum foil to protect from light.
This solution can also be stored indefinitely if protected from light.
4. Acrylamide initiator solution: 0.3 g (NH 4 )2 S 2 0 8 in 3 ml H 20. This solution can be stored for
only a week.
5. Phosphate-buffered saline, PBS: 1.1 mM KH 2PO 4 , 2.7 mM KCl, 8.1 mM Na 2 HPO 4 , 138 mM
NaCl (total of 150 mM) in 500 ml de-ionized H20. Stir under vacuum for >30 min to remove
dissolved gases from solution. Both light and 02 can cause the quenching of fluorescent
molecules, but this effect can be reduced by removing the dissolved gases from PBS, and protect-
ing the solution from light whenever possible. Adjust to pH 7.4 with HCl and NaOH. This solu-
tion should be degassed immediately before use.
6. A typical donor solution consists of 1 mM of a hydrophilic fluorescent tracer in PBS (see Chap-
ter 4). Examples of hydrophilic fluorescent tracers include lucifer yellow (457 Da) (Prausnitz, et
al., 1993 [a]; Chen, et al., 1998 [c]), calcein (623 Da) (Prausnitz, et al., 1993 [a]; Pliquett and
Weaver, 1996 [a]; Vanbever, et al., submitted), and sulforhodamine (607 Da) (Pliquett and
Weaver, 1996 [a]) (all from Molecular Probes; see Chapter 4). Wrap the donor solution
immediately in aluminum foil to protect it from light. Gently shake on a Nutator (Clay Adams,
Becton Dickinson) for >30 min to ensure complete dissolution. This solution should be made
immediately before use, right after preparing the PBS solution.
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III.2. Electrode Fabrication.
The permeation chambers are custom-
designed, side-by-side glass diffusion chambers
(Crown Bio Scientific), with an outer water jacket
(to maintain the temperature at 37 'C) and an
inner compartment (Figure 111.2) (Friend, 1992).
Side-by-side permeation chambers (where the
skin is mounted vertically), are preferable to
vertical permeation chambers (where the skin is
mounted horizontally) for two reasons. First, any
bubbles produced by the electrodes can easily
be removed from the system, before they reach
the skin. In a vertical chamber, the bubbles
would float upwards towards the skin. Second,
mounting the skin vertically eliminates gravity as
a possible driving force, which is important for
mechanistic studies. Here, gravity includes
Measuring
Donor Electrodes
Compartment
PBS Flow
Pulsing
Electrode
C= C=
Polyacryl-
amide Gel Sir Bar Receptor
PB
T Skin Compartment
S Flow PB,
PBS Flow
Pulsing
Electrode
Water Jacket
(37 -C)
Figure 111.2. Schematic diagram of chamber with flow-
protected electrodes. PBS is pumped around the outer
electrodes to remove any chemical by-products produced by
the electrodes.
effects such as the weight of the liquid pushing down on the skin.
Ports extend from the inner compartment, through the water jacket, to the outside, allowing direct
access to the inner compartment. Each chamber half has one large port (for sampling) and two smaller
additional ports on the far ends (for placement of the pulsing electrodes and the flow-protection system
around the electrodes). The volume of the inner compartment is ~3.1 ml, and the area of the circular
2
opening is 0.64 cm (0.9 cm diameter).
There are four electrodes in this system (Figures 111.2, 111.3, and III.4). The two outer electrodes are
used for pulsing, and the two inner electrodes for measuring the transdermal voltage. There are two
sets of electrodes: the inner measuring electrodes, and the outer pulsing electrodes.
The electrodes are made from silver wire, and the connectors are made from 200 l1 pipette tips,
with assorted amounts of tubing, all held in place by epoxy (Devcon). While the electrodes are gen-
erally reusable between experiments if sufficiently cleaned with fine-grain sandpaper, they should be
periodically examined. Worn-out or broken electrodes should be discarded. The pulsing electrodes
can typically survive about a month of intense use before wearing out; the measurement electrodes can
last somewhat longer.
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1II.2.1. Measurement Electrode Fabrication.
The main requirement for the measurement electrodes are that
Wire -.
they should not be able to move once they are snugly placed
within the chamber (Figure 111.3).
Truncated 1 ml Pipet Tip --
1. Cut off a piece of pure silver wire, ~0.040 inch diameter,
-0.5 cm long.
Epoxy (inside)
2. Solder the end of the silver wire to a piece of copper bell
wire, as shown in Figure 111.3.
3. Once the solder hardens, cover the solder (but not the silver Truncated 200 [ Pipet Tip
wire) with nonconducting silicone rubber (General Electric). Silicone Rubber
Use as little silicone rubber as possible, but make sure that Solder (inside)
the solder is completely covered. Wait for the silicone rub- Ag 
Wire - o
Figure HI.3. Measurement electrodeber to harden (~1 d). fabrication. Only the silver wire elec-
trode is exposed to the donor solution;
4. Cut the end off a 200 gl pipette tip. The hole at the end of the solder is encased in nonconducting
silicone rubber.
the pipette should be just large enough to accommodate the
wire.
5. Insert the wire with the silver electrode up through the end of the pipette tip. The silver electrode
should be placed so that when the pipette tip is placed snugly into the large port of the perme-
ation chamber, the silver electrode is positioned in the middle of the chamber.
6. If the 200 pl pipette tip is smaller than the large port, it could get stuck inside. Thus, a "handle"
is needed, so that there is a way to remove the pipette tip from the chamber (Figure III.3). Cut the
end off a 1 ml pipette tip so that the copper bell wire will just fit through the opening. Slide the
electrode wire through this pipette tip.
7. Completely fill the 200 l1 pipette with epoxy. Immediately insert the 1 ml pipette tip into the
epoxy at the top of the 200 p1 pipette tip. Hold everything in place until the epoxy cures, and
verify that the silver wire does not move while the epoxy is curing.
1II.2.2. Pulsing Electrode Fabrication.
Each pulsing electrode is designed to allow electrical pulses to be applied, as well as allowing a
stream of PBS to flow around the electrode and out to a waste beaker (Figure III.4). A separate port in
the permeation chamber supplies fresh PBS to the pulsing electrode (see Figure 111.2).
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1. Cut off a piece of pure silver wire, -0.040 inch diameter, Wire -*
-0.5 cm long.
2. Solder the end of the silver wire to a piece of copper bell Tygon Tubing -
wire, as shown in Figure III.4. Keep the solder to a mini-
Epoxy (inside)
mum, since the entire electrode, when completed, must still
fit within the small port of the permeation chamber.
Truncated 200 1d Pipet Tip -
3. Once the solder hardens, cover the solder (but not the silver
wire) with nonconducting silicone rubber. Use as little sili- Silicone Rubber
cone rubber as possible, but make sure that the solder is Solder (inside)
completely covered. This will ensure that the electrical 
Ag Wire ---
pulses are delivered by only the silver, not the solder. Wait Figure 11.4. Pulsing/flow-protection
electrode fabrication. This electrode is
for the silicone rubber to harden (-1 d). similar to the previous electrode (see
Figure 111.3), except an additional tube
4. Cut the end off a 200 pl pipette tip. The hole at the end of permits the continuous flow of PBS
around the electrode, to control the pH
the pipette should be slightly larger than the bell wire, so bn prouctfor the removal of chemical
that there is room for PBS to flow around the wire.
5. Insert the wire with the silver electrode up through the end of the pipette tip, as shown above in
Figure III.4. The silver electrode should be placed so that when the pipette tip is placed snugly
into the small port of the permeation chamber, the silver electrode is positioned in the middle of
the chamber.
6. Cut off a piece of Tygon tubing, 1/32 inch ID, -3 inches long. Insert it into the wider end of the
pipette as far as possible, wedging the bell wire into place.
7. Fill the wider end of the pipette with epoxy, to fix both the tubing and the wire in place. The
epoxy should completely seal off the end of the pipette. Make sure that the epoxy does not flow
far enough into the pipette tip so that it covers the opening of the tubing, and verify that the wire
and the tubing do not move while the epoxy is curing.
111.3. Electrode Flow-Protection System.
Each of the two pulsing electrodes is continuously washed in a stream of PBS, pumped by a peri-
staltic pump. For each of the pulsing electrodes, PBS is pumped from a reservoir into each compart-
ment through the side ports, up around the electrode (channeled by the polyacrylamide gel), and then
up through the tubing connected to the pulsing electrodes. From there, the PBS flows into a waste
flask (Figure 111.5).
Since the purpose of the flow-protection system is to wash any chemical by-products out of the
system, the pumps for this system do not need to be very precise. A good flowrate is -6 ml/min per
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electrode. Tygon tubing should be
used to connect the reservoir, the <
pumps, and the permeation cham-
ber together. The tube fittings
needed to connect the tubing to the Pulsing
Electrode
pump and the chamber will vary,
depending on the type of equipment Waste Flask
available. If a connector to the
Peristaltic Pump
chamber is not available, a good
one can be made by epoxying a
piece of Tygon tubing to a pipet tip. PBS Reservoir
Figure 111.5. Liquid circuit for a flow-protected pulsing electrode. There
are two pulsing electrodes, so this arrangement is used twice. PBS is
pumped into the permeation chamber from the PBS reservoir, up through
the pulsing electrode, to a waste flask.
III.4. The Electrical Circuit.
All of the components in the electrical circuit (shown in Figure 111.6), including the wires and the
clip leads, should be able to withstand high voltages and positioned with safety in mind. The electrical
circuitry should be set up in a protected area away from the permeation chamber (e. g., on a different
bench), so that any fluid leaks or
spills cannot reach the electrical com-
ponents. Modifications to the high-
voltage pulser have previously been
discussed in Section II.1.
The chamber is connected to the
circuit so that the receptor pulsing
electrode is positive and the donor
electrode is grounded (Figure 111.6).
This arrangement provides a favorable
driving force for a negatively charged
molecule. However, for a positively
charged species, the positive and
negative terminals to the chamber
should be interchanged.
The 9.8 Q resistor is a safety
device used to protect the system in
the event of a short circuit. It should
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Polyacrylamide Gel
9.8 Q
R D
+ t t tOscilloscope
Pulser PBS PBS PBS
~ Skin
1.2 Q
V
lox
Figure 111.6. Circuit diagram for transdermal voltage measurements.
The 9.8 0 resistor is a safety device in the event of a short circuit. The
transdermal voltage is measured by a high-voltage probe, and the cur-
rent is measured by a 10 x voltage probe across a 1.2 Q resistor placed
in series with the chamber. R indicates the receptor compartment and
D indicates the donor compartment. The two outer PBS streams and the
polyacrylamide gel around the pulsing electrodes are used to prevent
chemical contamination of the donor and receptor compartments by the
electrodes.
be a 50 W (or higher) noninductive power resistor.
Since the 1.2 Q resistor is in series with the skin, it can be used to measure the current across the
skin during pulsing. It should be a 50 W (or higher) noninductive power resistor. A 10 x voltage probe
from the digital oscilloscope should be connected across the 1.2 Q resistor. Once the voltage drop
across the resistor is known, the current can be determined by applying Ohm's law (Equation 3.2)..
The donor and receptor compartments each contain a measuring electrode. A grounded high-
voltage probe (Tektronix) is sequentially used to measure the voltages on either side of the skin.
111.5. Impedance Measurement Circuit.
The resistance of the skin should be V
checked to make sure the skin is in good Polyacrylamide Gel
condition. However, an ohmmeter or other DC
source should not be used to measure the
resistance of the skin, since it may cause R D
iontophoresis during the measurement. Some
5QmVRMSPBPB
commercial ohmmeters can apply voltages up 10 Hz
to -5 V during ordinary resistance measure-
ments. In "good" skin, these ohmmeters can 1.0 D
AA
generate very large current densities in the
skin, sometimes more than -0.5 mA / cm 2 . A v
current density of 0.5 mA / cm2 is also the
maximum current density that can be applied Figure 111.7. Circuit diagram for measuring the impedance ofthe skin. The AC source produces a 50 mV RMS, 10 Hz bipolar
to the skin in humans during iontophoresis. sine wave. The current across the skin can be determined by
measuring the RMS voltage across the 1.0 Q resistor in placed
Thus, such ohmmeters should never be used series with the skin. The voltage across the skin can be deter-mined with the voltmeter placed across the permeation cham-
ber (ignoring the contribution due to PBS, which is negligible
to measure the resistance of the skin, compared to the skin). The impedance of the skin can then be
A bipolar sinusoidal AC voltage source 
found by Ohm's Law.
does not deliver a net current to the skin, and should be used instead of a DC source. However, using
an AC voltage source gives the impedance, not the resistance, of the skin. At low frequencies (<1 kHz),
the skin's impedance approximates its resistance, but at higher frequencies, the capacitance of the skin
can introduce errors. Thus, besides low RMS voltages (<0.1 V), low frequencies (10 Hz or 100 Hz)
should be used.
Although commercial test equipment is available (e. g., Model 5R715 LCR Meter, Stanford Research
Systems), a skin impedance tester can also be set up using an AC sinewave generator. This circuit is
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shown in Figure 111.7. The AC source should be able to produce a 10 Hz, 50 mV (peak-to-peak) bipolar
sine wave. For a good piece of skin, the maximum RMS current this system will produce is -1 A.
In this circuit, the impedance of the skin can be determined by measuring the RMS voltage across
the 1.0 0 resistor. From this value, Ohm's Law gives the current (which should be <1 pA). The
voltage drop across the skin, divided by the current, gives the skin's impedance.
111.6. Resistance of PBS.
The skin, PBS, and some polyacrylamide gel are located between the two measurement electrodes.
The resistivities of the PBS and the polyacrylamide gel are constant, but should be measured.
1. Make up a solution of PBS (Solution 5 in Section 111.1).
2. Prepare the permeation chamber, with the four electrodes and the polyacrylamide gel (described
below in Section 111.7).
3. Fill the chamber with PBS.
4. Connect the high-voltage pulser and the flow-protection system to the chamber (see Figure 111.6).
Heat the chamber to 37 0C using the water jacket (the resistivity of PBS is a function of tempera-
ture).
5. Manually apply pulses to the chamber, starting from 0 V and increasing in units of 100 V, up to
1000 V. Apply 5 to 10 pulses per setting. For each pulse, record the voltage drops appearing
across the inner measurement electrodes (Uinner) and the 1.2 Q resistor (Ucurr, given that
Reurr = 1. 2 Q).
6. To find the current (I), apply Ohm's law to the 1.2 Q resistor:
I = Ucurr _ Ucurr (111.4)
Rcurr 1.2 Q
7. Plot the voltage drop across the inner measurement electrodes (Uisne,) versus the current (I). The
slope of the line is the resistance of the PBS and the polyacrylamide gel (lumped together in one
variable, RPBS) between the two measurement electrodes:
RPBS Uinner (111.5)
I
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111.7. Permeation Chamber Preparation.
The polyacrylamide gel around each pulsing electrode directs PBS in and out of the chamber, with-
out contacting the donor or receptor solutions (this is the hollowed-out regions that run around each of
the two pulsing electrodes in Figure 111.2).
111.7.1. Preparation of the Mold.
Acrylamide in solution takes approximately 10 min to polymerize into polyacrylamide gel. In this
time, the acrylamide solution has to poured into the chamber. To create the channels that run through
the polyacrylamide gel, plastic tubes are inserted into the chamber, which are then removed once the
acrylamide has polymerized. Preparing the mold for the permeation chambers can be done the day
before the experiment.
1. Find two flexible plastic tubes, approximately 9 inches long, that will fit through the two small
ports on each chamber half.
2. Slide the plastic tubes through these ports (use tweezers as needed), so that roughly 1 to
2 inches of tubing protrudes out on either side. These tubes are the mold for the electrode flow-
protection channel.
3. Place Parafilm (American National Can) around each opening tightly. Use two layers of Parafilm.
This should create a watertight seal around the openings, so the acrylamide solution does not
leak out.
4. Position each of the two chambers sideways, so that the large opening (where the skin is located)
is on top. The chambers should be braced in some fashion (propping them up on pencils or test
tubes) so that they can not tip or move when filled with liquid.
II. 7.2. Adding the Polyacrylamide Gel.
Acrylamide monomer in solution (Solution 1, from Section III. 1) will polymerize into a gel in approx-
imately 10 min upon addition of a catalyst (N,N,N',N'-tetramethylethylenediamine) (Bio-Rad) and a free
radical initiator (Solution 4). Synthesis of the polyacrylamide gel should be performed just before the
experiment (the chambers should already be prepared), since the polyacrylamide gel will begin de-
hydrating after a few hours.
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1. Thoroughly mix together 10 ml of acrylamide solution (Solution 1 from Section III. 1), 87.5 d of
the initiator (Solution 4), and 6 pd of N,N,N',N'-tetramethylethylenediamine in a 15 ml test tube.
2. For each chamber half, immediately pour in the acrylamide solution so that it reaches the level of
the large port. This should leave a donor volume of -2.1 ml.
3. Do not disturb the chambers while the gel is polymerizing, as disturbances will cause the gel to
take longer to harden, and the gel will set poorly as a result. It takes -10 min for the gel to
harden. Any leftover acrylamide solution can be used to monitor the gelling process.
4. After the gel forms, carefully remove the Parafilm around the each of the plastic tubes of the elec-
trode flow-protection system. Remove the plastic tubes through one of the small ports.
5. Before using, fill the permeation chambers with PBS to keep the polyacrylamide gel from drying
out.
III.8. Preparing the Equipment.
On the day of the experiment, the following should have already been prepared and assembled:
Solutions 1 through 4 (Section III.1), the permeation chamber and the electrodes (Sections 111.2 and
111.7.1), the electrode flow-protection system (Section 111.3), the electrical circuit (Section 111.4), the high-
voltage pulser (Section II.1), the skin (Section 1.1), and the impedance meter (Section 111.5).
Immediately before the experiment, Solutions 5 and 6 (Section III. 1), and the polyacrylamide gel in the
chamber (Section 111.7.2) need to be prepared. Once the gel in the chamber is ready, place the cham-
ber on a magnetic stirring plate and connect it to a 37 C water bath.
11I.9. Loading the Skin into the Chamber.
The condition of the skin is checked by measuring its electrical impedance and monitoring the
passive flux of the donor solution. The impedance of "good skin" should be >25 ku cm 2 at 100 Hz
(Prausnitz, et al., 1993 [a]; Chen, et al., 1998 [b]; M. R. Prausnitz, personal communication; Gowri-
shankar, personal communication). The passive flux of the donor solution across the skin after 1 h
should be negligible (below the detection limit of the spectrofluorimeter). Low impedances or large
passive fluxes indicate that the skin's integrity has been compromised in some way. This could be due
to a hole in the skin, shearing of the skin during the loading process, or the poor quality of skin's
preservation post mortum.
The impedance is measured across the two measurement electrodes in the permeation chamber.
However, besides the skin, this measurement also includes PBS and the polyacrylamide gel. The other
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impedances can be neglected, though, since the impedance of the skin is much larger than PBS (see
Section 3.5).
1. Float a piece of skin (see Section 1.1) in a dish of PBS for -1 min.
2. Gently remove the wax paper backing. Do not use tweezers. The skin should float on the sur-
face, with the stratum comeum side facing upwards.
3. Position the skin in the chamber so that the stratum corneum faces the donor compartment and
the epidermis faces the receptor compartment. Clamp the chamber shut.
4. Fill the donor and receptor compartments with PBS.
5. Connect the impedance meter (see Section 111.5) to the measurement electrodes. Good skin has
2
an impedance >25 kQ cm at 100 Hz. Poor skin should be discarded.
6. Disconnect the impedance meter.
7. Remove PBS from the donor compartment and add donor solution (Solution 6 from Section III. 1).
Add 1.5 mm "flea"-type magnetic stir bars to the donor and receptor compartments.
8. Connect the chamber to the pulsing circuit as shown in Figure 111.6.
9. Turn on the stirring plate and the water bath.
II1.10. Applying Pulsing.
High-voltage pulses should be applied to the skin at the rate of 1 pulse every ~5 s. Both the time
constant and the applied voltage should be set on the pulser as needed before pulsing is started. The
transdermal voltage is a nonlinear function of the applied voltage (see Figures 7.10 and 8.3) (Pliquett,
et al., 1995 [a]; Chen, et al., 1998 [c]). Thus, given a desired transdermal voltage, a guess of the
applied voltage should be made at this time.
1. After 1 h (passive control), make a measurement of the receptor chamber fluorescence. If the
fluorescence is significantly higher than the background, then the skin is leaking and should be
discarded.
2. Set the pulser to deliver the appropriate types of pulses.
3. Gradually start the pumps for the electrode flow-protection system. Make sure that the poly-
acrylamide gel in the chamber does not crack or break when this is turned on. If the gel breaks,
new gel will have to be made, and the experiment will have to be aborted.
4. Start the pulser. Record the time the experiment was started, and monitor the pulses to make
sure they are being applied at the correct rate (i. e., 1 pulse every 5 s).
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5. Every 15 min (starting at time 0), record the voltage in the donor and receptor compartments.
With a grounded high-voltage probe, these measurements should be made on subsequent pulses.
Also record the current through the 1.2 Q resistor.
6. After pulsing, turn off the pumps. Make a measurement of the receptor chamber fluorescence.
7. Mount the skin for fluorescence microscopy, as described in Section 11.3.
111.11. Calculating Transdermal Voltages.
The voltage drop across the skin can be determined by applying Ohm's Law to the current and the
voltage. The resistance of the intervening PBS (RPBS) should already be known (see Sections 3.5 and
111.6).
1. Ohm's Law is used to convert the average voltage drop (Ucurr) across the 1.2 Q resistor
( curr = . )
I = Urr Ucurr (111.6)
Rcurr 1.2 Q
2. The current across the skin (I) and the voltage drop across the measurement electrodes (Uinr)
should now be known. To calculate the transdermal voltage (Uskin), use the following equation:
Usin =: Uinner -I R PBS -
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IV. Chamber with Flow-Through System for Real-Time Measurements.
Although this is not the first flow-through system for studying skin permeation, with a working vol-
ume of only 400 p1, it has one of the highest time resolutions of any flow-through system - 14 s
(Figure IV.1). This is necessary for studying skin electroporation phenomenon, where many dramatic
changes can occur after only a few of pulses (Prausnitz, et al., 1994; Pliquett and Weaver, 1996 [al;
Chen, et al., 1998 [c]).
In addition to the flow-protected electrodes and the transdermal voltage measurement system
described in Appendix III, the system in this appendix will also measure both the molecular flux and
the transdermal voltage on an almost per-pulse basis (if pulses are applied at the rate of 1 pulse every
5.56 s, a time resolution of -14 s covers a little less than 3 pulses).
IV.1. Solutions.
The day before the experiment, prepare Solutions 1 through 5 (Solution 5, PBS, is needed to pre-
pare Solution 1). On the day of the experiment, prepare Solutions 5 (again) and 6, since these solu-
tions can not be stored and have to be used immediately.
Figure IV. 1. Flow-through experimental apparatus. The permeation chamber is in the middle of the
picture, on top of the stirring plate. To its right are the flow-through pumps (black). To the right of that
is the fluorimeter, containing the flow-through cuvette for real-time fluorescence measurements. On top
of the fluorimeter are the flow-protection pumps, the PBS reservoir, and the waste beaker. To the left of
the stirring plate is the differential high-voltage probe (flat black box). On the cart on the left are the
pulser (blue), the water bath, the electronic circuitry (on top and behind the water bath), and the com-
puter and oscilloscope which are connected to the high-voltage probe (middle level).
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1. Acrylamide monomer solution: 7.5 g of 19:1 acrylamide:bis(N,N'-methylene-bis-acrylamide)
powder (Bio-Rad) in 50 ml PBS (Solution 5, below). Prepare and mix together in a fume hood (the
monomer is carcinogenic). Let the solution stand for >12 h before using, to allow the monomer to
fully dissolve. This solution can be prepared well in advance of the experiment; it will not poly-
merize without addition of the catalyst.
2. Stock mounting solution: 10 mg Nile Red (Molecular Probes) in 20 ml acetone (Prausnitz, et al.,
1996 [a]). Wrap in aluminum foil to protect from light. This solution can be stored indefinitely if
protected from light.
3. Final mounting solution: 7.5 ml glycerol in 2.5 ml de-ionized water and mix thoroughly. Add
250 pl of the stock mounting solution (Solution 2). Wrap in aluminum foil to protect from light.
This solution can also be stored indefinitely if protected from light.
4. Acrylamide initiator solution: 0.3 g (NH 4 )2 S 20, in 3 ml H 2 0. This solution can be stored for
only a week.
5. Phosphate-buffered saline, PBS: 1.1 mM KH 2 PO 4 (0.40 g per 2.0 1 H 2 0), 2.7 mM KCl (0.40 g),
8.1 mM Na 2HPO 4 (2.30 g), 138 mM NaCl (16 g) (total of 150 mM) in de-ionized H 2 0. Although
the volume of the receptor compartment is very small (~400 ptl), a typical experiment can con-
sume a surprisingly large volume of PBS, since both the flow-through fluorescence measurements
and the electrode flow-protection systems are continuously pumping PBS through the chamber.
One experiment can consume up to 2.0 1 of PBS. Stir the PBS solution under vacuum for
>30 min to remove dissolved gases from solution. Both light and 02 can cause the quenching of
fluorescent molecules, but this can be reduced by removing the dissolved gases from PBS, and
protecting the solution from light whenever possible. Adjust to pH 7.4 with HCl and NaOH. This
solution should be degassed immediately before use.
6. A typical donor solution consists of 1 mM of a hydrophilic fluorescent tracer in PBS (see Chap-
ter 4). Examples of hydrophilic fluorescent tracers include lucifer yellow (457 Da) (Prausnitz, et
al., 1993 [a]; Chen, et al., 1998 [c]), calcein (623 Da) (Prausnitz, et al., 1993 [a]; Pliquett and
Weaver, 1996 [a]; Vanbever, et al., submitted), and sulforhodamine (607 Da) (Pliquett and
Weaver, 1996 [a]) (all from Molecular Probes). Wrap the donor solution immediately in aluminum
foil to protect it from light. Gently shake on a Nutator (Clay Adams, Becton Dickinson) for >30
min to ensure complete dissolution. This solution should be made immediately before use, right
after preparing the PBS solution.
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[V.2. Receptor Measurement Electrode Fabrication.
The permeation chambers are custom-de- PBS Flow
signed, side-by-side glass permeation cham- To Spectrofluorimeter
bers (Crown Bio Scientific), with an outer water
jacket (to maintain the temperature at 37 C) DonorCompartment
and an inner compartment (Figure IV.2) (Friend, PBS Flow PBS Flow
1992).
Ports extend from the inner compartment,
PulsingPusn
through the water jacket, to the outside, which Electrode ElectrodeElectrode OCutflowElcrd
allows direct access to the inner compartment.
Each chamber half has one large port (for the
measuring electrodes and the flow-through
sampling system), with two smaller additional Polyacryl-
ports on the far ends (for placement of the elec- amide Gel Stir Bar Mea uring Water Jacket
I Skin Electrodes t (37 *C)
trodes and the flow-protection system around PBS Flow Receptor PBS Flow
the electrodes). The volume of the inner com- Compartment
partment is -3.1 ml, and the area of the circular Figure IV.2. Skin permeation chamber with flow-through
opening is 0.64 cm 2 (0.9 cm diameter). sampling system. The two outer electrodes are used forpulsing, and the two inner electrodes are used to measure the
four electrodes in this system voltage drop across the skin. PBS is pumped around the
pulsing electrodes to remove any chemical by-products gener-
ated during pulsing. PBS is also pumped through the recep-(Figures IV.2). The two outer electrodes are tor compartment to a spectrofluorimeter for real-time detec-
tion.
used to apply pulses, and the two inner elec-
trodes are used to measure the transdermal voltage. Due to limitations of space within the donor and
receptor compartments, the electrodes are constructed to allow both electrical access and liquid flow to
the chamber. Thus, there are three types of electrodes in this system: the donor measurement elec-
trode, the receptor measurement electrode, and the pulsing electrodes (the same design is used in both
the donor and the receptor compartments).
The electrodes are made from silver wire, and the connectors are made from 200 pl pipette tips,
with assorted amounts of tubing. The fabrication of the donor measurement electrodes has been pre-
viously described in Section 111.2.1 (it was used for both compartments in Appendix III, but for this
system only one of these electrodes is needed in the donor compartment). The fabrication of the two
outer pulsing electrodes has been previously described in Section 111.2.2.
While the electrodes are generally reusable between experiments if sufficiently cleaned with fine-
grain sandpaper, they should be periodically examined. Worn-out or broken electrodes should be dis-
carded. The pulsing electrodes can typically survive about a month of intense use before wearing out;
the measurement electrodes can last somewhat longer.
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The receptor measurement electrode must allow PBS to flow Tygon Tubing
into and out of the receptor compartment, as well as detecting
pulses (Figure IV.3). Wire
1. Cut off a piece of pure silver wire, -0.040 inch diameter, Truncated 1 ml Pipet Tip-
~0.5 cm long. Teflon Tubing,,
2. Solder the end of the silver wire to a piece of copper bell
Epoxy (inside)
wire, as shown in Figure IV.3.
3. Once the solder hardens, cover the solder (but not the silver Truncated 200 il Pipet Tip-*
wire) with nonconducting silicone rubber. Use as little sili-
cone rubber as possible, but make sure that the solder is
completely covered. Wait for the silicone rubber to harden Silicone Rubber
(-1 d). Solder (inside)
Ag Wire-"'
4. Cut off a piece of Tygon tubing, 1/32 inch ID, -9 inches
long. This will be used for the inflow into the receptor Figure IV.3. Receptor side measure-
compartment. Cut off a piece of Teflon tubing, 1/ 16 inch ID, men lectro n o ut of the recepto o
-5 inches long. This will be used for outflow. In general, partment.
Tygon tubing is more flexible than Teflon tubing and is easier to manipulate. Thus, most of the
tubing in this system is made from Tygon tubing. However, Tygon tubing is not strong enough to
support the venting system; thus, Teflon tubing is used instead.
5. Cut the end off a 200 gl pipette tip. The hole at the end of the pipette should be large enough to
accommodate the wire and the two tubes. Cut the end off a 1 ml pipette tip so that the wire and
the two tubes will fit through that hole as well.
6. A hole needs to be drilled into the side of the 1 ml pipette for the Teflon outflow tubing. This hole
must be placed high enough so that the tubing clears the side of the port, and large enough to
accommodate the Teflon tubing. Insert the 200 gl pipette tip and the 1 ml pipette tip into the
large port of the permeation chamber. Mark the level where the 1 ml pipette tip just clears the
side of the port. Take the pipette tips out, and drill the hole in the side of the 1 ml pipette tip,
just above this level.
7. Insert the Teflon outflow tubing through the 200 pl pipette tip, through the opening of the 1 ml
pipette tip, and out through the hole on the side of the 1 ml pipette tip. Insert the Tygon inflow
tubing and the wire through the 200 gl pipette tip and the 1 ml pipette tip (see Figure IV.3). The
silver electrode should be placed so that when the 200 jl pipette tip is placed snugly into the
large port of the permeation chamber, the silver electrode is positioned in the middle of the
chamber. The two tubes should extend about 2 inches from the bottom of the 200 itd pipette tip.
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8. Fill the 200 11 pipette with epoxy, to immobilize the wire and the two tubes in place. Next, insert
the 1 ml pipette tip into the epoxy at the top of the 200 pl pipette tip (keeping the tubes and
wires properly positioned inside) and hold everything in place until the epoxy cures. Verify that
the wires and the tubing do not move while the epoxy is curing.
9. Completely insert the electrode through the large port of the receptor compartment, such that the
two tubes come out through the side. The silver wire electrode should be positioned in the
middle of the compartment. Mark both tubes where they emerge from the chamber. Take the
electrode out of the compartment and cut both tubes on those marks. The tubes should now be
the proper size for the receptor compartment.
IV.3. Flow-Through Sampling System.
In the receptor compartment, PBS is pumped from a reservoir, through the long Tygon tube of the
receptor measurement electrode, into the receptor compartment (Figure IV.4). It then flows back up
through the short Teflon tube of the electrode into a collection tube on the side of the electrode. From
there, the PBS is pumped to a cuvette inside the spectrofluorimeter, and then out to a waste flask.
IV.3. 1. Fabrication of the Receptor Venting System.
In a sealed receptor compartment with such a small volume (-400 tl), the minute pressure differ-
ences introduced by the peristaltic action of the pump can build up within the chamber. The receptor
compartment design allows these pressure differences to be eliminated.
Figure IV.4 shows a small collection tube (made from a centrifuge tube) near the outflow of the
receptor compartment. Liquid from the receptor compartment drips down into the collection tube,
which is pumped into the spectrofluorimeter detector. Transient pressure differences from the receptor
compartment are eliminated by venting the system at this location. The collection tube is not per-
manently fixed to the receptor measurement electrode, to allow for easier assembly and cleaning.
1. Cut the lid off of a 2 ml centrifuge tube.
2. Cut off a piece of Tygon tubing, 1/32 inch ID, -3 inches long.
3. Drill a hole in the bottom of the centrifuge tube. The piece of Tygon tubing should just fit inside
this hole.
4. Drill a second hole near the midpoint of the centrifuge tube. This hole should be just large
enough to accommodate the Teflon tube from the receptor measurement electrode.
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5. Attach the piece of Tygon tubing to the hole with epoxy. This tube should be flush with the
bottom of the centrifuge tube and should not protrude into it (Figure IV.4).
IV.3.2. Cuvette Fabrication.
The cuvette in the spectrofluorimeter has to accommodate both the inflow and outflow of liquid to
and from the permeation chamber. The volume of the liquid within the cuvette should be the smallest
volume needed to obtain an accurate fluorescence measurement. In addition, the apparatus described
in this appendix can be assembled and disassembled as needed.
The spectrofluorimeter cuvette
is a 1 ml polystyrene semi-micro
cuvette with two holes drilled into
the side (Figure IV.4). Liquid en-
ters through the upper hole and
exits through the lower hole. Since
the outflow rate of the cuvette is
higher than the inflow rate, the
level of liquid stays at a constant
height, immediately below the level
of the outlet. The height of liquid
within the cuvette depends on the
minimum volume of liquid in the
cuvette that yields a sufficiently
accurate signal in the spectro-
fluorimeter.
However, there is a cyclical
rise and fall in the height of liquid
within the cuvette, due to the dif-
ferences between the inflow rate
and the outflow rate. Since liquid
leaves the cuvette faster than it
enters, the level of liquid within
the cuvette will drop. However, the
liquid in the cuvette cannot be
drawn out unless the outlet is
Peristaltic Pump #1
Centrifuge Tube 1
S Reservoir\
Tygon Tubing -
Peristaltic Pump #2
Skin (in
Chamber)
PI
Receptor
Electrode
200 [ Pipet Tip
4-1 ml Semi-micro cuvette(in spectrofluorimeter)
20( Mrocapillary
Pipet Tip
Peristaltic Pump #3 Waste Flask
Figure IV.4. Liquid circuit for flow-through measurements of the receptor
compartment. PBS is pumped from a reservoir into the receptor measure-
ment electrode, down into the permeation chamber. PBS then exits the
receptor compartment into a collection (centrifuge) tube. From there, it is
pumped into a cuvette in the spectrofluorimeter for real-time detection.
Finally, PBS from the cuvette is pumped out into a waste flask. The
arrangement of pumps and tubing allow this system to maintain a constant
throughput.
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completely submerged. Once the outlet is exposed, the pump begins to draw in air instead of liquid.
When this occurs, the level of liquid in the cuvette will rise, since liquid is still entering the cuvette.
This level will rise until the outlet is submerged again, causing the cycle to repeat.
The cyclic rise and fall of the height of liquid within the cuvette systematically varies from the
bottom to the top of the outlet. This cycling pattern can be detected on relatively sensitive spectro-
fluorimeters. To minimize this effect, the outlet size must be kept as small as possible. A problem with
using very small tubing is that it can frequently become blocked by stray bits of dirt and debris,
especially from the skin. The amount of dirt and debris can be minimized by continuously flushing the
system (during the passive controls, and between experiments), and by very thorough washing of the
entire system before shutting it down. To clear a blocked tube, the system should be backflushed to
remove the clog.
Using a 200 1d microcapillary pipet tip (the inner diameter of the tip opening is roughly 500 L)
keeps the level reasonably constant. A diameter of only 500 [t for the outlet may not seem particularly
worrisome, but that size is significant compared to the working volume of the cuvette. With an outlet
this small, the cyclic changes in the height of the liquid in the cuvette are not significant compared to
the shot noise of the spectrofluorimeter.
Mixing within the cuvette is accomplished by the dripping of liquid into the cuvette. The height of
the inlet should be high enough to allow the falling liquid to form droplets. The volume of the cuvette is
small enough that the splashing of the drops into the liquid will cause adequate mixing to occur.
Before making the cuvette, the minimum volume of liquid that the spectrofluorimeter needs for an
accurate signal has to first be determined. Most spectrofluorimeters pass a vertical beam of light
through the cuvette. The beam of light is probably centered inside the cuvette, so that the liquid above
and below this beam do not contribute to the fluorescence measurement.
1. Make up a solution of an easily obtainable highly fluorescent molecule.
2. Add 1 ml of this test solution to a 1 ml semi-micro cuvette and place the cuvette in the spectro-
fluorimeter.
3. Pipet small amounts of liquid out of the cuvette until the readings on the spectrofluorimeter begin
to respond.
4. Attach a clamp to the top of the cuvette. This clamp will keep the cuvette from sliding down fully
into its holder; thus, the cuvette will sit higher in the incident beam of light.
5. Adjust the position of this clamp downward on the cuvette (forcing the cuvette to rise higher and
higher in the incident beam of light) until the readings on the spectrofluorimeter begin to
respond.
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6. Repeat Steps 3 to 5 until no more adjustments are needed. This is the minimum amount of liquid
needed for an accurate signal in the spectrofluorimeter. Lightly mark these levels on the side of
the cuvette.
7. Obtain two 200 pl microcapillary pipet tips. The openings of these pipet tips are approximately
500 g in diameter, smaller than the openings on the standard 200 pil pipet tips.
8. Two holes now should be drilled into the side of the cuvette to allow for inflow and outflow.
These holes should allow the two microcapillary pipette tips to just fit through. These holes
should be drilled on the same side of the cuvette, on a side that will not interfere with either the
excitation beam or the fluorescence emission from the cuvette. The first hole (for outflow) should
be drilled just above the first mark, and the second hole (for inflow) should be drilled approxi-
mately 1/4 inch above that.
9. The two microcapillary pipet tips should be attached to Tygon tubing with epoxy, for attachment
to the peristaltic pumps. However, they should not be attached to the cuvette. This allows the
entire system to be removed from the spectrofluorimeter for cleaning between experiments.
IV.3.3. Pump Balancing.
There are three pumps that are used in the flow-through sampling system. It is vital that these
pumps be properly "balanced," to avoid any accumulations or leakage within the flow-through system.
The three pumps should all have flowrates of ~0.03 ml/s, and should provide consistent flowrates over
very long times. However, these flowrates will not be identical. These differences cannot be avoided,
and in fact can be used advantageously to maintain the flow-through system at steady state. The differ-
ences in the flowrates of the various pumps may be on the order of 0.3 pl / s (±1% of the flowrate) or
less. While minuscule, these differences can still quickly build up in a system as small as this one
over time.
The pumps (see Figure IV.4) should be set up such that the fastest pump is Peristaltic Pump #3,
followed by Peristaltic Pump #2, with Peristaltic Pump #1 being the slowest. The differences in
flowrates will cause air to be drawn into the flow-through system in two places: the collection tube and
the spectrofluorimeter cuvette. This is necessary to keep the throughput of the system constant.
Determining which pump is the fastest requires very careful measurements of the flowrates of each of
the three pumps (up to three significant digits).
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IV.3.4. Flow-Through System Characteristics.
At this point, all of the components should now be in place, correctly connected by tubing. The
lengths of the tubing used to connect all of the components in the flow-through system probably will
vary. While most of the tubing lengths are relatively unimportant, the length of the tubing between the
chamber and the spectrofluorimeter should be minimized.
Although there is mixing within the tubing, the pump, and in the cuvette, the chamber/tubing/
pump/cuvette system is modeled as having two components: a plug flow region, where no mixing
occurs, and a continuous stirred tank reactor region, where instant perfect mixing occurs (Fogler,
1992).
Several parameters needed for this model: the cuvette volume (Veu), the liquid bulk flowrate (Q),
the reaction time (treact), and the residence time (T CU). The reaction time, treact, is the time it takes for
a molecule leaving the receptor compartment to reach the spectrofluorimeter (the plug flow region). The
residence time, TeUV, of the cuvette is the average time it takes for a molecule entering the cuvette to
leave (the continuous stirred tank reactor region) (Fogler, 1992). For an ideal continuous stirred tank
reactor, the residence time distribution of this system can be predicted as an exponentially decaying
function. The time constant for this decay gives TeUV, or the time resolution of the system. If this sys-
tem is properly set up, its performance should be reasonably close to ideal.
To measure treact and TeUV, a technique known as a "pulse-chase" experiment is used, where a drop
of tracer (the "pulse") is added to the system, and then flushed through it (the "chase"). The drop
should be as small and as narrow as possible (ideally, it should be a 6 function).
1. Make up a tracer solution of an easily obtainable highly fluorescent molecule.
2. Partially assemble the flow-through system, from the receptor measurement electrode onwards.
3. Pump water through the system until the spectrofluorimeter reads a constant background.
4. Add an aliquot of tracer to the receptor measurement electrode. (By selectively turning on and off
the pumps, this drop can be made reasonably small.)
5. Turn on the pumps and measure the time it takes for the spectrofluorimeter to first detect the
spike of tracer. This is the reaction time (treact)-
6. Pump water through the system until the spectrofluorimeter reads a constant background again.
7. Add another pulse of the tracer to the receptor measurement electrode.
8. Record the fluorescence on the spectrofluorimeter. If the system is behaving close to an ideal
system, after a short delay (treact), the fluorescence in the cuvette should quickly peak, then
decay exponentially afterwards.
9. Save the data from the spectrofluorimeter and import the data into a graphing program.
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10. Fit the decay of fluorescence to an exponential curve. The time constant for the exponential
decay of the curve is -ruv. This is also the time resolution of the system.
11. Assemble the rest of the flow-through system. This includes the polyacrylamide gel within the
permeation chamber (described below in Section IV.6).
12. Measure the average flowrate through the entire system (Q), using the waste stream. Ignore the
air getting pumped through the system.
13, The cuvette volume can be calculated by multiplying the residence time (TeUV) by the flowrate (Q)
(Fogler, 1992):
VCUV = CUV Q- (IV.1)
IV.4 The Electrical Circuit.
The electrical circuit (shown in Figure IV.5) has to perform two functions. First, it must deliver
high-voltage pulses to the permeation chamber once every 5 s. Second, it has to measure and record
the transdermal voltage and the current across the skin in real time. Since pulses are being applied to
the skin every 5 s, there is very little time to manually record data or make adjustments between
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1.2 Q
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Oscilloscope
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Figure IV.5. Electrical circuit for measuring voltages and currents on a per-pulse basis. The
9.8 0 resistor is a safety device in the event of a short circuit. The transdermal voltage is
measured by a 200 x differential voltage probe, and the current is measured by a 10 x voltage
probe across a 1.2 0 resistor placed in series with the chamber. Both voltage probes are
connected to an oscilloscope, which downloads the data into a computer for later analysis. R
indicates the receptor compartment and D indicates the donor compartment. The two outer
PBS streams and the polyacrylamide gel around the pulsing electrodes are used to prevent
chemical contamination of the donor and receptor compartments by the electrodes. The inner
PBS stream flows from the receptor compartment to a spectrofluorimeter for detection.
pulses. Thus, all of these operations have to be completely automated.
All of the components in the electrical circuit (shown in Figure IV.5), including the wires and the
clip leads, should be able to withstand high voltages and positioned with safety in mind. The electrical
circuitry should be set up in a protected area away from the permeation chamber (on a different bench),
so that any fluid leaks or spills cannot reach the electrical components. Modifications to the high-
voltage pulser have previously been discussed in Section II. 1.
In a commonly used protocol (Prausnitz, et al., 1993 [a]; Prausnitz, et al., 1995 [b]; Pliquett and
Weaver, 1996 [a]; Prausnitz, et al., 1996 [b]), the pulser delivers a high-voltage exponential pulse to
the permeation chamber once every -5 s. The current and the voltage during the pulse are detected by
two high-voltage probes connected to a digital oscilloscope. The data are then immediately downloaded
from the oscilloscope into a computer for later processing. The system stores all of the data and is
ready to download the next pulse in less than 5 s.
IV.4. 1. The Pulsing Circuit.
The chamber is connected to the circuit so that the receptor pulsing electrode is positive and the
donor electrode is grounded (Figure IV.5). This provides a favorable driving force for a negatively
charged molecule. However, for a positively charged species, the positive and negative terminals to the
chamber should be interchanged.
The 9.8 Q resistor is a safety device used to protect the system in the event of a short circuit. It
should be a 50 W (or higher) noninductive power resistor.
Since the 1.2 Q resistor is in series with the skin, it can be used to measure the current across the
skin during pulsing. It should also be a 50 W (or higher) noninductive power resistor. A 10 x voltage
probe from the digital oscilloscope should be connected across the 1.2 Q resistor. Once the voltage
drop across the resistor is known, the current can be determined by applying Ohm's law.
The donor and receptor compartments each contain a measuring electrode. Connected across these
electrodes is a 200 x differential high-voltage probe (B9017RT Active Differential Probe, Yokogawa).
Using a high-voltage probe in the receptor compartment that measures with respect to ground instead of
a differential probe is not recommended, since the grounded high-voltage probe can potentially intro-
duces other voltages, such as the polarization voltage of the pulsing electrodes.
Between the two measurement electrodes are the skin and PBS, where the resistivity of PBS is
constant for a given temperature. The differential probe is also connected to the oscilloscope.
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IV.4.2. Real-Time Data Acquisition and Storage.
The digital oscilloscope records data simultaneously from two channels, and uploads the acquired
data to a computer for subsequent analysis. The computer downloads the data from the oscilloscope
and stores it on disk. All of these operations must be completed in less than 5 s, before the next pulse
arrives.
One digital oscilloscope that has worked well is a Hewlett Packard 54601 with an 54641A RS-232
Interface Module (Hewlett Packard), which can be connected with an RS-232 cable to the serial port of a
personal computer.
The program the computer is running will be machine-specific, depending on which serial port the
oscilloscope is connected to, as well as the programming languages used by the computer and the
oscilloscope (see Section IV.4.3). In general, though, the computer program should be in a low-level
programming language, and the computer itself should be reasonably fast. The oscilloscope should be
transferring data in the most compact format available (i. e., as unformatted ASCII characters instead of
formatted arrays of numbers).
The computer program needs to direct the oscilloscope to transfer data to the computer once a
pulse has been triggered, and it should store the raw data on the hard drive (or on a ramdisk if enough
memory is available). No mathematical processing needs to be done during the experiment. The com-
puter has to be able to complete the transfer and save the data in under 5 s.
The 5 s spacing between pulses allows very little time for the correction of problems, so care must
be taken in setting up this system. Examples of problems that can occur include loose serial plugs,
line noise due to faulty or excessively long cables, errors in the proper recording of an NL ("New Line"
command, ASCII string #OA) or an EOT ("End of Transmission" command, ASCII string #04), improper
triggering of the oscilloscope by line noise in either voltage probe, and failure of the oscilloscope and
the computer to properly synchronize headers and data streams.
A transfer rate of 9600 baud between the oscilloscope and the computer allows roughly 1 kb of raw
data to be transferred in 5 s, which corresponds to a time resolution of approximately 10 ts for each
pulse waveform. Before starting, verify that there is adequate space on the hard drive, since one exper-
iment can consume nearly 1 MB of space.
IV.4.3. SAVEWAVE .CPP.
The following is the source code for SAVEWAVE .CPP, a computer program that measures and records
the transdermal voltage and current from the digital oscilloscope for each pulse. It is in Turbo C++
(Borland, Scotts Valley, CA).
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/* SAVEWAVE.CPP */
/* Program stores pulse waveform and current waveform for every pulse.
/* Program can store up to 1 pulse every 5 s. Data saved in 4 files.
/* The 2 preamble files contain data about the x and y settings on the
/* oscilloscope, saved in MatLab format (PREAMB1.M and PREAMB2.M) . The
/* 2 data files contain the actual waveform data, stored in ascii
/* (WAVE1.DAT and WAVE2.DAT) . Each wave is stored as a block of 500
/* bytes (no separators).
/* Oscilloscope RS-232 module (HP 54651A) should be connected to serial
/* port 1 on computer. Oscilloscope settings: Hit [Print/Utility],
/* then <RS-232 Menu>, and check these settings before running program:
/* Connect to <Computer>, Factors <Off>, Resolution <Low>,
/* Baud Rate <9600>, Handshake <Xon>
/* Tani Chen, 3/17/1997 */
#include <stdio.h>
#include <dos.h>
#include <string.h>
#include <bios.h>
#include <conio.h>
/* Bioscom port 0 = serial port 1 */
#define OscPort 0
/* Bioscom send = 1, read = 2, status = 3 */
#define Send 1
#define Read 2
#define Status 3
#define DataReady 0x0100
InitComl() /* Initialize
union REGS r;
r.h.ah = OxOO;
r.h.al = OxE3;
r.x.dx = OxOO;
int86(0x14, &r, &r);
printf(" Serial port 1
OscCom(char *command) /*
int i;
serial port 1 */
initialized.\n");
Send command to oscilloscope */
delay(100); /* Do not change! Timing necessary for oscilloscope to */
/* take readings correctly! */
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
bioscom(Send, command[i], OscPort);
bioscom(Send, OxOA, OscPort); /* Line feed */
printf(" Command: %s\n", command);
int ReadOsc() /* Wait for ready signal (?) */
int data;
int i = 0;
union REGS r;
while((data=bioscom(Status, 0, OscPort) & DataReady != 0x00l && i<10))
i++;
data = bioscom(Read, 0, OscPort);
data = data&OxOOFF;
return(data);
Preamble(int channel, char *filename)
/* Preamble format: l(byte), l(nrm), 4000(pnts), l(dummy) */
/* xincr, xorig, xref(dummy), yincr, yorig, yref(dummy) */
/* Stored as MatLab file */
int i;
char preamble[125];
char preamble2[125];
char *command;
FILE *fp;
if(channel == 1) /* Select channel */
OscCom(":WAV:SOUR CHAN1");
else if(channel == 2)
OscCom( ":WAV:SOUR CHAN2");
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"I
*1
"I
*1
*1
*1
*1
{
delay(500); /* Reset port for signaling... don't ask me why! Removing */
bioscom(Read, 0, OscPort); /* these lines will cause bytes to be lost!! */
command = ":WAV:PRE?"; /* No time to jump to subroutine...
/* Using OscCom here causes bytes to be lost! */
printf(" Command: %s\n", command);
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
f
bioscom(Send, command[i], OscPort);
bioscom(Send, OxOA, OscPort); /* Line feed */
i = 0; /* Enter data */
while((preamble[i]=ReadOsc()) != 10 && i<100)
{
i++;
preamble[i] = '\0'; /* Add line feed to end of data */
printf(" Channel %d data: %-.57s... \n", channel, preamble);
for(i=0; i<strlen(preamble); i++) /* Erase commas from preamble */
if(preamble[i] == ', ')
preamble[i] =
sprintf (preamble2, "preamble%d = [ %s 1; ", channel, preamble); /* Save */
fp = fopen(filename, "write"); /* data in Matlab format */
fprintf(fp, "%s\n", preamble2);
fclose(fp);
printf(" Preamble from channel %d stored in %s.\n", channel, filename);
Waveform(char *filenamel, char *filename2) /* Dump both channels to disk */
int i;
char *command;
char wavel [511]; /* (header=10 bytes) (data=500 bytes) (EOF=l byte) */
char wavela[501]; /* 500 data bytes + EOF */
char wave2[511]; /* Same for channel 2 */
char wave2a[501];
FILE *fp;
OscCom(":DIG CHAN1,CHAN2,I"); /* Store both traces in oscilloscope */
OscCom(":WAV:SOUR CHANl"); /* Select channel 1 */
command = ":WAV:DATA?"; /* No time to jump to subroutine...
printf(" Command: %s\n", command);
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
{
bioscom(Send, command[i], OscPort);
bioscom(Send, OxOA, OscPort); /* Line feed */
/* Waiting for pulse. ReadOsc spits out O's until the oscilloscope */
/* is ready to send data (which means the oscilloscope was triggered, */
/* which means a pulse was detected.) The O's are not part of the DIG */
/* header and really screw up data transferring (510 bytes from DIG)!!
printf(" Waiting");
while(i=ReadOsc) == 0)
printf(".");
printf("\n Pulse detected.\n");
for(i=0; i<511; i++) /* Pulse detected, reading data */
{
wavel[i] = ReadOsc);
if(wavel[i] == 0) /* 0 (no data) causes string to terminate early */
/* making a real mess of the rest of the program! */
wavel[i] = 1;
wavel[i] = '\0'; /* End of file */
OscCom(":WAV: SOUR CHAN2"); /* Then select channel 2 */
command = ":WAV:DATA?"; /* No time to jump to subroutine...
printf(" Command: %s\n", command);
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
bioscom(Send, command[i], OscPort);
bioscom(Send, OxOA, OscPort); /* Line feed */
for(i=0; i<511; i++) /* Read data, I hope */
wave2[i] = ReadOsc);
if(wave2[i] == 0) /* 0 (no data) causes string to terminate early */{ wave2[i] = 1;
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wave2[i] = '\0'; /*
for(i=0; i<511; i++)
if (wavel[iI == 26)
End of file */
/* Patch up data so this stupid PC can process it */
/* 26 = EOF, change to 25 to avoid crashing! */
wavel[i] = 25;
if(wavel[iI == 7) /* Turn off that stupid bell! */
wavel(i] = 8;
if(wavel[i] == 10)
wavel[i] = 11;
if(wave2[i] == 26)
wave2[i] = 25;
if (wave2 [i] == 7)
wave2[i] = 8;
if(wave2[i] == 10)
wave2[i] = 11;
/* Character 10 messes up byte count on disk!! *
/* Don't ask me why, just don't change this! */
/* And of course, repeat for channel 2 waveform */
i = 0; /* Delete useless header info (channel 2) /
while((wave2a[i] = wave2[i+101) != '\')
i++;
i = 0; /* Delete useless header info (channel 1) */
while((wavela[i] = wavel[i+10)) != '\')
i++;
primtf(" Channel 1 data (%d): %-.50s... \n", strlenwavela( wavela)
printf(" Channel 2 data (%d): %-.50s... \n", strlen(wave2a), wave2a);
OscCom(" :RUN"); /* Resume oscilloscope readings */
fp = fopen(filenamel, "append"); /* Save channel 1 as block of 500 */
fprintf(fp, "%.500s", wavela); /* bytes
fclose(fp);
printf(" Channel 1 data stored in %s.\n", filenamel);
fp = fopen(filename2, "append"); /* And channel 2 also */
fprintf(fp, "%.500s", wave2a);
fclose(fp);
printf(" Channel 2 data stored in %s.\n", filename2);
main)
FILE *fp;
int pulseno = 1;
int choice;
char *preamblel = "PREAMB1.M";
char *preamble2 = "PREAMB2.M";
char *waveforml = "WAVEl.DAT";
char *waveform2 = "WAVE2.DAT";
/* Preamble data file for
/* Preamble data file for
/* Waveform data file for
/* Waveform data file for
printf("*** Program Initialization ***\n");
printf("Initializing serial port 1 .... \n");
InitCom1 0;
printf("Setting up oscilloscope.... \n");
OscCom("RST"); /* Reset oscilloscope */
OscCom(":SYST:LOCK ON"); /* Prevents user from messing with settings */
OscCom(" :VIEW CHAN2"); /* Turn on channel 2 */
OscCom(":DITH OFF"); /* Turn off errors (oscilloscope *adds* errors!) */
OscCom(":WAV:POIN 500"); /* 500-byte data blocks. Limit of what can *I
/* be saved in under 5 s!
OscCom(":WAV:FORM BYTE"); /* Data goes from 0 to 255 */
OscCom(":ACQ:COMP 40"); /* Mininum threshold to trigger storage */
OscCom(":ACQ:TYPE NORM"); /* Normal acquisition (no averaging) */
/* Channel 1 = Uskin (high voltage probe, 1000x) */
/* Channel 2 = I (10x probe) */
OscCom(":TIM:RANG 5 MS"); /* Set x-axis to 5 ms across */
OscCom(":TIM:REF LEFT"); /* Align pulse with left side /
OscCom(" :CHAN2:PROB X10"); /* 10x probe for current (channel 2) /
OscCom(":CHAN2:BWL ON"); /* Clean up channel 2's signal */
OscCom(":CHAN1:BWL ON"); /* Clean up channel l's signal */
OscCom(":TRIG:MODE NORM"); /* Set up oscilloscope to respond to pulses */
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channel
channel
channel
channel
1
2
1
2
*/
*/
*/
*/
}
/* on channel 2 (Current)
OscCom(":TRIG:NREJ ON"); /* Turn on noise rejection */
printf("Enter voltage settings:\n"); /* Select ranges to display/record */
printf(" 1. High voltage (600 V/2.5 A)\n");
printf(" 2. Medium voltage (240 V/1 A)\n");
printf(" 3. Low voltage (120 V/0.5 A)\n");
printf("Choice?" ) ;
scanf ( '%d", &choice);
if (choice == 1)
OscCom(":CHAN1:RANG 4V");
OscCom(":CHAN1:OFFS 1.5V");
OscCom(":CHAN2:RANG 4V");
OscCom(":CHAN2:OFFS 1.5W");
OscCom(":TRIG:SOUR CHAN1");
OscCom(":TRIG:LEV 500MV");
else if(choice == 2)
OscCom(":CHAN1:RANG 1.6V");
OscCom(":CHAN1:OFFS 600MV");
OscCom(":CHAN2:RANG 1.6V");
OscCom(":CHAN2:OFFS 600MV");
OscCom(":TRIG:SOUR CHAN1");
OscCom(":TRIG:LEV 250MV");
else if(choice == 3)
OscCom(":CHAN1:RANG 800MV");
OscCom(":CHANl:OFFS 300MV");
OscCom(":CHAN2:RANG 800MV");
OscCom(":CHAN2:OFFS 300MV");
OscCom(":TRIG:SOUR CHAN1");
OscCom(":TRIG:LEV 400MV");
printf ("Getting preambles ... \n");
Preamble(1, preamblel); /* Get preamble data for channel 1 */
Preamble(2, preamble2) ; /* Get preamble data for channel 2 */
fp = fopen(waveforml, "write"); /* Delete data files from disk */
fclose(fp); /* so new files can be written */
fp = fopen(waveform2, "write");
fclose(fp);
printf ("*** Initialization Completed ***\n\n" );
printf("*** Receiving Waveforms ***\n");
printf("Press any key AFTER pulse to stop recording!\n");
while(kbhit() == 0) /* Stop reading waveforms when key is pressed */
printf("Pulse #%d... \n", pulseno);
pulseno++;
Waveform(waveforml, waveform2); /* Get waves */
printf("*** All Waveforms Recorded ***\n"');
OscCom(":SYST:LOCK OFF"); /* Allow use of oscilloscope again */
printf("\n*** End of Program ***\n");
delay(1000);
IV.5. Resistance of PBS.
The skin, PBS, and some polyacrylamide gel are located between the two measurement electrodes.
The resistivities of the PBS and the polyacrylamide gel are constant, but should be measured.
1. Make up a solution of PBS (Solution 5 from Section IV. 1).
2. Prepare the permeation chamber, with the four electrodes and the polyacrylamide gel (described
below in Section IV.6).
3. Fill the chamber with PBS.
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4. Connect the high-voltage pulser and the flow-protection system to the chamber (see Figure IV.5).
Heat the chamber to 37 0C using the water jacket.
5. Manually apply pulses to the chamber, starting from 0 V and increasing in units of 100 V, up to
1000 V. Apply 5 to 10 pulses per setting. For each pulse, record the voltage drops appearing
across the inner measurement electrodes (Uinner) and the 1.2 Q resistor (Uc,,, given that
Rcurr =1.2 Q).
6. To find the current (I), apply Ohm's law to the 1.2 Q resistor:
I = Ucurr Ucurr (IV.2)
Reurr 1.2 Q
7. Plot the voltage drop across the inner measurement electrodes (Uinner) versus the current (I). The
slope of the line is the resistance of the PBS and the polyacrylamide gel (lumped together in one
variable, RPBS) between the two measurement electrodes:
R PBS = Uinner (IV. 3)
P
IV.6. Permeation Chamber Preparation.
The polyacrylamide gel around each pulsing electrode directs PBS in and out of the chamber, with-
out contacting the donor or receptor solutions (this is the hollowed-out regions that run around each of
the two pulsing electrodes in Figure IV.2). On the receptor side, the polyacrylamide also keeps the
volume of the receptor compartment at a minimum (on the right half of Figure IV.2). Embedded in this
side are the tubes entering and leaving the receptor chamber, and the measurement electrode.
IV. 6.1. Preparation of the Mold.
Acrylamide in solution takes approximately 10 min to polymerize into polyacrylamide gel. In this
time, the acrylamide solution has to poured into the chamber. To create the channels that run through
the polyacrylamide gel, plastic tubes are inserted into the chamber, which are then removed once the
acrylamide has polymerized. Preparing the mold within the permeation chambers can be done the day
before the experiment.
-212-
1. Find two flexible plastic tubes, approximately 9 inches long, that will fit through the two small
ports on each chamber half.
2. Slide the plastic tubes through these ports (use tweezers as needed), so that roughly 1 to 2
inches of the tube protrudes out on either side. These tubes are the mold for the electrode flow-
protection channel.
3. Place Parafilm around each opening tightly. Use two layers of Parafilm. This should create a
watertight seal around the openings, so the acrylamide solution will not leak out.
4. Insert the receptor measuring electrode into the receptor compartment. Make sure the two tubes
that lead to the receptor compartment are angled toward the opening. Place Parafilm tightly
around this electrode as well.
5. Due to the elasticity of the tubing, however, the two tubes of the electrode are probably stuck next
to each other instead of on opposite sides of the chamber as shown in Figure IV.2. Using a thin
stainless steel wire, attach the outlet tubing to the top of the chamber. This wire will be removed
after the polyacrylamide gel has been added.
6. Position each of the two chambers sideways, so that the large opening (where the skin is located)
is on top. The chambers should be braced in some fashion (propping them up on pencils or test
tubes) so that they can not tip or move when filled with liquid.
IV.6.2. Adding the Polyacrylamide Gel.
Acrylamide monomer in solution (Solution 1 from Section IV. 1) will polymerize into a gel in approx-
imately 10 min upon addition of a catalyst (N,N,N',N'-tetramethylethylenediamine) (Bio-Rad) and a free
radical initiator (Solution 4). Most of the gel is still liquid (PBS, in this case), surrounded by cross-
linked polymer. Thus, the conductivity and the electrical properties of the polyacrylamide gel are
essentially the same as PBS.
Synthesis of the polyacrylamide gel should be performed just before the experiment (the chambers
should already be prepared), since polyacrylamide gel will begin dehydrating after a few hours.
1. Thoroughly mix together 10 ml of acrylamide solution (Solution 1 from Section IV. 1), 87.5 .d of
the initiator (Solution 4), and 6 .d of N,N,N',N'-tetramethylethylenediamine in a 15 ml test tube.
2. On the donor side, immediately pour in the acrylamide solution so that it reaches the level of the
large port (embedding the plastic tube for the flow-protection system). This should leave a donor
volume of -2.1 ml.
3. On the receptor side, immediately pour in the acrylamide solution, completely filling the chamber.
The top of the solution should be perfectly flush with the top of the chamber, and there should
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not be a meniscus above the chamber. The acrylamide solution will completely cover the plastic
tubing of the flow-protection system, and the silver measurement electrode. Make sure that the
liquid does not enter the two tubes that form the receptor compartment. The solution will shrink
slightly as it gels; this shrinkage is what forms the receptor compartment. Thus, to get a consis-
tent, reproducible volume for the receptor compartment, the solution should always be poured so
that it is flush with the top of the chamber.
4. Do not disturb the chambers while the gel is polymerizing, as disturbances will cause the gel to
take longer to harden, and the gel will set poorly as a result. It will take approximately 10 min for
the gel to harden. Any leftover acrylamide solution can be used to monitor the gelling process.
5. After the gel forms, carefully remove the Parafilm around the each of the plastic tubes of the elec-
trode flow-protection system. Remove the plastic tubes through one of the small ports. Do not
remove the receptor measurement electrode or the surrounding Parafilm.
6. Carefully remove the stainless steel wire holding the outlet tube of the receptor compartment in
place, which should now be held in place by the polyacrylamide gel.
7. Using a syringe, force air through the inlet and outlet tubes of the receptor chamber to ensure
that they are not blocked by stray bits of polyacrylamide gel.
8. Connect the collection tube (see Section IV.3. 1) to the outlet tube on the side of the receptor elec-
trode, as shown in Figure IV.4). Hold it in place with Parafilm.
9. Before using, fill the permeation chambers with PBS to keep the polyacrylamide gel from drying
out.
IV.7. Preparing the Equipment.
On the day of the experiment, the following should have already been prepared and assembled:
Solutions 1 through 4 (Section IV. 1), the permeation chamber and the electrodes (Sections IV.2, 111.2,
and IV.6. 1), the electrode flow-protection system (Section 111.3), the flow-through system in the spectro-
fluorimeter (Section IV.3), the electrical circuit (Section IV.4), the high-voltage pulser (Section II. 1), the
skin (Section 1.1), and the impedance meter (Section 111.5). Immediately before the experiment, Solu-
tions 5 and 6 from Section IV. 1, and the polyacrylamide gel in the chamber (Section IV. 6.2) need to be
prepared. Once the gel in the chamber is ready, place the chamber on a magnetic stirring plate and
connect it to a 37 0C water bath.
All of the tubes in the flow-through and the electrode flow-protection system should be flushed
through with PBS. Use a piece of Parafilm instead of human skin in the permeation chamber. There
should be a steady stream of air bubbles entering the flow-through system at the collection tube and
the spectrofluorimeter cuvette. The flushing should continue until the spectrofluorimeter gives stable
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readings for the fluorescence. This can take up to an hour in some cases, especially if the lines were
not sufficiently cleaned and flushed the last time the equipment was used.
IV.8. Loading Skin into the Chamber.
The condition of the skin is checked by measuring its electrical impedance and monitoring the
2
passive flux of the donor solution. The impedance of "good skin" should be >25 kQ cm at 100 Hz
(Prausnitz, et al., 1993 [al; Chen, et al., 1998 [b]; M. R. Prausnitz, personal communication; Gowri-
shankar, personal communication). Low impedances or large passive fluxes indicate that the skin's
integrity has been compromised in some way.
The impedance is measured across the two inner measurement electrodes in the permeation cham-
ber. However, besides the skin, this measurement also includes PBS and the polyacrylamide gel. The
other impedances can be neglected, though, since the impedance of the skin is much larger than PBS
(see Section 3.6).
1. Float a piece of skin (see Section 1.1) in a dish of PBS for -1 min.
2. Gently remove the wax paper backing. Do not use tweezers. The skin should float on the sur-
face, with the stratum corneum side facing upwards.
3. Fill the receptor compartment completely with PBS. There should not be any air bubbles pre-
sent.
4. Position the skin in the chamber so that the stratum corneum faces the donor compartment and
the epidermis faces the receptor compartment. Clamp the chamber shut. Verify that the receptor
compartment is still completely filled with PBS.
5. Fill the donor with PBS.
6. Connect the impedance meter (see Section 111.5) to the measurement electrodes. Good skin has
2
an impedance >40 k.Q cm at 100 Hz. Poor skin should be discarded.
7. Disconnect the impedance meter.
8. Remove the PBS from the donor compartment and add the donor solution (Solution 6). Add a
1.5 mm "flea"-type magnetic stir bar to the donor compartment.
9. Connect the chamber to the pulsing circuit as shown in Figure IV.5, verifying that all four elec-
trodes are properly connected.
10. Turn on the stirring plate and the water bath.
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IV.9. Passive Control.
After the skin has been loaded in the chamber, the flow-through system should be activated. The
skin should be left for at least 1 h to fully hydrate the skin and check for leaks (holes or tears in the
skin). Leaks can be detected by observing large or increasing readings in the background fluorescence
observed on the spectrofluorimeter. If the skin begins to leak, it should be discarded.
IV. 10. Pulsing Conditions.
High-voltage pulses should be applied to the skin at the rate of 1 pulse every -5 s. Both the time
constant and the applied voltage should be set on the pulser as needed before pulsing is started. The
transdermal voltage is a nonlinear function of the applied voltage (see Figures 7.10 and 8.3) (Pliquett,
et at., 1995 [a]; Chen, et al., 1998 [c]). Thus, given a desired transdermal voltage, a guess of the
applied voltage should be made at this time.
1. Set the pulser to deliver the appropriate types of pulses.
2. Gradually start the pumps for the electrode flow-protection system. Make sure that the poly-
acrylamide gel in the chamber does not crack or break when this is turned on. If the gel breaks,
new gel will have to be made, which will cause the experiment to be aborted.
3. Turn on the oscilloscope and the computer. They should be set to start recording once the first
pulse is applied. Make sure that all screen savers, energy savers, and any other software drivers
that can cause process interrupts in the computer have been completely turned off. The com-
puter should not be doing anything during the experiment besides downloading data. Any timing
glitches between the computer and the oscilloscope could cause either the computer or the
oscilloscope to crash.
4. Start the spectrofluorimeter for a time-based scan. The spectrofluorimeter should record fluore-
scence for the time of pulsing (typically 1 h), plus some additional time at the beginning to
measure the baseline, and some time at the end to measure recovery. The time interval between
successive measurements should be as short as possible (e. g., 0.5 s). Record about a minute of
passive flux (control) to establish the baseline.
5. Start the pulser. The oscilloscope and the computer should start recording pulses immediately
with the first pulse. Note the exact time when pulsing starts, on the clock and on the spectro-
fluorimeter (tstar). These times will be needed later to synchronize the pulsing data and the
fluorescence data.
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6. Since the spectrofluorimeter, the pulser, and the oscilloscope/computer are all automated, during
the experiment, the equipment should simply be monitored at all times in case something goes
wrong.
IV. 11. Ending the Experinent.
After pulsing, the recovery of the skin can be measured by recording the fluorescence once the
pulser has been turned off. Afterwards, the skin should be removed from the permeation chamber and
mounted on a microscope side for analysis. Voltage and current data from the computer and data from
the spectrofluorimeter should be saved on disk for later analysis. The standard curve should also be
measured.
1. After pulsing, turn off the pulser, but leave the rest of the equipment running. Wait until the
fluorescence reaches steady state to stop recording on the spectrofluorimeter.
2. Turn off all of the pumps.
3. Empty the donor compartment. Flush it out 3 x with PBS.
4. Open the permeation chamber and carefully remove the skin. Place it carefully on a microscope
slide. Gently spread the skin out so it lies flat, and lightly blot it dry with a paper towel. Do not
rub the skin.
5. Add a drop of mounting solution (Solution 3 from Section IV. 1).
6. Gently put a cover slip on top. This will cause the mounting solution to spread out and cover the
skin. Seal in place with nail polish. Bring the slide to a fluorescence microscope for immediate
analysis and photography (Section 11.3).
7. Save the data from the computer and from the spectrofluorimeter. These should be copied to a
workstation for later analysis (see Section IV. 13).
IV.12. Measuring the Standard Curve.
The standard curve should be measured under exactly same conditions that the experiment was
performed under, including the same flowrates, tubing, and the same measurement cuvette. Placing
the calibration solutions in separate cuvettes and measuring their fluorescence will not work, since the
volume of liquid within the cuvette needs to be exactly the same for each sample. Thus, each cali-
bration solution needs to be separately pumped through the spectrofluorimeter.
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Since the calibration curve is continually being pumped through the spectrofluorimeter, 10 ml will
be needed for each concentration, to allow the fluorescence in the system to go to steady state.
1. Prepare a standard curve, starting at the donor concentration. Make up 10 ml of solution for each
concentration.
2. Set up the spectrofluorimeter for a time-based scan.
3. Run each sample through the spectrofluorimeter. Start from the most dilute sample and increase
to the most concentrated. Record the times that each solution passes through the spectro-
fluorimeter. With only 10 ml of solution per concentration, steady state for each concentration in
this system will only last for a few minutes. It is usually simpler to let the spectrofluorimeter run
continuously, than to start and stop the spectrofluorimeter between each concentration and risk
missing the steady state regime.
4. Save the calibration curve onto disk for later analysis.
IV.13. Analysis of the Flux and Voltage Data.
All of the fluorescence, voltage, current, and calibration data needs to be downloaded into a com-
puter for analysis. Due to the amount of data one experiment can generate, a workstation, rather than a
PC, is recommended (e. g. Sun Sparc 10, Sun). A sample program, written in MatLab (MathWorks), is
given in Section IV. 13.4.
The first step in the analysis is to convert all of the flux and current data into the transdermal
voltage data. The next step is to calibrate and deconvolute the fluorescence data into molecular flux
data. The final step is to correlate the two sets of measurements, to determine the amount of molecular
flux that occurs during each pulse.
IV.13.1. Transdermal Voltage Calculations.
The voltage drop across the skin can be determined by applying Ohm's Law to the current and the
voltage. The resistance of the intervening PBS (RPBs) should already be known (see Sections 3.6 and
111.6).
1. Since the data from the oscilloscope has probably been transferred in a compacted format, the
first step is to uncompress the data and convert it into voltage data.
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2. Ohm's Law is used to convert the voltage drop (Ucurr) across the 1.2 Q resistor (Rcurr = 1.2 Q):
SUcurr -Ucurr (IV. 4)
Rcurr 1.2 Q
3. The current across the skin (I) and the voltage drop across the measurement electrodes (Uinner)
for each pulse should now be known. To calculate the transdermal voltage (U kin), use the follow-
ing equation:
U sin = Uinner -I RP - (IV.5)
IV. 13.2. Deconvolution of the Fluorescence Data.
The fluorescence measured in the spectrofluorimeter is the sum of two components: the molecular
flux out of the skin, and the mixing that occurs in the tubing and the cuvette (see Section IV.3.4). With
a model of the mixing that occurs in this system, the molecular flux across the skin can be determined.
1. Using the standard curve (Section IV. 12), convert all of the fluorescence data into concentrations.
These are molecular concentrations within the cuvette, not transdermal fluxes.
2. The molecular flux across the skin is determined by the following equation (Pliquett, et at., 1995
[b]).
C 2 -C 1 Q C 1 +CJ = VCuv C2 _1 + _ C2 .(IV.6)
A At A 2
In this equation, J is the molecular flux across the skin, Veuv is the volume of the cuvette (see
Section IV.3.4), A is the exposed area of the skin, C, and C2 are two successive measurements
on the spectrofluorimeter (expressed as concentrations), At is the length of time between two
subsequent measurements of C, and C2 , and Q is the average flowrate through the cuvette
(Section IV.3.4). C is assumed to be linear and J is assumed to be constant, both over the time
interval At, which should be kept small (0.5 s). This equation has to be applied to every pair of
measurements made on the spectrofluorimeter. Note that due to the mixing within the cuvette, the
time resolution for these measurements is not more accurate than trw .
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IV. 13.3. Correlation of Fluxes and Voltages.
At this point, there are two arrays of data, representing the transdermal voltages during each pulse,
and the molecular fluxes across the skin (at a time resolution of t,,v). These data need to be correlated
in time with each other.
1. Define the first pulse to occur at a time 0. Then the nth pulse occurs at time t:
t = (n - 1) tint'. (IV. 7)
2. To correlate the time on the spectrofluorimeter with the time of each pulse, the time on the
spectrofluorimeter (tluor) needs to be corrected for the elapsed time before pulsing was started
(tstart) and the plug flow time (treact)-
t=tfluor - tt - t react (IV. 8)
3. Now that the two measurements have been synchronized in time (t), the molecular flux during
each pulse can be determined. Note, however, that the time resolution is still Tv. If pulses
were applied more rapidly than that (tint < ccu), then the flux measurements will still be con-
founded by subsequent pulses.
IV.13.4. JvsU.m.
The following is the script file ("* .m file") for Jvsu.m, a MatLab 5 program which calibrates and
correlates the flux and voltage data to determine the molecular flux for each pulse.
% JvsU.m
% This program inputs raw voltage data (from 'savewave.cpp', files 'preambl.m',
% 'preamb2.m', 'wavel.dat', and 'wave2.dat') and raw fluorescence data from
% the Spex, outputed as ascii files, as 'calb.txt and 'fluor.txt' . See
% parameter list for correct formats. Program processes data, outputs a plot
% of flux (in 'CorrFlux') and transdermal voltages (in 'Uskin'), and plots
% those versus pulse number (in 'Number') . The results are saved in
% 'final.txt' as pulse number, skin voltage (in V), and flux (in mol/m2/s),
% for use in further analysis.
% Tani Chen, 4/17/97
% Modified on 6/9/97
clc
disp 'Intializing...
clear
close all
format
NumPulse = input(' Enter number of pulses. ->'); % Number of pulses delivered
NumData = 500; % Number of data points in each pulse
Rcur = 1.2; % Resistance of current-measuring resistor (Ohm)
Rpbs = 251; % Resistance of PBS in chamber (Ohm)
% SpexTime is for use with Bldg 20 (Runs Fl-F26s) . Uncomnent for those runs.
% SpexTime = 3900; % Length of time data was recorded on the Spex, in seconds.
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% % Number of data points = 2 * SpexTime + 1 (have to include
% % 0 s). Also see routines on entering calibration and flux
% % data! Unix routines cannot be adjusted with SpexTime!
SpexTime = 4500; % Length of time data was recorded on the spectrofluorimeter,
% in seconds. Despite the changeover in equipment, this
% variable is going to remain "SpexTime," even tho the Spex
% is no longer being used (it should really be called
% "PTITime"....)
SpexTime = 13500; % 3 h + 45 min run
% SpexTime = 28800; % 7 h + 1 h run
DeltaT = .5; % Sampling time on Spex (s)
% Sampling time on PTI (Also .5 s to preserve continuity)
ErrorV = 4.81; % Error in voltage measurement of probe: +/- 4.8 V (SD)
ErrorI = ErrorV/Rcur/200; % Error in current (voltage thru Rcur)
% PerErrF1 = .045; % Error in flux measurements: +/- 4.5% (SD)
% % This is only for the Spex!
PerErrFl = .022;
Signal = 14 * 2; % Number of points fluorescence signal is averaged over
Area = .64 / 100 / 100; % Area of the skin (m2)
PulseIntv = ((1*3600+20*60+52)/(873-1) + (1*3600+6*60+37)/(720-1) + (1*3600+6*60+41)/(720-1)) / 3;
% Time interval between pulses (s)
% *BTX autopulser only) !* This needs to be very accurate!!
% Data: 873 pulses = 1:20:52, 720 pulses = 1:06:37, 720 pulses = 1:06:41
% Note that pulse #1 = 0:00:00
% PulseIntv = ((1*3600 + 0*60 + 17) - (0*3600 + 0*60 + 40)) / 740;
% 740 pulses in 1 h (4.8338)
% PulseIntv = ((1*3600 + 0*60 + 27) - (0*3600 + 0*60 + 38)) / 710;
% 710 pulses in 1 h (5.0549)
PulseIntv = ((1*3600 + 0*60 + 53) - (0*3600 + 0*60 + 40)) / 730;
% 730 pulses in 1 h (4.9493)
% Pump characteristics for Runs F27 - ?
% (currently set to Pump Speed 99)
Pump = (.0301205 + .0295858 + .0285714) / 3 / 1000; % Pump flowrate with
% chamber (1/s)
PumpCuv = (.0303030 + .03125 + .0318471) / 3 / 1000; % Pump flowrate without
% chamber (1/s)
TauCh = (19.0223 + 29.9944 + 18.3699) / 3; % Residence time of whole system (s)
Tau = (18.2856 + 22.0411 + 23.4928) / 3; % Residence time of chamber only (s)
Tdelay = (65 + 64 + 63) / 3; % Time lag of entire system(s)
Toffset = (19 + 18 + 19) / 3; % Time lag of cuvette only (s)
% Pump speed 99: Pump =
% PumpCuv =
% TauCh =
% Tau =
% Tdelay =
% Toffset =
% Pump speed 77: Pump =
% PuMpCuv =
% TauCh =
% Tau =
% Tdelay =
% Toffset =
% Pump speed 55: Pump =
% PumpCuv =
% TauCh =
% Tau =
% Tdelay =
% Toffset =
% Pump speed 33: Pump =
% PuMpCuv =
% TauCh =
% Tau =
% Tdelay =
% Toffset =
.0301205, .0295858, .0285714
.0303030, .03125, .0318471
19.0223, 29.9944, 18.3699
18.2856, 24.0411, 23.4928
65, 64, 63
19, 18, 19
.0214592, .0223214, .0221239
.0248756, .0239234, .0238095
24.9851, 22.7287, 18.8472
30.7906, 35.5403, 28.0830
80, 75, 74
26, 25, 26
.0152905, .0192308, .0157233
.0165289, .0167364,.0165975
40.8933, 35.7017, 20.0055
37.8878, 40.7751, 41.3692
107, 104, 108
34, 30, 29
.00874126, .00898876, .00904159
.00996016, .00961538, .00959233
197.953, 180.041, 98.8818
53.5107, 62.2365, 60.1493
179, 196, 189
64, 57, 56
Pump characteristics for Runs F4 - F26s. Uncomment for those runs.
Pump = (.03238 + .03198 + .03212) / 3 / 1000; % Pump flowrate with
% chamber (1/s)
PumpCuv = (.03198 + .03191 + .03226) / 3 / 1000; % Pump flowrate without
% chamber (1/s)
TauCh = (20.4 + 24.0 + 27.6) / 3; % Residence time of whole system (s)
Tau = (14.6 + 16.0 + 12.8) / 3; % Residence time of chamber only (s)
Tdelay = (46 + 50 + 48) / 3; % Time lag of entire system(s)
Toffset (31 + 23 + 23) / 3; % Time lag of cuvette only (s)
Pump characteristics for Runs F1, F2, and F3. Uncomment for those runs.
Pump = (.06757 + .06281 + .07042) / 3 / 1000; % Pump flowrate with
% chamber (1/s)
PumpCuv = (.07042 + .07310 + .07788) / 3 / 1000; % Pump flowrate without
% chamber (1/s)
TauCh = (14.5 + 14.5 + 12.0) / 3; % Residence time of whole system (s)
Tau = (5.5 + 5.0 + 8.0) / 3; % Residence time of chamber only (s)
Tdelay = (18.2 + 18.0 + 18.0) / 3; % Time lag of entire system(s)
Toffset (8 + 9 + 7 + 7) / 4; % Time lag of cuvette only (s)
Vcuv = PumpCuv * Tau;
Vch = PumpCuv * TauCh;
% Volume of cuvette (and tubing) (1)
% Approx. volume of chamber (1)
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Tstart = input ( ' Enter starting time (don ' t add of f set). ->') + Tof f set;
MW = input(' Enter molecular weight of tracer. ->');
Charge = input(' Enter charge of tracer. ->');
Charge = abs(Charge); % Ignore negative sign
NA = 6.0221367e23; % Avogadro's number (1 / mol)
Elc = 1.60217733e-19; % Charge on the electron (C)
Thickn = 20 * le-6; % Thickness of the stratum corneum (m)
Condy = 1 / (67 / 100); % Conductivity of PBS (Ohm m)
disp 'Entering preamble data from "preambl.m"...'
preambl % Preamble format: 1(byte), 1(norm), 400(#points), 1(dummy), Xincr,
% Xorig, Xref, Yincr, Yorig, Yref
Xincr = preamblel(5); % Tick = (bucketnumber - Xref) * Xincr + Xorig
Xorig = preamblel(6); % Should be the same for both sets of data
Xref = preamblel(7);
Yincrl = preamblel(8); % Voltage = (data - Yref) * Yincr + Yorig
Yorigl = preamblel(9);
Yrefl = preamblel(10);
disp 'Entering preamble data from "preamb2.m" ... '
preamb2 % Same format as above
Yincr2 = preamble2(8); % Voltage = (data - Yref) * Yincr + Yorig
Yorig2 = preamble2(9);
Yref2 = preamble2(10);
disp 'Entering waveform data from "wavel.dat"... % Chamber voltage data
FileNo = fopen('wavel.dat', 'r');
Uch = fread(FileNo, [NumData, NumPulse], 'uchar');
Uch = ((Uch - Yrefl) * Yincrl + Yorigl) * 200;
% See preambles for equations. 200x high voltage probe
disp 'Entering waveform data from "wave2.dat"...' % Current voltage data
FileNo = fopen('wave2.dat', 'r');
Ucur = fread(FileNo, [NumData, NumPulse], 'uchar');
Ucur = (Ucur - Yref2) * Yincr2 + Yorig2; % See preambles for equations
Ucur = Ucur .* (Ucur > 0); % Get rid of negative current (noise)
Ucur = Ucur / Rcur; % Convert volts to amps
disp 'Deleting prepulse data from chamber voltages ...
for j = 1:NumPulse
Utemp = Uch(:, j); % Temporary matrix for each column
if max(Utemp) > 7
Loc(j) = min(find(Utemp > 7)); % Pulse detected when > 7 V. "Find" lists
else
Loc(j) = 50;
end
end % all the locations > 7. "Min" gives the
% location of the first pulse.
disp 'Deleting prepulse data from current measurements...'
for j = 1:NumPulse
Utemp = Ucur (:, j); % Temporary matrix
Locl = min(find(Utemp > .05)); % Same routine as above. Voltage > .1 V
% Change this for lower voltages...
if Locl > Loc(j)
Loc(j) = Locl;
end
Ucur(l:(NumData - Loc(j) + 1), j) = Ucur(Loc(j):NumData, j);
Ucur((NumData - Loc(j) + 2):NumData, j) = NaN;
Uch(1:(NumData - Loc(j) + 1), j) = Uch(Loc(j):NumData, j);
% Delete header and push data forward so 0 means start of pulse
Uch((NumData - Loc(j) + 2):NumData, j) = NaN; % Fill holes with "NaN"
end
disp 'Fitting chamber voltages (ignore log of zero errors) ...
Uch = log(Uch - Uch .* (Uch <= 0));
% Take logs of only positive numbers. Negative numbers are changed to O's
% (since the log of a negative number is complex!), then -Inf. NaN's
% reamain NaN's
Uch = isfinite(Uch) .* Uch; % Convert -Inf to NaN (former negative numbers)
for j = 1:NumPulse
Tick = ((1:500)' - Xref + Loc(j)) * Xincr + Xorig;
% Set up time vector for each pulse for curve fitting (s) . See preamble
Utemp = Uch(1:150, j);
if sum(isnan(Utemp)) == size(Utemp, 1) % If Utemp empty, then no line fit
Chamber(j, :) = [NaN NaN];
else
Chamber(j, :) = polyfit (Tick (isf inite(Utemp) ), Utemp(isfinite(Utemp)), 1);
% Linear fit (ln y = m * Time + b)
end
end
Chamber(:, 1) = -1 ./ Chamber(:, 1); % Tau(s) = -1 / m
TauPulse = Chamber(:, 1);
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Chamber(:, 2) = exp(Chamber(:, 2)); % Uch(V) = exp(b)
% Chamber(:, 1) = TauPulse = Tau (s)
% Chamber(:, 2) = Peak voltage across differential electrodes (V)
disp 'Fitting current measurements (ignore log of zero errors) . . . '
Ucur = log(Ucur - Ucur .* (Ucur <= 0)); % Take logs of positives
Ucur = isfinite(Ucur) .* Ucur; % Same routine as above
for j = 1:NumPulse % Same routine as above, except for current now
Tick = ((1:500)' - Xref + Loc(j)) * Xincr + Xorig; % (s)
Utemp = Ucur(1:150, j);
Current(j, :) = polyfit(Tick(isfinite(Utemp)), Utemp(isfinite(Utemp)),l);
end
Current(:, 2) = exp(Current(:, 2)); % Ucur(V) = exp(b) (Don't need Tau)
% Current(:, 2) = Peak currents across measuring resistor, Rcur (A)
disp 'Finding transdermal voltages...'
Uskin = Chamber(:, 2) - Current(:, 2) * Rpbs;
% Uskin = Uch - Upbs = Uch - I * Rpbs
Uskin = Uskin .* (Uskin<1e3) ./ (Uskin<1e3) .* (Uskin>D) ./ (Uskin>0);
% Get rid of errors (negatives, too large)
Rskin = Chamber(:, 2) ./ Current(:, 2) - Rpbs;
% Rskin = Uch / I - Rpbs (Rskin = Uskin / I (Ohm)
Rskin = Rskin .* (Rskin<le4) ./ (Rskin<1e4) .* (Rskin>0) ./ (Rskin>0);
% Get rid of errors (negatives, too large)
VoltTime = (0:(NumPulse - 1))' * PulseIntv;
% Time vector for Uskin, same size as Uskin (s)
% DM3000F format load (Bldg 20). Uncomment for Runs Fl-F26s.
% disp('Loading fluorescence calibration data from "calb.txt" (ignore file errors)...)
% rm temp.txt
% nrm temp2.txt
% % Delete header from calibration data.
% % 7802 = SpexTime * 2 + 1 (See initialization)
% ! tail -7802 calb.txt > temp2.txt
% % Delete trailer from calibration data
% % 7801 = SpexTime * 2 + 1 (See initialization)
% head -7801 temp2.txt > temp.txt
% rm temp2.txt
% FileNo = fopen('temp.txt', 'r');
% Calb = fscanf(FileNo, '%e %e', [2 7801]);
% Calb = Calb';
% Calb = Calb(:, 2) ; % Calibration curve (arbitrary x-axis)
% PTI format load (Bldg E25).
disp('Loading fluorescence calibration data from "calb.txt" (ignore file errors)...')
! rm temp.txt
% Delete header from calibration data (5 lines)
! tail +5 calb.txt > temp.txt
load temp .txt
Calb = temp(:, 2); % Calibration curve (arbitrary x-axis)
! rm temp.txt
disp('Calibrating data...') % Plot calibration data
Handle = semilogy(Calb);
set(figure(l), 'Position', [1160 6 1142 845))
set(Handle, 'Color', 'c')
xlabel( 'Point number')
ylabel( 'Fluorescence (counts/s)')
title('Raw Calibration Data from "calb.txt"')
disp(' Scaling graph (see page on right) ... ')
Choice = 1;
while Choice == 1
disp(' Click on bottom left corner.')
BotLeft = ginput(l);
disp(' Click on top right corner.')
TopRight = ginput(l);
axis ( [BotLeft (l) TopRight (1) BotLef t (2) TopRight (2) ) % Scale graph
Choice = input(' Enter 1 for re-scale, 2 to restart, 0 when done. ->');
if Choice == 2
axis auto
Choice = 1;
end
end
disp(' Entering calibration values...')
for j = 2:8 % Change the 8 to a 9 for the Bldg 20 runs (Runs Fl to F26s).
% Altho since 9 is usually less than the background level, it
% shouldn't really matter.
Choice = 1; % Get values for each calibration sample
while Choice == 1
disp(' Click on left-most region of sample #')
disp(j)
MouseLeft = ginput(l);
Handle = line( [MouseLeft(l) ;MouseLeft(l)], [BotLeft(2);TopRight(2)]);
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set(Handle, 'Color', 'r')
disp(' Click on right-most region.')
MouseRight = ginput(l);
Handle = line([MouseRight(1);MouseRight(1)], [BotLeft(2);TopRight(2)]);
set(Handle, 'Color', 'r')
Choice = input( Enter 1 to re-do, 0 when done. ->');
end
Coord(j) = mean (Calb (round (MouseLef t (1) ) :round (MouseRight (1))));
% Coord contains the calibration curve values (2 thru 10) (cps). Average
% of range selected by mouse
end
disp(' Figuring calibration equation (ignore log of zero errors) ... '
Conc = log([NaN le-1 le-2 le-3 le-4 le-5 le-6 le-7 le-81 * le-3);
% Concentration values (M). Sample #1 (= Donor = 1 mM) is ignored.
Coord = log(Coord);
close(l)
Handle = plot(Coord, 'co-'); % Plot calibration curve
set(figure(l), 'Position', [514 430 560 4203)
set(Handle, 'MarkerSize', 4)
set(Handle, 'MarkerFaceColor', 'c')
ylabel('log(fluorescence intensity)')
xlabel('Sample #')
title('Standard Curve Data')
axis([2 8 floor(min(Coord(2:8))) ceil(max(Coord(2:8)))])
% For the Bldg 20 runs (Runs Fl-F26s), these 8's should all be 9's. Again,
% it probably doesn't really matter....
Low = input(' Enter lowest sample number in linear region. ->');
High = input(' Enter highest sample number in linear region. ->');
CalbEqn = polyfit(Coord(Low:High), Conc(Low:High), 1); % Get curve fit
% parameters
% DM3000F format load (Bldg 20). Uncomment for Runs Fl-F26s.
% disp('Loading fluorescence flux data from "fluor.txt"...')
% ! rm temp.txt
% % Delete header from calibration data.
% % 7802 = SpexTime * 2 + 1 + tail(l) (See initialization)
% ! tail -7802 fluor.txt > temp2.txt
% % Delete trailer from calibration data
% % 7801 = SpexTime * 2 + 1 (See initialization)
% head -7801 temp2.txt > tenp.txt
% rm temp2 . txt
% FileNo = fopen('temp.txt', 'r');
% Fluor = fscanf(FileNo, '%e %e', [2 7801]); % Fluorescence data
% Fluor = Fluor';
% Fluor = Fluor(:, 2);
% ! rm temp.txt
% PTI format load (Bldg E25).
disp('Loading fluorescence flux data from "fluor.txt"...')
rm temp.txt
% Delete header from calibration data (5 lines)
tail +5 fluor.txt > temp.txt
load temp.txt
Fluor = temp(:, 2);
disp('Glitch removal...')
Handle = plot(Fluor, 'g');
axis tight
ylabel('Fluorescence (counts/s)')
xlabel('Point Number')
title('Raw Fluorescence Data from "fluor.txt"')
Choice = input(' Enter 1 for glitch removal, 0 if OK. ->');
while Choice == 1
Handle = plot(Fluor, 'go-');
set(figure(l), 'Position', [1160 6 1142 845])
set(Handle, 'MarkerSize', 4)
set(Handle, 'MarkerFaceColor', 'g')
axis tight
ylabel('Fluorescence (counts/s)')
xlabel ('Point Number')
title('Raw Fluorescence Data from "fluor.txt"')
disp(' Scaling graph (see page on right)...')
Choice = 1;
while Choice == 1
disp(' Click on bottom left corner.')
BotLeft = ginput(l);
disp(' Click on top right corner.')
TopRight = ginput(1);
axis([BotLeft(l) TopRight(1) BotLeft(2) TopRight(2)]) % Scale graph
Choice = input(' Enter 1 for re-scale, 2 to restart, 0 when done. ->');
if Choice == 2
axis auto
axis tight
Choice = 1;
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end
end
disp(' Click on left-most region.')
MouseLeft = ginput(l);
Handle = line( [MouseLeft(l); MouseLeft(l)], [BotLeft(2) TopRight(2)]);
set(Handle, 'Color', 'r')
disp(' Click on right-most region.')
MouseRight = ginput(l);
Handle = line([MouseRight(1); MouseRight(l)], [BotLeft(2) TopRight(2)]);
set(Handle, 'Color', 'r')
Choice = input(' Enter 1 to abort, 0 if correct. ->');
if Choice == 0
disp(' Deleting section...')
Fluor(floor(MouseLeft) :ceil (MouseRight)) NaN;
end
Choice = input(' Enter 1 for more removals, 0 when done. ->');
end
disp ('Converting fluorescences into concentrations (ignore
Fluor = Fluor(:) .^ (CalbEqn(l) * (1 - isnan(Fluor(:)))) *
isnan((Fluor(:)))));
% Fluorescence in (W) (from Conc)
dividing by zero errors)...');
exp(CalbEqn(2)) .* ((1 - isnan(Fluor(:))) ./ (l -
disp('Applying signal averaging...')
disp(' Number of points being averaged:')
disp(Signal)
for j = 1:(size(Fluor) - Signal)
Fluor(j) = mean(Fluor(j:(j + Signal - 1)));
end
Fluor((size(Fluor) - Signal + 1):size(Fluor)) = NaN;
disp('Finding lag times (see page on right)...')
Handle = plot(Fluor, 'y');
set(figure(l), 'Position', [1160 6 1142 845])
axis tight
ylabel('Fluorescence (counts/s)')
xlabel( 'Point Number')
title('Raw Fluorescence Data from "fluor.txt"')
disp(' Scaling graph...')
Choice = 1;
while Choice == 1
disp(' Click on bottom left corner.')
BotLeft = ginput(l);
disp(' Click on top right corner.')
TopRight = ginput(l);
axis([BotLeft(l) TopRight(l) BotLeft(2) TopRight(2)) % Scale graph
Choice = input(' Enter 1 for re-scale, 2 to restart, 0 when done. ->');
if Choice == 2
axis auto
axis tight
Choice = 1;
end
end
disp(' Click on start of rise.')
Tlag = ginput(l);
Tlag = Tlag(l); % Need only x coordinate
Handle = line([Tlag; Tlag], [BotLeft(2) TopRight(2)]);
set(Handle, 'Color', 'r')
if Tlag > size(Fluor, 1) % Didn't reach steady state
Tlag = NaN;
end
if Tlag < 0 % Didn't reach steady state
Tlag = NaN;
end
Tlag = Tlag/2 - Tstart; % Subtract off time until first pulse (includes Toffset)
Choice = input('Type 0 to continue. ->');
disp('Finding rise times (see page on right)...')
Handle = plot(Fluor, 'y');
set(figure(l), 'Position', [1160 6 1142 845])
axis tight
ylabel('Fluorescence (counts/s)')
xlabel ('Point Number')
title('Raw Fluorescence Data from "fluor.txt"')
disp(' Scaling graph...')
Choice = 1;
while Choice == 1
disp(' Click on bottom left corner.')
BotLeft = ginput(l);
disp(' Click on top right corner.')
TopRight = ginput(l);
axis( [BotLeft(l) TopRight(l) BotLeft(2) TopRight(2)3) % Scale graph
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Choice = input(' Enter 1 for re-scale, 2 to restart, 0 when done. ->');
if Choice == 2
axis auto
axis tight
Choice = 1;
end
end
disp(' Click on end of rise.')
TSS = ginput(l);
TSS = TSS(l); % Need only x coordinate
Handle = line([TSS; TSS], [BotLeft(2) TopRight(2)]);
set(Handle, 'Color', 'r')
if TSS > size(Fluor, 1) % Didn't reach steady state
TSS = NaN;
end
if TSS < 0 % Didn't reach steady state
TSS = NaN;
end
TSS = TSS/2 - Tstart; % Subtract off time until first
disp('Deleting data below the detection limit...')
DetLmt = exp(Conc(High));
for j = 1:(size(Fluor))
if Fluor(j) < DetLmt
Fluor(j) = NaN;
end
end
pulse (includes Toffset)
disp('Deconvoluting fluxes...')
% Routine taken from Pliquett, U., M. R. Prausnitz, Y. A. Chizmadzhev, and
% J. C. Weaver. "Measurement of Rapid Release Kinetics for Drug Delivery,"
% _Pharm Res_, 12(4) :549-55, 1995, Equations (7) and (8). With some
% additional modifications and simplifications.
for j = 1:(size(Fluor)-l)
Flux(j) = Vcuv*(Fluor(j + 1) - Fluor (j)) /Area/. 5 + PumpCuv/Area* (Fluor (j + 1)
% Flux in (mol / m2 / s)
end
disp('Correlating fluxes with pulses...')
FluxTime = ((l:(SpexTime * 2 + 1))' - Tstart) / 2; % Time vector for flux
% data.
MaxNo = (floor(NumPulse - (VoltTime(NumPulse) - max(FluxTime)) / PulseIntv));
% Figure out how many pulses correspond between flux data (which ends after
% SpexTime s) and voltage data (which = 720 * PulseIntv > SpexTime) .
% Should be about 700 pulses.
if MaxNo > NumPulse
MaxNo = NumPulse;
end
for j = 1:MaxNo
CorrFlux(j) = Flux(max(find(sign(FluxTime - VoltTime(j)) < 0)) + 1); % Phew!
% CorrFlux contains the flux at the instant when a pulse is applied (Time
% lags have already been accounted for, above.
% sign(FluxTime - VoltTime(j)) gives -1 for FluxTime < VoltTime and +1
% for >. find gives all the points where FluxTime < VoltTime and max
% gives the largest one (which is where FluxTime = VoltTime. Then we
% record the flux at that point.
+ Fluor(j))/2;
end
CorrFlux = CorrFlux .* (CorrFlux>0) ./ (CorrFlux>0); % Get rid of negatives
CorrFlux = CorrFlux'; % Put the matrix in the right orientation. I don't know
% why MatLab insists on transposing the matrix....
disp( 'Displaying flux vs voltage results (ignore negative data errors) ...
semilogy(Uskin, CorrFlux, 'w. '); % Plot flux vs transdermal voltage!
set(figure(l), 'Position', [1160 6 1142 845])
xlabel('Transdermal Voltage (V)')
ylabel('Instantaneous Flux (mol / m2 / s)')
title ('Instantaneous Flux versus Transdermal Voltage')
disp(' Adding error bars (ignore negative data errors)...')
for j = 1:MaxNo
Handle=line( [(Uskin(j ) -ErrorV) (Uskin(j)+ErrorV)], [CorrFlux(j) , CorrFlux(j) ]);
set(Handle, 'Color', 'r')
FluxErr = PerErrFl * CorrFlux(j);
Handle = line( [Uskin(j) , Uskin(j) I , [ (CorrFlux(j) - FluxErr) , (CorrFlux(j) + FluxErr)]);
set(Handle, 'Color', 'r')
end
hold on
Handle = semilogy(Uskin, CorrFlux, 'wd');
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'w')
hold off
% Plot flux vs transdermal voltage!
% This time, put dots on top of
% error bars so we can see them.
disp( 'Displaying flux vs current results (ignore negative data errors) ... ')
figure
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semilogy(Current(:,2), CorrFlux, 'w.'); % Plot current vs transdermal voltage
set(figure(2), 'Position', [1160 -895 1142 845])
xlabel('Current (A)')
ylabel('Instantaneous Flux (mol / m2 / s)')
title ('Instantaneous Flux versus Current')
disp(' Adding error bars (ignore negative data errors)...')
for j = 1:MaxNo
Handle=line( (Current (j, 2) - ErrorI) (Current(j, 2 ) +ErrorI)], [CorrFlux(j), CorrFlux(j)]);
set(Handle, 'Color', 'r')
FluxErr = PerErrFl * CorrFlux(j);
Handle = line( [Current (j, 2), Current(j, 2)], [(CorrFlux(j) - FluxErr), (CorrFlux(j) + FluxErr)]);
set(Handle, 'Color', 'r')
end
hold on
Handle = semilogy (Current(:, 2), CorrFlux, 'wd'); % Plot current vs voltage
set(Handle, 'MarkerSize', 2) % This time, put dots on top of
set(Handle, 'MarkerFaceColor', 'w') % error bars so we can see them.
hold off
disp('Displaying time courses for flux and voltage...')
Number = (1:MaxNo)';
figure
subplot(2, 1, 1) % Top plot is voltage versus time
Handle = plot(Number, Uskin, 'co');
axis tight
set(figure(3), 'Position', [514 430 560 420])
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'c')
xlabel( 'Pulse Number')
ylabel('Transdermal Voltage (V)')
title('Transdermal Voltage during the Experiment')
subplot(2, 1, 2) % Bottom plot (same figure) is flux versus time
Handle = plot(Number, CorrFlux, 'go');
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'g')
xlabel( 'Pulse Number')
ylabel('Instantaneous Flux (mol / m2 / s)')
title(' Instantaneous Flux during the Experiment')
disp('Displaying cumulative flux...')
CumFlux(l) = CorrFlux(l);
if isnan(CorrFlux(l)) == 1;
CumFlux = 0;
end
for j = 2:MaxNo
if isnan(CorrFlux(j)) == 0;
CumFlux(j) = CumFlux(j - 1) + CorrFlux(j);
else
CumFlux(j) = CumFlux(j - 1);
end
end
CumFlux = CumFlux * Area * PulseIntv * MW * 1e6;
figure
Handle = plot(CumFlux, 'yd');
set(figure(4), 'Position', [514 6 560 369])
axis tight
set(Handle, 'MarkerSize', 3)
set(Handle, 'MarkerFaceColor', 'y')
xlabel( 'Pulse Number')
ylabel('Cumulative Transport (ug)')
title('Cumulative Transport across the Skin')
disp('Results of experiment:')
disp(' Starting time of spectrofluorimeter [Tstart-Toffset]:')
disp(Tstart-Toffset)
Count = sum(isnan(CorrFlux)); % Number of NaN's in the flux data
disp(' Number of pulses analyzed [MaxNo]:')
disp(MaxNo)
disp ( ' Number of flux data points analyzed [Nanal ] : ')
Nanal = MaxNo - Count;
disp(Nanal)
disp(' Length of experiment [Length] (min):')
Length = MaxNo * PulqeIntv; % Length in s (not min)
disp(Length / 60)
disp(' Detection limit [DetLmt] (_M_):')
disp (DetLmt)
disp(' Number of points used in signal averaging [Signal]:')
disp(Signal)
disp(' Time lag before detection [Tlag] (s):')
disp(Tlag)
disp(' Estimated number of pulses before detection [Ndt]:')
Ndt = min(find(CorrFlux > 0));
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disp (Ndt)
disp(' Rise time [TSS] (s):')
format short g
disp(TSS);
format
disp(' Estimated number of pulses before steady state [Nss]')
Nss = round(TSS / PulseIntv + 1);
disp(Nss);
disp(' Average transdermal voltage [Uskavg] (V):')
Uskavg = sort (Uskin);
Uskavg = mean(Uskavg(1: (size(Uskavg,1) - sum(isnan(Uskavg)))));
disp(Uskavg)
disp(' Average time constant [Tauavg] (ms):')
Tauavg = mean(TauPulse) * 1000;
disp (Tauavg)
disp(' Average resistance of the skin [Rskavg] (Ohm):')
Rskavg = sort (Rskin);
Rskavg = mean (Rskavg (1: (size (Rskavg, 1) - sum(isnan (Rskavg)))));
disp (Rskavg)
disp(' Average flux [Javg] (mol / m2 / s):')
SortCF = sort(CorrFlux);
Javg = mean(SortCF(l:size(SortCF, 1) - Count));
disp (Javg)
disp(' Average flux (ug / cm2 / h):')
disp(Javg * MW * le6 / 100 / 100 * 3600)
disp(' Net transport (ug):')
disp (CumFlux(MaxNo))
disp (' Average transport number [Travg] :')
format short e
Tr = CorrFlux * Area * Length * NA * Charge * Elc ./ (NumPulse .* Uskin .* TauPulse ./ Rskin);
SortTr = sort(Tr);
Travg = SortTr(l:size(SortTr, 1) - Count);
Travg = sort(Travg);
Travg = mean(Travg(l: (size(Travg,l) - sum(isnan(Travg)))));
disp(Travg)
format
disp(' Fractional aqueous area for tracer [Fwavg]:)
Fwion = Thickn / Condy / Area ./ Rskin;
Fw = Fwion .* Tr / (Charge / 150);
SortFw = sort(Fw);
Fwavg = SortFw(l:size(SortFw, 1) - Count);
Fwavg = sort(Fwavg);
Fwavg = mean (Fwavg (1: (si ze (Fwavg, 1) - sum (isnan (Fwavg)))));
disp (Fwavg)
disp ('Displaying transport number and fractional aqueous area results...')
figure
subplot(2, 1, 1) % Top plot is transport number graph
Handle = plot(Number, Tr, 'mo');
axis tight
set(figure(5), 'Position', [12 -470 560 420])
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'c')
xlabel( 'Pulse Number')
ylabel( 'Transport Number')
title('Transport Number during the Experiment')
subplot(2, 1, 2) % Bottom plot is fractional aqueous area graph
Handle = plot(Number, Fw, 'wo');
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'w')
xlabel( 'Pulse Number')
ylabel('Fractional Aqueous Area')
title('Fractional Aqueous Area during the Experiment')
disp('Saving results to "final.txt" (Pulse Number, Uskin, Current, Flux,')
disp (' Transport Number, Fractional Aqueous Area)...')
disp(' (To load, type "load final.txt -ascii")')
Uskin = Uskin(l:MaxNo);
CorrFlux = CorrFlux(l:MaxNo);
Tr = Tr(l:MaxNo);
Fw = Fw(l:MaxNo);
Current = Current(:,2);
Final = ([Number' ; Uskin'; Current'; CorrFlux'; Tr'; Fw'])';
% All those stupid transposes are giving me a headache!
save final.txt Final -ascii
disp( 'exit')
disp(' ')
disp( 'End of program.')
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V. Chamber with Donor and Receptor Flow-Through Systems.
The flow-through system described in this appendix is similar to the one outlined in Appendix IV.
The two major additions discussed in this appendix are a donor recycling flow-through system, and a
real-time skin impedance measurement system. In all other respects, it is very similar to the one in
Appendix IV (see Figure V.1 and V.2).
In the first flow-through system (Appendix IV), there was a slight pressure difference between the
donor and receptor compartments. This pressure difference was created by the flow-through system on
the receptor side, needed to cause the flow of liquid out of the receptor compartment. By placing a
similar system on the donor side, this pressure difference between the two compartments was elimi-
nated.
With a flow-through system on the donor side, the contents of the donor compartment could also be
quickly changed at will, even during pulsing, simply by changing the tubing connected to it. Thus, the
donor compartment could be quickly flushed with PBS. This system thus allowed the quantitative mea-
Figure V.1. Double flow-through experimental apparatus. This system allows the simultaneous, real-
time recording of the transdermal voltage, molecular flux, and the impedance of the skin. The perme-
ation chamber is in the center of the photograph, on the stirring plate (not used). To the right of the
permeation chamber are the pumps (black) for the flow-through system and the donor recycling system.
To the right of the pumps is the spectrofluorimeter (white boxes), containing the flow-through cuvette (not
visible inside). On top of the spectrofluorimeter are the flow-protection pumps and the waste beaker. On
the far right is a water bath which heats the PBS reservoirs to 37 *C. To the left of the permeation
chamber is the differential high-voltage probe (flat black box). The top level of the cart holds the high-
voltage pulser (blue box with fan), the timing relay (clear box with electronics, suspended in front of the
pulser), the water bath (far left, used for heating the chamber to 37 0C), and various electronics (on top
of and behind the water bath). On the middle level of the cart are the computer and oscilloscope that
are used for recording voltages and currents. On the lower level of the cart is the computer used for
recording skin impedances. It is connected to the impedance meter (box with red numbers, just above
the permeation chamber) by a serial cable.
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surement of compounds extracted from within the skin, during and after pulsing.
A system for measuring the impedance of the skin in real time was also needed, to allow the con-
dition of the skin to be monitored at all times, even during high-voltage pulsing. Monitoring and
recording the impedance of the skin in real time between pulses (time resolution of -100 ms) has not
been previously reported.
V.1. Solutions.
The day before the experiment, prepare Solutions 1 through 5 (Solution 5, PBS, is needed to pre-
pare Solution 1). On the day of the experiment, prepare Solutions 5 (again) and 6, since these solu-
tions can not be stored and have to be used immediately.
1. Acrylamide monomer solution: 7.5 g of 19:1 acrylamide:bis(N,N'-methylene-bis-acrylamide)
powder (Bio-Rad) in 50 ml PBS (Solution 5, below). Prepare and mix together in a fume hood (the
monomer is carcinogenic). Let the solution stand for >12 h before using, to allow the monomer to
fully dissolve. This solution can be prepared well in advance of the experiment; it will not poly-
merize without addition of the catalyst.
2. Stock mounting solution: 10 mg Nile Red (Molecular Probes) in 20 ml acetone (Prausnitz, et al.,
1996 [al). Wrap in aluminum foil to protect from light. This solution can be stored indefinitely if
protected from light.
3. Final mounting solution: 7.5 ml glycerol in 2.5 ml de-ionized water and mix thoroughly. Add
250 pl of the stock mounting solution (Solution 2). Wrap in aluminum foil to protect from light.
This solution can also be stored indefinitely if protected from light.
4. Acrylamide initiator solution: 0.3 g (NH 4) 2 S 2 08 in 3 ml H2 0. This solution can be stored for
only a week.
5. Phosphate-buffered saline, PBS: 1.1 mM KH 2 PO 4 (0.40 g per 2.0 1 H 2 0), 2.7 mM KCl (0.40 g),
8.1 mM Na 2HPO 4 (2.30 g), 138 mM NaCl (16 g) (total of 150 mM) in de-ionized H20. Although
the volume of the receptor compartment is very small (-400 tl), a typical experiment can con-
sume a surprisingly large volume of PBS, since the flow-through measurement and the two elec-
trode flow-protection systems are continuously pumping PBS through the chamber. One experi-
ment can consume more than 2.0 1 of PBS. Stir the PBS solution under vacuum for >30 min to
remove dissolved gases from solution. Both light and 02 can cause the bleaching of fluorescent
molecules, but this can be reduced by removing the dissolved gases from PBS, and protecting the
solution from light whenever possible. Adjust to pH 7.4 with HCl and NaOH. This solution
should be degassed immediately before use.
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6. A typical donor solution consists of 1 mM of a hydrophilic fluorescent tracer in PBS (see Chap-
ter 4). Examples of hydrophilic fluorescent tracers include lucifer yellow (457 Da) (Prausnitz, et
at., 1993 [a]; Chen, et at., 1998 [c]), calcein (623 Da) (Prausnitz, et al., 1993 [a]; Pliquett and
Weaver, 1996 [a]; Vanbever, et at., submitted), and sulforhodamine (607 Da) (Pliquett and
Weaver, 1996 [a]) (all from Molecular Probes). Wrap the donor solution immediately in aluminum
foil to protect it from light. Gently shake on a Nutator (Clay Adams, Becton Dickinson) for >30
min to ensure complete dissolution. This solution should be made immediately before use, right
after preparing the PBS solution.
V.2. Electrode Placement.
The permeation chambers are custom-designed, side-by-side glass diffusion chambers (Crown Bio
Scientific), with an outer water jacket and an
inner compartment (Figure V.2) (Friend, 1992).
Ports extend from the inner compartment,
through the water jacket, to the outside, which
allows direct access to the inner compartment.
Each chamber half has one large port (for the
measuring electrodes and the flow-through
system), with two smaller additional ports on the
far ends (for placement of the electrodes and the
flow-protection system around the electrodes).
The volume of the inner compartment is
-3.1 ml, and the area of the circular opening is
0.64 cm2 (0.9 cm diameter).
There are four electrodes in this system
(Figures V.2). The two outer electrodes are
used to apply pulses, and the two inner
electrodes are used to measure the transdermal
voltage and the impedance of the skin. Due to
limitations of space within the donor and
receptor compartments, the electrodes are
constructed to allow both electrical access and
liquid flow to the chamber. There are two types
of electrodes in this system: the inner
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To Spectrofluorimeter
Inflow (PBS
Donor or Donor) PBS Flow
To WasteRecycle
PBS Flow PBS Flow
Pulsing Pulsing
Electrode Outflow Electrode
Polyacryl-
amide Gel W ater Jacket
Skin Measuring (37 *C)Electrodes
PBS Flow PBS Flow
Donor Compartment
Compartment
Figure V.2. Skin permeation chamber with double flow-
through system. The two outer electrodes are used for
pulsing, and the two inner electrodes are used to measure the
voltage drop across the skin and the impedance of the skin.
PBS is pumped around the pulsing electrodes to remove
chemical by-products generated during pulsing. PBS is also
pumped through the receptor compartment to a spectro-
fluorimeter for real-time detection. In the donor compart-
ment, the donor solution (PBS by itself, or with a fluorescent
tracer) can either be recycled or pumped to a waste beaker.
measurement/flow-through electrodes, and the outer pulsing electrodes.
The electrodes are made from silver wire, and the connectors are made from 200 U pipette tips,
with assorted amounts of tubing, all held in place by epoxy (Devcon). The fabrication of the measure-
ment electrodes has been previously described in Section IV.2 (it was used only in the receptor com-
partments in Appendix IV, but for this system, the same design is used for both compartments). The
fabrication of the two outer pulsing electrodes has been previously described in Section 111.2.2.
V.3. Donor Recycling System.
In addition to the two
pumps needed for the elect- Peristaltic Pump "A"
rode flow-protection system
(see Figure 111.5) and the
three pumps needed for the
receptor flow-through sys- Centrifuge Tube Et DonorM Electrode
tem (see Figure IV.4) two Reservoir (PBS only
additional pumps are also Donor Recycle Tygon Tubing
needed for the donor com-
partment recycling system
(for a total of seven pumps). Waste Stream Peristaltic Pump "B"
The two pumps of the donor
recycling system also need Skin (in
to be properly "balanced" to Chamber)
avoid any leaks or accu-
mulations within the donor
compartment. However, the Waste Flask
flowrates for this system do Figure V.3. Liquid circuit for the flow-through system in the donor compartment.This circuit can operate in two modes (switch on left). In the "recycle" mode (shown
above), PBS (with or without a fluorescent tracer) is pumped from the reservoir, to
not need to be as accurate the skin, and back to the reservoir. In the "flush" mode (with the switch down), PBS
as the ones on the receptor is pumped from the reservoir, to the skin, 
then out to a waste flask.
side.
The two pumps (see Figure V.3) should be set up such that the faster pump is Peristaltic Pump "B"
and the slower pump is Peristaltic Pump "A". The differences in flowrate will cause air to be drawn in
through the collection tube. Since the liquid from the collection tube either gets recycled back into the
donor reservoir or is removed as waste, the air bubbles will not contact the skin. This system can thus
maintain a constant pressure within the donor compartment.
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V.4. The Electrical Circuit.
The electrical circuit (shown in Figure V.4) has to perform three functions. First, it must deliver
high-voltage pulses to the permeation chamber once every 5 s. Second, it has to measure and record
the transdermal voltage and the current across the skin in real time. Third, it must record the
impedance of the skin at all times, even between pulses. Since pulses are being applied to the skin
every 5 s, there is very little time to manually record data or make adjustments between pulses. All of
these operations must be completely automated.
All of the components, including the wires and the clip leads, should be able to withstand high-
voltages and positioned with safety in mind. The electrical circuitry should be set up in a protected
area away from the permeation chamber so that any fluid leaks or spills do not reach the electrical
components.
The high-voltage pulsing circuit is the same one described in Section IV.4. Modifications to the
pulser have already been discussed in Section 11.1. Instructions on setting up and programming an
impedance meter are described below in Section V.4.1. A new program, described in Section V.4.5,
Polyacrylamide Gel
2k0n
Relay
9.8 Q
+
Pulser Oscilloscope RS-232 Bus
1.2 0
V: Computer10x
RS-232 Bus Computer
Figure V.4. The electrical circuit. The timing circuits of the high-voltage pulser (left) are connected to an electro-
mechanical relay (top), which switches off the impedance meter (Z near center) whenever a pulse is applied. The
impedance of the skin is measured continuously with a computer (bottom), except during a pulse. The 9.8 Q resistor
is a safety device in case of a short circuit. The transdermal voltage is measured by a 200 x differential high-voltage
probe, and the current is measured by a 10 x voltage probe across a 1.2 Q resistor placed in series with the cham-
ber. Both voltage probes are connected to an oscilloscope, which downloads the data into another computer (right). R
indicates the receptor compartment and D indicates the donor compartment. The two outer PBS streams and the
polyacrylamide gel around the pulsing electrodes are used to prevent chemical contamination of the donor and
receptor compartments by the electrodes.
-233-
also allows the transdermal voltage measurement system to record asynchronous or randomly spaced
pulses, instead of pulses at a fixed interval.
V.4.1. The Skin Impedance Measurement Circuit.
The main requirements for the impedance meter are that it produce a very low bipolar sinusoidal
current (<1 pA / cm 2 RMS) at a low frequency (<100 Hz), and that it has a way to download data in real
time and at high speeds to a computer, for storage and processing. A sinusoidal current measures the
impedance of the skin, not its resistance; but a true resistance measurement would require a DC
current, which could potentially cause iontophoresis of the skin. Low frequency impedances of the
skin compare favorably with actual skin resistances (Gowrishankar, personal communication), without
causing iontophoresis of the skin.
There are several impedance meters available that meet these requirements; one such meter is the
Model 5R715 LCR Meter (Stanford Research Systems). However, applying a 1000 V pulse to the
impedance meter would probably seriously damage or destroy the LCR meter. Thus, the LCR meter has
to be physically disconnected (using a electromechanical relay) from the high-voltage pulser whenever
a pulse is about to be applied. This can be done by connecting the flip-flop timing circuit of the pulser
(see Section 11.1) to the electromechanical relay (Figure V.4), such that whenever a pulse is to be
applied, the impedance meter is disconnected and the high-voltage pulser is connected to the perme-
ation chamber (E. A. Gift, personal communication).
The impedance meter should also be connected to a computer for data storage. For example, the
LCR Meter described above can be connected to a computer via an RS-232 cable to the serial port of a
computer. The program the computer is running will be machine-specific, depending on which serial
port the oscilloscope is connected to, and the programming languages of the computer and the oscillo-
scope (see Section V.4.2 and V.4.3). In general, though, the computer program should be in a low-level
programming language, and the computer itself should be reasonably fast.
The impedance meter should be transferring data in the most compact format available (i. e., as
unformatted ASCII characters instead of formatted arrays of numbers). The impedance meter should be
programmed to dump impedance data to the computer, regardless of whether or not it is actually
connected to the skin or not. Many impedance meters will start downloading an error flag (such as
9.9999 x 102 Q) if disconnected. These can be deleted in later processing steps.
The computer program should store the raw data, along with the time, on the hard drive (or on a
ramdisk if enough memory is available). Before starting, verify that there is adequate space on the hard
drive, since one experiment can consume over 2 MB. A sample program is listed in Sections V.4.2 and
V.4.3.
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No mathematical processing should be done during the experiment. Time resolutions of up to
100 ms can be obtained if care is taken in setting up the programs and connections. There is very
little time for the correction of problems. Examples of problems that can occur include loose serial
plugs, line noise due to faulty or excessively long cables or failure of the impedance meter and the
computer to properly synchronize headers and data streams.
V.4.2. SKININT.CPP.
The following is the source code for SKININT .CPP, a program to interface with an LCR meter (Model
5R715 LCR Meter, Stanford Research Systems) and measure the impedance and the capacitance of the
skin in real time. It is in Turbo C++ (Borland). Due to time constraints, this file simply stores the data
in raw form; there is another file (convert .m) in Section V.4.3 that converts the raw data for processing.
/* SKININT.CPP */
/* Program downloads and saves data from the LCRmeter, even if the
/* LCRmeter is just recording noise or off-scale readings. The data is */
/* saved to the file "INTRSKIN.DAT" for later processing. /
/* The encoded data is as follows:
/* Time: Time in seconds since start of experiment */
/* G/R/O: Good/Out-of-Range/Overrange */
/* 2: Range set on instrument (useless) */
/* C/R: Capacitance/impedance at 100 Hz */
/* value: Value in exponential notation, in Farads or Ohms
/* The LCRmeter should be protected from the high voltage pulse. The */
/* LCRmeter should be connected thru the RS-232 port to the back of */
/* COM1. The settings should be 9600 baud, parity off, even parity, 8 */
/* data bits. On the back of the machine, it should look like:
/* */
/* +--Baud-+ of/n o/e 7/8
/* * * I* * * * *
/* * I * I I I I */~
/* Tani Chen, 5/19/1998 */
#include <stdio.h>
#include <dos.h>
#include <string.h>
#include <bios.h>
#include <conio.h>
#include <time.h>
/* Bioscom port 0 = serial port 1 */
#define LcrPort 0
/* Bioscom send = 1, read = 2, status = 3 */
#define Send 1
#define Read 2
#define Status 3
#define DataReady 0x0100
InitComl() /* Initialize serial port 1 */
union REGS r;
r.h.ah = OxOO;
r.h.al = OxE3;
r.x.dx = OxOO;
int86(0x14, &r, &r);
printf(" Serial port 1 initialized.\n");
void LcrCom(char *command) /* Send command to LCRmeter */
int i;
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
bioscom(Send, commandti], LcrPort);
bioscom(Send, OxOA, LcrPort); /* Line feed */
/* printf(" Command: %s\n", command); */
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main()
printf("*** Program Initialization ***\n");
FILE *fp;
int i;
int j;
int Byte;
char *ZFile = "INTRSKIN.DAT"; /* Data file */
char ZData[30]; /* Holds data feed from LCRmeter */
clockt Zero, Timer;
double Time;
printf("Initializing serial port 1 .... \n");
InitComl();
LcrCom(" ");
printf ("Setting up
LcrCom("*RST");
LcrCom("PMOD4");
LcrCom("FREQ0");
LcrCom("VOLTO.1");
LcrCom("RNGH1");
LcrCom("RATEl");
LcrCom("OUTFO");
fp = fopen(ZFile,
fclose(fp);
printf ("Done.\n\n")
LCRmeter... ");
/* Reset LCRmeter */
/* Measure capacitance & resistance (impedance) */
/* Set frequence to 100 Hz */
/* Set drive voltage to 0.1 V */
/* Turn on range hold */
/* Set measurement rate to fast */
/* Verbose ASCII data transmission */
write"); /* Delete data files from disk
/ so new files can be written
*/
*/
printf("Press any key to start.\n");
while(kbhit() == 0)
i = getcho; /* Clear keyboard buffer */
printf("\n*** Receiving Data ***\n");
printf ("Double-tap Range Hold on LCRmeter!! \n");
printf ("Press any key to stop recording! \n\n");
Zero = clocko; /* Reset timer */
while(kbhit() == 0) /* Stop reading waveforms when key is pressed */
LcrCom("STRT");
LcrCom("*WAI");
LcrCom("XALL?");
/* Start measurement */
/* Wait until LCRmeter ready before getting data */
/* Get capacitance */
for(i=0; i<30; i++) /* Read data, I hope */
/* No time to jump to a subroutine! Doing so will lose bytes! */
while((Byte=bioscom(Status, 0, LcrPort) & DataReady != OxOO1 && i<10))
i++;
Byte = bioscom(Read, 0, LcrPort);
Byte = Byte&OxO0FF;
ZData[i] = Byte;
Timer = clocko;
ZData[30] = ' ';
/* Record time */
/* I don't know where character #30 is coming from! */
for (i=0; i<30; i++)
if (ZData[i] == 10 || ZData[i] == 0 I| ZData[i] == 13)
/* Delete the damn returns, carridge feeds, and null
for (j=i; j<29; j++)
characters!! */
ZData[j] = ZData[j+l];
ZData[29 ='
i = i - 1; /* Now that the bad character has been deleted, have to
re-check the next character in line */
ZData[29] =\0';
Time = (Timer - Zero) / CLKTCK; /* Calculate time in seconds */
printf("Datastream (%.3f s): %s\n", Time, ZData);
sound(1000);
delay(5);
nosound);
fp = fopen(ZFile, "append");
fprintf(fp, "%.4f ", Time); /* Save the elapsed time */
fprintf(fp, "%s\n", ZData); /* And the data stream */
fclose(fp);
printf("\n*** End of Program ***\n");
nosoundo;
delay(1000);
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V.4.3. convert.m.
The following is the MatLab 5 script file for convert.m, a program which converts data from
SKININT . cPP and the LCR meter (Model 5R715 LCR Meter, Stanford Research Systems) into three new
files that can be read by the MatLab script file, JUZ . m (see Section V.11.2). This program filters out
many of the noise errors and timing glitches that can occur while the data are being downloaded from
the LCR meter; however, it requires a very long time to run, up to 5 h per file in some cases. There are
several function calls to progress .m (Section V.4.4), a program that draws progress bars on the screen
to keep track of progress.
% Convert.m
% Converts data files from the LRC meter into 3 columns to be read by MatLab.
% This program takes a *long* time to convert the files!! Run overnight!
% Tani Chen 6/12/98
% *** CLEAR OLD STUFF OUT ***
clc
disp 'Intializing...
disp
clear
close all
format
% errortrap on
disp 'Directory of -/Working:'
!ls
disp '
Number = input('Enter number of files ->');
Filename(Number, 20) =
for k = 1:Number
kstring = num2str(k);
eval([' disp ' 'Enter filename for file #', kstring, ' '
Name = input(' ->', s');
StrLen(k) = size(Name, 2);
Filename(k, 1:size(Name, 2)) = Name;
end
disp
disp 'Files to convert:'
disp(Filename)
disp
for FileNo = 1:Number
FileString = num2str(FileNo);
NumString = num2str(Number);
eval(['disp(' 'Now converting file "', Filename(FileNo, 1:StrLen(FileNo)), " (', FileString, '/', NumString,
!rm temp.txt
eval([ '!wc -l ', Filename(FileNo, 1:StrLen(FileNo)), ' > temp.txt']);
File = fopen('temp.txt', 'r');
Temp = fread(File, 8, 'char');
Length = str2num(char(Temp'));
fclose (File);
File = fopen(Filename(FileNo, 1:StrLen(FileNo)), 'r');
% Handle = progress (0, 'Converting electrical data from "intrskin. dat"..');
eval ( [ 'Handle = progress (0, ' ' Converting electrical data from "', Filename (FileNo, 1: StrLen(FileNo)), '"
set(Handle, 'MenuBar', 'none');
set(Handle, 'NumberTitle', 'off');
for j = 1:Length
Pos = 1;
Temp = 0; % Null out previous reading
while Temp ~ 13 % Read until a carriage return (^M) is detected
Temp = fread(File, 1, 'char'); % Enter next byte
String(Pos) = char(Temp); % Store as string in String
Pos = Pos + 1; % Move to next character
end
Flag = 0 % Value flag (0 = Time, 1 = Capacitance, 2 = Impedance)
TempCap ='NaN';
TempImp = 'NaN';
TempTime = 'NaN';
for i = 1:size(String, 2)
if (String(i) == char(9) & Flag == 0) % Time deliminated by a <tab>
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TempTime = String(l:i - 1);
Pos = i; % Remember this location
Flag = 1; % Increase flag
end
if (String(i) == ', & Flag == 2) % Impedance deliminated by a
TempImp = String(Pos + 1:i - 1);
Flag = 3;
end
if (String(i) == ', ' & Flag == 1) % Capacitance deliminated by a
TempCap = String(Pos + 1:i - 1);
Pos = i; % Remember this location
Flag = 2; % Increase flag
end
if (i == size(String, 2) & Flag == 2)
TempImp = String(Pos + 1:i);
Flag = 4;
end
end
if (TempCap(l) == 'G' I TempCap(l) == '0')
Cap(j) = str2num(TempCap(4:size(TempCap, 2)));
if Cap(j) > 1e20
Cap(j) = NaN;
end
else
Cap(j) = NaN;
end
if (TempImp(l) == 'G' I TempImp(l) == '0')
Imp(j) = str2num(TempImp (4: size (TempImp, 2)));
if Imp(j) > le20
Imp(j) = NaN;
end
else
Imp(j) = NaN;
end
ZTime(j) = str2num(TempTime);
progress (j /Length)
end
fclose(File);
close (Handle)
eval(['disp Saving capacitance data to "', Filename(FileNo, 1:StrLen(FileNo)), cap ... ''']);
eval(['save ', Filename(FileNo, 1:StrLen(FileNo)), '.cap Cap -ascii']);
eval(['disp '' Saving impedance data to "', Filename(FileNo, 1:StrLen(FileNo)), 'imp"...'']);
eval ([save ', Filename(FileNo, 1:StrLen(FileNo)), '.imp Imp -ascii']);
eval(['disp Saving time data to " ', Filename(FileNo, l:StrLen(FileNo)), '.ztime" ... '1);
eval(['save ', Filename(FileNo, 1:StrLen(FileNo)), '.ztime ZTime -ascii']);
disp ' '
clear Cap
clear Imp
clear ZTime
end
disp( 'Done!')
% errortrap off
V.4.4. progress.m.
Many of the files in this appendix require long periods of time to run (hours to days). The following
MatLab 5 script file draws a progress bar on the screen, to monitor progress.
function fout = waitbar2(x,name)
%WAITBAR2 Display wait bar (uses Tags to keep track of objects).
% H = WAITBAR2(X, 'title') creates and displays a wait bar of
% fractional length X. The handle to the waitbar figure is
% returned in H. X should be between 0 and 1. Each
% subsequent call to waitbar, WAITBAR2(X), extends the length
% of the bar to the new position X.
% WAITBAR2 is typically used inside a FOR loop that performs a
% lengthy computation. A sample usage is shown below:
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% h = waitbar2(0, 'Please wait...');
% for i=1:100,
% % computation here %
% waitbar2(i/100)
% end
% close(h)
% Clay M. Thompson 11-9-92
% Copyright (c) 1992-93 by The MathWorks, Inc.
% $Revision: 1.9 $ $Date: 1993/09/24 18:57:13 $
x = max(0,min(100*x,100));
if nargin==2,
pos = get(0,'ScreenSize');
f = figure( 'position', [pos(3) /2-500 pos(4) /2-30 360 60],
'resize','off');
colormap( ])
h = axes('Xlim', [0 100], 'Ylim', [0 1]);
title(name)
axis off
set(h, 'box', 'on')
set(h,'position', [.05 .30 .9 .30])
set(h, 'YTickLabelMode', 'manual')
set(h,'YTickLabel', [])
xpatch = [0 x x 0];
ypatch = [0 0 1 1];
xline = [100 0 0 100 100];
yline = [0 0 1 1 0);
p = patch (xpatch, ypatch, 'b', 'Edgecolor'. 'b', 'EraseMode', 'none', 'tag 'waitpatch');
1 = line (xline, yline, ' eraseMode', 'none', 'tag', 'waitline');
set(l,'Color',get(gca,'Xcolor'))
else
p = findobj(gca,'tag','waitpatch');
1 = findobj(gca, 'tag', 'waitline');
if isempty(p) I isempty(l), error ('Couldn' 't find waitbar handles.'); end
xpatch = get(p, 'xdata');
xpatch = [xpatch(2) x x xpatch(2)];
set(p, 'Xdata' ,xpatch)
xline = get(l, 'xdata');
set(l, 'xdata' ,xline)
end
drawnow
if nargout==l,
fout = f;
end
V.4.5. WAVETIME.CPP.
The following is the source code for WAVETIME. CPP, a program to measure the transdermal voltage
and current for each pulse. Rather than relying on a fixed pulse interval, it simultaneously records the
time of the pulse. Randomly or irregularly spaced pulses can thus be recorded and correctly
processed. It is in Turbo C++ (Borland).
/* WAVETIME.CPP */
/* Program stores pulse waveform and current waveform for every pulse. */
/* Program can store up to 1 pulse every 5 s. Data saved in 4 files. */
/* The 2 preamble files contain data about the x and y settings on the */
/* oscilloscope, saved in MatLab format (PREAMBl.M and PREAMB2.M) . The */
/* 2 data files contain the actual waveform data, stored in ascii
/* (WAVEl.DAT and WAVE2.DAT) . Each wave is stored as a block of 500 */
/* bytes (no separators). */
/* Oscilloscope RS-232 module (HP 54651A) should be connected to serial */
/* port 1 on computer. Oscilloscope settings: Hit [Print/Utility], */
/* then <RS-232 Menu>, and check these settings before running program: */
/* Connect to <Computer>, Factors <Off>, Resolution <Low>, */
/* Baud Rate <9600>, Handshake <Xon> */
/* Tani Chen, 3/17/1997 */
#include <stdio.h>
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#include <dos.h>
#include <string.h>
#include <bios.h>
#include <conio.h>
#include <time.h>
/* Bioscom port 0 = serial port 1 */
#define OscPort 0
/* Bioscom send = 1, read = 2, status = 3 */
#define Send 1
#define Read 2
#define Status 3
#define DataReady OxO100
InitComl() /* Initialize serial port 1 */
union REGS r;
r.h.ah = Ox00;
r.h.al = OxE3;
r.x.dx = OxOO;
int86(Ox14, &r, &r);
printf(" Serial port 1 initialized.\n");
OscCom(char *command) /* Send command to oscilloscope */
int i;
delay(100); /* Do not change! Timing necessary for oscilloscope to */
/* take readings correctly!
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
bioscom(Send, command[i], OscPort);
bioscom(Send, OxOA, OscPort); /* Line feed */
printf(" Command: %s\n", command);
int ReadOsc() /* Wait for ready signal (?) */
int data;
int i = 0;
union REGS r;
while((data=bioscom(Status, 0, OscPort) & DataReady != OxOO1 && i<10))
i++;
data = bioscom(Read, 0, OscPort);
data = data&Ox00FF;
return(data);
Preamble(int channel, char *filename)
/* Preamble format: 1(byte), 1(nrm), 4000(pnts), 1(dummy) */
/* xincr, xorig, xref(dummy), yincr, yorig, yref(dummy) */
/* Stored as MatLab file */
I
int i;
char preamble[125];
char preamble2[125];
char *command;
FILE *fp;
if(channel == 1) /* Select channel */
OscCom(":WAV:SOUR CHANl");
else if(channel == 2)
OscCom(":WAV:SOUR CHAN2");
delay(500); /* Reset port for signaling... don't ask me why! Removing */
bioscom(Read, 0, OscPort); /* these lines will cause bytes to be lost!!
command = ":WAV:PRE?"; /* No time to jump to subroutine...
/* Using OscCom here causes bytes to be lost! */
printf(" Command: %s\n", command);
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
bioscom(Send, command[i], OscPort);
bioscom(Send, OxOA, OscPort); /* Line feed */
i = 0; /* Enter data */
while((preamble[i]=Read0sc()) != 10 && i<100)
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}
preamble[i] = '\O'; /* Add line feed to end of data */
printf(" Channel %d data: %-.57s... \n", channel, preamble);
for(i=O; i<strlen(preamble); i++) /* Erase commas from preamble */
if(preamble[i] == ,
preamble(i] =
sprintf (preamble2, "preamble%d = [ %s ];", channel, preamble); /* Save *I
fp = fopen(filename, "write"); /* data in Matlab format */
fprintf(fp, "%s\n", preamble2);
fclose(fp);
printf(" Preamble from channel %d stored in %s.\n", channel, filename);
Waveform(char *filenamel, char *filename2, char *filename3, int Zero)
/* Dump both channels and the time to disk */
int i;
char *command;
char wavel[511]; /* (header=10 bytes) (data=500 bytes) (EOF=l byte) '/
char wavela[501]; /* 500 data bytes + EOF */
char wave2[511]; /* Same for channel 2 */
char wave2a[501];
clockt Timer;
double Time;
FILE *fp;
OscCom(":DIG CHAN1,CHAN2"); /* Store both traces in oscilloscope */
OscCom(":WAV:SOUR CHAN1"); /* Select channel 1 */
command = ":WAV:DATA?"; /* No time to jump to subroutine...
printf(" Command: %s\n", command);
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
{
bioscom(Send, command[i], OscPort);
bioscom(Send, Ox0A, OscPort); /* Line feed */
/* Waiting for pulse. ReadOsc spits out O's until the oscilloscope */
/* is ready to send data (which means the oscilloscope was triggered, */
/* which means a pulse was detected.) The O's are not part of the DIG */
/* header and really screw up data transferring (510 bytes from DIG) !
printf(" Waiting");
while(i=ReadOsc) == 0)
printf(".);
printf("\n Pulse detected.\n");
sound(2048) ; /* Beep every time there's a pulse... */
delay(5);
nosoundo;
Timer = clock);
for(i=0; i<511; i++) /* Pulse detected, reading data */
wavel[i] = ReadOsc();
if(wavel[i] == 0) /* 0 (no data) causes string to terminate early */
{/ making a real mess of the rest of the program! */
wavel[i] = 1;
wavel[i] = '\0'; /* End of file */
OscCom(":WAV:SOUR CHAN2"); /* Then select channel 2 */
command = ":WAV:DATA?"; /* No time to jump to subroutine...
printf(" Command: %s\n", command);
for(i=0; i<strlen(command); ++i) /* 1 character at a time */
bioscom(Send, command[i], OscPort);
bioscom(Send, OxOA, OscPort); /* Line feed */
for(i=0; i<511; i++) /* Read data, I hope */
wave2 [ i] = Readosc();
if(wave2[i] == 0) /* 0 (no data) causes string to terminate early */
{ wave2[i] = 1;
wave2[i] = '\0'; /* End of file */
for(i=0; i<511; i++) /* Patch up data so this stupid PC can process it */
if(wavel[i] == 26) /* 26 = EOF, change to 25 to avoid crashing! */
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wavel[i] = 25;
}
if(wavel[i] == 7)
wavel[i] = 8;
if(wavel[i] == 10)
wavel[i] = 11;
if(wave2[i] == 26)
wave2 [i] = 25;
if(wave2[i] == 7)
/* Turn off that stupid bell! */
/* Character 10 messes up byte count on disk!!
/* Don't ask me why, just don't change this! */
/* And of course, repeat for channel 2 waveform */
wave2[i] = 8;
if(wave2[i] == 10)
wave2[i] = 11;
i = 0; /* Delete useless header info (channel 2)
while((wave2a[i] = wave2[i+10]) != '\0')
*/
i = 0; /* Delete useless header info (channel 1) */
while((wavela[i] = wavel[i+10]) != '\O')
i++;
printf(" Channel 1 data (%d): %-.50s ... \n", strlen(wavela), wavela);
printf(" Channel 2 data (%d): %-.50s... \n", strlen(wave2a), wave2a);
OscCom(":RUN"); /* Resume oscilloscope readings */
fp = fopen(filenamel, "append"); /* Save channel 1 as block of 500
fprintf(fp, "%.500s", wavela); /* bytes
fclose(fp);
printf(" Channel 1 data stored in %s.\n", filenamel);
fp = fopen(filename2, "append"); /* And channel 2 also */
fprintf(fp, "%.500s", wave2a);
fclose(fp);
printf(" Channel 2 data stored in %s.\n", filename2);
Time = (Timer - Zero) / CLKTCK;
fp = fopen(filename3, "append"); /* Time channel /
fprintf(fp, "%.4f\n", Time); /* Save the elapsed time */
fclose(fp);
printf(" Time of pulse: %.3f.\n", Time);
main()
FILE *fp;
int pulseno = 1;
int choice;
char *preamblel = "PREAMB1.M";
char *preamble2 = "PREAMB2.M";
char *waveforml = "WAVEl.DAT";
char *waveform2 = "WAVE2.DAT";
char *timefile = "TIME.DAT";
clock t Zero, Timer;
double Time;
/*
/*
/*
/*
/*
Preamble data
Preamble data
Waveform data
Waveform data
Time data for
file for channel 1 */
file for channel 2 */
file for channel 1 */
file for channel 2 *
each pulse */
printf("*** Program Initialization ***\n");
printf("Initializing serial port 1 .... \n");
InitComl ();
printf( "Setting up oscilloscope.... \n");
OscCom("*RST"); /* Reset oscilloscope */
OscCom(":SYST:LOCK ON"); /* Prevents user from messing with settings */
OscCom(":VIEW CHAN2"); /* Turn on channel 2 */
OscCom(":DITH OFF"); /* Turn off errors (oscilloscope *adds* errors!) */
OscCom(":WAV:POIN 500"); /* 500-byte data blocks. Limit of what can */
/* be saved in under 5 s! */
OscCom(":WAV:FORM BYTE"); /* Data goes from 0 to 255 */
OscCom(":ACQ:COMP 40"); /* Mininum threshold to trigger storage */
OscCom(":ACQ:TYPE NORM"); /* Normal acquisition (no averaging) */
/* Channel 1 = Uskin (high voltage probe, 1000x) */
/* Channel 2 = I (10x probe)
OscCom(":TIM:RANG 5 MS"); /* Set x-axis to 5 ms across /
OscCom(":TIM:REF LEFT"); /* Align pulse with left side */
OscCom(" :CHAN2:PROB X10"); /* 10x probe for current (channel 2) */
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{
}
OscCom(":CHAN2:BWL ON"); /* Clean up channel 2's signal */
OscCom(" :CHAN1:BWL ON"); /* Clean up channel 1's signal */
OscCom(" :TRIG:MODE NORM"); /* Set up oscilloscope to respond to pulses */
/* on channel 2 (Current) */
OscCom(" :TRIG:NREJ ON"); /* Turn on noise rejection */
printf("Enter voltage settings:\n"); /* Select ranges to display/record */
printf(" 1. High voltage (600 V/2.5 A)\n");
printf(" 2. Medium voltage (240 V/1 A)\n");
printf(" 3. Low voltage (120 V/0.5 A)\n");
printf(" 4. Lower voltage (60 V/0.25 A)\n");
printf("Choice?" );
scanf("%d", &choice);
if (choice == 1)
OscCom(":CHAN1:RANG 4V");
OscCom(":CHAN1:OFFS 1.5V");
OscCom(":CHAN2:RANG 4V");
OscCom(":CHAN2:OFFS 1.5V");
OscCom(":TRIG:SOUR CHAN1");
OscCom(":TRIG:LEV 500MV");
else if(choice == 2)
{
OscCom(":CHAN1:RANG 1.6V");
OscCom(":CHAN1:OFFS 600MV");
OscCom(":CHAN2:RANG 1.6V");
OscCom(":CHAN2:OFFS 600MV");
OscCom(":TRIG:SOUR CHAN1");
OscCom(":TRIG:LEV 250MV");
else if(choice == 3)
OscCom(":CHAN1:RANG 800MV");
OscCom(":CHAN1:OFFS 300MV");
OscCom(":CHAN2:RANG 800MV");
OscCom(":CHAN2:OFFS 300MV");
OscCom(":TRIG:SOUR CHAN1");
OscCom(":TRIG:LEV 200MV");
else if(choice ==4)
OscCom(":CHAN1:RANG 400MV");
OscCom(":CHAN1:OFFS 150MV");
OscCom(":CHAN2:RANG 400MV" );
OscCom(":CHAN2:OFFS 150MV");
OscCom(":TRIG:SOUR CHAN1");
OscCom(":TRIG:LEV 50MV");
printf("Getting preambles .. . \n");
Preamble(1, preamblel); /* Get preamble data for channel 1 */
Preamble(2, preamble2); /* Get preamble data for channel 2 */
fp = fopen(waveforml, "write"); /* Delete data files from disk */
fclose(fp); /* so new files can be written */
fp = fopen(waveform2, "write");
fclose(fp);
fp = fopen(timefile, "write");
fclose(fp);
printf("*** Initialization Completed ***\n\n");
printf("*** Receiving Waveforms ***\n");
printf("Press any key AFTER pulse to stop recording!\n");
Zero = clock(); /* Reset timer */
while(kbhit) == 0) /* Stop reading waveforms when key is pressed */
printf("Pulse #%d... \n", pulseno);
pulseno++;
Waveform(waveforml, waveform2, timefile, Zero); /* Get waves */
printf("*** All Waveforms Recorded ***\n");
OscCom(":SYST:LOCK OFF"); /* Allow use of oscilloscope again */
printf("\n*** End of Program ***\n" );
delay(1000);
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V.5. Permeation Chamber Preparation.
The polyacrylamide gel around each pulsing electrode directs PBS in and out of the chamber, with-
out contacting the donor or receptor solutions (the hollowed-out regions that run around each of the two
pulsing electrodes in Figure V.2). The polyacrylamide also keeps the volumes of the donor and
receptor compartments at a minimum. Embedded within the polyacrylamide gel are the tubes entering
and leaving each compartment, and the measurement electrodes.
V.5.1. Preparation of the Mold.
Acrylamide in solution takes approximately 10 min to polymerize into polyacrylamide gel. In this
time, the acrylamide solution has to poured into the chamber. To create the channels that run through
the polyacrylamide gel, plastic tubes are inserted into the chamber, which are then removed once the
acrylamide has polymerized. Preparing the mold within the permeation chambers can be done the day
before the experiment.
1. Find two flexible plastic tubes, approximately 9 inches long, that will fit through the two small
ports on each chamber half.
2. Slide the plastic tubes through these ports (use tweezers as needed), so that roughly 1 to
2 inches of the tube protrudes out on either side. These tubes are the mold for the electrode
flow-protection channel.
3. Place Parafilm around each opening tightly. Use two layers of Parafilm. This should create a
watertight seal around the openings, so the acrylamide solution can not leak out.
4. Insert the measuring electrodes into each compartment. Make sure the two tubes that lead into
the compartment are at an angle toward the opening. Place Parafilm tightly around this electrode
as well.
5. Due to the elasticity of the tubing, however, the two tubes of the electrode are probably stuck next
to each other instead of on opposite sides of the chamber as shown in Figure V.2. Using a thin
stainless steel wire, attach the outlet tubing to the top of the chamber. This wire will be removed
after the polyacrylamide gel has been added.
6. Position each of the two chambers sideways, so that the large opening (where the skin is located)
is on top. The chambers should be braced in some fashion (propping them up on pencils or test
tubes) so that they can not tip or move when filled with liquid.
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V.5.2. Adding the Polyacrylamide Gel.
Acrylamide monomer in solution (Solution 1) will polymerize into a gel in approximately 10 min
upon addition of a catalyst (N,N,N',N'-tetramethylethylenediamine) (Bio-Rad) and a free radical initiator
(Solution 4). Most of the gel is still liquid (PBS, in this case), surrounded by cross-linked polymer.
Thus, the conductivity and the electrical properties of the polyacrylamide gel are essentially the same
as PBS.
Synthesis of the polyacrylamide gel should be performed just before the experiment (the chambers
should already be prepared), since polyacrylamide gel will begin dehydrating after a few hours.
1. Thoroughly mix together 10 ml of acrylamide solution (Solution 1), 87.5 Pl of the initiator
(Solution 4 from Section V.1), and 6 p1 of N,N,N',N'-tetramethylethylenediamine in a 15 ml test
tube.
2. Immediately pour in the acrylamide solution, completely filling each chamber. The top of the
solution should be perfectly flush with the top of the chamber, and there should not be a
meniscus above the chamber. The acrylamide solution will completely cover the plastic tubing of
the flow-protection system, and the silver measurement electrode. Make sure that the liquid does
not enter the two tubes that form each compartment. The solution will shrink slightly as it gels;
this shrinkage is what forms the receptor compartment. Thus, to get a consistent, reproducible
volume, the solution should always be poured so that it is flush with the.
3. Do not disturb the chambers while the gel is polymerizing, as disturbances will cause the gel to
take longer to harden, and the gel will set poorly as a result. It will take approximately 10 min for
the gel to harden. Any leftover acrylamide solution can be used to monitor the gelling process.
4. After the gel forms, carefully remove the Parafilm around the each of the plastic tubes of the elec-
trode flow-protection system. Remove the plastic tubes through one of the small ports. Do not
remove the measurement electrodes or the surrounding Parafilm.
5. Carefully remove the stainless steel wires holding the outlet tubes in place. The tubes should
now be held in place by the polyacrylamide gel.
6. Using a syringe, force air through the inlet and outlet tubes of each compartment to ensure that
they are not blocked by stray bits of polyacrylamide gel.
7. Connect a collection tube (see Section IV.3. 1) to the outlet tube on the side of each measurement
electrode, as shown in Figures V.2 and V.3). Hold it in place with Parafilm.
8. Before using, fill the permeation chambers with PBS to keep the polyacrylamide gel from drying
out.
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V.6. Preparing the Equipment.
On the day of the experiment, the following should have already been prepared and assembled:
Solutions 1 through 4 (Section V.1), the permeation chamber and the electrodes (Sections V.2, IV.2,
111.2.2, and V.5.1), the flow-protection system (Section 111.3), the flow-through system in the spectro-
fluorimeter (Section IV.3), the electrical circuit (Section V.4), the high-voltage pulser (Section II. 1), the
donor recycle system (Section V.3), the impedance meter (Section V.4.1), and the skin (Section 1.1).
Immediately before the experiment, Solutions 5 and 6 from Section V.1, and the polyacrylamide gel in
the chamber (Section V.5.2) need to be prepared. Once the gel in the chamber is ready, place the
chamber on a magnetic stirring plate and connect it to a 37 0C water bath.
All of the tubes in the flow-through system, the electrode flow-protection system, and the donor
recycling system should be flushed with PBS. Use a piece of Parafilm instead of human skin in the
permeation chamber. There should be a steady stream of air bubbles entering the flow-through system
at the collection tube and the spectrofluorimeter cuvette, and another stream of air bubbles entering the
donor outflow system. The flushing should continue until the spectrofluorimeter gives stable readings
for the fluorescence. This can take up to an hour in some cases, especially if the lines were not suffi-
ciently cleaned and flushed the last time the equipment was used.
V.7. Loading Skin into the Chamber.
The condition of the skin is checked by measuring its electrical impedance and monitoring the
passive flux of the donor solution. The impedance of "good skin" should be >25 kQ cm2 at a frequency
of 100 Hz (Prausnitz, et al., 1993 [al; Chen, et at., 1998 [b]; M. R. Prausnitz, personal communi-
cation; Gowrishankar, personal communication). The passive flux of the donor solution across the
skin after an hour should be negligible (below the detection limit of the spectrofluorimeter). Low
impedances or large passive fluxes indicate that the skin's integrity has been compromised in some
way.
The impedance is measured across the two measurement electrodes in the permeation chamber.
However, besides the skin, this measurement also includes PBS and the polyacrylamide gel. The other
impedances can be neglected, though, since the impedance of the skin is much larger than PBS (see
Section 3.7).
1. Float a piece of skin (see Section 1.1) in a dish of PBS for ~1 min.
2. Gently remove the wax paper backing. Do not use tweezers. The skin should float on the sur-
face, with the stratum comeum side facing upwards.
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3. Fill the receptor compartment completely with PBS. There should not be any air bubbles pre-
sent.
4. Position the skin in the chamber so that the stratum corneum faces the donor compartment and
the epidermis faces the receptor compartment. Clamp the chamber shut. Verify that the receptor
compartment is still completely filled with PBS.
5. Turn on the donor recycle system and fill the donor with PBS. Some light "jiggling" of the donor
compartment may be necessary to allow any air bubbles trapped within the donor compartment to
escape.
6. Once the donor compartment has been completely filled with PBS (no more air bubbles), turn off
the pumps.
7. Connect the impedance meter (see Section V.4.1) to the measurement electrodes. Good skin has
2
an impedance >25 kI) cm at 100 Hz. Poor skin should be discarded.
8. Set up the donor system so that fresh donor solution is pumped into the donor compartment, and
the outflow from the donor compartment goes to a waste beaker.
9. Turn on the pumps. Once the donor solution has traveled through the entire donor compartment
and out to the waste beaker, change the tubing so that the donor solution continuously gets
recycled (see Figure V.3).
10. Connect the chamber to the pulsing circuit as shown in Figure V.4, verifying that all four elec-
trodes are properly connected.
11. Turn on the water bath.
12.. Run the impedance monitoring program (Section V.4.1). Continue taking impedance measure-
ments throughout the entire passive control period.
V.8. Passive Control.
After the skin has been loaded in the chamber, the flow-through system should be activated. The
skin should be left for at least 1 h to fully hydrate the skin and check for leaks (holes or tears in the
skin). Leaks can be detected by observing large or increasing readings in the background fluorescence
observed on the spectrofluorimeter. If the skin begins to leak, it should be discarded. During this
period, the impedance meter should continue to measure and record the impedance of the skin.
-247-
V.9. Pulsing Conditions.
High-voltage pulses should be applied to the skin at the rate of 1 pulse every -5 s. Both the time
constant and the applied voltage should be set on the pulser as needed before pulsing is started. The
transdermal voltage is a nonlinear function of the applied voltage (see Figures 7.10 and 8.3) (Pliquett,
et al., 1995 [a]; Chen, et al., 1998 [c]). Thus, given a desired transdermal voltage, a guess of the
applied voltage should be made at this time.
1. Set the pulser to deliver the appropriate types of pulses.
2. Make sure the impedance meter and its computer are still running.
3. Gradually start the pumps for the electrode flow-protection system. Make sure that the poly-
acrylamide gel in the chamber does not crack or break when this is turned on. If the gel breaks,
new gel will have to be made, and the experiment will have to be aborted.
4. Turn on the oscilloscope and the computer. They should be set to start recording once the first
pulse is applied. Make sure that all screen savers, energy savers, and any other software drivers
that can cause process interrupts in the computer have been completely turned off. The com-
puter should not be doing anything during the experiment besides downloading data. Any timing
glitches between the computer and the oscilloscope could cause either the computer or the
oscilloscope to crash.
5. Start the spectrofluorimeter for a time-based scan. The spectrofluorimeter should record fluore-
scence for the time of pulsing (typically 1 h), plus some additional time at the beginning to
measure the baseline, and some time at the end to measure recovery. The time interval between
successive measurements should be as short as possible (e. g., 0.5 s). Record about a minute of
passive flux (control) to establish the baseline.
6. Start the pulser. The oscilloscope and the computer should start recording pulses immediately
with the first pulse. Note the exact time when pulsing starts, on the clock and on the spectro-
fluorimeter (tstar). These times will be needed later to synchronize the pulsing data and the
fluorescence data.
7. Since the spectrofluorimeter, the pulser, the oscilloscope/computer, and the impedance
meter/computer are all automated, during the experiment, the equipment should simply be moni-
tored at all times in case something goes wrong.
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V.10. Ending the Experiment.
After pulsing, the recovery of the skin can be measured by recording the fluorescence once the
pulser has been turned off. Afterwards, the skin should be removed from the permeation chamber and
mounted on a microscope side for analysis. Voltage, current, impedance, and time data from the two
computers and data from the spectrofluorimeter should all be saved on disk for later analysis. The
standard curve should also be measured (see Section IV. 12).
1. After pulsing, turn off the pulser, but leave the rest of the equipment running. Wait until the
fluorescence reaches steady state to stop recording on the spectrofluorimeter. Wait until the
impedance measurements of the skin reaches steady state before stopping the impedance com-
puter.
2. Turn off all of the pumps.
3. Open the permeation chamber and carefully remove the skin (some liquid within the donor and
receptor compartments will come out when this is done). Place the skin gently on a microscope
slide. Gently spread the skin out so it lies flat, and lightly blot it dry with a paper towel. Do not
rub the skin.
4. Add a drop of mounting solution (Solution 3 from Section V. 1).
5. Gently put a cover slip on top. This will cause the mounting solution to spread out and cover the
skin. Seal in place with nail polish. Bring the slide to a fluorescence microscope for immediate
analysis and photography (Section 11.3).
6. Save the data from the two computers and from the spectrofluorimeter. These should be copied to
a workstation for later analysis.
V.11. Analysis of the Flux, Voltage, and Impedance Data.
All of the fluorescence, voltage, current, impedance, time, and calibration data needs to be
downloaded into a computer for analysis. Due to the amount of data one experiment can generate (up to
10 MB), a workstation, rather than a PC, is strongly recommended (e. g. Sun Sparc 10, Sun).
The first step in the analysis is to convert all of the flux and current data into the transdermal
voltage data. The next step is to calibrate and deconvolute the fluorescence data into molecular flux
data. The final step is to correlate in time the three sets of measurements: impedance, voltage, and
flux.
Section IV. 13.1 outlines the calculations to determine the transdermal voltage during each pulse.
Section IV. 13.2 outlines the method of deconvoluting the fluorescence data to determine the molecular
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flux. Section V. 11.1 describes how to combine the three sets of measurements in time. Section V.11.2
has a sample program that loads in all of the raw data, calibrates it, and records the time sequence of
each measurement.
V. 11.1. Time Correlations of the Data.
At this point in the analysis, there should be three arrays of data, representing the transdermal
voltages appearing during each pulse, the molecular fluxes across the skin (at a time resolution of TcUy,
and the impedance of the skin throughout the entire experiment. These data need to be correlated in
time with each other.
1. Define the first pulse to occur at a time 0. If the pulsing times from the voltage data (tvolt) do not
start at 0, subtract off the time of the first pulse (to), so the first pulse is at time 0:
t = tvo1 t -to. (V.1)
2. To correlate the time on the spectrofluorimeter with the time of each pulse, the time on the
spectrofluorimeter (tfluor) needs to be corrected for the elapsed time before pulsing was started
( start) and the plug flow time (treact)
t = tfluor ~ tstart - t react * (V.2)
3. To correlate the time of the impedance meter (timp) with the time of each pulse, the data set
(which can be nearly 100 000 lines long at this point) has to be scanned through to find the time
of the first "break" or "error" in the impedance measurements (this can and probably should be
done graphically, rather than numerically; the first "glitch" in the impedance data can be spotted
very quickly). This time (to) should correspond to the time when the first pulse was applied.
The impedance meter should have been disconnected at this point; thus, the impedance
measured at that point would be erroneous. Subtract off the time of the first pulse (to), so that
the first pulse occurs at time 0:
t = timp - to. (V.3)
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V.11.2. JUz.m.
The following is the script file for jUz.m, a MatLab 5 program which loads in the flux, voltage, and
impedance data, and calibrates and correlates the data in time. There are also several function calls to
progress .m (see Section V.4.4).
% JUZ.m
% This program inputs data from the fluorimeter, the osciliscope, and the LRC meter,
% synchronizes and calibrates the data, and outputs it as 2 final data files.
% Tani Chen 6/11/98
% *** CLEAR OLD STUFF OUT *
clc
disp 'Initializing...'
clear
close all
format
Cuts
Rcur
Rpbs
Toffse
Area
Flow
TauCuv
Vcuv
MeasFi
NA
e
Condy
Thickn
INITIALIZING CONSTANTS *
= 500;
= 1.2;
= 240;
t = (19 + 18 + 19) / 3;
= .64 / 100 / 100;
= (.0303030 + .03125 +
= (18.2856 + 22.0411 +
= Flow * TauCuv;
q = 0.170239344262;
= 6.0221367e23;
= 1.60217733e-19;
= 1 / (67 / 100);
= 20 * le-6;
% Number of data points in each pulse
% Resistance of current-measuring resistor (Ohm)
% Resistance of PBS in chamber (Ohm)
% Time lag to cuvette (s)
% Area of the skin (m2)
.0318471) / 3 / 1000; % Flowrate thru system
23.4928) / 3; % Residence time of cuvette
% Volume of cuvette
% Time between measuremets on LRC meter in fast mode (s)
% Avogadro's number (1 / mol)
% Charge on the electron (C)
% Conductivity of PBS (Ohm m)
% Thickness of stratum corneum (m)
% *** INPUT PARAMETERS ***
Pulse = input(' Enter number of pulses during delivery phase. ->');
Ext = input( ' Enter number of pulses during extraction phase. ->');
Total = Pulse + Ext;
Tstart = input(' Enter starting time (don''t add offset). ->') + Toffset;
MW = input(' Enter molecular weight of tracer. ->');
q = input(' Enter molecular charge of tracer. ->');
q = abs(q); % Ignore negative sign
% *** LOAD VOLTAGE DATA ***
disp 'Loading preamble data from "preambl.m"...'
preambl
% Format: 1(byte), 1(norm), 400(#points), 1(dummy), Xincr, Xorig, Xref, Yincr, Yorig, Yref
Xincr = preamblel(5); % Tick = (bucketnumber - Xref) * Xincr + Xorig
Xorig = preamblel(6);
Xref = preamblel(7);
Yincrl = preamblel(8); % Voltage = (data - Yref) * Yincr + Yorig
Yorigl = preamblel(9);
Yrefl = preamblel(10);
disp 'Loading preamble data from "preamb2.m"...'
preamb2
Yincr2 = preamble2(8) ; % Voltage = (data - Yref)
Yorig2 = preamble2(9);
Yref2 = preamble2(10);
disp 'Loading waveform data from "wavel.dat"...'
File = fopen('wavel.dat', 'r');
Uch = fread(File, [Cuts, Total], 'uchar');
Uch = ((Uch - Yrefl) * Yincrl + Yorigl) * 200;
Uch = Uch .* (Uch > 0);
disp 'Loading waveform data from "wave2.dat"...'
File = fopen('wave2.dat', 'r');
Ucur = fread(File, [Cuts, Total], 'uchar');
Ucur = (Ucur - Yref2) * Yincr2 + Yorig2;
Ucur = Ucur .* (Ucur > 0);
Ucur = Ucur / Rcur;
% *** LOAD TIME DATA ***
disp 'Loading pulse time data from "time.dat"...'
* Yincr + Yorig
% Chamber voltage data
% 200x high voltage probe
% Get rid of noise
% Current voltage data
% Get rid of negative current (noise)
% Convert volts to amps
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load time.dat
PulseTime = time(1:Total); % Delete extra time points
PulseTime = PulseTime + (30 + 24 * 3600) * (PulseTime < 0);
% When time goes across midnight, computer clock resets causing the time to "jump" backwards
% by 86400 s
PulseTime = PulseTime - PulseTime(l);
clear time
PulseTime = PulseTime + 24 * 3600 * (PulseTime < 0);
% When time goes across midnight, computer clock resets causing the time to "jump" backwards
% by 86400 s
% *** CONVERT VOLTAGE DATA TO Uskin, I, and Tau
% Calculates Uskin(time), Rskin(time), I(time), Tau(time)
disp 'Deleting prepulse data from chamber voltages. ..'
Handle = progress (0, 'Deleting prepulse data f rom chamber voltages. . .');
set(Handle, 'MenuBar', 'none');
set(Handle, 'NumberTitle', 'off');
for j = 1:Total
Utemp = Uch(:, j);
if max(Utemp) > 7
Loc(j) = min(find(Utemp > 7));
else
Loc(j) = 50;
end
progress(j/Total)
end
close (Handle)
disp 'Deleting prepulse data from current measurements ...'
Handle = progress (0, 'Deleting prepulse data from current measurements...');
set(Handle, 'MenuBar', 'none');
set(Handle, 'NumberTitle', 'off');
for j = 1:Total
Utemp =Ucur(:, j);
Locl = min(find(Utemp > .05));
if Locl > Loc(j)
Loc(j) = Locl;
end
Ucur(1:(Cuts - Loc(j) + 1), j) = Ucur(Loc(j):Cuts, j);
Ucur((Cuts - Loc(j) + 2):Cuts, j) = NaN;
Uch(l:(Cuts - Loc(j) + 1), j) = Uch(Loc(j):Cuts, j);
% Delete header and push data forward so 0 means start of pulse
Uch((Cuts - Loc(j) + 2):Cuts, j) = NaN; % Fill holes with "NaN"
progress(j/Total)
end
close (Handle)
disp 'Fitting chamber voltages (ignore log of zero errors) ...
Handle = progress(0, 'Fitting chamber voltages ...');
set(Handle, 'MenuBar', 'none');
set(Handle, 'NumberTitle', 'off');
drawnow
Uch = log(Uch - Uch .* (Uch <= 0));
% Take logs of only positive numbers. Negative numbers are changed to 0's
% (since the log of a negative number is complex!), then -Inf. NaN's
% reamain NaN's
Uch = isfinite(Uch) .* Uch;
% Convert -Inf to NaN (former negative numbers)
for j = 1:Total
Tick = ((1:500)' - Xref + Loc(j)) * Xincr + Xorig;
% Set up time vector for each pulse for curve fitting (s)
Utemp = Uch(1:150, j);
if sum(isnan(Utemp)) == size(Utemp, 1) % If Utemp empty, then no line fit
Chamber(j, :) = [NaN NaN];
else
Chamber(j, :) = polyfit(Tick(isfinite(Utemp)), Utemp(isfinite(Utemp)), 1);
% Linear fit (ln y = m * PulseTime + b)
end
progress(j/Total)
end
close (Handle)
Chamber(:, 1) = -1 ./ Chamber(:, 1); % Tau(s) = -1 / m
Tau = Chamber(:, 1) * 1e3; % Tau in (ms)
Chamber(:, 2) = exp(Chamber(:, 2)); % Uch(V) = exp(b)
% Chamber(:, 1) = Tau (s)
% Chamber(:, 2) = Peak voltage across differential electrodes (V)
disp 'Fitting current measurements (ignore log of zero errors) ...
Handle = progress (0, 'Fitting current measurements...');
set(Handle, 'MenuBar', 'none');
set(Handle, 'NumberTitle', 'off');
drawnow
Ucur = log(Ucur - Ucur .* (Ucur <= 0)); % Take logs of positives
-252-
for j = 1:Total % Same routine as above, except for current now
Tick = ((1:500)' - Xref + Loc(j)) Xincr + Xorig; % (s)
Utemp = Ucur(1:150, j);
Current(j, :) = polyf it (Tick (isf inite (Utemp) ), Utemp(isfinite(Utemp)),1);
progress(j/Total)
end
close (Handle)
Current(:, 2) = exp(Current(:, 2)); % Ucur(V) = exp(b)
% Current(:, 2) = Peak currents across measuring resistor, Rcur (A)
Icur = Current(:,2); % Icur(A) = Current
disp 'Finding transdermal voltages...
Uskin = Chamber(:, 2) - Current(:, 2) * Rpbs;
% Uskin = Uch - Upbs = Uch - I * Rpbs
Uskin = Uskin .* (Uskin<1e3) ./ (Uskin<1e3) .* (Uskin>O) ./ (Uskin>O);
% Get rid of errors (negatives, too large)
Rskin = Chamber(:, 2) ./ Current(:, 2) - Rpbs;
% Rskin = Uch / I - Rpbs (Rskin = Uskin / I (Ohm)
Rskin = Rskin .* (Rskin<1e4) ./ (Rskin<1e4) .* (Rskin>O) ./ (Rskin>0);
% Get rid of errors (negatives, too large)
% *** LOAD IMPEDANCE DATA ***
disp 'Loading capacitance data from "intrskin.dat.cap" (ignore divide by zero'
disp ' errors)...'
load intrskin.dat .cap
Cap = intrskin;
Cap = Cap .* (Cap > 0) ./ (Cap > 0);
disp 'Loading impedance data from "intrskin.dat.imp" (ignore divide by zero errors)...'
load intrskin.dat. imp
Imp = intrskin;
Imp = Imp .* (Imp > 0) ./ (Imp > 0);
disp 'Loading impedance measurement time data from "intrskin.dat. ztime"...
load intrskin. dat .ztime
ZTime = intrskin;
ZTime = ZTime + (30 + 24 * 3600) * (ZTime < 0);
% Clock resets after midnight, need to add 86400 s to time
disp 'Loading passive impedance data from "passive.dat. imp" (ignore divide by zero'
disp ' errors)...'
load passive.dat.imp
Pass = passive;
Pass = Pass .* (Pass > 0) ./ (Pass > 0);
disp 'Loading passive impedance time data from "passive.dat.ztime" ...'
load passive.dat.ztime
PassTime = passive;
clear passive
clear intrskin
% *** CALIBRATE ZTIME TO TIME
disp 'Calibrating impedance times ...'
disp ' Click on figure to zoom to appropriate region.'
Handle = plot (ZTime (1:1200), zeros(l, 1200), 'y*'); % Plot calibration curve
set(figure(l), 'Position', [514 430 560 4201)
xlabel('Time (s)')
title('Impedance Times')
axis tight
zoom on
Choice = input(' Type 0 when graph is zoomed over point. ->');
disp ' Click on starting point.'
ZCalb = ginput(l); % Find point
zoom off
close all
ZCalb = ZCalb(l); % X-axis is the time
ZCalb(l:size(ZTime, 2)) = ZCalb; % Fill up matrix with that time
ZCalb = min(find(ZCalb < ZTime)); % And compare with ZTime to find element with that time
ZCalb = ZTime(ZCalb) + MeasFrq; % ZCalb is that time, plus an offset (for next measurement)
ZTime = ZTime - ZCalb; % Correct ZTime for ZCalb. ZTime is now equivalent to Time.
% *** CALCULATING IMPEDANCES FOR EACH PULSE ***
disp 'Calculating impedances during each pulse (ignore divide by zero errors)...'
Handle = progress(O, 'Calculating impedances during each pulse...');
set(Handle, 'MenuBar', 'none');
set(Handle, 'NumberTitle', 'off');
ImRec = zeros(Total, 20) ./ 0; % Initialize matrixes
ImRecTime = zeros(Total, 20) ./ 0;
for j = 1:(Total - 1)
PStart = min(find(PulseTime(j) < ZTime)) - 1;
PEnd = min(find(PulseTime(j + 1) < ZTime)) - 1;
TempImp = Imp(PStart:PEnd);
TempTime = ZTime(PStart:PEnd);
TempImp(size(TempImp, 2)) = NaN;
while isnan(TempImp(l)) == 1
TempTime(1:size(TempImp, 2) - 1) = TempTime(2:size(TempImp, 2));
TempImp(1:size(TempImp, 2) - 1) = TempImp(2:size(TempImp, 2));
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% Same routine as aboveUcur = isfinite(Ucur) .* Ucur;
TempTime(size(TempImp, 2)) = 0;
TempImp(size(TempImp, 2)) = 0;
end
TempTime = TempTime(l:min(find(isnan(TempImp))) - 2);
TempImp = TempImp(l:min(find(isnan(TempImp))) - 2);
if size(TempTime, 2) == 0
TempTime = NaN;
TempImp = NaN;
end
TempTime = TempTime - TempTime (1);
MatSize = size(TempImp, 2) * (size(TempImp, 2) < 20) + 20 * (size(TempImp, 2) > 20);
% MatSize = 20 if TempImp> 20, otherwise MatSize = size of TempImp
ImRec(j, 1:MatSize) = TempImp(l:MatSize);
ImRecTime(j, 1:MatSize) = TempTime(l:MatSize);
TempImp = sort(TempImp);
TempImp = mean(TempImp(l: (size(TempImp, 2) - sum(isnan(TempImp)))));
ImPulse(j) = TempImp;
progress(j / (Total - 1))
end
ImRec = ImRec'; % Flip matrixes to correct orientation
ImRecTime = ImRecTime';
ImRec = ImRec(1:20, :); % Delete excess points during recovery phases
ImRecTime = ImRecTime(1:20, :);
ImRec = ImRec ./ (ImRec > 0); % Fill O's with NaN's
ImRecTime = ImRecTime ./ (ImRec > 0);
close (Handle)
% *** LOAD CALIBRATION DATA *
disp 'Loading fluorescence calibration data from "calb.txt" (ignore file errors)...
rm temp.txt
% Delete header from calibration data (5 lines)
tail +5 calb.txt > temp.txt
load temp.txt
Calb = temp(:, 2); % Calibration curve (arbitrary x-axis)
! rm temp.txt
% *** CALCULATE CALIBRATION CURVE ***
disp 'Calibrating data. .. ' % Plot calibration data
Handle = semilogy(Calb);
set(figure(l), 'Position', [1160 6 1142 845])
set(Handle, 'Color', 'w')
xlabel ('Point number')
ylabel('Fluorescence (counts/s)')
title( 'Raw Calibration Data from "calb.txt"' )
disp ' Scaling graph (see page on right)...'
Choice = 1;
while Choice == 1
disp ' Click on bottom left corner.
BotLeft = ginput(l);
disp ' Click on top right corner.'
TopRight = ginput(l);
axis ([BotLeft (1) TopRight(l) BotLeft(2) TopRight(2)]) % Scale graph
Choice = input(' Enter 1 for re-scale, 2 to restart, 0 when done. ->');
if Choice == 2
axis auto
Choice = 1;
end
end
disp ' Entering calibration values ...
for j = 2:8
Choice = 1;
while Choice == 1
String = num2str(j);
eval(['disp '' Click on left-most region of sample #', String, ' ' '');
MouseLeft = ginput(l);
Handle = line( [MouseLeft(l) ;MouseLeft(l)], [BotLeft(2) ;TopRight(2)]);
set(Handle, 'Color', 'r')
disp ' Click on right-most region.'
MouseRight = ginput (1);
Handle = line( [MouseRight(l) ;MouseRight(l)] , [BotLeft(2) ;TopRight(2)]);
set(Handle, 'Color', 'r')
Choice = input(' Enter 1 to re-do, 0 when done. ->');
end
Coord (j) = mean (Calb (round (MouseLef t (1) :round (MouseRight (1))));
end
disp' Figuring calibration equation (ignore log of zero errors) .. .
Conc = log( [NaN le-1 le-2 le-3 le-4 la-5 le-6 le-7 le-8] * le-3);
% Concentration values (M) . Sample #1 (= Donor = 1 mM) is ignored.
Coord = log(Coord);
close(l)
Handle = plot (Coord, ' co-') ; % Plot calibration curve
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set(figure(l), Position', [514 430 560 420])
set(Handle, 'MarkerSize', 4)
set(Handle, 'MarkerFaceColor', 'c')
ylabel('log(fluorescence intensity)')
xlabel('Sample #')
title('Standard Curve Data')
axis([2 8 floor(min(Coord(2:8))) ceil(max(Coord(2:8)))])
Low = input(' Enter lowest sample number in linear region. ->');
High = input( Enter highest sample number in linear region. ->');
CalbEqn = polyfit(Coord(Low:High), Conc(Low:High), 1); % Get curve fit
% *** LOAD FLUX DATA ***
% PTI format load (Bldg E25).
disp 'Loading fluorescence flux data from "fluor.txt" (ignore file errors)...! rm temp.txt
% Delete header from calibration data (5 lines)
! tail +5 fluor.txt > temp.txt
load temp.txt
Fluor = temp(:, 2);
FlLength = size(Fluor, 1); % Length of fluorescence measurements (1/2 s)
% *** DELETE JUNK (GLITCHES)
disp 'Glitch removal...'
Handle = plot(Fluor, 'g');
axis tight
ylabel('Fluorescence (counts/s)')
xlabel('Point Number')
title ( ' Raw Fluorescence Data f rom " f luor. txt"')
Choice = input(' Enter 1 for glitch removal, 0 if OK. ->');
while Choice == 1
Handle = plot(Fluor, 'g');
set(figure(l), 'Position', [1160 6 1142 845])
set(Handle, 'MarkerSize', 4)
set(Handle, 'MarkerFaceColor', 'g')
axis tight
ylabel('Fluorescence (counts/s)')
xlabel ('Point Number')
title('Raw Fluorescence Data from "fluor.txt"')
disp ' Scaling graph (see page on right)...'
Choice = 1;
while Choice == 1
disp ' Click on bottom left corner.'
BotLeft = ginput(l);
disp ' Click on top right corner.'
TopRight = ginput(l);
axis([BotLeft(l) TopRight(l) BotLeft(2) TopRight(2)]) % Scale graph
Choice = input(' Enter 1 for re-scale, 2 to restart, 0 when done. ->');
if Choice == 2
axis auto
axis tight
Choice = 1;
end
end
disp ' Click on left-most region.'
MouseLeft = ginput(l);
Handle = line( [MouseLeft(l); MouseLeft(l)], [BotLeft(2) TopRight(2)]);
set(Handle, 'Color', 'r')
disp ' Click on right-most region.'
MouseRight = ginput(l);
Handle = line([MouseRight(l); MouseRight(l)], [BotLeft(2) TopRight(2)]);
set(Handle, 'Color', 'r')
Choice = input(' Enter 1 to abort, 0 if correct. ->');
if Choice == 0
disp ' Deleting section...'
Fluor(floor (MouseLeft) :ceil(MouseRight)) = NaN;
end
Choice = input(' Enter 1 for more removals, 0 when done. ->');
end
close(l)
% *** CONVERT TO CONCENTRATIONS ***
disp 'Converting fluorescences into concentrations (ignore dividing by zero errors)...'
Fluor = Fluor(:) .^ (CalbEqn(l) * (1 - isnan(Fluor(:)))) * exp(CalbEqn(2)) .* ((1 - isnan(Fluor(:))) ./ (1 -
isnan((Fluor(:)))));
% Fluorescence in (M) (from Conc)
% *** SIGNAL AVERAGING FLUORESCENCE MEASUREMENTS ***
disp 'Applying signal averaging over 28 points...'
% This is now hard-wired into the program!!
FlSz = size(Fluor, 1) - 28;
Fluor(l:FlSz) = ( Fluor( 1:FlSz ) + Fluor( 2:FlSz+ 1) + Fluor( 3:FlSz+ 2) + Fluor( 4:FlSz+ 3) +
Fluor( 5:FlSz+ 4) + Fluor( 6:FlSz+ 5) + Fluor( 7:FlSz+ 6) + Fluor( 8:FlSz+ 7) + Fluor( 9:FlSz+ 8)
+ Fluor(10:FlSz+ 9) + Fluor(ll:FlSz+10) + Fluor(12:FlSz+ll) + Fluor(13:FlSz+12) +
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Fluor(14:FlSz+13) + Fluor(15:FlSz+14) + Fluor(16:FlSz+15) + Fluor(17:FlSz+16) + Fluor(18:FlSz+17)
+ Fluor(19:FlSz+18) + Fluor(20:FlSz+19) + Fluor(21:FlSz+20) + Fluor(22:FlSz+21) +
Fluor(23:FlSz+22) + Fluor(24:FlSz+23) + Fluor(25:FlSz+24) + Fluor(26:FlSz+25) + Fluor(27:FlSz+26)
+ Fluor(28:FlSz+27))/28;
Fluor((size(Fluor) - 28 + 1):size(Fluor)) = NaN;
% *** FIND LAG TIME ***
disp 'Finding lag times (see page on right)...'
Handle = plot(Fluor, 'g');
set(figure(l), 'Position', [1160 6 1142 845])
axis tight
ylabel('Fluorescence (counts/s)')
xlabel('Point Number')
title('Raw Fluorescence Data from "fluor.txt"')
disp ' Scaling graph...'
Choice = 1;
while Choice == 1
disp ' Click on bottom left corner.
BotLeft = ginput(l);
disp ' Click on top right corner.'
TopRight = ginput(l);
axis([BotLeft(1) TopRight(1) BotLeft(2) TopRight(2)]) % Scale graph
Choice = input(' Enter 1 for re-scale, 2 to restart, 0 when done. ->');
if Choice == 2
axis auto
axis tight
Choice = 1;
end
end
disp ' Click on start of rise.'
Tlag = ginput(l);
Tlag = Tlag(l); % Need only x coordinate
Handle = line([Tlag; Tlag], [BotLeft(2) TopRight(2) );
set(Handle, 'Color', 'r')
if Tlag > size(Fluor, 1) % Didn't reach steady state
Tlag = NaN;
end
if Tlag < 0 % Didn't reach steady state
Tlag = NaN;
end
Tlag = Tlag/2 - Tstart; % Subtract off time until first pulse (includes Toffset)
close(l);
% *** REMOVE DATA BELOW DETECTION *
disp 'Deleting data below detection limit (ignore divide by zero errors)...
DetLmt = exp(Conc(High));
FlSize = size(Fluor, 1);
Fluor = Fluor .* (Fluor > DetLmt) ./ (Fluor > DetLmt);
% *** DECONVOLUTION ROUTINE ***
disp 'Deconvoluting fluxes...'
% Routine taken from Pliquett, U., M. R. Prausnitz, Y. A. Chizmadzhev, and
% J. C. Weaver. "Measurement of Rapid Release Kinetics for Drug Delivery,
% _ Pharm Res_, 12(4) :549-55, 1995, Equations (7) and (8). With some
% additional modifications and simplifications.
FlSize = size(Fluor, 1) - 1;
Flux(l:FlSize) = Vcuv * (Fluor(2:FlSize + 1) - Fluor(1:FlSize)) / Area / .5 + Flow / Area (Fluor(2:FlSize + 1) +
Fluor(l:FlSize)) / 2;
% Flux in (mol/m2 s)
% *** CORRELATE FLUXES AND PULSES ***
disp 'Correlating fluxes with pulses...'
FluxTime = (1:FlLength)' / 2 - Tstart; % Time matrix for each flux measurement
Handle = progress(0, 'Correlating fluxes with pulses...');
set(Handle, 'MenuBar', 'none');
set(Handle, 'NumberTitle', 'off');
for j = 1:Total
CorrFlux(j) = Flux(min(find(PulseTime(j) < FluxTime))); % (mol/m2 s)
progress(j/Total)
end
close(Handle)
% *** INTEGRATE FLUORESCENCE CURVES ***
Transport = 0;
Extract = 0;
for j = 1:(Pulse - 1)
if (isnan(CorrFlux(j)) == 0 & isnan(CorrFlux(j + 1)) == 0)
Transport = Transport + (CorrFlux(j) + CorrFlux(j + 1)) / 2 * (PulseTime(j + 1) - PulseTime(j)) Area;
end
end
for j = Pulse:(Total - 1)
if (isnan(CorrFlux(j)) == 0 & isnan(CorrFlux(j + 1)) == 0)
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Extract = Extract + (CorrFlux(j) + CorrFlux(j + 1)) / 2 * (PulseTime(i + 1) - PulseTime(j)) * Area;
end
end
TnptMass = Transport * MW * 1e6;
ExtMass = Extract * MW * 1e6;
% *** CALCULATIONS ***
AvgPass = sort(Pass);
AvgPass = mean(AvgPass(1: (size(AvgPass, 2) - sum(isnan(AvgPass)))));
AvgPass = AvgPass / 1000; % Convert to kOhms
AvgRskin = sort(Rskin(1:Pulse));
AvgRskin = mean(AvgRskin (1: (size(AvgRskin, 1) -
if (Pulse + 1) > Total
AvgRskEx = NaN;
else
AvgRskEx = sort(Rskin(Pulse + 1:Total));
AvgRskEx = mean (AvgRskEx (1: (size(AvgRskEx, 1)
end
sum(isnan(AvgRskin));
- sum(isnan(AvgRskEx)))));
AvgUskin = sort(Uskin(l:Pulse));
AvgUskin = mean (AvgUskin(1: (size(AvgUskin, 1) - sum(isnan(AvgUskin)))));
if (Pulse + 1) > Total
AvgUskEx = NaN;
else
AvgUskEx = sort(Uskin(Pulse + 1:Total));
AvgUskEx = mean (AvgUskEx (1: (size(AvgUskEx, 1) - sum(isnan(AvgUskEx) ))));
end
AvgIcur = sort(Icur(l:Pulse));
AvgIcur = mean(AvgIcur(l: (size(AvgIcur, 1) - sum(isnan(AvgIcur)))));
if (Pulse + 1) > Total
AvgIEx = NaN;
else
AvgIEx = sort(Icur(Pulse + 1:Total));
AvgIEx = mean(AvgIEx(l: (size(AvgIEx, 1) - sum(isnan(AvgIEx)))));
end
AvgTau = sort(Tau(l:Pulse));
AvgTau = mean(AvgTau(l: (size(AvgTau, 1) - sum(isnan(AvgTau)))));
if (Pulse + 1) > Total
AvgTauEx = NaN;
else
AvgTauEx = sort(Tau(Pulse + 1:Total));
AvgTauEx = mean (AvgTauEx (1: (size(AvgTauEx, 1) - sum(isnan(AvgTauEx)))));
end
AvgFlux = sort(CorrFlux(l:Pulse));
AvgFlux = mean(AvgFlux(l: (size(AvgFlux, 2) - sum
AvgFluxM = AvgFlux * MW * 1e6 * 3600 / 100 / 100;
if (Pulse + 1) > Total
AvgFlEx = NaN;
else
AvgFlEx = sort(CorrFlux(Pulse + 1 :Total));
AvgFlEx = mean (AvgFlEx (1: (size (AvgFlEx, 2) - s
end
AvgFlExM = AvgFlEx * MW * le6 * 3600 / 100 / 100;
(isnan(AvgFlux)))));
um(isnan(AvgFlEx)))));
if Total == Pulse
ExtLen = NaN;
else
ExtLen = PulseTime(Total) - PulseTime(Pulse + 1);
end
NoImp = size(Imp,2) - sum(isnan(Imp));
Anal = Total - sum(isnan(CorrFlux));
if Total == 1
Tr(l) = NaN;
else
Tr(l:Total - 1) = CorrFlux(1:Total - 1)' Area (PulseTime(2:Total)
Icur(l:Total - 1) ./ Tau(l:Total - 1);
end
Tr(Pulse) = NaN;
Tr(Total) = NaN;
AvgTr =
AvgTr =
if Total ==
AvgTrEx =
else
AvgTrEx
AvgTrEx
end
Fw =
AvgFw =
AvgFw =
if Total ==
AvgFwEx =
else
PulseTime(l:Total - 1)) * NA * q * e ./
sort(Tr(l:Pulse));
mean(AvgTr(l:(size(AvgTr, 2) - sum(isnan(AvgTr)))));
Pulse
NaN;
= sort(Tr(Pulse + 1:Total));
= mean(AvgTrEx(l: (size(AvgTrEx, 2) - sum(isnan(AvgTrEx)))));
Thickn / Condy / Area ./ Rskin .* Tr' / (q / 150);
sort(Fw(l:Pulse));
mean(AvgFw(l: (size(AvgFw, 1) - sum(isnan(AvgFw)))));
Pulse
NaN;
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AvgFwEx = sort(Fw(Pulse + 1:Total));
AvgFwEx = mean(AvgFwEx(l: (size(AvgFwEx, 1) - sum(isnan(AvgFwEx)))));
end
if Total == Pulse
AvgImpEx = NaN;
AvgImp = NaN;
ImPulse = NaN;
else
AvgImp = sort(ImPulse(l:Pulse));
AvgImp = mean(AvgImp(1: (size(AvgImp, 2) - sum(isnan(AvgImp)))));
AvgIrpEx = sort(ImPulse(Pulse + 1:Total - 1));
AvgImpEx = mean (AvgImpEx (1: (size(AvgImpEx, 2) - sum(isnan(AvgImpEx)))));
end
% *** SAVE DATA ***
disp 'Saving data...'
disp
disp
disp
disp
disp
disp
disp
disp
disp
disp
disp
disp
Saving "final.txt'
Column 1:
Column 2:
Column 3:
Column 4:
Column 5:
Column 6:
Column 7:
Column 8:
Column 9:
Columns 10-29:
Columns 30-49:
Final(:, 1) = (1:Total)';
Final(:, 2) = PulseTime;
Final(:, 3) = Uskin;
Final(:, 4) = Rskin;
Final(:, 5) = Icur;
Final(:, 6) = CorrFlux';
Final(:, 7) = Tr';
Final(:, 8) = Fw;
if Total == 1
Final(:, 9) = NaN;
else
Final(l:(Total - 1), 9)
end
Final(Total, 9) = NaN;
Final(:, 10:29) = ImRec';
Final(:, 30:49) = ImRecTi
save final.txt Final -asc
disp
disp
disp
disp
Pulse number'
Pulse time (s)'
Peak transdermal voltage (V)'
Peak transdermal resistance during pulsing (Ohm)'
Peak current (A)
Instantaneous molecular flux (mol/m2 s)'
Transport number'
Fractional aqueous area'
Average inter-pulse 100 Hz impedances (Ohm)'
Inter-pulse 100 Hz impedances (Ohm)'
Inter-pulse impedance measurement times (s)'
= ImPulse';
me';
ii
Saving "finalimp.txt"...'
Column 1: Impedance measurement time (s)
Column 2: 100 Hz Impedance (Ohm)'
Column 3: Capacitance (Farads)'
FinalImp(:, 1) = ZTime';
FinalImp(:, 2) = Imp';
FinalImp(:, 3) = Cap';
save finalimp.txt FinalImp -ascii
% *** PLOT RESULTS ***
disp 'Plotting results...
figure
subplot(3, 1,1)
Handle = plot(PulseTime, Uskin, 'wo');
set(figure(l), 'Position', [1160 6 1142 845])
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'w')
xlabel('Time (s)')
ylabel('Uskin, 0 (V)')
title('Peak Transdermal Voltage')
subplot (3, 1, 2)
Handle = plot(PulseTime, CorrFlux, 'go');
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'g')
xlabel('Time (s)')
ylabel('Flux (mol/m2 s)')
title( 'Instantaneous Molecular Flux')
if isnan(ImPulse) ~= 1
subplot(3,1,3)
Handle = plot (PulseTime (1: Total - 1), ImPulse, 'yo');
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'g')
xlabel('Time (s)')
ylabel('Flux (mol/m2 s)')
title('Inter-pulse 100 Hz Impedances')
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end
figure
subplot(3, 1,1)
Handle = plot(PulseTime(l:Pulse), Uskin(1:Pulse), 'wo');
set(figure(2), 'Position', [6 -895 1142 845])
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'w')
xlabel('Time (s)')
ylabel('Uskin, 0 (V)')
title('Peak Transdermal Voltage')
subplot(3,1,2)
Handle = plot(PulseTime(l:Pulse), CorrFlux(l:Pulse), 'go');
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'g')
xlabel('Time (s)')
ylabel('Flux (mol/m2 s)')
title('Instantaneous Molecular Flux')
subplot(3,1,3)
if Total Pulse
Handle = plot(PulseTime(l:Pulse), ImPulse(1:Pulse), 'yo');
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'g')
xlabel'Time (s)')
ylabel('Flux (mol/m2 s)')
title('Inter-pulse 100 Hz Impedances')
end
figure
subplot(3,1,1)
Handle = plot(PulseTime(Pulse + 1:Total), Uskin(Pulse + 1:Total), 'wo');
set(figure(3), 'Position', [1160 -895 1142 845])
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'w')
xlabel('Time (s)')
ylabel('Uskin, 0 (V)')
title('Peak Transdermal Voltage')
subplot(3,1,2)
Handle = plot(PulseTime(Pulse + l:Total),
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'g')
xlabel('Time (s)')
ylabel('Flux (mol/m2 s)')
title('Instantaneous Molecular Flux')
if isnan(ImPulse) -= 1
subplot(3,1,3)
Handle = plot(PulseTime(Pulse + 1:Total
axis tight
set(Handle, 'MarkerSize', 2)
set(Handle, 'MarkerFaceColor', 'g')
xlabel('Time (s)')
ylabel('Flux (mol/m2 s)')
title('Inter-pulse 100 Hz Impedances')
end
% *** PRINT RESULTS
disp ' '
disp 'Summary:'
disp '--------'
disp 'Pre-pulse measurements:'
String = num2str(AvgPass);
eval(['disp '' Average passive impedance:
String = num2str(max(PassTime));
eval(('disp '' Length of passive phase:
String = num2str(max(PassTime) / 3600);
eval(['disp '
CorrFlux(Pulse + 1:Total), 'go');
- 1), ImPulse(Pulse + 1:Total - 1), 'yo');
', String, ' kohm'' ']);
String, ' s'' ']);
String, ' h' ');
disp ' '
disp 'Transport measurements:'
String = num2str(Pulse);
eval(['disp '' Number of pulses: ', String, ' '' ;
String = num2str(PulseTime(Pulse));
eval(['disp '' Length of transport phase: ', String, ' s'' );
String = num2str(PulseTime(Pulse) / 3600);
eval(['disp '' = ', String, ' h' ']);
String = num2str(AvgImp);
eval(['disp '' Average skin impedance: ', String, ' Ohm'' 'I);
String = num2str(AvgUskin);
eval(['disp '' Average peak transdermal voltage: ', String, ' V'' 'j);
String = num2str(AvgRskin);
eval(['disp '' Average skin resistance: ', String, ' Ohm'' 'I);
String = num2str(AvgIcur);
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eval ( [ ' disp I ' Average peak current: ', String, ' A' '');
String = num2str(AvgTau);
eval('disp '' Average time constant: ', String, ms' 'I);
String = num2str(Tlag);
eval(['disp '' Time lag before detection of transport: ', String, s'
String = num2str(AvgFlux);
eval(['disp '' Average molecular flux: ', String, mol/m2 s'
String = num2str(AvgFluxM);
eval(['disp '' = ', String, ug/cm2 h'' ']);
String = num2str(Transport);
eval(['disp ' Total amount transported: ', String, mol'' ']);
String = num2str(TnptMass);
eval(['disp ' , String, ug '
String = num2str(AvgTr);
eval(['disp '' Average transport number: ', String, ' ''
String = num2str(AvgFw);
eval(['disp ' Average fractional aqueous area: ', String, ''
disp ' '
disp 'Extraction measurements:'
String = num2str(Ext);
eval(['disp '' Number of pulses: ', String, ''
String = num2str(ExtLen);
eval(['disp '' Length of extraction phase: ', String, ' s' '');
String = num2str(ExtLen / 3600);
eval(['disp '' = , String, ' h'' 'I);
String = num2str(AvgImpEx);
eval(['disp '' Average skin impedance: ', String, ' Ohm'' 'I);
String = num2str(AvgUskEx);
eval(['disp ' ' Average peak transdermal voltage: ', String, ' V ' '');
String = num2str(AvgRskEx);
eval(['disp '' Average skin resistance: ', String, ' Ohm'' ']);
String = num2str(AvgIEx);
eval(['disp '' Average peak current: ', String, ' Al' ');
String = num2str(AvgTauEx);
eval(['disp '' Average time constant: ', String, ' ms'' 'I);
String = num2str(AvgFlEx);
eval(['disp ' Average molecular flux: ', String, ' mol/m2 s' ' ']);
String = num2str(AvgFlExM);
eval(['disp '' = ', String, ' ug/cm2 h' 'I);
String = num2str(Extract);
eval(['disp '' Amount extracted after pulsing: ', String, ' mol' ');
String = num2str(ExtMass);
eval(['disp '' = ', String, ' ug' '');
String = num2str(AvgTrEx);
eval(['disp '' Average transport number: ', String, ' ''
String = num2str(AvgFwEx);
eval 'disp ' ' Average fractional aqueous area: ', String, ' ' '
disp ' '
disp 'Summary:'
String = num2str(Total);
eval(['disp '' Total number of pulses: ', String, ' '' '3);
tring = num2str(PulseTime(Total));
String = num2str(NoImp);
eval(['disp ' ' Number of impedance measurements analyzed: ', String, ' ' '
String = num2str(size(Fluor, 1));
eval ( [ 'disp ' ' Number of f luorescence measurements analyzed: ', String, ' ' ' '3);
String = num2str(PulseTime(Total));
eval(['disp '' Total length of experiment: ', String, ' s''
String = num2str(PulseTime(Total) / 3600);
eval(['disp '' = ', String, ' h'' '1);
String = num2str (Anal);
eval ( [ 'disp ' ' Total number of pulses analyzed: ', String, ' ''
String = num2str(DetLmt);
eval (['disp ' ' Detection limit of spectrofluorimeter: ', String, ' mol/m2 s' '
% *** DONE! ***
disp '
disp 'End of program.'
disp ' Don ' t forget to copy the results into " summary. txt"!
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